Neuroprotective effects of flavonoids and polyphenols

1. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders
2. A bird’s-eye view of the multiple biochemical mechanisms that propel pathology of Alzheimer’s disease: recent advances and mechanistic perspectives on …
3. A blueberry extract-supplemented diet rescues phenotypes in drosophila melanogaster models of parkinson disease
4. A Comparative Study on the Phenolic Composition and Biological Activities of Morus alba L. Commercial Samples
5. A Comparison of the Antioxidant Activity with the Total Phenolic and Total flavonoid contents of the Leaves and Stem-bark of Anogeissus leiocarpa (DC.) Guill& Pirr …
6. A comprehensive database and analysis framework to incorporate multiscale data types and enable integrated analysis of bioactive polyphenols
7. A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis
8. A Current Understanding of Alzheimer’s Disease and the Prospects of Phytopharmacological Intervention as a Management Strategy
9. A meta-analysis of tea drinking and risk of Parkinson’s disease
10. A molecular approach in drug development for Alzheimer’s disease
11. A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
12. A Novel GSK3β Inhibitor Reduces Tau Pathology in Alzheimer’s Disease
13. A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols
14. A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against Neurodegenerative diseases
15. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa
16. A Review of Antioxidants and Alzheimer
17. A review of antioxidants and Alzheimer’s disease
18. A review of genome mutation and Alzheimer’s disease
19. A review on cholinesterase inhibitors for Alzheimer’s disease
20. A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
21. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
22. A Review on Medicinal Plants for Alzheimer’s disease
23. A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
24. A review on potential mechanisms of Terminalia chebula in Alzheimer’s disease
25. A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer’s disease
26. A review on the beneficial effects of tea polyphenols on human health
27. A review on the status of the phenolic compounds and antioxidant capacity of the flour: Effects of cereal processing
28. A review–probable mechanism of action of curcumin for the treatment of Alzheimer disease (AD)
29. A review: inflammatory process in Alzheimer’s disease, role of cytokines
30. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
31. A Study on the Role of Mimosa Pudica (Thottar Chinungi) on the Experimental Models of Parkinsonism (Nadukku Vatham)
32. A synopsis on the linkage between age-related dementias and vascular disorders
33. A systematic review on the role of natural products in modulating the pathways in Alzheimer’s disease
34. Acacetin—A simple flavone exhibiting diverse pharmacological activities
35. Accumulation of citrus flavanones in bovine milk following citrus pulp incorporation into the diet of dairy cows
36. Acetyl-cholinesterase Inhibition by Extracts and Isolated Flavones from Linaria reflexa Desf. (Scrophulariaceae)
37. Acetylated flavonoid Glycosides Potentiating NGF Action from Scoparia dulcis
38. Activation of pro‐survival Akt and ERK1/2 signalling pathways underlie the anti‐apoptotic effects of flavanones in cortical neurons
39. Acute effects of flavonoid-rich blueberry on cognitive and vascular function in healthy older adults
40. Adult‐onset brain tumors and neurodegeneration: Are polyphenols protective?
41. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease
42. Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease
43. Advances in research on active constituents of Chinese materia medica in treatment of Alzheimer’s disease [J]
44. Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity
45. Age-related cognitive impairment as a sign of geriatric neurocardiovascular interactions: may polyphenols play a protective role?
46. Aging risk factors and Parkinson’s disease: contrasting roles of common dietary constituents
47. Alcohol Consumption in Predementia and dementia Syndromes
48. Alcohol intake and risk of dementia
49. Alcohol, wine and mental health: focus on dementia and stroke
50. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Göteborg
51. Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents
52. Alpha-secretase ADAM10 regulation: insights into Alzheimer’s disease treatment
53. Alpha-Synuclein and synuceinopathies as related to Parkinson’s disease
54. Alpha-synuclein oligomers—neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
55. Altered Micro-RNA Regulation and Neuroprotection Activity of Eremostachys labiosiformis in Alzheimer’s Disease Model
56. Alzheimer’s and Parkinson’s Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier-Ligand Docking to Screen Natural Compounds Related to Classic …
57. Alzheimer’s Dementia: Can It Be Prevented?
58. Alzheimer’s disease (AD) genes: Enrichment in cancer genes and those related to comorbid conditions, risk factors (pollution and pathogens) or beneficial agents …
59. Alzheimer’s Disease & Treatment
60. Alzheimer’s Disease & Treatment
61. Alzheimer’s Disease & Treatment
62. Alzheimer’s Disease & Treatment, Vol. 1
63. Alzheimer’s disease and antioxidant therapy: how long how far?
64. Alzheimer’s disease and its current treatments; Is there a possibility for a cure
65. Alzheimer’s Disease and Metal Contamination: Aspects on Genotoxicity
66. Alzheimer’s disease and natural products: Future regimens emerging from nature
67. Alzheimer’s disease and other Neurodegenerative disorders
68. Alzheimer’s Disease and Oxidative Stress
69. Alzheimer’s Disease and Parkinson’s Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and …
70. Alzheimer’s Disease and the Main Aspects-Literature Review
71. Alzheimer’s DISEASE AND THE MICROBIOME
72. Alzheimer’s disease as oligomeropathy
73. Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
74. Alzheimer’s Disease Theranostics
75. Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
76. Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
77. Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
78. Alzheimer’s disease: A challenge in managing with certain medicinal plants-Areview
79. Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL …
80. Alzheimer’s Disease: An Approach for Non-Pharmacological Therapies
81. Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
82. Alzheimer’s Disease: Early Diagnosis & Fundamental Therapeutics
83. Alzheimer’s disease: from pathology to therapeutic approaches
84. Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms
85. Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the …
86. Alzheimers Disease & Parkinsonism
87. Ameliorating effect of ethanol leaf extract of Ficus hispida Linn. on amyloid beta Aβ (25-35) induced cognitive deficits and oxidative stress in Alzheimer’s mice
88. Amelioration of 6-Hydroxydopamine-Lesion Induced Neurotoxicity by Different Extracts of Ocimum sanctum Leaves in Rodent Model of Parkinson’s Disease
89. Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type
90. Amentoflavone Ameliorates Aβ1–42-Induced Memory Deficits and oxidative stress in Cellular and Rat Model
91. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through PI3K/Akt and ERK signaling pathways
92. Amentoflavone suppresses amyloid β1–42 neurotoxicity in Alzheimer’s disease through the inhibition of pyroptosis
93. AMP‐activated protein kinase: a potential player in Alzheimer’s disease
94. Amyloid A-Beta Peptide: In-Cell Studies and Mechanism of Polyphenol-Based Inhibition to Aggregation
95. Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer’s disease
96. Amyloid β-Peptide (1–42)-Induced oxidative stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
97. Amyloid β-protein assembly as a therapeutic target of Alzheimer’s disease
98. Amyloid‐β deposition in Alzheimer transgenic mice is associated with oxidative stress
99. An alternative approach to drug discovery for Alzheimer’s disease dementia
100. An Evaluation of Cholesterol-lowering Effect of Soy Protein and Isoflavones on Postmenopausal Women and Hypercholesterolemic Humans.
101. An Overview of Parkinson’s Disease and Oxidative Stress: Herbal Scenario
102. An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
103. An overview on global trends in nanotechnological approaches for Alzheimer therapy
104. An overview on potential neuroprotective compounds for management of Alzheimer’s disease
105. An overview on therapeutics attenuating amyloid β level in Alzheimer’s disease: Targeting neurotransmission, inflammation, oxidative stress and enhanced …
106. An update on plant-originated treatment for Alzheimer’s disease
107. An updated review on Anti-Alzheimer’s herbal drugs
108. Analgesic and acetylcholinesterase inhibition potential of polyphenols from Scolopia crenata (Flacourtiaceae): An endemic medicinal plant of India
109. Analysis of amino acid and phenolic content in honey by UPLC-ESI-MS/MS
110. Analysis of technological developments in the treatment of Alzheimer’s disease through patent documents
111. Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson’s Disease
112. Anesthesia Implications of the Use of Essential Oils in Alzheimer’s Dementia
113. Animal models of Parkinson’s disease: a gateway to therapeutics?
114. Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease
115. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer’s type
116. Anti-acetylcholinesterase and antioxidant activities and HPLC-MS analysis of polyphenol from extracts of Nelsonia canescens (Lam.) Spreng.
117. Anti-adipogenic Effect of a Dietary flavonoid Fisetin in 3T3-L1 Cells
118. Anti-aging and anti-aggregation properties of polyphenolic compounds in C. elegans
119. Anti-Alzheimer potential of Green Moong Bean
120. Anti-Alzheimer’s studies on β-sitosterol isolated from Polygonum hydropiper L.
121. Anti-amnesic Effect of Leea indica Extract in Scopolamine-induced Amnesia of Alzheimer’s Type in Rats
122. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer’s β-amyloid fibrils in vitro
123. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease
124. Anti-amyloidogenic properties of some phenolic compounds
125. Anti-Demential Effect of EGB 761 on dementia Induced Wistar Rats
126. Anti-Inflammatory Agents in Parkinson’s Disease
127. Anti-inflammatory and immune therapy for Alzheimer’s disease: current status and future directions
128. Anti-inflammatory and immunomodulatory properties of dietary flavonoids
129. Anti-inflammatory Effects of flavonoid Compounds on TNBS-induced Acute Colitis in Rats
130. Anti-inflammatory effects of flavonoids in Neurodegenerative disorders
131. Anti-inflammatory Effects of O-methylated Flavonoid
132. Anti-inflammatory, anti-diabetic, and anti-Alzheimer’s effects of prenylated flavonoids from Okinawa propolis: an investigation by experimental and computational …
133. Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids
134. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease
135. Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing
136. Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?
137. Antiaging Interventions: An Insight into Polyphenols and Brain Aging
138. Antiapoptotic role of Agaricus blazei extract in rodent model of Parkinson’s disease
139. Antidementic activity of Brassica oleracea l. var. Italica (brassicaceae) flower on memory deficit in young male rats
140. Antidepressant flavonoids and their relationship with oxidative stress
141. Antihepatotoxic, nephroprotective, and antioxidant activities of phenolic compounds from Satureja macrostema leaves against carbon tetrachloride-induced hepatic …
142. Antioxidant activity and total phenolic content of ethanolic extract of Caesalpinia bonducella seeds
143. Antioxidant activity of selected phenols estimated by ABTS and FRAP methods.
144. Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention
145. Antioxidant and anti‐inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental …
146. Antioxidant and Anticholinesterase Activities of Macrosphyra Longistyla (DC) Hiern Relevant in the Management of Alzheimer’s Disease
147. Antioxidant and Choline Esterase Inhibitory Activity of Phenolic Rich Extracts from Bombax ceiba L. Flowers.
148. Antioxidant and neuroprotective Effects of Synthetic Curcumin Analogues and Natural Phenolics
149. Antioxidant and neuroprotective properties of blueberry polyphenols: a critical review
150. Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence
151. Antioxidant Capacity and Behavioral Relevance of a Polyphenolic Extract of Chrysanthellum americanum in a Rat Model of Irritable Bowel Syndrome
152. Antioxidant Capacity is Decreased in Alzheimer’s Disease and Mild Cognitive Impairment Patients
153. ANTIOXIDANT EFFECT OF flavonoids IN Neurodegenerative DISEASES.
154. Antioxidant effect of flavonoids present in Euterpe oleracea Martius and Neurodegenerative diseases: A literature review
155. Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach
156. Antioxidant Nutraceuticals and Parkinson’s Disease
157. Antioxidant phenolic constituents from Parthenocissus tricuspidata
158. Antioxidant plant polyphenols and cognitive disorders
159. ANTIOXIDANT PROPERTIES OF A Ginkgo biloba LEAF EXTRACT (EGb 761) IN ANIMAL MODELS OF Alzheimer’s AND Parkinson’s DISEASES.
160. Antioxidant properties of Crocus sativus L. and its constituents and relevance to Neurodegenerative diseases; focus on Alzheimer’s and Parkinson’s disease
161. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer’s disease
162. Antioxidant therapy in Alzheimer’s disease: theory and practice
163. Antioxidants and Alzheimer’s disease: from bench to bedside (and back again)
164. Antioxidants and dementia risk: consideration through a cerebrovascular perspective
165. Antioxidants as a potential therapy against age-related Neurodegenerative diseases: amyloid beta toxicity and Alzheimer’s disease
166. Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
167. Antioxidants, diet, polyphenols and dementia
168. Apolipoprotein ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
169. Apples and their products effect on neurodegeneration and Alzheimer’s disease
170. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer’s disease
171. Applying Epigenetics to Alzheimer’s Disease via the Latent Early–life Associated Regulation (LEARn) Model
172. Applying transcriptomic and proteomic knowledge to Parkinson’s disease drug discovery
173. Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
174. Are polyphenols strong dietary agents against neurotoxicity and neurodegeneration?
175. Arecanut (Areca catechu L) decreases Alzheimer’s disease symptoms: Compilation of research works
176. Artemisia amygdalina Upregulates Nrf2 and Protects Neurons Against oxidative stress in Alzheimer Disease
177. Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer’s disease
178. Assessment of anticholinesterase activities and antioxidant potentials of Anisomeles indica relevant to the treatment of Alzheimer’s disease
179. Assessment of the effect of selected African plants on an in vitro model of Parkinson’s disease
180. association of tea consumption with risk of Alzheimer’s disease and anti-beta-amyloid effects of tea
181. ATR-IR study of the mechanism of aluminum chloride induced Alzheimer’s disease; curative and protective effect of Lipidium sativum water extract on …
182. Attention-deficit/hyperactivity disorder–unifying mechanism involving antioxidant therapy: Phenolics, reactive oxygen species, and oxidative stress
183. Attenuation of iNOS and COX2 by blueberry polyphenols is mediated through the suppression of NF-κB activation
184. Auraptene Mitigates Parkinson’s Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species
185. Autophagy in Alzheimer’s disease and promising modulatory effects of herbal medicine
186. Autophagy, polyphenols and healthy ageing
187. Aβ propagation and strains: implications for the phenotypic diversity in Alzheimer’s disease
188. BACE inhibitors as potential therapeutics for Alzheimer’s disease
189. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease
190. Baicalein reduces β‐amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
191. Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease
192. Behavioral and neurochemical alterations induced by vanillin in a mouse model of Alzheimer’s disease
193. Beneficial effect of flavone derivatives on Aβ-induced memory deficit is mediated by peroxisome proliferator-activated receptor γ coactivator 1α: a comparative study
194. Beneficial effect of the flavonoid luteolin on neuroinflammation
195. Beneficial effects of flavonoids against Parkinson’s disease
196. Beneficial Effects of flavonoids on Neurological Disorders
197. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson’s disease: the role of glia and NRf2 regulation
198. Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration
199. Beneficial effects of phenolic compounds from fruit and vegetables in Neurodegenerative diseases
200. Beneficial effects of polyphenols on chronic diseases and ageing
201. Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation
202. Benefits from dietary polyphenols for brain aging and Alzheimer’s disease
203. Berry phenolics and their antioxidant activity
204. Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer’s disease
205. Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
206. Biflavonoids as potential small molecule therapeutics for Alzheimer’s disease
207. Bioactive composition and promising health benefits of natural food flavors and colorants: potential beyond their basic functions
208. Bioactive flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers-Implications for Parkinson’s Disease
209. Bioactivity of olive oil phenols in neuroprotection
210. Bioanalytical Approach to the Interaction of Novel sym-Triazine Derivatives with Alzheimer’s Disease Biomarkers
211. Bioanalytical Approaches to Investigate Antioxidant Molecules and Nucleic Acid-Protein Interactions in Alzheimer’s Disease
212. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts
213. Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer’s disease
214. Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases
215. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
216. Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease
217. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis
218. Biological reactivity of polyphenolic− glutathione conjugates
219. Biopharmaceutical Monotargeting versus ‘Universal Targeting’of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds
220. Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
221. Biophenols: Enzymes (β-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.)
222. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from …
223. Bioprocessing Strategies to Enhance L-DOPA and Phenolic Bioactives in the Fava Bean (Vicia Faba)
224. Biosynthesized metal nanoparticles as potential Alzheimer’s disease therapeutics
225. Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils
226. Blanching alters the phenolic constituents and in vitro antioxidant and anticholinesterases properties of fireweed (Crassocephalum crepidioides)
227. Blueberry polyhphenols and neuroprotection
228. Blueberry polyphenols and neuroprotection
229. Botanical phenolics and brain health
230. Botanics: a potential source of new therapies for Alzheimer’s disease
231. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer’s disease
232. Brain food for Alzheimer-free ageing: focus on herbal medicines
233. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease
234. Brain iron accumulation in Parkinson’s disease: An investigation of genes related to iron metabolism and homeostasis and dietary behavior data in a case …
235. Brain iron metabolism dysfunction in Parkinson’s disease
236. Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson’s disease
237. C0550 Neuroinflammation in Alzheimer’s Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
238. Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats
239. Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer’s disease?
240. Can consuming flavonoids restore old microglia to their youthful state?
241. Can we prevent Parkinson’s disease
242. Cannabis Flavonoids—Antioxidant & Anti-Inflammatory Benefits
243. Carbohydrates and Glycomimetics in Alzheimer’s Disease Therapeutics and Diagnosis
244. Carbon nanomaterials and amyloid beta interactions: Possible potentials in the detection and treatment of Alzheimer’s disease
245. Catechin polyphenols: neurodegeneration and neuroprotection in Neurodegenerative diseases
246. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
247. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for Neurodegenerative diseases
248. Cellular and molecular aspects of Parkinson treatment: future therapeutic perspectives
249. Cellular and molecular mechanisms of antioxidants in Parkinson’s disease
250. Cellular phenotypes as inflammatory mediators in Parkinson’s disease: interventional targets and role of natural products
251. Cerebral area differential redox response of neonatal rats to selenite-induced oxidative stress and to concurrent administration of highbush blueberry leaf polyphenols
252. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s …
253. Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms
254. Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury
255. Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of in silico …
256. Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
257. Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
258. Characterization of neurotoxic effects of NMDA and the novel neuroprotection by phytopolyphenols in mice.
259. Characterization of phenolic compounds using UPLC–HRMS and HPLC–DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves
260. CHARACTERIZATION OF THE neuroprotective ACTIVITY OF THE polyphenol (-)-EPIGALLOCATECHIN-3-GALLATE IN THE BRAIN
261. Charnoly body as a novel biomarker of nutritional stress in Alzheimer’s Disease
262. Chemical fingerprint of Bacopa monnieri L. and Rosmarinus officinalis L. and their neuroprotective activity against Alzheimer’s disease in rat model’s putative …
263. Chemical structures, bioactivities and molecular mechanisms of citrus polymethoxyflavones
264. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease
265. Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior
266. Chocolate/Cocoa Polyphenols and Oxidative Stress
267. Cholinesterase inhibitors as Alzheimer’s therapeutics
268. Chroman-like cyclic prenylflavonoids promote neuronal differentiation and neurite outgrowth and are neuroprotective
269. Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer’s disease transgenic mouse model
270. Chronic Hypoxia Alters mRNA Expression of the Genes Related to Alzheimer’s Disease in Primary Neuronal Cells
271. Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
272. Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to …
273. Cinnamon, a promising prospect towards Alzheimer’s disease
274. Citrus Fruit Polyphenols and Flavonoids: Applications to Psychiatric Disorders
275. Clinical benefit and preservation of flavonols in dark chocolate manufacturing
276. Clinical Development of a Novel Parkinsonian Drug in USA
277. Cocoa and dark chocolate polyphenols: from biology to clinical applications
278. Cocoa flavanols, exercise and the brain
279. Cocoa Powder Triggers neuroprotective and Preventive Effects in a Human Alzheimer 0 s Disease Model by Modulating BDNF Signaling Pathway
280. Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer’s disease model by modulating BDNF signaling pathway
281. Coffee phenolic phytochemicals and kaempferol protect against oxidative damage of neuronal cells and memory impairments
282. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review
283. Cognitive Function and Consumption of Fruit and Vegetable Polyphenols in a Young Population: Is There a Relationship?
284. Cognitive stimulation with leisure activities for prevention of cognitive decline and dementia: The aktiva study
285. Cognitive-enhancing effect of quercetin in a rat model of Parkinson’s disease induced by 6-hydroxydopamine
286. Combating oxidative stress disorders with citrus flavonoid: Naringenin
287. Combination of EPA with carotenoids and polyphenol synergistically attenuated the transformation of microglia to M1 phenotype via inhibition of NF-κB
288. Commentary: The flavonoid Baicalein Rescues Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer’s Disease
289. Comparative analysis of total phenolic and total flavonoid contents, rutin, tannins and antioxidant capacity in Apiaceae and Lamiaceae families
290. Comparative antioxidant activity of twenty traditional Indian medicinal plants and its correlation with total flavonoid and phenolic content
291. Comparative evaluation of Helichrysi flos herbal extracts as dietary sources of plant polyphenols, and macro-and microelements
292. Comparative evaluation of the antioxidant and anti-Alzheimer’s disease potential of coumestrol and puerarol isolated from pueraria lobata using molecular modeling …
293. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative …
294. Comparison of protective effects of four polyphenols on neuropathology and behavior of APP/PS1-21 transgenic mice, a model of Alzheimer’s disease
295. Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
296. Complementary Therapies for Parkinson’s Disease: What’s Promoted, Rationale, Potential Risks and Benefits
297. Compositional Changes in Anthocyanins, Flavonols, and Ellagitannins in Processed Blackberries
298. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
299. Computational approaches to the investigation of proteins involved in Parkinson’s Disease
300. Computational modeling of multi-target-directed inhibitors against Alzheimer’s disease
301. Computer-aided structure-based design of multitarget leads for Alzheimer’s disease
302. Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species
303. Conservative iron chelation for Neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
304. Considerations for the use of polyphenols as therapies in Neurodegenerative diseases
305. Consumption of anthocyanin-rich cherry juice for 12 weeks improves memory and cognition in older adults with mild-to-moderate dementia
306. Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer’s disease
307. Consumption of polyphenol plants may slow aging and associated diseases
308. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
309. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
310. Copper-Catalyzed Oxidative Esterification of 2-Carbonyl Substituted Phenols with Alcohols
311. Correlation between the polyphenol content and antioxidant effect of Cynara scolymus L. mother tincture
312. Critical Evaluation of Current Alzheimer′ s Drug Discovery (2018-19) & Futuristic Alzheimer drug model approach
313. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson’s disease
314. Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
315. Curcumin and Its Nanoformulations as Therapeutic for Alzheimer’s Disease
316. Curcumin exposure induces expression of the Parkinson’s disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells
317. Curcumin has potent anti‐amyloidogenic effects for Alzheimer’s β‐amyloid fibrils in vitro
318. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models
319. Curcumin prevents and ameliorates biochemical and behavioral toxicities of MPTP in C57Bl/6J mice: its potential use in preventing and treating parkinsonism
320. Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson’s disease
321. Current Alzheimer’s management with berries fruits therapy
322. CURRENT Alzheimer’s MANAGEMENT WITH DIETARY SEEDS THERAPY
323. Current and emerging pharmacological targets for the treatment of Alzheimer’s disease
324. Current and emerging therapeutic targets of Alzheimer’s disease for the design of multi-target directed ligands
325. Current and investigational drugs for treatment of Alzheimer’s disease
326. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer’s disease
327. Current evidence on the effect of dietary polyphenols intake on chronic diseases
328. Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson’s disease
329. Current perspectives and mechanisms of relationship between intestinal microbiota dysfunction and dementia: a review
330. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
331. Current status of metals as therapeutic targets in Alzheimer’s disease
332. Cytological profiling of natural product scaffolds libraries for Parkinson’s disease
333. Cytoprotection by Achyrocline satureioides (Lam) DC and some of its main flavonoids against oxidative stress
334. Cytoprotective effects of phenolic antioxidants and essential fatty acids in human blood monocyte and neuroblastoma cell lines: Surrogates for neurological damage in …
335. De B. Acetylcholinesterase inhibitory properties of black tea and its polyphenolic components
336. Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
337. dementia IN SURINAME
338. Dementia, preclinical studies in neurodegeneration and its potential for translational medicine in South America
339. Design and characterization of enzymatic deglycosylation systems to produce drugs against Alzheimer’s disease
340. Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer’s disease
341. Design and Molecular dynamic investigations of 7, 8-Dihydroxyflavone Derivatives as potential neuroprotective Agents Against Alpha-synuclein
342. Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential neuroprotective Agents Against Alpha-synuclein
343. Design and systhesis of nanoparticles for therapy and imaging of Alzheimer’s disease
344. Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease
345. Design, Synthesis and Biological Assessment of Ferulic Acid Derivatives as Inhibitors of β-Amyloid Oligomerization in Alzheimer’s Disease
346. Design, synthesis and biological evaluation of 3-piperazinecarboxylate sarsasapogenin derivatives as potential multifunctional anti-Alzheimer agents
347. Design, synthesis and biological evaluation of scutellarein derivatives as potential anti-Alzheimer’s disease candidates based on metabolic mechanism
348. Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment
349. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer’s disease
350. Designing multi-targeted therapeutics for the treatment of Alzheimer’s disease
351. Destabilization of Alzheimer’s Aβ42 protofibrils with a novel drug candidate wgx-50 by molecular dynamics simulations
352. Determination of Flavonoids
353. Determination of total flavonoid content of different parts of Garcinia cowa
354. Development and application of nano-flavor-drug carriers in Neurodegenerative diseases
355. Development and validation of analytical methods for the identification and quantification of phenolic compounds from Euterpe oleracea fruits
356. Development of a grape seed polyphenolic extract with anti‐oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies
357. Development of Electrochemical Sensors for the Analysis of Therapeutic Compounds and Proteases related to Alzheimer’s disease
358. Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the …
359. Development of tau aggregation inhibitors for Alzheimer’s disease
360. Development of technologies for the production of polyphenolic nutraceuticals from muscadine grapes and rabbiteye blueberries
361. Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches
362. Diabetes and Alzheimer’s disease: can tea phytochemicals play a role in prevention?
363. Diet and brain health: which role for polyphenols?
364. Diet And Lifestyle Guidelines And Desirable Levels Of Risk Factors And Protective Factors For Prevention Of Dementia-A Scientific Statement From Joint …
365. Diet and medical foods in Parkinson’s disease
366. Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
367. Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
368. Diet and nutrition in dementia and cognitive decline
369. Diet and the Risk of Parkinson’s Disease—Research Suggests Dietary Interventions May Prevent It and Lessen Symptom Severity By Densie Webb, PhD, RD
370. Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer’s disease pathology?
371. Dietary coconut and amyloid beta metabolism in the pathogenesis of Alzheimer’s disease
372. Dietary Directions Against dementia Disorders
373. Dietary factors in the etiology of Parkinson’s disease
374. Dietary fatty acids and predementia syndromes
375. Dietary fatty acids intake: possible role in cognitive decline and dementia
376. Dietary fatty acids, cognitive decline, and dementia
377. Dietary flavonoid intake in older adults: how many days of dietary assessment are required and what is the impact of seasonality?
378. Dietary flavonoid intake to reduce the risk of chronic diseases
379. Dietary flavonoids as potential neuroprotectants
380. Dietary flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy
381. Dietary intake of natural antioxidants: vitamins and polyphenols
382. Dietary lipids and their oxidized products in Alzheimer’s disease
383. Dietary modifications in Parkinson’s disease: A neuroprotective intervention?
384. Dietary modulation of oxidative stress in Alzheimer’s disease
385. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
386. Dietary phenolics in apples and cider and their bioavailability in healthy humans and subjects with an ileaostomy
387. Dietary Plant Lectins May be an ‘Unknown Etiology’in Parkinson’s Disease and Dietary Bioactive Compounds Affect Lifespan and Fat Storage Aspects of …
388. Dietary polyphenols and mitochondrial function: role in health and disease
389. Dietary polyphenols and neurogenesis: Molecular interactions and implication for brain ageing and cognition
390. Dietary polyphenols and the prevention of diseases
391. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects
392. Dietary Polyphenols as Modulators of Brain Functions: Biological Actions and Molecular Mechanisms…
393. Dietary polyphenols as potential remedy for dementia
394. Dietary Polyphenols—Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review
395. Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
396. Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis
397. Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s Disease
398. Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson’s …
399. Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress
400. Dietary Supplements as Cognitive Enhancers: The Role of Flavonoid-Rich Foods and their Relevance in Age-Related Neurodegeneration
401. Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer’s markers in SAMP8 mice
402. Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols
403. Differential Protection among Fractionated Blueberry Polyphenolic Families against DA-, Aβ42- and LPS-Induced Decrements in Ca2+ Buffering in Primary …
404. Direct Evaluation of Alzheimer’s Disease-Specific oxidative stress with Multiphoton Microscopy
405. Discovery development of drugs for alzheimers disease neuroinflammation and elucidating their molecular mechanism of action
406. Discovery of Gut Bacteria Specific to Alzheimer’s Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on …
407. Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult: A Drug Discovery Effort against Alzheimer’s Disease
408. Disease contraindication drug use behavior in patients with Parkinson’s disease
409. Disruption of Calcium Homeostasis in Alzheimer’s Disease: Role of Channel Formation by β Amyloid Protein
410. Dissecting molecular mechanisms in the living brain of dementia patients
411. Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1–42)
412. Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations
413. Docking of GSK-3β with novel inhibitors, a target protein involved in Alzheimer’s disease
414. Docking study and structure-activity relationships of human glutaminyl cyclase inhibitors for the drug discovery of Alzheimer’s disease
415. Does Parkinson’s disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?
416. Dopamine-Mediated oxidative stress Associated with Neurodegeneration in Parkinson Disease
417. Dopaminergic Neuroprotection with Atremorine in Parkinson´ s Disease
418. Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells
419. Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells
420. Dracocephalum moldavica L. and Melissa officinalis L.: Chemistry and bioactivities relevant in Alzheimer’s disease therapy
421. Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades
422. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease
423. Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease
424. Dual/multitargeted xanthone derivatives for Alzheimer’s disease: where do we stand?
425. DYRK1A inhibition as potential treatment for Alzheimer’s disease
426. Dysregulation of stress systems and nitric oxide signaling underlies neuronal dysfunction in Alzheimer’s disease
427. Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer’s disease
428. Eat to Beat Alzheimer’s
429. EFEITO PROTETOR DO RESVERATROL NA DOENÇA DE ALZHEIMER
430. Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection
431. Effect of Black Raisins (Vitis vinifera) on Aluminum Chloride Induced Alzheimer’s Disease in Male Albino Rat.
432. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer’s disease in rats
433. Effect of Chinese herbal medicine on Alzheimer’s disease
434. Effect of dietary supplementation of dates in Alzheimer’s disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status
435. Effect of extraction procedures, genotypes and screening methods to measure the antioxidant potential and phenolic content of orange-fleshed sweetpotatoes …
436. Effect of Imperatorin in Neuropathology of Parkinson’s Disease: An In Silico Study
437. Effect of oil palm phenolics on beta amyloid deposition in cholesterol induced rat model of Alzheimer’s disease: Histological evidence
438. Effect of phenolic-rich plant materials on protein and lipid oxidation reactions
439. Effect of plant extracts on Alzheimer’s disease: An insight into therapeutic avenues
440. Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia
441. Effect of polyphenols on protein misfolding
442. Effects and mechanisms of actions of phytochemicals on Alzheimer’s disease neuropathology
443. Effects and Possible Mechanisms of Some Phytochemicals on Drosophila Models of Alzheimer’s Disease
444. Effects of berry polyphenols on cognitive function in humans
445. Effects of Berry, Pomegranate, Grape and their Biophenols on Cognitive Function: A General Re-view
446. Effects of biflavonoids from Garcinia madruno on a triple transgenic mouse model of Alzheimer’s disease
447. Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia
448. Effects of Dietary Components on Microglia Inactivation in Alzheimer’s Disease
449. Effects of dietary docosahexaenoic acid supplementation on pathology and cognition in a mouse model of Alzheimer’s disease
450. Effects of essential oils and aromatherapy on cognitive function in dementia: laboratory studies and application in aged care facility residents
451. Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia
452. Effects of flavonoids on MMP-13 Expression of IL-1β-treated Articular Chondrocytes and Their Cellular Mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT …
453. Effects of green tea polyphenol on cognitive and acetylcholinesterase activities
454. Effects of Horticultural Activities and Flower Tea Drinking Based on Reminiscent Storytelling on Demented Elders’ Cognitive and Emotional Functions
455. Effects of huanglian-jie-du-tang and its modified formula on the modulation of amyloid-β precursor protein processing in Alzheimer’s disease models
456. Effects of Isoflavone Extract from Fermented Soybean, Chungkukjang, on Cell Cycle Arrest and Apoptosis of MCF-7 Cells
457. Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats
458. Effects of medicinal plants on Alzheimer’s disease and memory deficits
459. Effects of peptides on the structure of lipid bilayers: Implication for its therapeutic effect in Alzheimer’s disease
460. Effects of polyphenols on brain ageing and Alzheimer’s disease: focus on mitochondria
461. Effects of resveratrol and other polyphenols on Sirt1: relevance to brain function during aging
462. Effects of resveratrol and other polyphenols on the most common brain age-related diseases
463. Effects of stilbenoid polyphenols (pterostilbene and gnetol) on cardiomyocyte hypertrophy in vitro and in vivo in spontaneously hypertensive heart failure rats
464. Effects of tea catechins on Alzheimer’s disease: Recent updates and perspectives
465. Effects of the flavonoids, silibinin and catechin, on the motility of extended cooled caprine sperm
466. Effects of various flavonoids on the-synuclein fibrillation process
467. Effects on Cognition of Berry, Pomegranate, Grape and Biophenols: A General Review
468. EFFICACY STUDY OF BRAHMYADI YOGA IN THE MANAGEMENT OF Alzheimer’s DISEASE (SMRITI BHRAMSHA)
469. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer’s disease
470. Electroanalysis of α-Synuclein Aggregation Related to Parkinson’s Disease
471. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson’s disease–A review
472. Emerging role of polyphenolic compounds in the treatment of Neurodegenerative diseases: a review of their intracellular targets
473. Emerging Signal Regulating Potential of Genistein against Alzheimer Disease: A Promising Molecule of Interest
474. Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer’s disease
475. Enhancing human cognition with cocoa flavonoids
476. Enrichment of phenolic antioxidants from cranberry (Vaccinium macrocarpon) to improve biological functionality
477. Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson’s disease
478. Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent …
479. Epigallocatechin-3-gallate, a promising molecule for Parkinson’s disease?
480. Epigenetic drug discovery for Alzheimer’s disease
481. Epigenetic effects of natural polyphenols: A focus on SIRT1‐mediated mechanisms
482. ESPEN guidelines on nutrition in dementia
483. Establishing a Connection between Alzheimer’s Disease and Cellular Energy Transduction
484. Establishment of CD method for studies of amyloid-oligomerization process during Alzheimer disease
485. Estimation of antioxidative properties of the natural polyphenols in the oxidation process of model liposome membranes
486. Estimation of dietary flavonoid intake and major food sources of Korean adults
487. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
488. Ethanol extract of Epipremnum aureum leaves attenuate intranigral-rotenone induced Parkinson’s disease in rats
489. Ethnobotanical treatment strategies against Alzheimer’s disease
490. Ethnomedicinal Survey of Plants Used as Remedy for Alzheimer’s Disease in Ebonyi State, Nigeria
491. Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs
492. Eupatilin: a natural pharmacologically active flavone compound with its wide range applications
493. Evaluating the neuroprotective effects of fermented rooibos herbal tea in Wistar rats exposed to bisphenol-A during gestation and lactation
494. Evaluation of anti-oxidant activities and total phenolic content of Chromolaena odorata
495. Evaluation of antioxidant activities and total phenolic content of methanolic extract of Rhodiola heterodanta roots
496. evaluation of antiparkinson activity of hesperetin pyridoxine against olanzepine and manganese induced parkinsonism
497. Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease
498. Evaluation of Memory Enhancing Activity of Methanolic Extract of Oxalis corniculata Linn on dementia in Experimental Animals
499. Evaluation of plant phenolic metabolites as a source of Alzheimer’s drug leads
500. Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays
501. Evaluation to the antioxidant activity of total flavonoids extract from persimmon (Diospyros kaki L.) leaves
502. Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism
503. Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows
504. Evolutionary medicine’perspectives on Alzheimer’s Disease: Review and new directions
505. Exploration of Mitochondrial Dysfunction, Depolarization and Polyphenols by Creative Synthesis for Product Development
506. Exploring the benefits of cellular models to uncover bioactive polyphenols for neurodegeneration
507. Exploring the bioavailability of (poly) phenols from berries and their potential activities in humans
508. Exploring the efficacy of natural products in alleviating Alzheimer’s disease
509. Exploring the mechanism of flavonoids through systematic bioinformatics analysis
510. Exploring the potential of marine microbes in clinical management of Alzheimer’s disease: A road map for bioprospecting and identifying promising isolates
511. Extra-virgin olive oil for potential prevention of Alzheimer disease
512. Extra-virgin olive oil for potential prevention of Alzheimer disease
513. Factors affecting the levels of tea polyphenols and caffeine in tea leaves
514. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination?
515. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer’s disease
516. Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls
517. Fight Alzheimer’s with Vitamins and Antioxidants
518. Fight Parkinson’s and Huntington’s with Vitamins and Antioxidants
519. First synthesis of the antiangiogenic homoisoflavanone, cremastranone
520. Flavan-3-ol compounds from wine wastes with in vitro and in vivo antioxidant activity
521. Flavanols, mild cognitive impairment, and Alzheimer’s dementia
522. Flavanonol glucosides from the aerial parts of Agrimonia pilosa Ledeb. and their acetylcholinesterase inhibitory effects
523. Flavins and flavoproteins: applications in medicine
524. Flavone: An Important Scaffold for Medicinal Chemistry
525. Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration?
526. Flavones from the root of Scutellaria baicalensis Georgi—drug of the future in neurodegeneration and neuroprotection
527. Flavones: An important scaffold for medicinal chemistry
528. flavonoid baicalein attenuates activation-induced cell death of brain microglia
529. flavonoid bioactivity: transport across blood-brain-barrier and neuroprotective effects. In vivo studies
530. flavonoid enhances the glyoxalase pathway in cerebellar neurons to retain cellular functions
531. flavonoid hesperidin induces synapse formation and improves memory performance through the astrocytic TGF-β1
532. flavonoid in enhancing memory function
533. flavonoid inhibitors of alpha-synuclein fibrillation: A therapeutic strategy for Parkinson’s disease, and, The effect of membranes on SMA fibrillation
534. flavonoid Intake and Dementia
535. flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries
536. flavonoid modulation of GABAA receptors
537. flavonoid transport across blood-brain barrier: Implication for their direct neuroprotective actions
538. flavonoid transport across RBE4 cells: a blood-brain barrier model
539. flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia
540. Flavonoid-based therapies in the early management of Neurodegenerative diseases
541. Flavonoid-rich foods (FRF): A promising nutraceutical approach against lifespan-shortening diseases
542. Flavonoidal Compound Derived from Chrysanthemum indicum L. Suppresses MUC5AC Mucin Gene Expression, Production and Secretion from Cultured …
543. Flavonoids
544. flavonoids and Aging
545. flavonoids and anthranquinones as xanthine oxidase and monoamine oxidase inhibitors: a new approach towards inflammation and oxidative stress
546. flavonoids and brain health: multiple effects underpinned by common mechanisms
547. flavonoids and cognition: potential therapeutic role in Alzheimer’s disease
548. flavonoids and cognition: the molecular mechanisms underlying their behavioural effects
549. flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies
550. flavonoids and dementia: an update
551. flavonoids and Diarylheptanoids: neuroprotective Activities of Phytochemicals
552. flavonoids and neuroprotection: biochemical and population-based analyses of potential neuroprotective factors related to dementia.
553. flavonoids and Phenolic Acids as Potential Natural Antioxidants
554. flavonoids and the aging brain
555. flavonoids and the brain: Evidences and putative mechanisms for a protective capacity
556. flavonoids and their relation to human health
557. flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
558. flavonoids as detoxifying and pro-survival agents: What’s new?
559. flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects
560. flavonoids as neuroprotective and therapeutic agents against aging related neurological disorders
561. flavonoids as novel neuroprotective nutraceuticals
562. flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders
563. flavonoids as regulators of amyloid precursor protein processing
564. flavonoids as therapeutic agents in Alzheimer’s and Parkinson’s diseases: a systematic review of preclinical evidences
565. flavonoids in Foods and Their Role in Healthy Nutrition
566. flavonoids in human health: from structure to biological activity
567. flavonoids in neurodegeneration: Limitations and strategies to cross CNS barriers
568. flavonoids in the treatment of Alzheimer’s and other Neurodegenerative diseases
569. flavonoids in Transgenic Alzheimer’s Disease Mouse Models
570. flavonoids in Transgenic Alzheimer’s Disease Mouse Models
571. flavonoids inhibit heparin-induced aggregation of the third repeat (r3) of microtubule-binding domain of Alzheimer’s tau protein
572. flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in …
573. flavonoids with Novel Nicotinic Activity as Potential Pharmacotherapies to Treat Ethanol-Induced Neurotoxicity
574. Flavonoids-food sources and health benefits
575. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease
576. Flavonoids: an overview
577. Flavonoids: Broad Spectrum Agents on Chronic Inflammation
578. Flavonoids: important biocompounds in food
579. Flavonoids: its working mechanism and various protective roles
580. Flavonoids: modulators of brain function?
581. Flavonol Glycosides and Phenolic Compounds from Euphorbia maculata
582. Flavonol-rich dark cocoa significantly decreases plasma endothelin-1 and improves cognition in urban children
583. Food antioxidants and Alzheimer’s disease
584. Food, polyphenols and neuroprotection
585. Forestalling the Epidemics of Parkinson’s Disease Through Plant-Based Remedies
586. Formation of the 42-mer Amyloid 𝜷 Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer’s Disease
587. Formulation development and optimization of novel drug delivery systems for the treatment of alzheimers disease
588. Free radical scavenging activity and qualitative analysis of polyphenols by RP-HPLC in the flowers of Couroupita guianensis Abul.
589. Free radical–mediated damage to brain in Alzheimer’s disease: role of acrolein and preclinical promise of antioxidant polyphenols
590. Free radicals and polyphenols: The redox chemistry of Neurodegenerative diseases
591. From the baker to the bedside: yeast models of Parkinson’s disease
592. Fruit and vegetable intake and its association with dementia in the English Longitudinal Study of Ageing
593. Fruit polyphenols and their effects on neuronal signaling and behavior in senescence
594. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer’s disease
595. Functions of flavonoids in the central nervous system: astrocytes as targets for natural compounds
596. Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the oxidative stress Hypothesis
597. Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer’s Amyloid β‐Peptide Aggregation
598. Gene-environment interaction research and transgenic mouse models of Alzheimer’s disease
599. GENERAL PRACTITIONER’S APPROACH TO DIAGNOSIS, DISCLOSURE AND MANAGEMENT OF dementia IN THE
600. Genetics of iron regulation and the possible role of iron in Parkinson’s disease
601. Genistein ameliorates learning and memory deficits in amyloid β (1–40) rat model of Alzheimer’s disease
602. Ginger components as anti-Alzheimer drugs: focus on drug design
603. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo‐controlled double‐blind study
604. Ginkgo biloba as an alternative medicine in the treatment of anxiety in dementia and other psychiatric disorders
605. Ginkgo biloba extract in Alzheimer’s disease: from action mechanisms to medical practice
606. Gold Nanoparticles and Peptoids as Novel Inhibitors of Amyloid Beta Aggregation in Alzheimer’s Disease
607. Gold nanoparticles and peptoids as novel inhibitors of Aβ aggregation in Alzheimer’s disease
608. Gold Nanoparticles in Diagnosis and Treatment of Alzheimer’s Disease
609. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer’s disease
610. Green Tea confers Protection on the Retina in MPTP Mice Model of Parkinson’s Disease
611. Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: A systematic review
612. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth
613. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration
614. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate promotes the rapid protein kinase C‐and proteasome‐mediated degradation of Bad: implications for …
615. Green tea polyphenols enhance sodium nitroprusside‐induced neurotoxicity in human neuroblastoma SH‐SY5Y cells
616. Green tea polyphenols prevent Parkinson’s disease: in vitro and in vivo studies
617. GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review
618. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer’s disease.
619. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review
620. Health benefits of nongallated and gallated flavan-3-ols: a prospectus
621. Health effects of foods rich in polyphenols
622. Healthy Eating to Reduce the Risk of Dementia
623. Hepatoprotective effects of apple polyphenol extract on aluminum-induced liver oxidative stress in the rat
624. Herbal treatment of Parkinsonism: a review
625. Herbs and dementia: a focus on Chinese and other traditional herbs
626. Herbs and Nutrients for Neurologic Disorders: Treatment Strategies for Alzheimer’s, Parkinson’s, Stroke, Multiple Sclerosis, Migraine, and Seizures
627. Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling
628. Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and …
629. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity
630. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults
631. Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents
632. Hippocampal neurogenesis in Alzheimer’s disease: is there a role for dietary modulation?
633. Histological Evidence Of The Effect Of Oil Palm Phenolics In Atherogenic Diet Induced Rat Model Of Alzheimer’s Disease
634. HPLC-DAD fingerprinting analysis, antioxidant activities of Tithonia diversifolia (Hemsl.) A. Gray leaves and its inhibition of key enzymes linked to Alzheimer’s …
635. HPLC-PDA isolation and LC-MS/MS detection of an acetylcholinesterase inhibitory flavonoid from Tephrosia purpurea (L.) Pers. in zebrafish brain
636. Human Tau Isoform Aggregation and Selective Detection of Misfolded Tau from Post-Mortem Alzheimer’s Disease Brains
637. Hypericum perforatum improve memory and learning in Alzheimer’s model:(experimental study in mice)
638. Hypericum perforatum phenolic compounds: protective role in the toxicity induced by heterologous expression of α-synuclein and huntingtin in yeast cells
639. Hyperphosphorylation of Tau Protein in Down’s dementia and Alzheimer’s disease: methylation and implications in prevention and therapy
640. Identification of 5-methoxyflavone as a novel DNA polymerase-beta inhibitor and neuroprotective agent against beta-amyloid toxicity
641. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease
642. Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by Aβ 42 aggregates
643. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients
644. Il trattamento con RSV e l’espressione transgenica di PGC-1α proteggono i neuroni dopaminergici nel modello MPTP murino del morbo di Parkinson.
645. Immuno-modulatory effects of microbial metabolites of flavan-3-ols and dimeric procyanidins
646. Impact of Diet on the Pathogenesis of Alzheimer’s Disease
647. Impact of flavonoids on cellular and molecular mechanisms underlying age-related cognitive decline and neurodegeneration
648. Impact of heat treatment on selected vegetables: bioaccessibility of (poly) phenolic compounds after in vitro gastrointestinal digestion and colonic microbiota …
649. Impact of plant-derived flavonoids on Neurodegenerative diseases
650. Implication of green tea as a possible therapeutic approach for Parkinson disease
651. Implications for Degenerative Disorders: Antioxidative Activity, Total Phenols, Flavonoids, Ascorbic Acid, β-Carotene and β-Tocopherol in Aloe vera
652. Implications of polyphenols on endogenous antioxidant defense systems in human diseases
653. Improved mitochondrial function in brain aging and Alzheimer disease-the new mechanism of action of the old metabolic enhancer piracetam
654. In search of therapeutic solutions for Alzheimer’s disease
655. In silico investigation of the pharmacological mechanisms of beneficial effects of Ginkgo biloba L. on Alzheimer’s Disease
656. In silico studies applied to natural products with potential activity against Alzheimer’s disease
657. In vitro anti-nitrosative, antioxidant, and cytotoxicity activities of plant flavonoids: a comparative study
658. In vitro antioxidant activity and total phenolic content of ethanolic leaf extract of Stevia rebaudiana Bert.
659. In vitro antioxidant, anti-diabetes, anti-dementia, and inflammation inhibitory effect of Trametes pubescens fruiting body extracts
660. In vitro enzyme inhibition potentials and antioxidant activity of synthetic flavone derivatives
661. In vitro evaluation of extracts from Mentha species for potential treatment of Alzheimer’s disease
662. In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids fromGingko biloba yellow leaves
663. In vivo antioxidant activity of total flavonoids from indocalamus leaves in aging mice caused by D-galactose
664. In Vivo Characterization of CLR01, an Aggregation and Toxicity Inhibitor, with anAlzheimer’s Disease Focus
665. In Vivo Imaging Agents Based on flavonoids for Amyloid’s Plaques in the Brains of Patients with Alzheimer’s Disease
666. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial
667. In-depth investigation of the binding of flavonoid taxifolin with bovine hemoglobin at physiological pH: Spectroscopic and molecular docking studies
668. In-Vitro Assessment Of Phenolic, Flavonoid, Flavonolic Contents And Antioxidant Activities Of Plant Pleurotus Ostreatus For Neurodegenerative Disorders
669. In-vitro cholinesterase inhibitory activity of dry fruit extract of Phyllanthus emblica relevant to the treatment of Alzheimer’s disease
670. In-vitro evaluation of acetylcholinesterase inhibition and antioxidant activity of selected Palestinian medicinal plants: Implications for Alzheimer’s disease …
671. In-Vitro Evaluation of Cholinesterase Inhibitory and Antioxidant Activities of Tamarindus indica for the Treatment of Alzheimer’s Disease
672. In-vitro screening of acetylcholinesterase inhibitory activity of extracts from Palestinian indigenous flora in relation to the treatment of Alzheimer’s disease
673. In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease
674. Indian Herbal Medicines used for Treatment of Dementia: An Overview
675. Indian herbs and their therapeutic potential against Alzheimer’s Disease and other neurological disorders
676. Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer’s disease hippocampus
677. Induction of neuronal differentiation of murine N2a cells by two polyphenols present in the mediterranean diet mimicking neurotrophins activities: resveratrol and …
678. Inflammaging as a prodrome to Alzheimer’s disease
679. Inflammation in Alzheimer’s Disease, and Prevention with Antioxidants and Phenolic Compounds–What Are the Most Promising Candidates?
680. Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications
681. Inflammation: role in Parkinson’s disease and target for therapy
682. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons: possible relevance to the etiology of Parkinson’s disease
683. INFLUENCE OF EXTRACT AND PHENOL GLYCOSIDES FROM ROSE PETALS ON THE FIBRILS OF AMYLOID PEPTIDE Aβ (1-42). STUDY BY …
684. Influence of hesperidin combined with Sinemet on genetical and biochemical abnormalities in rats suffering from Parkinson’s disease
685. Influence of nitrogen fertilizer micro‐dosing on phenolic content, antioxidant, and anticholinesterase properties of aqueous extracts of three tropical leafy vegetables
686. Influences of Diet, Exercise, and Stress on Hippocampal Health in Depression and Alzheimer’s Disease
687. inhibition and antioxidant activity of selected Palestinian medicinal plants: Implications for Alzheimer’s disease therapy
688. Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds
689. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism
690. Inhibition of early upstream events in prodromal Alzheimer’s disease by use of targeted antioxidants
691. Inhibition of Hepatic Insulin Resistance by Licorice flavonoids as Mediated by PTP1B Repression
692. Inhibition of Rat Prostate Testosterone 5α-Reductase Activity by Isoflavonoids
693. Inhibition of α-Synuclein contributes to the ameliorative effects of dietary flavonoids luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells
694. Inhibitory Effect of a flavonoid Dihydromyricetin against Aβ40 Amyloidogenesis and Its Associated Cytotoxicity
695. Inhibitory Effects of Bombusae concretio Salicea on Neuronal Secretion of Alzheimer’s β-Amyloid Peptides, a Neurodegenerative Peptide
696. Inhibitory Effects of Isoflavonoids on Rat Prostate Testosterone 5α-Reductase
697. Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids
698. Inhibitory potential of plant secondary metabolites against Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural …
699. Inhibitory properties of phenolic compounds against enzymes linked with human diseases
700. Insights on Metal Ions and Misfolded Proteins in Alzheimer’s Disease Using flavonoid Derivatives and X-ray Fluorescence Microscopy.
701. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance
702. Intake of flavonoids and risk of dementia
703. Intake of flavonoids and risk of dementia
704. Interaction between 24‐hydroxycholesterol, oxidative stress, and amyloid‐β in amplifying neuronal damage in Alzheimer’s disease: three partners in crime
705. Interaction between flavonoids and the blood–brain barrier: in vitro studies
706. Interaction of polyphenols with other food components as a means for their neurological health benefits
707. Interaction of α-synuclein with Rhus typhina tannin–Implication for Parkinson’s disease
708. Interplay between Alpha-Synuclein and oxidative stress in Parkinson´ s Disease Cell Models
709. Intranasal therapeutic strategies for management of Alzheimer’s disease
710. Investigating blood plasma levels of cytokines and amyloid-β as potential diagnostic biomarkers for preclinical Alzheimer’s disease
711. Investigating the neuroprotective effect of plant (poly) phenols in models of Parkinson´ s disease
712. Investigation of an Interaction of flavonoids on the Antioxidant Activity of Alpha Tocopherol
713. Investigation of anti-inflammatory compounds from food and plant libraries for use in Alzheimer’s disease
714. Investigation of in-vitro antioxidant potential in crotalaria verrucosa along with identification and quantification of its polyphenolic compounds
715. Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease
716. Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon …
717. Involvement of astrocytes in Alzheimer’s disease from a neuroinflammatory and oxidative stress perspective
718. Iridoid Glycosides and Phenolic Glycosides from Buddleja asiatica with Anti-inflammatory and Cytoprotective Activities
719. Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects
720. Iron as a therapeutic target for Parkinson’s disease
721. Iron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein …
722. Is pharmacological prevention of Alzheimer’s a realistic goal?
723. Isoflavones and Alzheimer’s disease: the effects of soy in diet
724. Isolation of eupatorin (3′,5-dihydroxy-4′,6,7-trimethoxyflavone) from Albizia odoratissima and its application for l-tryptophan sensing
725. Isolation of flavonoides from Artemisia macrocephala anticholinesterase activity: Isolation, characterization and its in vitro anticholinesterse activity supported by …
726. Isolation, synthesis, and metabolism of polyphenols: Stilbenoids, gallotannins and ellagitannins
727. Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia
728. Lamiaceae family plants as a potential anticholinesterase source in the treatment of Alzheimer’s disease
729. Lamiaceae phenols as multifaceted compounds: bioactivity, industrial prospects and role of “positive-stress”
730. Lavandula stoechas (L) a Very Potent Antioxidant Attenuates dementia in Scopolamine Induced Memory Deficit Mice
731. Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer’s disease treatment
732. Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer’s disease
733. Lifestyle patterns as a modifiable risk factor for late-life cognitive decline: A narrative review regarding dementia prevention
734. Lifestyle-related factors in predementia and dementia syndromes
735. Links between insulin resistance, lipoprotein metabolism and amyloidosis in Alzheimer’s Disease
736. Lipid Peroxidation and Mitochondrial Dysfunction in Alzheimer’s and Parkinson’s Diseases: Role of Natural Products as Cytoprotective Agents
737. Liposomal flavonoid in Combating Age-Related Cerebral Oxidative Damage
738. Literature Evidence and ARRIVE Assessment on neuroprotective Effects of Flavonols in Neurodegenerative Diseases’ Models
739. Literature Evidence and Arrive Assessment on neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models
740. Literature-related discovery: common factors for Parkinson’s disease and Crohn’s disease
741. Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
742. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease
743. Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer’s disease
744. Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE−/− Mice Experimental Model
745. Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating Neuroinflammation
746. Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
747. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia
748. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent
749. Management of cognitive determinants in senile dementia of Alzheimer’s type: therapeutic potential of a novel polyherbal drug product
750. Management of oxidative stress and other pathologies in Alzheimer’s disease
751. Mangiferin: a multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
752. Mannosylated liposomal flavonoid in combating age-related ischemia–reperfusion induced oxidative damage in rat brain
753. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
754. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
755. Mechanisms of aging and potential role of selected polyphenols in extending healthspan
756. Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
757. Mechanisms of neuroprotection by polyphenols
758. Mechanistic description of natural herbs in the treatment of dementia: A systematic review
759. Medical management of Parkinson’s disease: focus on neuroprotection
760. Medicinal chemistry approaches for the treatment and prevention of Alzheimer’s disease
761. Medicinal plants and Alzheimer’s disease: Integrating ethnobotanical and contemporary scientific evidence
762. Medicinal plants and dementia therapy: herbal hopes for brain aging?
763. Medicinal plants as protective strategies against Parkinson’s disease
764. Medicinal plants from northeastern Brazil against Alzheimer’s disease
765. Medicinal Plants from Northeastern Brazil against Alzheimer’s Disease
766. Medicinal plants of Brazil and Alzheimer’s disease: Evolution in traditional use and pre-clinical studies
767. Medicinal Plants with Acetylcholinesterase Inhibitory Activity: Therapeutic Potential of Brazilian Plants for the Treatment of Alzheimer’s Disease
768. Medicinal Plants, Phytochemicals and Alzheimer’s
769. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and …
770. Mediterranean and MIND diets containing olive biophenols reduces the prevalence of Alzheimer’s disease
771. Mediterranean diet and risk for Alzheimer’s disease
772. Mediterranean Diet as a Potential Strategy to Reduce Cognitive Decline and dementia in Elderly
773. Mediterranean diet in predementia and dementia syndromes
774. Mediterranean diet, cognitive function, and dementia: a systematic review
775. Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins …
776. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
777. Metabolic and immune risk factors for dementia and their modification by flavonoids: New targets for the prevention of cognitive impairment?
778. Metabolic links between diabetes and Alzheimer’s disease
779. Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
780. Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer’s disease using liquid chromatography mass spectrometry
781. Metal Binding of flavonoids and Their Distinct Inhibition Mechanisms Toward the Oxidation Activity of Cu2+–β-Amyloid: Not Just Serving as Suicide Antioxidants!
782. Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or …
783. Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease
784. Metal dyshomeostasis and inflammation in Alzheimer’s and Parkinson’s diseases: possible impact of environmental exposures
785. Metal dysregulation in the pathogenesis of Alzheimers disease An experimental study in rat brain and cultured neuroblastoma cells
786. Metal ions and metal complexes in Alzheimer’s disease
787. Metals and amyloid‐β in Alzheimer’s disease
788. Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
789. Methylglyoxal, glyoxal, and their detoxification in Alzheimer’s disease
790. MICE MODEL OF Parkinson’s DISEASE
791. Microwave assisted extraction of flavonoids from cultivated Epimedium sagittatum: Extraction yield and mechanism, antioxidant activity and chemical composition
792. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study
793. MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer’s disease prevention pilot trial
794. Mitigating Alzheimer’s disease with natural polyphenols: a review
795. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer’s disease
796. Mitochondria as potential targets in Alzheimer disease therapy: An update
797. Mitochondria as targets for neuronal protection against excitotoxicity: a role for phenolic compounds?
798. Mitochondria in neuroprotection by phytochemicals: bioactive polyphenols modulate mitochondrial apoptosis system, function and structure
799. Mitochondria-targeted protective compounds in Parkinson’s and Alzheimer’s diseases
800. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease
801. Mitochondrial cascade hypothesis of Alzheimer’s disease: myth or reality?
802. Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
803. Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection
804. Mitochondrial dysfunction—a pharmacological target in Alzheimer’s disease
805. Mitochondrial dysfunction: cause and consequence of Alzheimer’s
806. Mitochondrial dysfunction: cause and consequence of Alzheimer’s disease
807. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer’s disease—therapeutic aspects
808. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer’s disease?
809. Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
810. Mitochondrial Therapeutic Approaches in Parkinson’s Disease
811. Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer’s disease
812. Modulating Effect of Diet on Alzheimer’s Disease
813. Modulation of Alzheimer-like Pathology in Type 2 Diabetic Rats via Grape Seed or Ginseng Extracts
814. Modulation of endogenous antioxidant system by wine polyphenols in human disease
815. Modulation of mitochondrial calcium as a pharmacological target for Alzheimer’s disease
816. Modulation of multiple neuroinflammatory signalling pathways by the dietary glycosidic flavonoid tiliroside
817. MODULATION OF NEUROINFLAMMATION BY MEDICINAL HERBS AND FLAVONOIDS
818. Modulation of Nrf2 by olive oil and wine polyphenols and neuroprotection
819. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and Neurodegenerative disorders
820. Modulation of Pro-inflammatory Mediators by Eugenol in AlCl3 Induced dementia in Rats
821. Molecular characterization of multi-targets by bis (7)-tacrineat amyloid β cascade associated with Alzheimer’s disease
822. Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1–42 Dimer
823. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols
824. Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer’s disease
825. Molecular mechanisms underlying the flavonoid-induced inhibition of α-synuclein fibrillation
826. Molecular pathology and pharmacogenomics in Alzheimer’s disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression
827. Molecular pharmacology of rosmarinic and salvianolic acids: Potential seeds for Alzheimer’s and vascular dementia drugs
828. Molecular study of cell culture models of Parkinson’s disease and Huntington’s disease.
829. Molecular targets in Alzheimer’s disease: from pathogenesis to therapeutics
830. Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy
831. Monoamine Oxidase B and Free Radical Scavenging Activities of Natural flavonoids in Melastoma candidum D. Don
832. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
833. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
834. Mucuna pruriens seeds in treatment of Parkinson’s disease: pharmacological review
835. Mulberry fruit extract protects against memory impairment and hippocampal damage in animal model of vascular dementia
836. Multi-target directed drugs as a modern approach for drug design towards Alzheimer’s disease: an update
837. Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease
838. Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer’s disease
839. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer’s disease
840. Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer’s disease drugs
841. Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease
842. Multiple pharmacological activities of Caesalpinia crista against aluminium-induced neurodegeneration in rats: Relevance for Alzheimer’s disease
843. Multipotent natural agents to combat Alzheimer’s disease. Functional spectrum and structural features1
844. Na+‐K+‐ATPase, a potent neuroprotective modulator against Alzheimer disease
845. Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for Neurodegenerative diseases and brain tumors
846. Nano-encapsulation of a natural polyphenol, green tea catechins: way to preserve its antioxidative potential
847. Nanoformulations of polyphenols for prevention and treatment of cardiovascular and metabolic disorders
848. Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease
849. Nanoparticle formulations in the diagnosis and therapy of Alzheimer’s disease
850. Nanoparticles as nanocarriers of resveratrol for Alzheimer’s disease
851. Nanotechnology and Alzheimer’s Disease: What has been Done and What to Do’
852. Nanotechnology based Theranostic approaches in Alzheimer’s disease management: current status and future perspective
853. Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
854. Nanotherapeutic strategies for the treatment of Alzheimer’s disease
855. Nardostacys Jatamansi DC Protects from the loss of memory and cognition deficits in sleep deprived Alzheimer’s disease (Ad) mice model
856. Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin …
857. Naringin ameliorates memory deficits in experimental paradigm of Alzheimer’s disease by attenuating mitochondrial dysfunction
858. Natural Antioxidants in Dementia: An Overview
859. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer’s disease–a translational perspective
860. Natural compounds and their derivatives as multifunctional agents for the treatment of alzheimer disease
861. Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
862. Natural compounds for Alzheimer’s disease therapy: a systematic review of preclinical and clinical studies
863. Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder
864. Natural Neuroprotectives for the Management of Parkinson’s Disease
865. Natural phenolic compounds as therapeutic and preventive agents for cerebral amyloidosis
866. Natural phytochemicals in the treatment and prevention of dementia: An overview
867. Natural Phytoestrogens: A Class of Promising neuroprotective Agents for Parkinson Disease
868. Natural plant-derived acetylcholinesterase inhibitors: Relevance for Alzheimer’s disease
869. Natural polyphenols against Neurodegenerative disorders: potentials and pitfalls
870. Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases
871. Natural polyphenols effects on protein aggregates in Alzheimer’s and Parkinson’s prion-like diseases
872. Natural polyphenols in the treatment of Alzheimer’s disease
873. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
874. Natural Product Chemical Probe Discovery against Parkinson’s Disease
875. Natural product formulations for the prevention and treatment of Alzheimer’s disease: a patent review
876. Natural product polyphenols of relevance to human health
877. Natural products against Alzheimer’s disease: Pharmaco-therapeutics and biotechnological interventions
878. Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s disease
879. Natural products and their derivatives as multifunctional ligands against Alzheimer’s disease
880. Natural products as a source of Alzheimer’s drug leads
881. Natural products as promising drug candidates for the treatment of Alzheimer’s disease: molecular mechanism aspect
882. Natural products combating neurodegeneration: Parkinson’s disease
883. Natural Products for the Treatment of Alzheimer’s Disease: Present and Future Expectations
884. Natural Products for Treatment of Alzheimer’s Disease
885. Natural products in Alzheimer’s disease therapy: would old therapeutic approaches fix the broken promise of modern medicines?
886. Natural Products-Based Drugs: Potential Therapeutics against Alzheimer’s Disease and other Neurological Disorders
887. Natural stilbenes effects in animal models of Alzheimer’s disease
888. Natural Therapeutics for Alzheimer’s Disease
889. Naturally Inspired Privileged Structures in Drug Discovery: Multifunctional Compounds for Alzheimer’s Disease Treatment
890. Nature as a source of metabolites with cholinesterase‐inhibitory activity: an approach to Alzheimer’s disease treatment
891. neuro Protective Role of Selected medicinal Plant In Alzheimers Disease Design of Novel Drugs
892. Neuro-nutrients as anti-Alzheimer’s disease agents: A critical review
893. Neurobiological aspects of Alzheimer’s disease
894. Neurobiological effects of Hyperforin and its potential in Alzheimer’s disease therapy
895. Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits
896. Neurocognitive improvement through plant food bioactives: A particular approach to Alzheimer’s disease
897. Neurodegenerative diseases: might citrus flavonoids play a protective role?
898. Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin
899. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer’s disease
900. Neurogenic traditional Chinese medicine as a promising strategy for the treatment of Alzheimer’s disease
901. Neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals
902. Neuroinflammatory mechanisms in Parkinson’s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention
903. Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?
904. Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases
905. Neuronal death in Alzheimer’s disease and therapeutic opportunities
906. Neuronutrition and Alzheimer’s disease
907. Neuropharmacological Activity of Apium graveolens L. and its neuroprotective Effect on MPTP-Induced Parkinson-Like Symptoms
908. Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—a mini-review
909. Neuroprotection by natural polyphenols: molecular mechanisms
910. Neuroprotection in Alzheimer Disease
911. Neuroprotection of brain-targeted bioactive dietary artoindonesianin O (AIO) from mulberry on rat neurons as a novel intervention for Alzheimer’s disease
912. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway
913. neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features
914. neuroprotective actions of flavonoids
915. neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice
916. neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson’s disease therapeutics
917. neuroprotective effect and antioxidant activity of Passiflora edulis fruit flavonoid fraction, aqueous extract, and juice in aluminum chloride-induced Alzheimer’s …
918. neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
919. neuroprotective effect of brassica oleracea sprouts crude juice in a cellular model of Alzheimer’s disease
920. neuroprotective effect of cocoa flavonids on in vitro oxidative stress
921. neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease
922. neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: possible behavioural and …
923. neuroprotective effect of flavonoids via up-regulation of Nrf2-ARE pathway, in MPP+-induced PC12 cells
924. neuroprotective Effect of Flavonoids: A Systematic Review
925. neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson’s disease
926. neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer’s …
927. neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats
928. neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis
929. neuroprotective effect of natural products against Alzheimer’s disease
930. neuroprotective effect of olive oil polyphenols in Alzheimer’s disease
931. neuroprotective effect of phytic acid in Parkinson’s disease
932. neuroprotective effects associated with wine and its phenolic constituents
933. neuroprotective effects of amantadine–flavonoid conjugates
934. neuroprotective effects of citrus Fruit-Derived flavonoids, nobiletin and Tangeretin in Alzheimer’s and Parkinson’s Disease
935. neuroprotective effects of digested polyphenols from wild blackberry species
936. neuroprotective effects of epigallocatechin gallate in cell culture and animal models of Parkinson’s disease
937. neuroprotective effects of fisetin in Alzheimer’s and Parkinson’s Diseases: From chemistry to medicine
938. neuroprotective effects of naturally occurring polyphenols on quinolinic acid‐induced excitotoxicity in human neurons
939. neuroprotective effects of phenolic and carboxylic acids on oxidative stress-induced toxicity in human neuroblastoma SH-SY5Y cells
940. neuroprotective Effects of Polyphenols
941. neuroprotective Effects of Polyphenols in Aging and Age‐Related Neurological Disorders
942. neuroprotective Effects of Quercetin in Alzheimer’s Disease
943. neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma
944. neuroprotective effects of resveratrol in Alzheimer disease pathology
945. neuroprotective effects of rutin and quercetin flavonoids in glaucium corniculatum methanol and water extracts
946. neuroprotective effects of selected microbial-derived phenolic metabolites and aroma compounds from wine in human sh-sy5y neuroblastoma cells and their …
947. neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1
948. neuroprotective natural products for the treatment of Parkinson’s disease by targeting the autophagy–lysosome pathway: A systematic review
949. neuroprotective potential of withania somnifera in rotenone induced parkinsonism in mice
950. neuroprotective properties of a standardized extract from Myracrodruon urundeuva Fr. All.(Aroeira-Do-Sertao), as evaluated by a Parkinson’s disease model in rats
951. neuroprotective properties of dietary polyphenols in Parkinson’s disease
952. neuroprotective Properties of Partridgeberry (Vaccinium vitis-idaea L. var. minus Lodd) Polyphenols
953. neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease
954. neuroprotective role of antioxidant and pyranocarboxylic acid derivative against AlCl3 induced Alzheimer’s disease in rats
955. neuroprotective Role of Green Tea Polyphenols on the Superior Colliculus in MPTP Mice Model of Parkinson’s Disease
956. neuroprotective role of natural polyphenols
957. neuroprotective strategies in Parkinson’s disease
958. neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
959. neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
960. neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism
961. neuroprotective therapies for Alzheimer’s disease
962. Neurosupportive role of vanillin, a natural phenolic compound, on rotenone induced neurotoxicity in SH-SY5Y neuroblastoma cells
963. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
964. New acetylcholinesterase inhibitors for Alzheimer’s disease
965. New methodology for the biomimetic synthesis of Flavan-3, 4-diols and derivatives
966. NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols
967. Nitric oxide mediates neurovascular coupling in the brain effect of polyphenols in animal models of Alzheimer’s disease
968. Nonpeptide neurotrophic agents useful in the treatment of Neurodegenerative diseases such as Alzheimer’s disease
969. Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions
970. Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease
971. Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology
972. Nootropic Medicinal Plants: Therapeutic Alternatives for Alzheimer’s disease
973. Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer’s disease treatment
974. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer’s therapy
975. Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
976. Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson’s Disease
977. Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties
978. Novel neuroprotective Therapies for Alzheimer’s and Parkinsons’s Disease
979. Novel photoaffinity probes of homoisoflavonoids for target identification of retinal neovascularization
980. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease
981. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity
982. Novel tacrine-scutellarin hybrids as multipotent anti-Alzheimer’s agents: Design, synthesis and biological evaluation
983. Novel tactics for neuroprotection in Parkinson’s disease: role of antibiotics, polyphenols and neuropeptides
984. Novel targets for parkinsonism-depression comorbidity
985. Novel therapeutic strategies for dementia
986. Novel Therapeutics in Alzheimer’s Disease
987. Nutraceutical potential of phenolics from′ brava′ and′ mansa′ extra-virgin olive oils on the inhibition of enzymes associated to Neurodegenerative disorders in …
988. Nutraceutical Potential of Phenolics fromBrava´ andMansa´ Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in …
989. Nutraceuticals and amyloid Neurodegenerative diseases: a focus on natural phenols
990. Nutraceuticals and their preventive or potential therapeutic value in Parkinson’s disease
991. Nutraceuticals in cognitive impairment and Alzheimer’s
992. Nutraceuticals in cognitive impairment and Alzheimer’s disease
993. Nutraceuticals in the Prevention or Treatment of Parkinson’s Disease
994. Nutraceuticals Neuroprotect Naturally: Alzheimer’s disease, Parkinson’s disease, Stroke and Major Depressive Disorder
995. Nutraceuticals: a novel concept in prevention and treatment of Alzheimer’s disease and related disorders
996. Nutraceuticals: an emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
997. Nutraceuticals: dietary flavonoids
998. Nutrients in the Prevention of Alzheimer’s Disease
999. Nutrition and AGE-ing: Focusing on Alzheimer’s Disease
1000. Nutrition and the risk for Parkinson’s disease: review of the literature
1001. Nutrition and the risk of Alzheimer’s disease
1002. Nutrition increases Survival and Reverses NAFLD and Alzheimer’s disease
1003. Nutrition Society Silver Medal Lecture Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
1004. Nutrition: Review on the possible treatment for Alzheimer’s disease
1005. Nutritional and pharmacological strategies to regulate microglial polarization in cognitive aging and Alzheimer’s disease
1006. Nutritional approaches to combat oxidative stress in Alzheimer’s disease
1007. Nutritional approaches to modulate oxidative stress in Alzheimer’s disease
1008. Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients
1009. Nutritional habits, risk, and progression of Parkinson disease
1010. Nutritional prevention of cognitive decline and dementia
1011. O-Methylated flavonoid Isorhamnetin Protects against oxidative stress via Activation of Nrf2 and Target Gene Expression
1012. Oil palm phenolics inhibit the in vitro aggregation of β-amyloid peptide into oligomeric complexes
1013. Old age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa
1014. Olive biophenols reduces Alzheimer’s pathology in SH-SY5Y cells and APPswe mice
1015. Olive polyphenols: New promising agents to combat aging-associated neurodegeneration
1016. Omics and Epigenetics of Polyphenol-Mediated Neuroprotection: The Curcumin Perspective
1017. On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer’s disease
1018. ON THE THERAPEUTIC PROPERTIES OF NATURALLY OCCURRING FLAVONOID-QUERCETIN: A MAGICAL THERAPEUTIC AGENT
1019. One‐compound‐multiple‐targets strategy to combat Alzheimer’s disease
1020. Original Research Phenolics, antioxidant and anti-inflammatory activities of Melia azedarachextracts
1021. Orobol: An Isoflavone Exhibiting Regulatory Multifunctionality against Four Pathological Features of Alzheimer’s Disease
1022. Orthosiphon stamineus improves memory in scopolamine-induced amnesia model of cholinergic hypothesis of Alzheimer’s disease
1023. Outsmarting Alzheimer’s: What You Can Do to Reduce Your Risk
1024. Overview of Alzheimer’s disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds
1025. Overviews of biological importance of quercetin: A bioactive flavonoid
1026. Oxidant/antioxidant imbalance and the risk of Alzheimer’s disease
1027. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8‐hydroxyguanine levels in substantia nigra
1028. Oxidative modification of vesicular transporters in an animal model of Alzheimer’s disease
1029. oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
1030. oxidative stress and amyloid beta toxicity in Alzheimer’s disease: intervention in a complex relationship by antioxidants
1031. oxidative stress and inflammation: what polyphenols can do for us?
1032. oxidative stress and neuroinflammation in Alzheimer’s disease and amyotrophic lateral sclerosis: From biology to therapeutic strategies
1033. oxidative stress events and neuronal dysfunction in Alzheimer’s disease: focus on APE1/Ref-1-mediated survival strategies
1034. oxidative stress in Alzheimer patients in different stages of the disease
1035. oxidative stress in Alzheimer’s Disease: A Review on Emergent Natural Polyphenolic Therapeutics
1036. oxidative stress in Alzheimer’s disease: implications for prevention and therapy
1037. oxidative stress in Parkinson’s disease
1038. oxidative stress in Parkinson’s disease
1039. oxidative stress in Parkinson’s disease; parallels between current animal models, human studies and cells
1040. Oxidative stress: a bridge between Down’s syndrome and Alzheimer’s disease
1041. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease
1042. Parkinson’s disease and tea: a quantitative review
1043. Parkinson’s Disease Model in vitro and in C. elegans
1044. Parkinson’s Disease-associated LRRK2 Mutation Causes Abnormal Protein Accumulation-related Cytotoxicity
1045. Parkinson’s disease: from pathogenesis to pharmacogenomics
1046. Parkinson’s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation
1047. Partridgeberry polyphenols protect primary cortical and hippocampal neurons against β-amyloid toxicity
1048. Past and Present Drug Development for Alzheimer’s Disease
1049. Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer’s disease by inhibition of glial activation, cholinesterase, and oxidative stress
1050. Pelargonidin improves passive avoidance task performance in a rat amyloid beta25-35 model of Alzheimer’s disease via estrogen receptor independent pathways
1051. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer’s disease
1052. Pharmacoepigenomic interventions as novel potential treatments for Alzheimer’s and Parkinson’s diseases
1053. Pharmacogenomics in Alzheimer’s disease
1054. Pharmacogenomics of Alzheimer’s disease: Novel therapeutic strategies for drug development
1055. Pharmacokinetics and Tissue Distribution of 14C-Labeled Grape Polyphenols in the Periphery and the Central Nervous System Following Oral Administration
1056. PHARMACOLOGICAL ACTIVITY OF NATURAL PRODUCTS IN VITRO AND IN ANIMAL MODELS OF Parkinson’s DISEASE AND DEPRESSION
1057. Pharmacological effects of active components of Chinese herbal medicine in the treatment of Alzheimer’s disease: a review
1058. PHARMACOLOGICAL EVALUATION OF TRIPHALA CHURNA INSTREPTOZOTOCIN (ICV) INDUCED dementia IN RATS
1059. Pharmacological Investigation and Unraveling Mechanism of Action ofJasminum sambac Flowers for Predicated Treatment of Alzheimer’s Disease
1060. Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson’s disease
1061. Pharmacological properties and therapeutic potential of naringenin: a citrus flavonoid of pharmaceutical promise
1062. PHARMACOLOGY OF OLIVE BIOPHENOLS IN Alzheimer’s DISEASE PREVENTION AND TREATMENT
1063. Pharmacophore-based drug design of novel potential tau ligands for Alzheimer’s disease treatment
1064. Pharmacotherapies for Alzheimer’s disease: beyond cholinesterase inhibitors
1065. Pharmacotherapies for Alzheimer’s Disease: From Natural Compounds to Target Synthetic Drugs
1066. Phenolic Acid Intake, Delivered Via Moderate Champagne Wine Consumption, Improves Spatial Working Memory Via the Modulation of Hippocampal and Cortical …
1067. Phenolic acids exert anticholinesterase and cognition-improving effects
1068. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity
1069. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
1070. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
1071. Phenolic composition, antioxidant and enzyme inhibitory activities of acetone, methanol and water extracts of Clinopodium vulgare L. subsp. vulgare L.
1072. Phenolic compounds and their health benefits: A review
1073. Phenolic compounds characteristic of the mediterranean diet in mitigating microglia-mediated neuroinflammation
1074. Phenolic compounds from edible algae: Bioactivity and health benefits
1075. Phenolic Compounds from the Leaves and Stems of Desmodium Caudatum
1076. Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases
1077. Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases
1078. Phenolic compounds of green tea: Health benefits and technological application in food
1079. Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-β aggregation pathway
1080. Phenolic compounds prevent the oligomerization of α‐synuclein and reduce synaptic toxicity
1081. Phenolic Compounds with IL-6 Inhibitory Activity from Akebia quinata
1082. Phenolic content of grapevine leaves (Vitis labrusca var. Bordo) and its neuroprotective effect against peroxide damage
1083. Phenolic content, enzyme inhibitory and antioxidative activity potentials of Phlomis nissolii and P. pungens var. pungens
1084. Phenolic contents and bioactive potential of peach fruit extracts
1085. Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L
1086. Phenolic Extracts from Clerodendrum volubile Leaves Inhibit Cholinergic and Monoaminergic Enzymes Relevant to the Management of Some Neurodegenerative …
1087. Phenolic profile and antioxidative properties of pulp and seeds of Randia monantha Benth
1088. Phenolic profile of three wild edible mushroom extracts from Ordu, Turkey and their antioxidant properties, enzyme inhibitory activities
1089. Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var; florentina
1090. Phenylpropanoids and Alzheimer’s disease: A potential therapeutic platform
1091. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson’s disease in mice
1092. Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
1093. Phosphorylation and sequence dependency of neurofilament protein oxidative modification in Alzheimer disease
1094. Phyto‐Tacrine Hybrids as Promising Drugs to Treat Alzheimer’s Disease
1095. Phytochemical and pharmacological properties of flavonols
1096. Phytochemical Evaluation of Lagerstroemia indica (L.) Pers. Leaves as Anti-Alzheimer’s
1097. Phytochemicals and cognitive health: Are flavonoids doing the trick?
1098. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
1099. Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
1100. Phytochemicals, Antioxidants, and Cholinesterase Inhibitory Profiles of Elatostema Papillosum Leaves: An Alternative Approach for Management of Alzheimer’s …
1101. Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus
1102. PLANT BASED INDIAN TRADITIONAL MEDICINE FOR Neurodegenerative DISEASES-A NOVEL APPROACH TO TREAT ALZHEIMER
1103. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson’s Disease Models
1104. Plant phenolics affect oxidation of tryptophan
1105. Plant phenolics as functional food ingredients
1106. Plant polyphenols as dietary antioxidants in human health and disease
1107. Plant polyphenols as dietary modulators of brain functions
1108. Plant polyphenols as natural drugs for the management of Down syndrome and related disorders
1109. Plants as potential sources for drug development against Alzheimer’s disease
1110. Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey
1111. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders
1112. Plasma antioxidant status in patients with Alzheimer’s disease and cognitively intact elderly: a meta-analysis of case-control studies
1113. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson’s disease
1114. Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease
1115. Polymethoxyflavones: Novel β-secretase (BACE1) inhibitors from citrus peels
1116. polyphenol amentoflavone affords neuroprotection against neonatal hypoxic‐ischemic brain damage via multiple mechanisms
1117. polyphenol antioxidants from natural sources and contribution to health promotion
1118. polyphenol composition, antioxidant and bioplaguicide activities of the solid residue from hydrodistillation of Rosmarinus officinalis L.
1119. polyphenol compounds and PKC signaling
1120. polyphenol health effects on cardiovascular and Neurodegenerative disorders: A review and meta-analysis
1121. polyphenol modulation of blood flow and oxygenation
1122. polyphenol Pharmacokinetics and Cardiovascular, Cognitive and Exercise Pharmacodynamics following Montmorency Tart Cherry Intake in Humans
1123. polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases
1124. Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway
1125. Polyphenol-rich Boswellia serrata gum prevents cognitive impairment and insulin resistance of diabetic rats through inhibition of GSK3β activity, oxidative …
1126. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk
1127. Polyphenolic antioxidants and neuronal regeneration
1128. Polyphenolic Compound from Vitis vinifera L. have Potential for the Alzheimer Disease Treatment
1129. Polyphenolic compounds for treating Neurodegenerative disorders involving protein misfolding
1130. Polyphenols and brain health
1131. Polyphenols and cognitive function
1132. Polyphenols and health: new and recent advances
1133. Polyphenols and human health: a review
1134. Polyphenols and human health: prevention of disease and mechanisms of action
1135. Polyphenols and inflammation
1136. Polyphenols and Metabolites Enhance Survival in Rodents and Nematodes—Impact of Mitochondria
1137. Polyphenols and Neurodegenerative diseases
1138. Polyphenols and Neurodegenerative Diseases
1139. Polyphenols and neuroprotection against ischemia and neurodegeneration
1140. Polyphenols and public health
1141. Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits
1142. Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease
1143. Polyphenols As Natural, Dual-Action Therapeutics For Alzheimer’s Disease
1144. Polyphenols beyond barriers: a glimpse into the brain
1145. Polyphenols derived from lychee seed suppress Aβ (1-42)-induced neuroinflammation
1146. Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective
1147. Polyphenols from Food and Natural Products: Neuroprotection and Safety
1148. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative
1149. Polyphenols in dementia: From molecular basis to clinical trials
1150. Polyphenols in disease: from diet to supplements
1151. Polyphenols in health and disease: practice and mechanisms of benefits
1152. Polyphenols in neurodegeneration and neuroendocrine alterations: a metabolomic approach
1153. Polyphenols in Parkinson’s disease: A systematic review of in vivo studies
1154. Polyphenols in the Prevention of Alzheimer’s Disease: some food for thought?
1155. Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
1156. Polyphenols neuroprotective effect in a Parkinson’s disease yeast model: phosphoproteome alterations
1157. Polyphenols suppress and modulate inflammation: possible roles in health and disease
1158. Polyphenols Targeting Brain Cells Longevity, Brain’s Redox Status, and Neurodegenerative Diseases
1159. Polyphenols-What’s Behind their Antiaging Brain Reputation
1160. Polyphenols: a diverse class of multi-target anti-HIV-1 agents
1161. Polyphenols: Food sources and health benefits
1162. Polyphenols: multipotent therapeutic agents in Neurodegenerative diseases
1163. Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!
1164. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease
1165. Pomegranate’s neuroprotective effects against Alzheimer’s disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites
1166. Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols
1167. Possible role of common spices as a preventive and therapeutic agent for Alzheimer’s disease
1168. Possible therapeutic role of grape (Vitis vinifera) leaves polyphenolic extract in the regression of aluminium-induced Alzheimer’s disease in rats
1169. Possible Therapeutic Uses of Salvia triloba and Piper nigrum in Alzheimer’s Disease–Induced Rats
1170. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer’s disease
1171. Potent Inhibitory Effect of flavonoids in Scutellaria baicalensis on Amyloid β Protein-Induced Neurotoxicity
1172. Potential application of dietary polyphenols from red wine to attaining healthy ageing
1173. Potential beneficial effects of a diet with walnuts in aging and Alzheimer’s disease
1174. Potential complementarity of high-flavanol cocoa powder and spirulina for health protection
1175. Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro
1176. Potential health benefits of tea polyphenols—a review
1177. Potential of medicinal plant compounds to targeting Tau protein in the therapy of Alzheimer’s disease–A review
1178. Potential of South African medicinal plants targeting the reduction of Aβ42 protein as a treatment of Alzheimer’s disease
1179. Potential protection of green tea polyphenols against 1800 MHz electromagnetic radiation-induced injury on rat cortical neurons
1180. Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease
1181. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
1182. Potential role of olive oil phenolic compounds in the prevention of Neurodegenerative diseases
1183. Potential Role of Vitamin C in the Prevention of Alzheimer’s Disease
1184. Potential therapeutic strategies for Alzheimer’s disease targeting or beyond β-amyloid: insights from clinical trials
1185. Potential therapeutic strategies to prevent the progression of alzheimer to disease states
1186. Precautionary Ellagic Acid Treatment Ameliorates Chronically Administered Scopolamine Induced Alzheimer’s Type Memory and Cognitive Dysfunctions in …
1187. Preclinical and potential applications of common western herbal supplements as complementary treatment in Parkinson’s disease
1188. Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer’s disease
1189. Prediction of Anti‐Alzheimer’s Activity of flavonoids Targeting Acetylcholinesterase in silico
1190. Prenylated flavonoids from the Roots of Sophora flavescens Promote Vascular Relaxation via Endothelium-Dependent Mechansims
1191. Pretreatment with natural flavones and neuronal cell survival after oxidative stress: a structure− activity relationship study
1192. Prevention and reversal of Alzheimer’s disease: treatment protocol
1193. Prevention and treatment of Alzheimer disease and aging: antioxidants
1194. Prevention of Dementia
1195. Prevention of oxidative injury by flavonoids from stems and leaves of Scutellaria Baicalensis georgi in PC12 cells
1196. Preventive and Therapeutic Effects of Traditional Medicines on Diabetic Complications: Sophora flavescens, Pueraria lobata, Coptis chinensis, Cirsium …
1197. Preventive effect of small-leaved kuding tea (Ligustrum robustum (Roxb.) Bl.) polyphenols on D-galactose-induced oxidative stress and aging in mice
1198. PREVENTIVE EFFECTS OF GREEN TEA CATECHINS ON DEMENTIA
1199. Primary Prevention of Alzheimer’s Disease (AD)
1200. Processing of the β‐amyloid precursor protein and its regulation in Alzheimer’s disease
1201. Profiling of in vitro neurobiological effects and phenolic acids of selected endemic Salvia species
1202. Progress in drug development for Alzheimer’s disease: an overview in relation to mitochondrial energy metabolism
1203. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset.
1204. Proposed Mechanism of Alzheimer’s Disease: the Role of oxidative stress A Review of Scientific Literature
1205. Prospective associations between single foods, Alzheimer’s dementia and memory decline in the elderly
1206. Protection of Okadaic Acid-induced Tau Hyperphosphorylation by Bioflavonoids in Neuroblastoma Cells
1207. Protective effect of a (poly) phenol-rich extract derived from sweet cherries culls against oxidative cell damage
1208. Protective effect of a phenolic‐rich fraction from Schisandra chinensis against H2O2‐induced apoptosis in SH‐SY5Y cells
1209. Protective effect of black tea extract against aluminium chloride-induced Alzheimer’s disease in rats: A behavioural, biochemical and molecular approach
1210. Protective effect of daidzein against streptozotocin‐induced Alzheimer’s disease via improving cognitive dysfunction and oxidative stress in rat model
1211. Protective effect of ginger (Zingiber officinale) on Alzheimer’s disease induced in rats
1212. Protective Effect of Green Tea Extract on Neuronal Cell Death in Alzheimer Model using -amyloid Peptide
1213. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils
1214. Protective effect of iris germanica l. In β-amyloid-induced animal model of Alzheimer’s disease
1215. Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons
1216. Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer’s disease
1217. Protective effect of mulberry crude extract against nonylphenol-induced thyroid disruption by inhibiting the activity of deiodinase in rats
1218. Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats
1219. Protective effect of Picrorhiza kurroa on Alzheimer’s disease induced by aluminium chloride in rats
1220. Protective effect of raisin (currant) against spatial memory impairment and oxidative stress in Alzheimer disease model
1221. Protective effect of rutin, a polyphenolic flavonoid against haloperidol‐induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical …
1222. Protective effect of standardized extract of Passiflora incarnata flower in Parkinson’s and Alzheimer’s disease
1223. Protective Effect of the Leaves of Solanum torvums wartz on Drosophila melanogaster against β-Amyloid Induced Alzheimer Disease
1224. Protective effects of berry polyphenols against age-related cognitive impairment
1225. Protective effects of dietary polyphenols in human diseases and mechanisms of action
1226. Protective effects of fisetin and other berry flavonoids in Parkinson’s disease
1227. Protective effects of flavonoid baicalein against menadione-induced damage in SK-N-MC cells
1228. Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions
1229. Protective effects of foods containing flavonoids on age-related cognitive decline
1230. Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta-secretases …
1231. Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease
1232. Protective effects of Portulaca oleracea against rotenone mediated depletion of glutathione in the striatum of rats as an animal model of Parkinson’s disease
1233. Protective effects of water extract of propolis on dopaminergic neurons, brain derived neurotrophic factor and stress oxidative factors in the rat model of Parkinson’s …
1234. Protective role of caffeic acid in an Aβ25-35-induced Alzheimer’s disease model
1235. Protein drug targets of lavandula angustifolia on treatment of rat Alzheimer’s disease
1236. Protein folding and aggregation into amyloid: the interference by natural phenolic compounds
1237. Proteomics in traditional Chinese medicine with an emphasis on Alzheimer’s disease
1238. Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease
1239. Quercetin enrich diet during the early-middle not middle-late stage of Alzheimer’s disease ameliorates cognitive dysfunction
1240. Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer’s disease
1241. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution
1242. Rational approach to discover multipotent anti-Alzheimer drugs
1243. Rational Design, Preparation, and Analysis of Chemical Reagents for Investigating Multiple Pathological Factors in Alzheimer’s Disease
1244. Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson’s disease
1245. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
1246. Recent advances from metabolomics and lipidomics application in Alzheimer’s disease inspiring drug discovery
1247. Recent advances in health promoting effect of dietary polyphenols
1248. Recent advances in herbal medicines treating Parkinson’s disease
1249. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)
1250. Recent Advances in Nanoencapsulation Systems Using PLGA of Bioactive Phenolics for Protection against Chronic Diseases
1251. Recent advances in the antioxidant therapies for Alzheimer’s disease: Emphasis on natural antioxidants
1252. Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy
1253. Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?
1254. Recent advances in the genetics of Parkinson’s disease
1255. Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer’s disease
1256. Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease
1257. Recent findings in Alzheimer disease and nutrition focusing on epigenetics
1258. Recent Plant Based Remedies for Alzheimer’s Disease, Parkinson’s Disease and Cerebral Ischemic Stroke
1259. Recent progress in multifunctional metal chelators as potential drugs for Alzheimer’s disease
1260. Recent Studies on Mechanisms of New Drug Candidates for Alzheimer’s Disease Interacting with Amyloid-β Protofibrils Using Molecular Dynamics Simulations
1261. Recent trends in drug discovery against Alzheimer’s disease: use of natural products and nutraceuticals from botanicals
1262. Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson’s disease
1263. Recent updates on the association between Alzheimer’s disease and vascular dementia
1264. Recent Updates on the Association Between Alzheimer’s Disease and Vascular Dementia
1265. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
1266. Recovery of new diarylheptanoid sources in Betulaceae: Characterisation of the phenolic profile of Corylus species by HPLC-ESI-MS methods
1267. Recycling acetate for improving flavanones production from Escherichia coli
1268. Red grape juice and Alzheimer’s disease
1269. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of …
1270. Red wine retards Abeta deposition and neuroinflammation in Alzheimer’s disease
1271. Red wine, resveratrol, and Alzheimer’s disease
1272. Redox chemistry of green tea polyphenols: therapeutic benefits in Neurodegenerative diseases
1273. Reduction is the New Youth: The Effect of Polyphenols on Brain Aging and Diseases
1274. Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration
1275. Relationship between Wine Consumption and Alzheimer’s Disease
1276. Relationship of Wine Consumption with Alzheimer’s Disease
1277. Relationships of dietary patterns, foods, and micro-and macronutrients with Alzheimer’s disease and late-life cognitive disorders: a systematic review
1278. Research Article Improvement of Learning and Memory by Morin, A flavonoid in Young and Aged Mice
1279. Research of polyphenols with neuroprotective potential in a yeast model of degeneration
1280. Restoration of stressor-induced calcium dysregulation and autophagy inhibition by polyphenol-rich açaí (Euterpe spp.) fruit pulp extracts in rodent brain cells in vitro
1281. Resveratrol and Grape’s Extract-Loaded Solid Lipid Nanoparticles for the Treatment of Parkinson’s and Alzheimer’s Diseases
1282. Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer’s disease
1283. Resveratrol—a boon for treating Alzheimer’s disease?
1284. Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia
1285. Reverse Alzheimer’s Disease Naturally: Alternative Treatments for dementia including Alzheimer’s Disease
1286. Review of natural products on Parkinson’s disease pathology
1287. Review of Traditional and Natural Methods of Treating Alzheimer’s Disease
1288. REVIEW ON CURRENT TREATMENT STRATEGY IN Alzheimer’s DISEASE AND ROLE OF HERBS IN TREATING NEUROLOGICAL DISORDERS
1289. Review on potential phytocompounds in drug development for Parkinson disease: a pharmacoinformatic approach
1290. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
1291. Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy
1292. Rhodiola rosea L.-An evaluation of safety and efficacy in the context of a neurological disorder, Alzheimer Disease
1293. Role of Acetylcholinesterase Inhibitors and Alzheimer Disease
1294. Role of alpha-synuclein primary structure and oxidative stressin Parkinson’s disease pathology
1295. Role of amyloid-β–metal interactions in Alzheimer’s disease
1296. Role of flavonoids in Neurodegenerative Disorders with Special Emphasis on Tangeritin
1297. Role of flavonoids in oxidative stress
1298. ROLE OF HESPERETIN & PYRIDOXINE PROTECT IN THE NIGROSTRIATAL DOPAMINERGIC PROJECTION IN A NEUROTOXIN MODEL OF PARKINSON’S
1299. Role of intestinal microbiota in the generation of polyphenol‐derived phenolic acid mediated attenuation of Alzheimer’s disease β‐amyloid oligomerization
1300. Role of medicinal plants against Alzheimer’s disease
1301. Role of medicinal plants in Neurodegenerative diseases with special emphasis to alzheimer’s
1302. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer’s disease
1303. Role of Nutraceuticals in Alzheimer’s disease
1304. Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy
1305. Role of plant polyphenols in Alzheimer’s disease
1306. Role of plant-derived flavonoids and their mechanism in attenuation of Alzheimer’s and Parkinson’s diseases: An update of recent data
1307. Role of polyphenols in cell death control
1308. Role of Polyphenols in the prevention of neurodegeneration
1309. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer’s and Parkinson’s diseases
1310. Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a …
1311. Role of the APP non-amyloidogenic signaling pathway and targeting α-secretase as an alternative drug target for treatment of Alzheimer’s disease
1312. Role of the Microbiome in polyphenol Metabolite-Mediated Attenuation of β-amyloid and tau Protein Misfolding in Alzheimer’s Disease
1313. Roles of AMP-activated protein kinase in Alzheimer’s disease
1314. Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion
1315. Roundoc Rx: Neurodegenerative Disease: Part 2—Top Herbs and Supplements for Addressing Alzheimer’s and Parkinson’s Disease
1316. Rutin as a natural therapy for Alzheimer’s disease: Insights into its mechanisms of action
1317. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson’s disease
1318. Screening and evaluation of natural compounds for therapeutic application in Alzheimer’s disease
1319. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer’s disease and in other Neurodegenerative diseases
1320. Secretase inhibitors for the treatment of Alzheimer’s disease: Long road ahead
1321. Secretory phospholipase A2-IIA in Alzheimer’s disease and inflammatory responses in astrocytes
1322. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
1323. Separations with Raman Spectroscopy for Identification of Oxidatively Modified Components in Parkinson’s Disease
1324. Serum concentrations of vitamin E and carotenoids are altered in Alzheimer’s disease: A case-control study
1325. Several targets involved in Alzheimer’s disease amyloidogenesis are affected by morin and isoquercitrin
1326. Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
1327. Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function
1328. Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function
1329. Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664
1330. Signaling pathway cross talk in Alzheimer’s disease
1331. Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
1332. Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer’s disease mouse model
1333. Silymarin’s inhibition and treatment effects for Alzheimer’s disease
1334. Simple In Vivo Models of Alzheimer’s Disease
1335. Simultaneous determination of phenolic compounds in Catharanthus roseus leaves by HPLC method
1336. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases
1337. Sir-2.1 mediated attenuation of α-synuclein expression by Alaskan bog blueberry polyphenols in a transgenic model of Caenorhabditis elegans
1338. Sirtuins as novel targets for Alzheimer’s disease and other Neurodegenerative disorders: experimental and genetic evidence
1339. Sirtuins in Alzheimer’s disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics
1340. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues
1341. Small molecule natural products and Alzheimer’s disease
1342. Sophora Tomentosa Extract Prevents MPTP-Induced Parkinsonism in C57BL/6 Mice Via the Inhibition of GSK-3β Phosphorylation and Oxidative Stress
1343. Spices And Herbs: An Essential Guide To Spice Up Your Health And Flavor Your Diet
1344. ß-Amyloid and oxidative stress in the Pathogenesis of Alzheimer’s Disease
1345. Stahl’s Illustrated Alzheimer’s Disease and Other Dementias
1346. Statistical and Data Mining Methodologies for Behavioral Analysis in Transgenic Mouse Models of Alzheimer’s Disease: Parallels with Human AD Evaluation
1347. Stem Cell Biology for Therapeutic Development in Parkinson’s Disease
1348. STEM CELL-BASED THERAPY FOR Alzheimer’s DISEASE
1349. Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
1350. Strategies for Multi-target Directed Ligands: Application in Alzheimer’s Disease (AD) Therapeutics
1351. Structural Analysis of Flavonoid/Drug Target Complexes: Natural Products as Lead Compounds for Drug Development
1352. Structural Elucidation of Novel Phenolic Glycosides in Cimicifugae Rhizoma by Structure-based Chemical Screening using LC-NMR and LC-UV-MS
1353. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
1354. Structure-activity relationships of flavonoids
1355. Structure–activity relationships of acetylated flavone glycosides from Galeopsis ladanum L.(Lamiaceae)
1356. Studies on Amyloid Beta Peptide Aggregation and Its Modulation by Garlic Components: Relevance to Alzheimer’s Disease
1357. Studies on the Leaves of Punica Granatum Linn. and its Invitro Inhibition of Ache for Potential Use in Alzheimer’s Treatment
1358. Study of oxidative stress and Alzheimer’s disease in transgenic mice and pharmacological agents to counteract nutritional deficiency
1359. Study of Possible neuroprotective Effects of Certain Drugs on Experimentally Induced Parkinson’s Disease in Rats
1360. Study on neuroprotective capacity of key flavonoids of ampelopsis grossedentata
1361. Sub-critical solvent extraction of flavonoid-rich grape by-products
1362. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
1363. Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na+, K+-ATPase and cholinesterases
1364. Suppression of presymptomatic oxidative stress and inflammation in neurodegeneration by grape-derived polyphenols
1365. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity
1366. Sweet Cherry Phenolic Compounds: Identification, Characterization, and Health Benefits
1367. Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease
1368. Synergistic action of melatonin in combination with Anti-Parkinsonian drugs in experimental model of parkinson s disease
1369. Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson’s disease model
1370. Synergistic Effect of Selected Hydroxy Cinnamic Acid Derivative (HCA) With Rivastigmine in Dementia
1371. Synergistic neuroprotective effects of Withania somnifera with specific dietary derived polyphenols
1372. Synergistic properties of bioavailable phenolic compounds from olive oil: electron transfer and neuroprotective properties
1373. Synthesis and antioxidant activity of phenolic amides
1374. Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization
1375. Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants
1376. Synthesis and evaluation of neuroprotective selenoflavanones
1377. Synthesis of Isooctyl Phenol Analogs from Insect-Flower
1378. Synthesis of phenolic amides and evaluation of their antioxidant and anti-inflammatory activity in vitro and in vivo
1379. Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson’s disease
1380. T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer’s disease: potential pools of new biomarkers
1381. Target-based selection of flavonoids for Neurodegenerative disorders
1382. Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
1383. Targeting dysregulation of brain iron homeostasis in Parkinson’s disease by iron chelators
1384. Targeting ERK signaling pathway by polyphenols as novel therapeutic strategy for neurodegeneration
1385. Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines
1386. Targeting miRNAs by polyphenols: novel therapeutic strategy for aging
1387. Targeting multiple Alzheimer’s disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
1388. Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease
1389. Targeting Parkinson’s-tyrosine hydroxylase and oxidative stress as points of interventions
1390. Targeting the Nrf2/amyloid-beta liaison in Alzheimer’s disease: A rational approach
1391. Targeting the progression of Parkinson’s disease
1392. Targeting α-synuclein aggregation for Parkinson’s disease treatment
1393. Targeting α-Synuclein as a Parkinson’s Disease Therapeutic
1394. Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
1395. Tea and Parkinson’s disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits
1396. Tea flavonoids and their effect on chronic inflammation induced in Trypanosoma brucei brucei infected mice
1397. Tea-Derived Polyphenols and Stilbenes on Amyloid Neurotoxicity
1398. The ability of three African herbal remedies to offer protection against an in vitro model of Parkinson’s disease
1399. The action of polyphenols in diabetes mellitus and Alzheimer’s disease: A common agent for overlapping pathologies
1400. The Alzheimer’s Prevention Cookbook: 100 Recipes to Boost Brain Health
1401. The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization
1402. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
1403. The anti-amyloidogenic effect is exerted against Alzheimer’s β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure
1404. The Antimicrobial Activity Mechanism of Sophoraflavanone B against Methicillin-Resistant Staphylococcus aureus
1405. The antioxidant properties of 4–quinolones compared to structurally related flavonoids
1406. The Association Between Dietary flavonoid Intake and Chronic Obstructive Pulmonary Disease, Systemic Inflammation, and Comorbidity Burden
1407. The beneficial and deleterious role of dietary polyphenols on chronic degenerative diseases by regulating gene expression
1408. The beneficial effects of dietary flavonoids: Sources, bioavailability and biological functions
1409. The beneficial effects of fruit polyphenols on brain aging
1410. The beneficial role of Naringin-a citrus bioflavonoid, against oxidative stress-induced neurobehavioral disorders and cognitive dysfunction in rodents: A systematic …
1411. THE BENEFITS OF RESVERATROL WITH POLYPHENOLS IN Parkinson’s DISEASE WITH Alzheimer’s CHANGES
1412. The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson’s disease
1413. The cascade of oxidative stress and tau protein autophagic dysfunction in Alzheimer’s disease
1414. The Change of Neurotransmitters in Plasma of dementia Patients after Aromatherapy.
1415. The Crocus sativus compounds trans-crocin 4 and trans-crocetin modulate the amyloidogenic pathway and tau misprocessing in Alzheimer disease neuronal cell …
1416. The development of preventives and therapeutics for Alzheimer’s disease that inhibit the formation of β-amyloid fibrils (fAβ), as well as destabilize preformed fAβ
1417. The Effect of Essential Oil on Plasma Level of 5-HT in dementia Patients
1418. The effect of Ginkgo biloba extract on parkinsonisminduced biochemical changes in brain of irradiated rats
1419. The effect of green tea consumption on oxidative stress markers and cognitive function in patients with Alzheimer’s disease: A prospective intervention study
1420. The effect of polyphenols on protein degradation pathways: implications for neuroprotection
1421. The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats
1422. The effects of flavonoid and other polyphenol consumption on cognitive performance: a systematic research review of human experimental and epidemiological …
1423. The effects of the flavonoid baicalein and osmolytes on the Mg 2+ accelerated aggregation/fibrillation of carboxymethylated bovine 1SS-α-lactalbumin
1424. The Effects of the Green Tea polyphenol Epigallocatechin Gallate on the Central Nervous, Endocrine, and Innate Immune Systems
1425. The epidemiology of Parkinson’s disease: risk factors and prevention
1426. The flavanol (−)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against …
1427. The flavone luteolin improves central nervous system disorders by different mechanisms: a review
1428. The flavonoid baicalein promotes NMDA receptor‐dependent long‐term potentiation and enhances memory
1429. The flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights …
1430. The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model …
1431. The flavonoids ameliorates: protective mechanisms in Neurodegenerative diseases
1432. The GC-MS analyses of the n-hexane extract of Nitraria schoberi L., its total phenolics and in vitro antioxidant activity
1433. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide‐induced toxicity: involvement of its flavonoid constituents and protein …
1434. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide‐induced toxicity: involvement of its flavonoid constituents and protein …
1435. The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
1436. The gut microbiota links dietary polyphenols with management of psychiatric mood disorders
1437. The Healthy Mind Cookbook: Big-flavor Recipes to Enhance Brain Function, Mood, Memory, and Mental Clarity
1438. The immunomodulatory and anti-inflammatory role of polyphenols
1439. The impact of flavonoids on memory: physiological and molecular considerations
1440. The impact of fruit flavonoids on memory and cognition
1441. The impact of gastrointestinal modifications, blood-brain barrier transport, and intracellular metabolism on polyphenol bioavailability: an overview
1442. The influence of beverage composition on delivery of phenolic compounds from coffee and tea
1443. The influence of common free radicals and antioxidants on development of Alzheimer’s Disease
1444. The influence of oxidative stress in Alzheimer’s disease-possible beneficial relevance of the antioxidants from wheatgrass juice. Review Article
1445. The influence of plant extracts on Ȼ Amyloid induced pathologies in an APP/PS1 mouse model of Alzheimer’s disease
1446. The interactions of flavonoids within neuronal signalling pathways
1447. The mechanisms of action of flavonoids in the brain: direct versus indirect effects
1448. The medicinal chemistry of natural and semisynthetic compounds against Parkinson’s and Huntington’s diseases
1449. The Mind Diet: A Scientific Approach to Enhancing Brain Function and Helping Prevent Alzheimer’s and Dementia
1450. The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition
1451. The molecular basis of working mechanism of natural polyphenolic antioxidants
1452. The n-Butanol Fraction and Rutin from Tartary Buckwheat Improve Cognition and Memory in an In Vivo Model of Amyloid-β-Induced Alzheimer’s Disease
1453. The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction
1454. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
1455. The neuroprotective potential of flavonoids: a multiplicity of effects
1456. The neuroprotective potential of phenolic-enriched fractions from four Juniperus species found in Portugal
1457. The Nrf2/HO-1 Axis as Targets for Flavanones: Neuroprotection by Pinocembrin, Naringenin, and Eriodictyol
1458. The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease
1459. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer’s disease
1460. The oxidative stress hypothesis in Alzheimer’s disease
1461. The potential of flavonoids for the treatment of Neurodegenerative diseases
1462. The potential role of dietary polyphenols in Parkinson’s disease
1463. The prenylflavonoid xanthohumol reduces Alzheimer-like changes and modulates multiple pathogenic molecular pathways in the neuro2a/APPswe cell …
1464. The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
1465. The protective role of plant biophenols in mechanisms of Alzheimer’s disease
1466. The relevance body mass index on the oxidative stress status of Alzheimer’s disease pathology
1467. The role of dietary coconut for the prevention and treatment of Alzheimer’s disease: potential mechanisms of action
1468. The Role of HIV-1 Proteins in Alzheimer’s Disease Pathology
1469. The role of iron-induced fibrin in the pathogenesis of Alzheimer’s disease and the protective role of magnesium
1470. The role of lifestyle factors in cognitive aging and dementia
1471. The role of lipids and membranes in the pathogenesis of Alzheimer’s disease: a comprehensive view
1472. The role of natural products in Alzheimer’s and Parkinson’s disease
1473. The role of natural products in the discovery of new drug candidates for the treatment of Neurodegenerative disorders II: Alzheimer’s disease
1474. The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer’s disease
1475. The role of nutrition in the prevention and treatment of dementia
1476. The Role of oxidative stress and Cholesterol in Animal Models of Alzheimer’s Disease
1477. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation …
1478. The role of phytochemicals in the treatment and prevention of dementia
1479. The role of polyphenolic antioxidants in health, disease, and aging
1480. The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer’s disease
1481. The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review
1482. The role of rutin and diosmin, two citrus polyhydroxyflavones in disease prevention and treatment
1483. The role of the ubiquitin proteasome system in Alzheimer’s disease
1484. The Safe and Effective Applications of Essential Oils in Alzheimer’s Dementia
1485. The science of cocoa flavanols: bioavailability, emerging evidence, and proposed mechanisms
1486. The Simplicity of dementia A Guide for Family and Carers
1487. The Structural Hybrids of Acetylcholines-terase Inhibitors in the Treatment of Alzheimer’s Disease: A Review
1488. The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer’s disease
1489. The Therapeutic Role of Turmeric in Treatment and Prevention of Alzheimer’s Disease
1490. The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies
1491. The Treatment of Brain Inflammation in Alzheimer’s Disease. Can Traditional Medicines Help?
1492. The use of cell-free systems to characterize Parkinson’s disease-related gene products
1493. The use of flavonoids in central nervous system disorders
1494. The use of herbal medicine in Alzheimer’s disease—a systematic review
1495. The Use of herbal supplements on minimizing the clinical manifestations of Alzheimer’s disease
1496. The Use of Polyphenols for the Treatment of Alzheimer’s Disease
1497. Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?
1498. Therapeutic agents in Alzheimer’s disease through a multi-targetdirected ligands strategy: recent progress based on tacrine core
1499. Therapeutic approaches to Alzheimer’s disease through stimulating of non-amyloidogenic processing of amyloid precursor protein
1500. Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson’s disease
1501. Therapeutic effect of modulating TREM-1 via anti-inflammation and autophagy in Parkinson’s disease
1502. Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer’s disease
1503. Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer’s disease
1504. Therapeutic implications of anti-inflammatory natural products in Alzheimer’s disease
1505. Therapeutic interventions for the suppression of Alzheimer’s disease: quest for a remedy
1506. Therapeutic potential of baicalein in Alzheimer’s disease and Parkinson’s disease
1507. Therapeutic Potential Of Catechins And Derivatives For The Prevention Of Alzheimer’s
1508. Therapeutic Potential Of Catechins And Derivatives For The Prevention Of Alzheimer’s Disease
1509. Therapeutic potential of luteolin in transgenic Drosophila model of Alzheimer’s disease
1510. Therapeutic potential of natural products in Parkinson’s disease
1511. Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed)
1512. Therapeutic Potential of Polyphenols in Parkinson’s Disease
1513. Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview
1514. Therapeutic potentials of microalgae in the treatment of Alzheimer’s disease
1515. Therapeutic potentials of plant iridoids in Alzheimer’s and Parkinson’s diseases: A review
1516. Therapeutic role of sirtuins in Neurodegenerative disease and their modulation by polyphenols
1517. Therapeutic strategies targeting amyloid-β in Alzheimer’s disease
1518. Therapeutics of Alzheimer’s disease: Past, present and future
1519. Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions
1520. Therapies for prevention and treatment of Alzheimer’s disease
1521. Thymus pulegioides L. as a rich source of antioxidant, anti-proliferative and neuroprotective phenolic compounds
1522. Tissue injury by reactive oxygen species and the protective effects of flavonoids
1523. To Study The Ameliorative Effect Of Hydroalcholic Extract Of Caryota urens (Arecaceae) On Streptozotocin Induced Alzheimer’s Model In Mice
1524. Tomato (Lycopersicon esculentum) seeds: new flavonols and cytotoxic effect
1525. Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer’s disease
1526. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later
1527. Total Phenolic and flavonoid Content and Biological Activities of Extracts and Isolated Compounds of Cytisus villosus Pourr.
1528. Total Phenolic, Flavonoid, Fatty Acid Contents and Cytotoxic, Antioxidant, and Antimicrobial Activities of Hedysarum aucheri
1529. Total Synthesis of an C-CH2-C Linked Ochnaflavone
1530. Total Synthesis of Ochnaflavone Analogs Having CNH-C and CSC Linkages
1531. Total Synthesis of Ochnaflavone, A Potent Plant-originated Biflavonoid with Anti-inflammatory Activity
1532. Towards a bioinformatics analysis of anti-Alzheimer’s herbal medicines from a target network perspective
1533. Toxic exposure and life style factors on ageing brain Neurodegenerative disease, Alzheimer’s and Parkinson’s: Role of natural antioxidants to ameliorate the condition
1534. Traditional and modern medicine harmonizing the two approaches in the treatment of neurodegeneration (Alzheimer’s disease-AD)
1535. Traditional Chinese medicines and Alzheimer’s disease
1536. Traditional Medicine in the Treatment of dementia and Alzheimer’s Disease
1537. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
1538. Transthyretin chemical chaperoning by flavonoids: Structure–activity insights towards the design of potent amyloidosis inhibitors
1539. Treatment of Alzheimer Disease with Phytochemicals Other Than Curcumin
1540. Treatment of inflammatory bowel disease via green tea polyphenols: Possible application and protective approaches
1541. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson’s disease: Possible involvement of PI3K/ERβ signaling
1542. Type 2 diabetes mellitus and Alzheimer’s disease: bridging the pathophysiology and management
1543. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer’s Disease Model Mice
1544. Ulmosides A: flavonoid 6-C-glycosides from Ulmus wallichiana attenuates lipopolysacchride induced oxidative stress, apoptosis and neuronal death
1545. Understanding Alzheimer’s Disease and Other Dementias
1546. UNDERSTANDING PHYTOTHERAPY OF Alzheimer’s DISEASE: LAST DECADE AND COMING FUTURE
1547. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and Neurodegenerative diseases
1548. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity
1549. Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
1550. Validation of neuroprotective action of a commercially available formulation of olive polyphenols in a zebra-fish model vis-a-vis pure hydroxytyrosol
1551. Vanillin attenuated behavioural impairments, neurochemical deficts, oxidative stress and apoptosis against rotenone induced rat model of Parkinson’s disease
1552. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: a new approach to therapy
1553. VISCUM ALBUM ENHANCES BLOOD SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVEL IN EXPERIMENTAL MODEL OF Alzheimer’s …
1554. Walnut supplementation in the diet reduces oxidative damage and improves antioxidant status in transgenic mouse model of Alzheimer’s disease
1555. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
1556. Whole-food diet worsened cognitive dysfunction in an Alzheimer’s disease mouse model
1557. Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s disorders?
1558. Wine consumption, cognitive function and dementias–A relationship?
1559. Wine flavonoids in health and disease prevention
1560. Wine phenolics
1561. Wine Polyphenols and Neurodegenerative Diseases: An Update on the Molecular Mechanisms Underpinning Their Protective Effects
1562. Wine polyphenols: potential agents in neuroprotection
1563. Wine-Derived Phenolic Metabolites in the Digestive and Brain Function
1564. Withanolides: biologically active constituents in the treatment of Alzheimer’s disease
1565. Xanthone and flavone derivatives as dual agents with acetylcholinesterase inhibition and antioxidant activity as potential anti-alzheimer agents
1566. Xenobiotic metabolism and berry flavonoid transport across the blood− brain barrier
1567. Zingiber officinale and Alzheimer’s disease: evidences and mechanisms
1568. α-Synuclein Aggregation and Parkinson’s Disease
1569. α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson’s disease
1570. α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
1571. α-Synuclein misfolding and Parkinson’s disease
1572. α‐Synuclein oligomers and clinical implications for Parkinson disease
1573. β-Synuclein Assembly as a Therapeutic Target of Parkinson’s Disease and Related Disorders
1574. … -DAD Fingerprinting Analysis, Antioxidant Activity of Phenolic Extracts from Blighia sapida Bark and Its Inhibition of Cholinergic Enzymes Linked to Alzheimer’s …
1575. … -rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease
1576. … , Biological Evaluation And Molecular Modeling Studies Of Novel Multifunctional neuroprotective Drugs For The Treatment Of Parkinson’s Disease: An Effort …
1577. … , α-Glucosidase, Pancreatic Lipase, Acetyl-and Butyrylcholinesterase Inhibition Activity of Chaenomeles Fruits Determined by Polyphenols and other Chemical …
1578. … acid and E. resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson’s disease: a pharmacoinformatics study
1579. … and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
1580. … and antioxidant potentials of a medicinal plant Abroma augusta: Implications for the alternative treatment therapy of cognitive deficits in Alzheimer’s disease
1581. … and their acetyl cholinesterase inhibitory and antioxidant activities from leaves of Acanthopanax henryi: potential complementary source against Alzheimer’s disease
1582. … bovine 1SS-alpha-lactalbumin as a model for disease-related amyloidogenic polypeptides: The effects of osmolytes, the flavonoid baicalein, and the GroEL …
1583. … chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: A Preliminary anti- Alzheimer’s study
1584. … chrysin loaded solid lipid nanoparticles against Amyloid β25–35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer’s …
1585. … composition, antioxidant potential and in vitro inhibitory activity of leaves and acorns of Quercus suber on key enzymes relevant for hyperglycemia and Alzheimer’s …
1586. … effects of inhaled Hypericum scabrum L.(Hypericaceae) essential oil against scopolamine-induced Alzheimer’s type dementia/Scopolamine ile oluşturulan …
1587. … effects of water extract of propolis on dopaminergic neurons, brain derived neurotrophic factor, and stress oxidative Factors in the rat model of Parkinson’s …
1588. … efficiency of co-administration of Ginkgo biloba and Trifolium pretense against sodium arsenite-induced neurotoxicity and dementia in different regions of brain and …
1589. … fingerprint analysis, antioxidant properties, and inhibition of cholinergic enzymes (acetylcholinesterase and butyrylcholinesterase) of phenolic extracts from Irvingia …
1590. … flavonoid attenuates cognitive dysfunction and neuronal loss associated with amyloid β (25-35)-induced oxidative stress: an experimental model of Alzheimer’s …
1591. … for the Therapy of Proteinopathies Underlying the Neurodegenerative Conditions: Protein Misfolding and Fibrillization in Alzheimer’s Disease and Parkinson’s …
1592. … from sesame cake reduce oxidative stress and amyloid-β-induced toxicity by upregulation of SKN-1 in a transgenic Caenorhabditis elegans model of Alzheimer’s …
1593. … Impairment Attenuating Effect of Phenolic Compound Rich Fraction of Trianthema portulacastrum in Scopolamine Induced Alzheimer’s Disease Like Condition
1594. … IN THE PREVENTION AND MANAGEMENT OF AGE RELATED Neurodegenerative DISORDERS WITH SPECIAL REFERENCE TO SENILE DEMENTIA
1595. … in tumor necrosis factor like weak inhibitor of apoptosis induced dopaminergic neuronal cell death and microglial activation in invitro and in vivo models of Parkinson …
1596. … INDUCES PKD1 ACTIVATION AND PROTECTS DOPAMINERGIC NEURONS IN CELL CULTURE AND MITOPARK ANIMAL MODELS OF Parkinson’s …
1597. … inhibitory potential and estimation of alkaloids (lycorine and galanthamine) from Crinum species: an important source of anticancer and anti-Alzheimer drug
1598. … KATEKIN GAMBIR TERHADAP KADAR BACE-1 DAN BETA AMYLOID 42 CAIRAN SEREBROSPINAL PADA TIKUS Sprague dawley MODEL ALZHEIMER
1599. … modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer’s …
1600. … mombim L.(Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer’s …
1601. … neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate
1602. … of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological …
1603. … of diagnostic agents, self-assembly inhibitors, and hippocampal transcriptional changes specific to amyloid β-proteinassemblies linked to Alzheimer’s disease
1604. … of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer’s disease mice model
1605. … of flavonoids, baicalein, and daidzein in estrogenic and neuroprotective effects: a development of potential health products and therapeutic drugs against Alzheimer’s …
1606. … of hydroalcoholic extract of Ziziphora clinopodioides L. on spatial memory and neuronal density of hippocampal CA1 region in rats with sporadic Alzheimer’s …
1607. … of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer’s …
1608. … of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology …
1609. … OF THE POSSIBLE ANTIOXIDANT EFFECTS OF PEGANUM HARMALA AND GINKGO BILOBA IN AMELIORATING Alzheimer’s DISEASE IN RAT MODEL
1610. … OF ΑLPHA-YNUCLEIN SEEDED NUCLEATION-DEPENDENT AGGREGATION AND TOXICITY AS A POTENTIAL THERAPEUTIC STRATEGY FOR Parkinson’s …
1611. … performance in relation to urinary anthocyanins and their flavonoid-based products following blueberry supplementation in older adults at risk for dementia
1612. … pluricaulis (Shankhapushpi) ameliorates human microtubule-associated protein tau (hMAPτ) induced neurotoxicity in Alzheimer’s disease Drosophila model
1613. … pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s …
1614. … STRESS, NEUROINFLAMMATION AND NEURODEGENERATION AGAINST LIPOPOLYSACCHARIDE-INDUCED Alzheimer’s DISEASE VIA JNK-3 AND …
1615. … the brain functions by bitter (Vernonia amygdalina) and water bitter (Struchium sparganophora) leaves extracts: comparison of phenolic constituents versus nootropic …
1616. … the functional diversity of flavonoids derived from Chinese Materia Medica: Drug developments for the prevention of Alzheimer’s disease and osteoporosis
1617. … with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia
1618. “A GREAT PERTURBATION IN NATURE”-Parkinson’s DISEASE AND SLEEP DISORDERS–
1619. “Polyphenolic-food” Effects on Brain Health (Human Data review)
1620. 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine is a potent neurotoxin: Gamma-tocopherol recuperate behavior, dopamine, and oxidative stress on Parkinsonic …
1621. 10. neuroprotective effects of oxyresveratrol from fruit against neurodegeneration in Alzheimer’s disease
1622. 15 Alzheimer’s Disease and Other Forms of Dementia
1623. 15 Apple Phenolics and Alzheimer’s Disease
1624. 15 Botanical Phenolics and Neurodegeneration
1625. 15 Dietary flavonoids as neuroprotective Agents
1626. 15 Green Tea Flavan-3-ols
1627. 16 Actions of Bioactive Phytochemicals in Cell Function and Alzheimer’s Disease Pathology
1628. 17 Effects of flavonoids on Cognitive Performance
1629. 19 Natural Phenolics and Metal Metabolism in Neurodegenerative Diseases
1630. 19 The neuroprotective Capacity of Achyrocline satureioides (Lam) DC and Its Flavonoids
1631. 2 Direct Evaluation of Alzheimer’s Disease-Specific oxidative stress with Multiphoton Microscopy
1632. 3, 5, 4′-trihydroxy-6, 7, 3′-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell …
1633. 4 Coffee and Alzheimer’s Disease: Animal and Cellular Evidence
1634. 6 neuroprotective Mechanisms: oxidative stress as a Target for neuroprotective Therapies in Alzheimer’s and Parkinson’s
1635. 6-Shogaol has neuroprotective Effects in Parkinson’s Disease Model
1636. 7, 8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders
1637. 7, 8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders
1638. 8 Neuroprotection by Dietary and Citrus Flavonoids
1639. A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats
1640. A botanical containing freeze dried açai pulp promotes healthy aging and reduces oxidative damage in sod1 knockdown flies
1641. A brief review on the neuroprotective mechanisms of vitexin
1642. A Close Look at Echium amoenum Processing, Neuroactive Components, and Effects on Neuropsychiatric Disorders
1643. A cocoa peptide protects Caenorhabditis elegans from oxidative stress and β-amyloid peptide toxicity
1644. A Combination of Green Tea Extract and l-Theanine Improves Memory and Attention in Subjects with Mild Cognitive Impairment: A Double-Blind Placebo-Controlled …
1645. A comparative study of the in vitro enzyme inhibitory and antioxidant activities of Butea monosperma (Lam.) Taub. and Sesbania grandiflora (L.) Poiret from Pakistan …
1646. A comparative study on the antioxidant and immunomodulatory properties of curcumin conjugated gold nanospheres and free curcumin
1647. A comparative thin layer chromatography study of different brands of five herbal remedies
1648. A Comparison of Inhibitory Effects on Catecholamine Secretion between CGP42112 and CGP42112 plus PD123319
1649. A comparison of the efficacy and tolerability of interferon-beta (INFb) products used as initial or follow-up therapy for the treatment of relapsing multiple sclerosis …
1650. A Comprehensive Insight on the Health Benefits and Phytoconstituents of Camellia sinensis and Recent Approaches for Its Quality Control
1651. A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases
1652. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies
1653. A crosssectional study of ethnopharmacology in the Noakhali district of Bangladesh and exploring potential ocular immunostimulatory activity of the medicinal …
1654. A current perspective on the inhibition of cholinesterase by natural and synthetic inhibitors
1655. A current update on phytochemistry, pharmacology and herb–drug interactions of Hypericum perforatum
1656. A diet for dopaminergic neurons?
1657. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of …
1658. A life-course contribution of nutrition to future cognitive decline
1659. A Mini Review on the Protective Effect of Lignans for the Treatment of Neurodegenerative Disorders
1660. A mixture of fucoxanthin and punicic acid prevents obesity in high-fat diet-induced obese mice
1661. A New Therapeutic Concept of LMT356 for Stroke Therapy: Extension of the Thrombolytic Time Window of tPA
1662. A Novel Approach towards Nutraceuticals and Biomedical Applications
1663. A Novel neuroprotective and Antioxidative Efficacy of a Unique Combination of Standardized Huperzia serrata, Convolvulus pluricaulis and Celastrus …
1664. A pharmacognostic and pharmacological review on Vigna aconitifolia (Moth bean)
1665. A Pharmacological Review of Bioactive Constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch
1666. A Pilot Study to Evaluate Chemopreventive Effects of Blueberry (Vaccinium spp.)
1667. A Polysaccharide Produced by a New Streptomyces Strain Modulates Immunological Activity in RAW264. 7 Cells
1668. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects
1669. A possible role for π-stacking in the self-assembly of amyloid fibrils
1670. A potential alternative against Neurodegenerative diseases: Phytodrugs
1671. A Potential Natural Product Combination Targeting Memory Disorders
1672. A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical …
1673. A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: in vitro and in vivo efficacy and molecular …
1674. A refined concept: α-synuclein dysregulation disease
1675. A review of dietary Ziziphus jujuba fruit (Jujube): developing health food supplements for brain protection
1676. A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone
1677. A review of neuroprotective agents
1678. A Review of neuroprotective Agents
1679. A review of some medicinal plants used for nervous disorders
1680. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to Neurodegenerative processes
1681. A review of the medicinal properties and applications of Pycnanthus angolensis (Welw) Warb
1682. A review of the pharmacology and toxicology of aucubin
1683. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy
1684. A review of therapeutic effects of curcumin
1685. A review of three commonly used herbs which enhance memory and new evidences which show their combination could improve memory in young animals
1686. A review on ethnomedicinal, phytochemical, and pharmacological significance of Terminalia sericea Burch. Ex DC.
1687. A review on medicinal importance, pharmacological activity and toxicology of ”Nutraceuticals”
1688. A review on medicinal properties of saffron toward major diseases
1689. A Review on Natural Antioxidants
1690. A review on natural memory enhancers (Nootropics)
1691. A Review on Neuronutrition
1692. A review on nutraceuticals: classification and its role in various diseases
1693. A Review on Pharmaceutically Important Medicinal plant: Bacopa monnieri
1694. A Review on Phytochemistry and Pharmacology of Otostegia persica (Burm. f.) Boiss.
1695. A review on possible therapeutic effect of Nigella sativa and thymoquinone in Neurodegenerative diseases
1696. A review on spikenard (Nardostachys jatamansi DC.)-an ‘endangered’essential herb of India
1697. A review on the phytopharmacological studies of the genus Polygala
1698. A review on the possible neuroprotective effects of Moringa oleifera leaf extract
1699. A Review on Therapeutic Potentials of Crocetin-A Carotenoid Derived from Saffron
1700. A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its …
1701. A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
1702. A review study on medicinal plants affecting amnesia through cholinergic system
1703. A Role for Activated Microglia and Peroxynitrite in Lewy Body Diseases–Implications for Prevention and Control
1704. A Role for Orexin Neuron Activity in Cytotoxic Chemotherapy-Induced Fatigue
1705. A Role of Gallic Acid in Oxidative Damage Diseases: A Comprehensive Review
1706. A simple and efficient HPLC method for quantitative analysis of Gingkolides extracted from Ginkgonis Semen
1707. A Splicing Variant of AIMP2 as a Therapeutic Controller for Neurodegenerative Diseases
1708. A status review on the medicinal properties of essential oils
1709. A STUDY ON ANTI-INFLANNATORY AND neuroprotective EFFECTS OS COSTUNOLIDE ON LIPOPOLYSACCHARIDE ACTIVATED MURINE BRAIN …
1710. A STUDY ON CNS EFFECTS OF MILK EXTRACT OF NUTS OF SEMECARPUS ANACARDIUM. LINN,(ANACARDIACEAE).
1711. A study on nephroprotectiveness and pharmacokinetic properties of selected nutraceuticals and evaluation of chronic renal failure inducing model for their …
1712. A Synthetic Snake-Venom-Based Tripeptide Protects PC12 Cells from the Neurotoxicity of Acrolein by Improving Axonal Plasticity and Bioenergetics
1713. A systematic and comprehensive review on Withania somnifera (L.) dunal-an indian ginseng
1714. A systematic Approach to Evaluate Herb-drug Interaction Mechanisms: Investigation of a Purified Ginseng Extracts
1715. A systematic overview of the scientific literature on the association between Mediterranean Diet and the Stroke prevention
1716. A systematic review on Piper longum L.: Bridging traditional knowledge and pharmacological evidence for future translational research
1717. A systematic review on the vocational pharmacy education and pharmacists’ role in the Singapore’s healthcare system
1718. A therapeutic connection between dietary phytochemicals and ATP synthase
1719. A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compounds
1720. AARP Prescription for Drug Alternatives: All Natural Options for Better Health without the Side Effects
1721. AARP The Immortality Edge: Realize the Secrets of Your Telomeres for a Longer, Healthier Life
1722. ABC transporters and drug efflux at the blood-brain barrier
1723. Açaí: An Extraordinary Antioxidant-Rich Palm Fruit
1724. Acanthus ebracteatus leaf extract provides neuronal cell protection against oxidative stress injury induced by glutamate
1725. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats
1726. Acer okamotoanum protects SH-SY5Y neuronal cells against hydrogen peroxide-induced oxidative stress
1727. Acetyl cholinesterase inhibition potential and antioxidant activities of ferulic acid isolated from Impatiens bicolor Linn
1728. Acetylcholinesterase from human erythrocytes membrane: a screen for evaluating the activity of some traditional plant extracts
1729. Acetylcholinesterase inhibition and antioxidant activities of polysaccharide-peptide complexes from edible mushrooms
1730. Acetylcholinesterase inhibition and antioxidant activity of Syzygium cumini, S. aromaticum and S. polyanthum from Indonesia
1731. Acetylcholinesterase inhibition and in vitro and in vivo antioxidant activities of Ganoderma lucidum grown on germinated brown rice
1732. Acetylcholinesterase inhibition by medicinal plants: A Review
1733. Acetylcholinesterase Inhibition, Antioxidant, Antiinflammatory, Antimicrobial and Phytochemical Properties of Huernia hystrix
1734. Acetylcholinesterase inhibitors of natural origin
1735. Acetylcholinesterase Inhibitory Activity and Antioxidant Activity of Selected Medicinal Plant Extracts Used Against Cognitive Dysfunction and Memory Loss in Sri …
1736. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products
1737. Acetylcholinesterase inhibitory and antioxidant properties of root extract from Pueraria mirifica
1738. Acetylcholinesterase inhibitory effect of capsicum oleoresins–an in vitro study
1739. Acetylcholinesterase Inhibitory Potential and Insecticidal Activity of an Endophytic Alternaria sp. from Ricinus communis
1740. Acetylcholinesterase inhibitory potentiality of some minor fruits of West Bengal, India
1741. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family
1742. Acetylcholineterase inhibitory and antioxidant properties of Rhododendron yedoense var. Poukhanense bark
1743. Achillea fragrantissima: Pharmacology Review
1744. Acid Intake, Delivered Via Moderate Champagne Wine Consumption, Improves Spatial Working Memory Via the Modulation of Hippocampal and Cortical …
1745. Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases
1746. Activation of anti-oxidant of curcumin pyrazole derivatives through preservation of mitochondria function and Nrf2 signaling pathway
1747. Activation of Autophagy by Globular Adiponectin Protects against Ethanolinduced Apoptosis in HepG2 Cells
1748. Activation of Protease-activated Receptor 2 through Gastric Refluxants Stimulates Proliferation and Interleukin (IL)-6, IL-8 and Matrix Metallopeptidase (MMP) …
1749. Activation of the NRF2 Pathway in Non-adherent Mammosphere Culture System
1750. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague‐Dawley rats
1751. Acute and Chronic Exercise Effects on NrF2 and Antioxidants in the Muscle and Brain Tissue of Sprague Dawley Rats
1752. Acute Autophagy-Dependent Non-inflammatory Epithelial Death Plays as an Intrinsic Defense to Bacteria
1753. Acute neurocognitive effects of epigallocatechin gallate (EGCG)
1754. Add Life to Your Years & Years To Your Life: Experience New Energy, Strength & Vitality to Age Gracefully, Joyfully & Healthily
1755. Adenosine monophosphate (AMP)-activated protein kinase: a new target for nutraceutical compounds
1756. Adherence to Mediterranean diet and subjective cognitive function in men
1757. Adiponectin Modulates Anti-Inflammatory MicroRNA Expression in RAW 264.7 Macrophages
1758. Administration of chinpi, a component of the herbal medicine ninjin-youei-to, reverses age-induced demyelination
1759. Advanced chemometric modeling approaches for the design of multitarget drugs against Neurodegenerative diseases
1760. Advanced Glycation Endproducts (AGEs) in Food: Health Implications and Mitigation Strategies
1761. Advanced glycation endproducts: what is their relevance to diabetic complications?
1762. Advances in Date Palm (Phoenix dactylifera L.) Breeding
1763. Advances in drug discovery to assess cholinergic neurotransmission: a systematic review
1764. Advances in Nutraceuticals
1765. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
1766. Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
1767. Advances in therapeutics for Neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species
1768. Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors
1769. Advancing medicine with food and nutrients
1770. Advancing neuroprotective-based treatments for schizophrenia
1771. Advocacy in Geriatric Neurology
1772. Aerobic exercise, diet, and neurocognition among individuals with high blood pressure
1773. African medicinal plants acting on the reproductive, cardiovascular, and central nervous systems
1774. Age before beauty
1775. Age-related deficits in electron transport chain complexes in rat neurons and 3xTg-AD mouse neurons
1776. Age-related differences in stress response: Increase markers for oxidative stress and liver damage after heat stress in aged rats?
1777. Age-related epigenetic drift and phenotypic plasticity loss: implications in prevention of age-related human diseases
1778. Age-Related Neurodegenerative
1779. Age-related oxidative protein damages in central nervous system of rats: modulatory role of grape seed extract
1780. Ageing and eating
1781. Ageing and Neurodegenerative diseases
1782. Ageing, cellular senescence and Neurodegenerative disease
1783. Ageing: biology and nutrition
1784. Ageless Brain: Think Faster, Remember More, and Stay Sharper by Lowering Your Brain Age
1785. Aging and Microglial Activation in Neurodegenerative Diseases
1786. Aging and the cerebral microvasculature: clinical implications and potential therapeutic interventions
1787. Aging is not a disease: implications for intervention
1788. Aging microglia: relevance to cognition and neural plasticity
1789. Aging without growing old
1790. Aging, Nutrition and Taste: Nutrition, Food Science and Culinary Perspectives for Aging Tastefully
1791. Aging: an important factor for the pathogenesis of Neurodegenerative diseases
1792. Aging: minimizing free radical damage
1793. AIMP1 as a Modulator of Immune Functions and Pharmacological Implications
1794. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies
1795. Alcohol, ageing and cognitive function: a nutritional perspective
1796. Alkaloids from Peumus boldus and their Acetylcholinesterase, Butyrylcholinesterase and Prolyl Oligopeptidase Inhibition Activity
1797. Allergen-specific memory CD4 T cells require IL-7 signaling for its homeostasis in mediastinal lymph node
1798. Allergic Asthma Pathogenesis and Antioxidant Therapy
1799. Almonds and brain functionality
1800. Alpha-lipoic acid and mesuagenin c-induced co-regulation of nf-κβ-cytokines and chemokines via pi3k-akt/gsk-3β and erk1/2 in in vitro neuronal models/Muhamad …
1801. Alpha-synuclein suppresses retinoic acid-induced neuronal differentiation by targeting the glycogen synthase kinase-3β/β-catenin signaling pathway
1802. Alpha-Synuclein-Induced Dysregulation of Neuronal Differentiatio
1803. Alpha-synuclein, oxidative stress and autophagy failure: dangerous liaisons in dopaminergic neurodegeneration
1804. Alteration of cholesterol homeostasis in the Huntington’s disease brain
1805. Altered brain metabolism of iron as a cause of Neurodegenerative diseases?
1806. Aluminium (III) as a promoter of cellular oxidation
1807. Aluminum Induced Reproductive Dysfunction in Male Rats: The Ameliorative Effect of Saffron Extract
1808. Always Eat After 7 PM: The Revolutionary Rule-Breaking Diet That Lets You Enjoy Huge Dinners, Desserts, and Indulgent Snacks—While Burning Fat …
1809. Amazing Bible Healing Plants, Remedies and Recipes
1810. Amazing Health Benefits of Green Tea
1811. Amelioration of oxidative stress in differentiated neuronal cells by rutin regulated by a concentration switch
1812. Amelioration of scopolamine-induced learning and memory impairment by 𝛼-Pinene in C57BL/6 mice
1813. Amelioration of the Impact of Physical Fatigue on Cognitive Performance by Phytochemicals: The Effect of a Blackcurrant Supplement: A thesis presented in partial …
1814. Ameliorative Effects of ferulic acid against lead acetate-induced oxidative stress, mitochondrial dysfunctions and toxicity in prepubertal rat brain
1815. Ameliorative effects of ferulic Acid against lead acetate-induced oxidative stress, mitochondrial dysfunctions and toxicity in prepubertal rat brain.
1816. Ameliorative effects of lotus seedpod proanthocyanidins on cognitive deficits and oxidative damage in senescence-accelerated mice
1817. Ameliorative Effects of Nutraceuticals in Neurological Disorders
1818. Ameliorative Potential of Euphorbia hirta (Linn.) Extract against Lipopolysaccharide Induced-neuroinflammation and Oxidative Damage in Rats
1819. Amino acids in human nutrition and health
1820. Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling
1821. Amphiphilic nanocarrier systems for curcumin delivery in Neurodegenerative disorders
1822. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
1823. AMPK-dependent Hypoglycemic Effect of Ajoene, a Stable Garlic Component
1824. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB
1825. Amyloid ß-derived switch-peptides as tool to study conformational changes relevant in degenerative diseases
1826. Amyloid State of Proteins in Human Disease
1827. Amyloidogenic Peptide Structure, Aggregation, And Membrane Interaction
1828. Amyloidogenic protein–membrane interactions: mechanistic insight from model systems
1829. An egg yolk’s phospholipid-pennyroyal nootropic nanoformulation modulates monoamino oxidase-A (MAO-A) activity in SH-SY5Y neuronal model
1830. An Energy Restricted Mediterranean Diet Does Not Compromise Dietary Antioxidant Intake: Preliminary Evidence in the Balearic Islands Subgroup of the …
1831. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect®
1832. An ex vivo erythrocyte study: the protective effects of antioxidants against the toxicity of heavy metals in cigarette smoke.
1833. An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an …
1834. An Herbalist’s Guide to Formulary: The Art & Science of Creating Effective Herbal Remedies
1835. An In Vitro and In Vivo Cholinesterase Inhibitory Activity of Pistacia khinjuk and Allium sativum Essential Oils
1836. An investigation into pro-apoptotic targets in experimental glaucoma and the neuroprotective effects of Ginkgo biloba in retinal ganglion cells
1837. An Investigation Into the neuroprotective Properties of Curcumin
1838. An investigation of potential sources of nutraceuticals from the Niger Delta areas, Nigeria for attenuating oxidative stress
1839. An Investigation To Explore The neuroprotective Efficacy Of Zingiber Officinale By Evaluation Of Alterations In Certain Neurochemical Parameters Under …
1840. An Isolation, Characterization and In-vitro Evaluation Study of Cholinesterase Inhibitory and Antioxidant Activities of Mimosa pudica for the Treatment …
1841. An Open clinical study of Siddha drugs Thirutharakchatha Chooranam (Internal) and Aruganver Thylam (External) in the treatment of Viyagulaunmatham (Depression)
1842. An optoelectronic tongue based on an array of gold and silver nanoparticles for analysis of natural, synthetic and biological antioxidants
1843. An overview of benzo [b] thiophene-based medicinal chemistry
1844. An Overview of Natural Beverages
1845. An Overview of Target Specific Neuro-Protective and Neuro-Restorative Strategies
1846. An overview of the molecular mechanisms and novel roles of Nrf2 in Neurodegenerative disorders
1847. An overview of the pharmacology of olive oil and its active ingredients
1848. An overview on inventions related to ginger processing and products for food and pharmaceutical applications
1849. An Overview on Neurodegenerative Diseases and Possible Leads from Natural Products
1850. An Overview on Nutraceuticals as Pharmacological Agents.
1851. An Unashamed Defense of Coffee
1852. An untapped resource in the spotlight of medicinal biotechnology: The genus Scutellaria
1853. An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine
1854. An update on the role of medicinal plants in amelioration of aluminium toxicity
1855. An Updated Review of Pharmacological, Standardization Methods and Formulation Development of Rutin
1856. An updated review on Catharanthus roseus: phytochemical and pharmacological analysis
1857. An updated review on herbal drugs: Nootropic activity and possible mechanisms
1858. Analgesic and antibutyrylcholinestrasic activities of the venom prepared from the Mediterranean jellyfish Pelagia noctiluca (Forsskal, 1775)
1859. Analysis and entrapment of select antioxidants from chokecherry and Saskatoon berry fruits
1860. Analysis of Cardiovascular Adverse Drug Reactions Reported the Korea Drug and Food Administration
1861. Analysis of Metabolites of Major Components in Natural Medicines
1862. Analysis of methanolic extracts and crude polysaccharides from the leaves of Chuanminshen violaceum and their antioxidant activities
1863. Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease
1864. Analysis of natural product regulation of opioid receptors in the treatment of human disease
1865. Analysis of selected medicinal plants as antioxidants with therapeutic potential for treating diseases related to free radical damage
1866. Analysis of the antioxidant activity of 4-(5-chloro-2-hydroxyphenylamino)-4-oxobut-2-enoic acid derivatives using quantum-chemistry descriptors and molecular …
1867. Analytical methods for characterizing bioactive terpene lactones in ginkgo biloba extracts and performing pharmacokinetic studies in animal and human
1868. and Cognitive Decline
1869. Anethum Graveolens linn (Umbelliferae) extract attenuates stress-induced urinary biochemical changes and improves cognition in scopolamineinduced amnesic rats
1870. Animal Model of Cognitive Decline and Neural Transplantation of Stem Cells as a Prospective Therapy
1871. Annurca apple-rich diet restores long-term potentiation and induces behavioral modifications in aged rats
1872. Anthocyanin tissue bioavailability in animals: Possible implications for human health. A systematic review
1873. Anthocyanin-rich açai (Euterpe oleracea Mart.) fruit pulp fractions attenuate inflammatory stress signaling in mouse brain BV-2 microglial cells
1874. Anthocyanins and human health: biomolecular and therapeutic aspects
1875. Anthocyanins and Their Metabolites as Therapeutic Agents for Neurodegenerative Disease
1876. Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide
1877. Anthocyanins from Black Chokeberry (Aroniamelanocarpa Elliot) Delayed Aging-Related Degenerative Changes of Brain
1878. Anthocyanins improve hippocampus-dependent memory function and prevent neurodegeneration via JNK/Akt/GSK3β signaling in LPS-treated adult mice
1879. Anthocyanins in Food
1880. Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex
1881. Anthocyanins protect from complex I inhibition and APPswe mutation through modulation of the mitochondrial fission/fusion pathways
1882. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats
1883. Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination
1884. Anthocyanins: From plant pigments to health benefits at mitochondrial level
1885. Anthocyanins: Janus Nutraceuticals Displaying Chemotherapeutic and neuroprotective Properties
1886. Anthocyanins: Multi-target agents for prevention and therapy of chronic diseases
1887. Anthostema aubryanum Baill: Its Anti-inflammatory and Antioxidant Activities of the root bark extract
1888. Anti-Acetylcholinesterase Activities of Mono-Herbal Extracts and Exhibited Synergistic Effects of the Phytoconstituents: A Biochemical and Computational Study
1889. Anti-Acetylcholinesterase, Anti-Inflammatory and Anti-Oxidant Activities of Raw-Extract Centella Asiatica (RECA) on Lipopolysaccharide (LPS)-Induced …
1890. Anti-Ageing Medicines: The Facts, What Works and What Doesn’t
1891. Anti-aging Effect of the Ethanol Extract from G. bimaculatus
1892. Anti-aging Properties of 4-hydroxybenzoic acid in Caenorhabditis elegans
1893. Anti-amnesic effect of aqueous extract of Crataeva nurvala stem bark in scopolamine induced amnesia
1894. Anti-amnesic effect of Dendropanax morbifera via JNK signaling pathway on cognitive dysfunction in high-fat diet-induced diabetic mice
1895. Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa
1896. Anti-amyloidogenic Effect of Anti-inflammatory Compound, Thiacremonone in Astrocytes
1897. Anti-cholinesterase potential of diverse botanical families from Malaysia: Evaluation of crude extracts and fractions from liquid-liquid extraction and acid-base …
1898. Anti-Fatigue and Hypnotic Effects of a Traditional Herbal Extract on Multiple Sclerosis Patients: A double blind randomized clinical trial
1899. Anti-Fatigue and Hypnotic Effects of a Traditional Herbal Extract on Multiple Sclerosis Patients: A double blind randomized clinical trial.
1900. Anti-fibrillogenic and fibril destabilizing effects of metal ions on cystatin fibrils
1901. Anti-genotoxic Effects of Ethyl Acetate Fraction from Agrimonia pilosa Ledeb in LPS-stimulated RAW 264.7 Cells
1902. Anti-glycative and anti-inflammatory effects of protocatechuic acid in brain of mice treated by D-galactose
1903. Anti-helicobacter and anti-inflammatory effects of ethanol extract of Sohamhyoongtang in Helicobacter pylori-induced inflammation in human gastric epithelial …
1904. Anti-inflammatory Activities of l-Methone and Camphor Isolated from Agastache rugosa (Fisch. & Mey.) Kuntze
1905. Anti-inflammatory Activity and Protective Ability of Water Extract from Pinus densiflora Bark against DNA Damage
1906. Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial Cells
1907. Anti-Inflammatory Activity of Sulfur-containing Compounds from Garlic
1908. Anti-inflammatory and antioxidant activities of Memecylon umbellatum. Burm. f. leaf extract under in vitro
1909. Anti-inflammatory and Pro-inflammatory Mediators as Potential Targets for Chemoprevention and Therapy
1910. Anti-inflammatory Dietary Ingredients, Medicinal Plants, and Herbs Exert Beneficial Health Effects in Aging
1911. Anti-inflammatory Effect of 4-tert-butyl Phenyl Salicylic Acid in Lipopolysaccharides-Stimulated Raw 264.7 Mouse Macrophage Cells
1912. Anti-inflammatory Effect of Clematis mandshurica in LPS-induced RAW 264.7 cells
1913. Anti-Inflammatory Effect of Erinacine C on NO Production Through Down-Regulation of NF-κB and Activation of Nrf2-Mediated HO-1 in BV2 Microglial Cells Treated …
1914. Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity
1915. Anti-inflammatory effects of rice bran components
1916. Anti-inflammatory function of Phyllostachys edulis extract in the hippocampus of HIV-1 transgenic rats
1917. Anti-inflammatory natural foods
1918. Anti-ischemic effect of Ginkgo biloba extract: facts and myths
1919. Anti-metastatic Activity of Pinosylvin, a Natural Stilbenoid, is Associated with the Suppression of MMPs
1920. Anti-microbial Activity of AC-care, a Composition of Herbal Extract, Against Propionibacterium Acne
1921. Anti-Neurodegenerative effects of sage (Salvia officinalis) via modulation of stress response signaling in C. elegans
1922. Anti-neuroinflammatory effects of Ephedra sinica Stapf extract-capped gold nanoparticles in microglia
1923. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells
1924. ANTI-NOCICEPTIVE AND ANTI-INFLAMMATORY EFFECTS OF AN ETHANOLIC EXTRACT OF THE AERIAL PARTS OF HILLERIA LATIFOLIA (LAM.) H. WALT …
1925. Anti-oxidant Properties of Some Lesser Known Fruits and Vegetables Consumed by families in South East Zone of Nigeria.
1926. Anti-oxidants and their role in disease management
1927. Anti-Oxidants, the Aging Brain and Age-Related Brain Disorders
1928. Anti-oxidative and anti-inflammatory effects of 2-cyclopropylimino-3-methyl-1, 3-thiazoline hydrochloride on glutamate-induced neurotoxicity in rat brain
1929. Anti-platelet aggregation activity of melaleuca bracteata var. revolution gold derived betulinic acid and its derivatives
1930. Anti-senescence compounds: a potential nutraceutical approach to healthy aging
1931. Anti-wrinkle Effect of Korean Rice Wine Cake
1932. Anti‐amyloidogenic activity of tetracyclines: studies in vitro
1933. Antiaging effects of bioactive molecules isolated from plants and fungi
1934. Antiamnesic Effect of Broccoli (Brassica oleracea var. italica) Leaves on Amyloid Beta (Aβ)1–42-Induced Learning and Memory Impairment
1935. Antiapoptotic effects of EGb 761
1936. Antibacterial activities of selected medicinal plants used to treat sexually transmitted infections in Blouberg area, Limpopo Province
1937. Antibacterial, antioxidant, antifungal and anti-inflammatory activities of crude extract from Nitraria schoberi fruits
1938. Antibody Based Diagnostic and Therapeutic
1939. Anticholinesterase and antioxidant effects of traditional herbal medicines used in the management of Neurodegenerative diseases in mauritius
1940. Anticholinesterase and antioxidative properties of aqueous extract of Cola acuminata seed in vitro
1941. Anticholinesterase constituents from the leaves of Spondias mombin L.(Anacardiaceae)
1942. Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats
1943. Antidepressant Plant Species from the Portuguese-Speaking African Countries (PALOP)
1944. Antidepressant Principles of the Roots of Polygala tenuifolia
1945. Antidepressant-and anxiolytic-like activities of an oil extract of propolis in rats
1946. Antidepressant‐like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus
1947. Antidepressive‐like effects and antioxidant activity of green tea and GABA green tea in a mouse model of post‐stroke depression
1948. Antidiabetic Effect of Codonopsis Lanceolata through the Regulation of Glucose Metabolism in C75BL/KsJ-db/db Mice
1949. Antidiabetic effects of tea
1950. Antidiabetic Screening and Phytochemical Investigation of Selected Medicinal Plants
1951. Antidotal effects of curcumin against neurotoxic agents: An updated review
1952. Antifibrotic Effects of Juglans sinensis Extract against CCl4-induced Liver Fibrosis in Rats
1953. Antifungal and antioxidant activity of Crassocephalum bauchiense (Hutch.) Milne-Redh ethyl acetate extract and fractions (Asteraceae)
1954. Antihyperglycemic activity of ethylacetate extract of Abelmoschus esculentus seed in alloxan induced hyperglycemic mice model
1955. Antihyperglycemic and Antihyperlipidemic Effects of Fermented Rhynchosia nulubilish in Alloxan-induced Diabetic RatsRhynchosia nulubilish in Alloxan …
1956. Antiinflammatory Properties of Dietary n-3 Polyunsaturated Fatty Acids Protect Against Cognitive Decline in Aging and Neurodegenerative Diseases
1957. Antimicrobial Activity and Quantum-chemical Studies of Novel 2-Arylidenehydrazinyl-4-arylthiazole Derivatives
1958. Antimicrobial and antioxidant properties of medicinal plants used by the Bentian tribe from Indonesia
1959. AntiNeurodegenerative and Antidiabetic Activity of Lichens
1960. Antioxidant actions of spices and their phytochemicals on age-related diseases
1961. Antioxidant Activities and Anti-tyrosinase Activity of Tribulus terrestris
1962. Antioxidant activities of the essential oils and extracts of Biebersteinia multifida DC
1963. Antioxidant Activity and Anti-inflammatory Effect of the Ethyl Acetate Fraction from Aruncus dioicus var. kamfschaticus
1964. Antioxidant activity and enzymes inhibitory properties of several extracts from two Moroccan Asteraceae species
1965. Antioxidant activity and protecting health effects of common medicinal plants
1966. Antioxidant activity of a solution of thymol in ethanol
1967. Antioxidant activity of Aegle marmelos, Withania somnifera, Bacopa monnieri, Centella asiatica, Sida cordifolia and Mucuna pruriens and its correlation with …
1968. ANTIOXIDANT ACTIVITY OF COLDENIA PROCUMBENS LINN. WHOLE PLANT METHANOLIC EXTRACT
1969. Antioxidant Activity of Dichloromethane Fraction from Equisetum hyemale L.
1970. Antioxidant activity of Dung beetle extracts on a high fat diet in Sprague-Dawley rats
1971. Antioxidant Activity of Extracts from Equisetum hyemale L.
1972. Antioxidant activity of oral administration of Rosmarinus officinalis leaves extract on rat’s hippocampus which exposed to 6-Hydroxydopamine
1973. Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms
1974. Antioxidant Activity of Water Extract from Green Tea
1975. Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of Pulmonaria officinalis and Centarium umbellatum extracts
1976. Antioxidant activity, acetylcholinesterase inhibitory potential and phytochemical analysis of Sarcocephalus latifolius Sm. bark used in traditional medicine in …
1977. Antioxidant and a-glucosidase inhibitory activity of Adina rubella Hance in vitro
1978. Antioxidant and acetylcholinesterase inhibition properties of Amorpha fruticosa L. and Phytolacca americana L.
1979. Antioxidant and acetylcholinesterase inhibitory activities of leaf extract and fractions of Albizia adianthifolia (Schumach) WF Wright
1980. Antioxidant and acetylcholinesterase inhibitory potential of thai medicinal plants
1981. Antioxidant and anti-acetylcholinesterase activities of extracts from Rapistrum rugosum in Tunisia
1982. ANTIOXIDANT AND ANTI-ACETYLCHOLINESTERASE POTENTIAL FROM WASTE OF SELECTED SOLANACEOUS PLANTS: ISOLATION AND …
1983. Antioxidant and anti-inflammatory activities of the root of Mussaenda glabrata
1984. Antioxidant and anti-inflammatory activity of Polygonatum sibiricum rhizome extracts
1985. Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression
1986. Antioxidant and anti-inflammatory related activities of certain botanicals frequently used in Ayurveda and other indigenous systems of medication
1987. Antioxidant and antiacetylcholinesterase activities of chard (Beta vulgaris L. var. cicla)
1988. Antioxidant and antiacetylcholinesterase activities of different granulometric classes of Salix alba (L.) bark powders
1989. Antioxidant and antiacetylcholinesterase activities of Sorbus torminalis (L.) Crantz (wild service tree) fruits
1990. Antioxidant and anticholinesterase activities of aqueous extract of Uraria picta (Jacq.) DC
1991. Antioxidant and anticholinesterase activities of the essential oil of Eugenia dysenterica DC
1992. Antioxidant and anticholinesterase activity of essential oils and ethanol extracts of Thymus algeriensis and Teucrium polium from Algeria
1993. Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species
1994. Antioxidant and anticholinesterase investigations of Rumex hastatus D. Don: potential effectiveness in oxidative stress and neurological disorders
1995. Antioxidant and anticholinesterase potential of six thymus species
1996. Antioxidant and Antimicrobial Investigations of dichloromethane (DCM) Extract of Garcinia cowa Bark
1997. Antioxidant and antiproliferative properties of water extract from Mahonia bealei (Fort.) Carr. leaves
1998. Antioxidant and cyclooxygenase-2-inhibiting effect of purple corn cob extract-loaded nanofiber patch on motor recovery in spinal cord injury rats
1999. Antioxidant and cytotoxicity effects of Luteolin
2000. Antioxidant and free radical scavenging activities of Ervatamia coronaria Stapf. leaves
2001. Antioxidant and Free Radical Scavenging Activity of Different Fractions from Synurus deltoides Nakai Leaves
2002. ANTIOXIDANT AND HEMOLYTIC ACTIVITIES OF NOVEL ORGANIC COMPOUNDS AND SOME PLANT EXTRACTS
2003. Antioxidant and Inhibitory Effects of Aqueous Extracts of Salvia officinalis Leaves on Pro-Oxidant-Induced Lipid Peroxidation in Brain and Liver In Vitro
2004. Antioxidant and its Applications
2005. Antioxidant and neuroprotective Activities of Mogami-benibana (Safflower, Carthamus tinctorius Linne)
2006. Antioxidant and neuroprotective Effects of Kaempferol and Tannic Acid against 6-Hydroxydopamine-induced Oxidative Stress
2007. Antioxidant and neuroprotective Effects of KM-34, A Novel Synthetic Catechol, Against Oxidative Stress-Induced Neurotoxicity
2008. Antioxidant and neuroprotective Effects of Scrophularia striata Extract Against Oxidative Stress-Induced Neurotoxicity
2009. Antioxidant and Non-enzymatic Glycation Inhibition Ability of Rosa davurica
2010. Antioxidant and other properties of green and black tea
2011. Antioxidant and oxidative stress: A mutual interplay in age-related diseases
2012. Antioxidant and phytochemicals of hexane and ethanolic extracts of Canarium schweinfurthii burseraceae.
2013. Antioxidant and pro-oxidant capacity of catecholamines and related compounds. Effects of hydrogen peroxide on glutathione and sphingomyelinase activity in …
2014. Antioxidant capacity of Melissa Officinalis L. on Biological Systems
2015. Antioxidant compounds and nutraceutical benefits of mediterranean red fruit
2016. Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro
2017. Antioxidant Constituents from a Vietnam Herbal Tea Gynostemma laxum
2018. ANTIOXIDANT CONTRIBUTION OF LAVENDER (Lavandula angustifolia)
2019. Antioxidant effect of alkynylselenoalcohol compounds on liver and brain of rats in vitro
2020. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results
2021. ANTIOXIDANT MEXIDOL. The main neuropsychotropic effects and the mechanism of action mechanism of action.
2022. Antioxidant Nutraceuticals as Health Drinks for Prevention of Diseases
2023. Antioxidant Nutraceuticals as Health Drinks for Prevention of Diseases
2024. Antioxidant Nutraceuticals for the Prevention and Treatment of Acute and Chronic Lung Diseases
2025. Antioxidant potential in fresh and processed products of selected fruits
2026. Antioxidant potential of Morinda pubescens fruits
2027. Antioxidant potential of the ethanol extract of the leaves of Vitex negundo L
2028. Antioxidant potentials of tannic acid on lipid peroxidation induced by several pro-oxidants in cerebral and hepatic lipids
2029. Antioxidant profiles of new chemical entities as multifunctional hits for the treatment of Neurodegenerative disorders
2030. Antioxidant Properties and Chemopreventive Potential Of the Bioactive Constituents Of the Roots Of Decalepis Hamiltonii
2031. Antioxidant properties of
2032. Antioxidant properties of 4-hydroxyquinolines
2033. Antioxidant properties of Calendula officinalis L. (Asteraceae) on Fe2+-initiated peroxidation of rat brain mitochondria
2034. Antioxidant Properties of Curcumin: Impact on Neurological Disorders
2035. Antioxidant properties of food products containing lycopene are increased by the presence of chlorophyll
2036. Antioxidant properties of Lippia javanica (Burm. f.) Spreng.
2037. Antioxidant properties of medicinal plants used in the Southern Ecuador
2038. ANTIOXIDANT PROPERTIES OF RED ONIONS, WHITE ONIONS (Allium cepa) AND GARLIC (Allium sativum).
2039. Antioxidant properties of selected African vegetables, fruits and mushrooms: A review
2040. Antioxidant Property Is the Basic Feature of Kampo Medicine
2041. Antioxidant strategies for Neurodegenerative diseases
2042. Antioxidant supplementation in the treatment of aging-associated diseases
2043. Antioxidant targeting by deferiprone in diseases related to oxidative damage
2044. Antioxidant Therapies for Neurodegenerative Diseases: Mechanisms, Current Trends, and Perspectives
2045. Antioxidant Therapies for Neuroprotection—A Review
2046. Antioxidant therapy and its effectiveness in oxidative stress-mediated disorders
2047. Antioxidant therapy effectiveness: an up to date
2048. Antioxidant therapy: current status and future prospects
2049. Antioxidant Therapy: Potential and Limitations
2050. Antioxidant therapy: Still in search of the ‘magic bullet’
2051. Antioxidant treatment induces hyperactivation of the HPA axis by upregulating ACTH receptor in the adrenal and downregulating glucocorticoid receptors in the …
2052. Antioxidant, Anti-inflammatory and neuroprotective Activities of a Plant Extract Derived from Traditional Chinese Medicine: SuHeXiang Wan (AT000)
2053. Antioxidant, antibacterial and antiacetylcholinesterase activities of Phalaris canariensis from Tunisia
2054. Antioxidant, antityrosinase, anticholinesterase, and nitric oxide inhibition activities of three Malaysian Macaranga species
2055. Antioxidants
2056. Antioxidants and cognitive function/Discussion/Comment
2057. Antioxidants and Healthy Life
2058. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity
2059. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity
2060. Antioxidants and human diseases
2061. Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases
2062. Antioxidants and Prooxidants: Effects on Health and Aging
2063. Antioxidants and the Comet assay
2064. Antioxidants as a preventive therapeutic option for age related Neurodegenerative diseases
2065. Antioxidants as treatment for Neurodegenerative disorders
2066. Antioxidants for the prevention and treatment of multiple sclerosis: an overview
2067. Antioxidants in health and disease
2068. Antioxidants in health, disease and aging
2069. Antioxidants in Huntington’s disease
2070. Antioxidants in medicinal plants
2071. Antioxidants of edible mushrooms
2072. Antioxidants World Congress
2073. Antioxidants, quinone reductase inducers and acetylcholinesterase inhibitors from Spondias tuberosa fruits
2074. Antioxidants: Dietary scavengers in lifestyle diseases
2075. Antioxidants: Its medicinal and pharmacological applications
2076. Antioxidants: new-generation therapeutic base for treatment of polygenic disorders
2077. Antioxidants: real medicines?
2078. Antioxidants: real medicines?: main topic
2079. Antioxidants: scientific literature landscape analysis
2080. Antioxidative activity and ameliorative effects of memory impairment of sulfur‐containing compounds in Allium species
2081. Antioxidative activity and anti-inflammatory effects of diarylheptanoids isolated from Alnus hirsuta
2082. Antioxidative and neuroprotective effects of Loranthus parasiticus (L.) Merr (Loranthaceae) against oxidative stress in NG108-15 cells
2083. Antioxidative and neuroprotective effects of volatile components in essential oils from Chrysanthemum indicum Linné flowers
2084. Antioxidative Components from the Whole Plants of Veronica peregrina
2085. Antioxidative effects of Rhodiola genus: Phytochemistry and pharmacological mechanisms against the diseases
2086. Antioxidizing Effect and Antimicrobial Activities of Saponins from Kalopanacis Cortex (Kalopanax pictus), Soybean (Glycine max) and Ginseng (Panax …
2087. Antiproliferative Activities of Halophyte Plant, Calystegia soldanella, Growing Near Southern and Western Seashores in Korea
2088. Antitumoral and Anticholinesterasic Activities of the Seven Species from Rubiaceae
2089. Anxiolytic Effects of the JA-Q: Involvement of GABAergic System
2090. Anxiolytic-like Effects of PNE-70 Using the Elevated Plus-Maze and Hole-board Apparatus in Mice
2091. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
2092. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model
2093. Apigetrin from Scutellaria baicalensis Georgi Inhibits Neuroinflammation in BV-2 Microglia and Exerts neuroprotective Effect in HT22 Hippocampal Cells
2094. Apios americana Medik flowers extract protects PC12 cells against H2O2 induced neurotoxicity via regulating autophagy
2095. Apium plants: Beyond simple food and phytopharmacological applications
2096. Application of phytochemicals for the treatment of Neurodegenerative diseases.
2097. Application of precision medicine in Neurodegenerative diseases
2098. Application of quercetin in neurological disorders: from nutrition to nanomedicine
2099. Application of resveratrol in diabetes: rationale, strategies and challenges
2100. Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus
2101. Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae …
2102. Appraisal of scopolamine-induced antiamnesic effect of Sphaeranthus indicus in mice
2103. Aqueous extract of the Chinese medicine, Danggui‐Shaoyao‐San, inhibits apoptosis in hydrogen peroxide‐induced PC12 cells by preventing cytochrome c release …
2104. Aqueous–ethanol extracts of some South African seaweeds inhibit beta‐amyloid aggregation, cholinesterases, and beta‐secretase activities in vitro
2105. Araucaria angustifolia (Bertol.) Kuntze has neuroprotective action through mitochondrial modulation in dopaminergic SH-SY5Y cells
2106. Arcopilus aureus, a Resveratrol-Producing Endophyte from Vitis vinifera
2107. Are antioxidant supplements effective for the prevention and treatment of diseases?
2108. ARE ANTIOXIDANTS GOOD THERAPEUTIC CANDIDATES FOR HUNTINGTON’S DISEASE?
2109. Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration?
2110. Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of Neurodegenerative brain disorders?
2111. Aronia melanocarpa treatment and antioxidant status in selected tissues in Wistar rats
2112. Ashwagandha Root Extract Inhibits Acetylcholine Esterase, Protein Modification and Ameliorates H2O2-Induced oxidative stress in Rat Lymphocytes
2113. Asian Medicinal Remedies for Alleviating Aging Effects
2114. Asparagus adscendens root extract enhances cognition and protects against scopolamine induced amnesia: An in-silico and in-vivo studies
2115. Assessing neuroprotective Agents for Aβ-Induced Neurotoxicity
2116. Assessment of acetylcholinesterase and tyrosinase inhibitory and antioxidant activity of Alchemilla vulgaris and Filipendula ulmaria extracts
2117. Assessment of anti-cholinesterase activity and cytotoxicity of cagaita (Eugenia dysenterica) leaves
2118. Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L.(St. John’s wort)
2119. Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents
2120. Assessment of In-House Natural Product and Synthetic Compound Libraries Based on In vitro Inhibition of Cholinesterases
2121. Assessment of natural herbal based antitussive and expectorant efficacy of respiratory symptom
2122. Assessment of neuroprotective efficacy of phytochemicals against oxidatiive stress mediated neurodegeneratiion in Drosophilla mellanogaster
2123. Assessment of the Effect of Green tea Consumption on Fibrinogen Among Adult Healthy Sudanese Volunteers
2124. Association of blood antioxidants status with visual and auditory sustained attention
2125. Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic review
2126. Astrocyte heterogeneity: impact to brain aging and disease
2127. Asymmetric Synthesis of D-and L-ribo-Phytosphingosine
2128. Atherosclerosis: Pathophysiology and promising herbal remedies in traditional Persian medicine
2129. Atherothrombosis and oxidative stress: mechanisms and management in elderly
2130. Atividade antioxidante e hepatoprotetora de plantas brasileiras, contendo compostos fenólicos.
2131. Atropa acuminata Royle Ex Lindl. blunts production of pro-inflammatory mediators eicosanoids., leukotrienes, cytokines in vitro and in vivo models of acute …
2132. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures
2133. Attenuation of aluminum chloride-induced neuroinflammation and caspase activation through the AKT/GSK-3β pathway by hesperidin in wistar rats
2134. Australian Native Plants–A Source of Novel Anti-inflammatory Compounds
2135. Autism spectrum disorders: Potential neuro-psychopharmacotherapeutic plant-based drugs
2136. Autism, Genetics
2137. Autism: Synthetic-and plant-derived control and treatment
2138. Autophagy and microglia: novel partners in neurodegeneration and aging
2139. Autophagy in health and disease
2140. Autophagy in Neurodegeneration: Latest developments on eating ourselves out of disease
2141. Avocado as a major dietary source of antioxidants and its preventive role in Neurodegenerative diseases
2142. Avocado Juice Prevents the Formation of Trypsin Amyloid-Like Fibrils in Aqueous Ethanol
2143. AzBilliards. com> Main Category> Non Pool Related> Why Is The Food Industry Trying To Kill Us?-Top 10 Food Additives to Avoid
2144. Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain
2145. Bacteriocin produced by Bacillus strain, isolated from Korean traditional fermented food kimchi shows broad antibacterial activity in optimized media
2146. Baicalein as a potent neuroprotective agent: A review
2147. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo
2148. Baicalein protects C6 glial cells against hydrogen peroxide-induced oxidative stress and apoptosis through regulation of the Nrf2 signaling pathway
2149. Baicalein suppresses Repeat Tau fibrillization by sequestering oligomers
2150. Baicalein suppresses Tau fibrillization by sequestering oligomers
2151. Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and …
2152. Balsamite major Desf.: Redox properties, antiinflammatory and cytoprotective effects
2153. Basic Research to Breakthroughs in Antibody Therapeutics
2154. BBA-Molecular Basis of Disease
2155. Beer as an Integral Part of Healthy Diets: Current Knowledge and Perspective
2156. Behavioral and Biochemical Consequences of Simulated Vehicle Exhaust Exposure in Rats
2157. BEHAVIORAL ECONOMICS APPROACH TO PERIMENOPAUSE, A LEARNING CULPABILITY OF WOMEN IN DEVELOPING NATIONS
2158. Benefical effects of mediterranean diet in neuroinflammation and related diseases
2159. Beneficial Effects of Carvacrol on Insulin Resistance in High Fat Diet-induced Diabetic Mice
2160. Beneficial effects of date palm fruits on Neurodegenerative diseases
2161. Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
2162. Beneficial effects of ellagic acid against animal models of scopolamine-and diazepam-induced cognitive impairments
2163. Beneficial Effects of Extra Virgin Olive Oil (n-9 Fatty Acids) on Neurological Disorders
2164. Beneficial Effects of Ginkgo biloba in Neurological Disorders
2165. Beneficial effects of green tea catechins on Neurodegenerative diseases
2166. Beneficial effects of green tea catechins on neurological disorders
2167. Beneficial effects of propolis on neurological disorders
2168. Beneficial Effects of Resveratrol Administration—Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions
2169. Beneficial upshots of naturally occurring antioxidant compounds against neurological disorders
2170. Benefits of curcumin in brain disorders
2171. Benefits of grape chemicals on human health
2172. Benefits of the Mediterranean Diet in the Elderly Patient
2173. Benefits of tree nuts consumption on aging and age-related diseases: mechanisms of actions
2174. Benzimidazole derivatives: active class of antioxidants
2175. Berberine and neurodegeneration: A review of literature
2176. Berberine–A Neuropsychiatric Pharmacotherapy
2177. Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats
2178. Berries and Health: A review of the evidence
2179. Berries: Properties, Consumption and Nutrition
2180. Berry fruit enhances beneficial signaling in the brain
2181. Berry fruit supplementation and the aging brain
2182. Berry Supplementation and Their Beneficial Effects on Some Central Nervous System Disorders
2183. Berryfruit Cognitive Study: Final Report Berryfruit Cognitive Study
2184. Beverage Impacts on Health and Nutrition
2185. Beverages of lemon juice and exotic noni and papaya with potential for anticholinergic effects
2186. Binding modes of phthalocyanines to amyloid β peptide and their effects on amyloid fibril formation
2187. Bio prospection of antioxidant potential of Pinus roxburghii Sarg collected from different Himalayan regions of India
2188. Bioactive chemicals and health benefits of grapevine products
2189. Bioactive Compounds as Therapeutic Alternatives
2190. Bioactive Compounds Contained in Mediterranean Diet and Their Effects on Neurodegenerative Diseases
2191. Bioactive compounds from endemic plants of Southwest Portugal: Inhibition of acetylcholinesterase and radical scavenging activities
2192. Bioactive compounds from ethnobotanically-selected plants in Indonesia
2193. Bioactive compounds from macroalgae in the new millennium: implications for Neurodegenerative diseases
2194. Bioactive compounds in medicinal plants: A condensed review
2195. Bioactive compounds of chestnuts as health promoters
2196. Bioactive compounds of kimchi inhibit apoptosis by attenuating endoplasmic reticulum stress in the brain of amyloid β-injected mice
2197. BIOACTIVE COMPOUNDS WITH NEUROPHARMACOLOGICAL PROPERTIES FROM MEDICINAL PLANTS–A BRIEF REVIEW
2198. Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions
2199. Bioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry
2200. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease
2201. Bioactive nutraceuticals and dietary supplements in neurological and brain disease: prevention and therapy
2202. Bioactive Oxidised Products of Omega-6 and Omega-3, Excess Oxidative Stress, Oxidised Dietary Intake and Antioxidant Nutrient Deficiencies, in the Context of a …
2203. Bioactive properties of Chamaerops humilis L.: antioxidant and enzyme inhibiting activities of extracts from leaves, seeds, pulp and peel
2204. Bioactive Substances of Plant Origin 30
2205. Bioactives from culinary spices and herbs: a review
2206. Bioactivity of essential oils and their volatile aroma components
2207. Bioactivity of Morus alba l. Extracts-An overview
2208. Bioactivity Screening of One Hundred Kind Pure Compounds by ABTS and DPPH Method
2209. Bioavailability and toxicity of aluminium to the freshwater pond snail, Lymnaea stagnalis at neutral pH
2210. Biochemical and thermodynamic characterization of a novel, low-molecular-weight xylanase from Bacillus sp. CSB40 isolated from traditional Korean food
2211. Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements
2212. Biochemical insights related to the propensity of phytochemicals in forestalling/reversing neuronal dysfunctions
2213. Biochemical pharmacology of functional foods and prevention of chronic diseases of aging
2214. Biochemical profile and in vitro neuroprotective properties of Carpobrotus edulis L., a medicinal and edible halophyte native to the coast of South Africa
2215. Biochemical properties and neuroprotective effects of compounds in various species of berries
2216. Biochemical Studies on Phytocystain Purified from Brassica Alba Yellow Indian Mustard Seeds
2217. Bioconversion of SB enhances otoprotective effect against noise induced hearing loss in mouse
2218. Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products
2219. Biodiversity and Therapeutic Potential of Medicinal Plants
2220. Biodiversity, biology and conservation of medicinal plants of the Thar Desert
2221. Bioinformatics Approaches to Find Potential Therapeutic Candidates Using Microarray and Protein-Protein Interaction Resources for Psoriasis
2222. BIOKINETICS OF GINGER TO MITIGATE HEALTH RELATED DISORDERS
2223. Biological activities of (−)-epicatechin and (−)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health
2224. Biological activities of mimosine isolated from Leucaena leucocephala and identification of bioactive compounds from subtropical plant Bidens pilosa
2225. Biological activities of the natural antioxidant oleuropein: Exceeding the expectation–A mini-review
2226. Biological activity and phytochemistry of firethorn (Pyracantha coccinea MJ Roemer)
2227. Biological activity of HPLC-characterized ethanol extract from the aerial parts of Haplophyllum tuberculatum
2228. BIOLOGICAL ACTIVITY OF SOME NATURAL AND SYNTHETIC N6-SUBSTITUTED ADENOSINE DERIVATIVES (CYTOKININ RIBOSIDES)
2229. Biological activity of Spondias pinnata: a review
2230. Biological and chemical insights of Morina persica L.: A source of bioactive compounds with multifunctional properties
2231. Biological applications of designed hairpin peptides: as antimicrobials and as inhibitors of amyloidogenesis
2232. Biological Evaluation of Natural Product as a Potent Hsp90 Inhibitor.
2233. Biological fingerprinting of herbal samples by means of liquid chromatography
2234. Biologically active metabolites of plants. 7. Alkaloids from Corydalis yanhusuo and their biological activity.
2235. Biologically relevant secondary metabolites of Vaccinium uliginosum: bioassay-directed natural products identification of anti-neuroninflammatory agents in the Alaska …
2236. Biology-oriented development of novel lipophilic antioxidants with neuroprotective activity
2237. Biomarkers in long‐term vegetarian diets
2238. Biomarkers of Foods and Nutraceuticals: Applications in Efficacy, Safety, and Toxicity
2239. Biopesticides from plants: Calceolaria integrifolia sl
2240. Bioprospecting plants for natural antioxidants: An overview
2241. Bioscience frontiers in neuromedical intervention following brain injury
2242. Biotechnology, In Vitro Production of Natural Bioactive Compounds, Herbal Preparation, and Disease Management (Treatment and Prevention)
2243. Black berry juice attenuates neurological disorders and oxidative stress associated with concurrent exposure of aluminum and fluoride in male rats
2244. Black chokeberry (Aronia melanocarpa) and its products as potential health-promoting factors-An overview
2245. Black tea: The plants, processing/manufacturing and production
2246. Blood brain barrier inflammation and potential therapeutic role of phytochemicals
2247. BLUEBERRIES
2248. Blueberries and neuronal aging
2249. Blueberry Opposes β-Amyloid Peptide-Induced Microglial Activation Via Inhibition of p44/42 Mitogen-Activation Protein Kinase
2250. Blueberry supplementation improves memory in older adults
2251. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats
2252. Boost Your Brain Power in 60 Seconds: The 4-week Plan for a Sharper Mind, Better Memory, and Healthier Brain
2253. Botanicals and phytochemicals active on cognitive decline: The clinical evidence
2254. Boysenberry and blackcurrant drinks increased the plasma antioxidant capacity in an elderly population but had little effect on other markers of oxidative stress
2255. BPA and Nutraceuticals, Simultaneous Effects on Endocrine Functions
2256. Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline
2257. Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function
2258. Brain Fitness for Women: Keeping Your Head Clear & Your Mind Sharp at Any Age
2259. Brain Food
2260. Brain food: How nutrition alters our mood and behaviour
2261. Brain iron metabolism and its perturbation in neurological diseases
2262. Brain Protective and Erythrocytes Hemolysis Inhibition Potentials from Galls of Guiera senega lensis JF Gmel (Combretaceae)” PAED Sombie,” A. Hilou,” AY …
2263. Brain-Building Nutrition: The Healing Power of Fats and Oils
2264. Brief Challenges on Medicinal Plants: An Eye‐Opening Look at Ageing‐Related Disorders
2265. Brine shrimp lethality test and acetylcholine esterase inhibition studies on selected South African medicinal plants
2266. Broad bean (Vicia faba L.) pods: a rich source of bioactive ingredients with antimicrobial, antioxidant, enzyme inhibitory, anti-diabetic and health-promoting properties
2267. Cacao and Human Health: from Head to Foot–A Review
2268. Caenorhabditis elegans: a model organism for nutraceutical safety and toxicity evaluation
2269. CAFFEIC ACID AVERTED INTRACEREBROVENTRICULAR COLCHICINE-INDUCED MEMORY DEFICITS IN RATS
2270. Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity
2271. CAFFEINATED BEVERAGE CONSUMPTION IN UNDERGRADUATE STUDENTS AT A PUBLIC MID-WESTERN UNIVERSITY
2272. Caffeinated Beverages, Behavior, and Brain Structure
2273. Caffeoylquinic acid induces ATP production and energy metabolism in human neurotypic SH-SY5Y cells
2274. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of Neurodegenerative diseases provide multiple targets for neuroprotection
2275. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction
2276. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential
2277. Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity
2278. Calorie restriction mimetics and aging
2279. Can crosstalk between DOR and PARP reduce oxidative stress mediated neurodegeneration?
2280. Can nonalcoholic beer, silicon and hops reduce the brain damage and behavioral changes induced by aluminum nitrate in young male Wistar rats?
2281. Can tea consumption be a safe and effective therapy against diabetes mellitus-induced neurodegeneration?
2282. Cannabinoids: A Group of Promising neuroprotective Agents
2283. Canyon Ranch 30 Days to a Better Brain: A Groundbreaking Program for Improving Your Memory, Concentration, Mood, and Overall Well-Being
2284. Capillarisin attenuates muscle damage after intense exercise
2285. Capsicum annuum bioactive compounds: Health promotion perspectives
2286. Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators
2287. Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation
2288. Cardioprotective and neuroprotective roles of oleuropein in olive
2289. CARNOSINE: A POTENT MODULATOR FOR DIFFERENT DISEASES
2290. Carotenoids of microalgae used in food industry and medicine
2291. Carthamus, Salvia and Stachys species protect neuronal cells against oxidative stress-induced apoptosis
2292. Castanea sativa Mill. Leaves as New Sources of Natural Antioxidant: An Electronic Spin Resonance Study
2293. Catalpol: a potential therapeutic for Neurodegenerative diseases
2294. Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats
2295. Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway
2296. Catharanthus roseus: Detoxification and Hepatic Protection of Aflatoxin B1
2297. Cell aging: molecular mechanisms and implications for disease
2298. Cell and Nanoparticle Tracking PET Imaging Study using Bioorthogonal F-18 Labeling Protocols.
2299. Cell culture models of oxidative stress and injury in the central nervous system
2300. Cell death and neuronal arborization upon quercetin treatment in rat neurons
2301. Cell Protective Signaling Pathway of Activated Protein C
2302. Cellular and mitochondrial effects of alcohol consumption
2303. Cellular Antioxidant Defenses and Amelioration by Biopigments with Particular Focus on mRNA Oxidations
2304. Cellular prion protein-dependent signaling pathway for proinflammatory cytokine-and β-amyloid-induced cofilin-actin rod formation, A
2305. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, Neurodegenerative disorders and longevity
2306. Centella asiatica (Gotu kola) as a neuroprotectant and its potential role in healthy ageing
2307. Centella asiatica attenuates D-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice
2308. Centella asiatica, an Ayurvedic Medicinal Plant, Prevents the Major Neurodegenerative and Neurotoxic Mechanisms Associated with Cognitive Impairment
2309. Centella asiatica: phytochemistry and mechanisms of neuroprotection and cognitive enhancement
2310. Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy
2311. Central nervous system diseases and Scutellaria: a review of current mechanism studies
2312. Cerebrovascular and neuronal cellular consequences of amyloid-βinduced nuclear factor-κB activation
2313. Chaenomeles–health promoting benefits
2314. Challenges on the processing of plant-based neuronutraceuticals and functional foods with emerging technologies: Extraction, encapsulation and therapeutic …
2315. Chamomile: a herbal agent for treatment of diseases of the elderly
2316. Changes & Directions of Education for Other Health Care Professionals: Medical & Dental Education in Korea
2317. Changes in the Central Glutamatergic Nervous Activity Following Chronic Intracerebroventricular Administration of Nicotine in Rats
2318. Changes of Anti-inflammatory Activity of Gardeniae Fructus by Processing
2319. Changes of Catecholamine Secretion in the Perfused Adrenal Medulla of the Alloxan-Induced Diabetic Rats
2320. CHANGES TO THE BRAIN FOUNDATION BOARD
2321. Changing paradigm to target microglia in Neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation
2322. Characteristcs of Pathogen-specific Memory T cells in the Liver during acute viral infection
2323. Characteristics, Biological Properties and Analytical Methods of Trans-Resveratrol: A Review
2324. Characteristics, composition, and antioxidant activities in vitro and in vivo of Gynostemma pentaphyllum (Thunb.) Makino seed oil
2325. Characterization and bioavailability of neuroprotective grape seed extract in an animal model
2326. Characterization of antimicrobial and antioxidant metabolites from Pinus gerardiana and Picea smithiana growing in North Western Himalayas
2327. Characterization of Autophagic Cell Death Mechanism in Two Different Dopaminergic Neuronal Models
2328. Characterization of Novel Regulators of Helper T Cell Proliferation
2329. Characterization of Physicochemical Properties for ADME/PK Study and New Drug Discovery
2330. Characterization of Tau Oligomeric Strains: Implications for Disease Phenotypes
2331. Characterization of the neuroprotective potential of derivatives of the iron chelating drug deferiprone
2332. Characterizing the inhibition of α‐synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP
2333. Chemical analysis and antioxidant activities of bark extracts from four endemic species of Hyrcanian forests in Iran
2334. Chemical analysis and neurobiological effects of Newfoundland wild blueberries
2335. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals
2336. Chemical characterization and antioxidant properties of a new coffee blend with cocoa, coffee silverskin and green coffee minimally processed
2337. Chemical Composition and Antioxidant Activity of Aloe saponaria
2338. Chemical composition and antioxidant, antibacterial and antifungal activities of the essential oils from Bidens pilosa Linn. var. Radiata
2339. Chemical composition and biological activity of Capparis spinosa L. from Lipari Island
2340. Chemical composition and in vitro antioxidative activity of a lemon balm (Melissa officinalis L.) extract
2341. Chemical Composition Antioxidant and Antimicrobial Activities of the Essential Oils of Matricaria aurea Loefl. Growing in Tunisia
2342. Chemical composition of the lipophilic fraction of Livistona australis R. Br. Mart.,(Arecaceae) fruit pulp and evaluation of its antioxidant and antihyperlipidemic …
2343. Chemical composition of the perennial plant sorghum and fodder prepared and hay.
2344. Chemical composition, antioxidant potential, macromolecule damage and neuroprotective activity of Convolvulus pluricaulis
2345. Chemical constituents from the fruits of Citrus unshiu and their inhibitory effects on acetylcholinesterase
2346. Chemical Constituents of Selected Herbal Medicines
2347. Chemical Constituents of Soft Coral Lobophytum compactum in the Sea Vietnam and Cytotoxic and Antioxidant Activities of Some Diterpenes and Sterols
2348. Chemical Constituents with Pancreatic Lipase Inhibitory Activity from the Rhizomes of Anemarrhena asphodeloides.
2349. Chemical modification of the multitarget neuroprotective compound fisetin
2350. Chemical modulators of protein misfolding and Neurodegenerative disease
2351. Chemical profiling and in vitro biological effects of Cardiospermum halicacabum L. (Sapindaceae) aerial parts and seeds for applications in Neurodegenerative …
2352. Chemical profiling, antioxidant, enzyme inhibitory and molecular modelling studies on the leaves and stem bark extracts of three African medicinal plants
2353. Chemical standardization of some anti inflammatory rasayana plants used in Indian system of medicine
2354. Chemical transformations and phytochemical studies of bioactive components from extracts of rosmarinus officinalis L.
2355. Chemical, molecular pharmacology and neuroprotective properties of the essential oil derived from Aloysia citrodora Palau
2356. Chemistry and Biochemistry of Terpenoids from Curcuma and Related Species
2357. Chemistry and functional properties in prevention of Neurodegenerative disorders of five Cistus species essential oils
2358. Chemistry and health effects of bioactive compounds in selected culinary aromatic herbs
2359. Chemistry and pharmacological properties of some natural and synthetic antioxidants for heavy metal toxicity
2360. Chemistry and pharmacology of naturally occurring bioactive compounds
2361. Chemistry and pharmacology of Withania somnifera: An update
2362. Chemistry of Advanced Materials 3 (2)(2018) 36-59 Antioxidant, Anti-inflammatory and neuroprotective Activities of a Plant Extract Derived from Traditional Chinese …
2363. Chemistry of functional foods and their role in disease control
2364. Chemo-botanical and neurological accounts of some ayurvedic plants useful in mental health
2365. Chemoprevention of Inflammation-Associated Colorectal Carcinogenesis: Molecular Targets and Underlying Mechanisms
2366. Cherry phytochemicals
2367. Chicoric acid supplementation ameliorates cognitive impairment induced by oxidative stress via promotion of antioxidant defense system
2368. Chinese Herbal Medicine Used Against Depression in China
2369. Chinese Medicines in Neurological Diseases: Pharmacological Perspective
2370. Chinical Application of Adult Stem Cell Therapy in Neurological Disorders; Present and Future
2371. Chiral Self-Recognition of 3, 5-Dinitrobenzoylleucine Derivatives using Pirkle-type Chiral Stationary Phases
2372. Chitooligosaccharide (CHOS) mediated regulation of intestinal inflammatory condition in colitis mice
2373. Chloroquine inhibits glutamate‐induced death of a neuronal cell line by reducing reactive oxygen species through sigma‐1 receptor
2374. Chocolate, air pollution and children’s neuroprotection: What cognition tools should be at hand to evaluate interventions?
2375. Chocolate, air pollution and children’s neuroprotection: What cognition tools should be at hand to evaluate interventions?
2376. Cholesterol, Statins and the Truth about Cardiovascular Health and Disease
2377. Cholinesterase inhibition of selected 4-methylcoumarins in comparison to their antioxidant activity
2378. Cholinesterase inhibitor (Altenuene) from an endophytic fungus Alternaria alternata: optimization, purification and characterization
2379. Cholinesterase inhibitors from plants: possible treatment strategy for neurological disorders-a review
2380. Cholinesterase inhibitory, anti-oxidant and anti-tyrosinase activities of three Iranian species of Dracocephalum
2381. Cholinesterase, β-amyloid aggregation inhibitory and antioxidant capacities of Chinese medicinal plants
2382. Chromatographic Fingerprint Analysis, Acetylcholinesterase Inhibitory Properties and Antioxidant Activities of Redflower Ragleaf (Crassocephalum Crepidioides) …
2383. Chromolaena odorata (L.) RM King & H. Rob.(Asteraceae) in sub-Saharan Africa: A synthesis and review of its medicinal potential
2384. Chronic administration of quercetin prevent spatial learning and memory deficits provoked by chronic stress in rats
2385. Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress
2386. Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity
2387. Chrysophanol: a natural anthraquinone with multifaceted biotherapeutic potential
2388. Cilostazol, a Phosphodiesterase Inhibitor Attenuates Endotoxin Shock and LPS-induced Inflammation by Independence of cAMP, MAPK, and NK-kappaB …
2389. Cinnamon and chronic diseases
2390. Cistanches Herba: a neuropharmacology review
2391. Citrus: A Perspective for Developing Phytomedicines for Neurodegenerative Diseases
2392. Clean Cuisine: An 8-Week Anti-Inflammatory Diet that Will Change the Way You Age, Look & Feel
2393. Clinical aspects of functional foods and nutraceuticals
2394. Clinical benefits and pharmacology of scutellarin: a comprehensive review
2395. Clinical benefits of green tea consumption for cognitive dysfunction
2396. Clinical natural medicine handbook
2397. Clinical Pharmacological Aspects of Herb-drug Interaction
2398. Clinical research on traditional chinese medicine compounds and their preparations for amyotrophic lateral sclerosis
2399. Clinical trials of resveratrol
2400. Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence
2401. Cocoa and chocolate in human health and disease
2402. Cocoa and chocolate: chemistry, biochemistry, and beneficial brain effects
2403. Cocoa and health
2404. Cocoa and human health: from head to foot—a review
2405. Cocoa beans improve mitochondrial biogenesis via PPARγ/PGC1α dependent signalling pathway in MPP+ intoxicated human neuroblastoma cells (SH-SY5Y)
2406. Cocoa phytochemicals: recent advances in molecular mechanisms on health
2407. Coconut (Cocos nucifera) ethanolic leaf extract reduces Amyloid-β (1-42) aggregation and paralysis prevalence in transgenic Caenorhabditis elegans independently …
2408. Coenzyme Q10: From bench to clinic in aging diseases, a translational review
2409. Coffee and its active compounds are neuroprotective
2410. Coffee Consumption and Chronic Diseases: Nutrigenomics Perspectives
2411. Coffee Diterpene Kahweol Inhibits Metastasis via STAT3 Inactivation
2412. Coffee intake can promote activity of antioxidant enzymes with increasing MDA level and decreasing HDL-cholesterol in physically trained rats
2413. Coffee–Chemical Composition and Potential Impact on Health
2414. Coffee–functional food and medicinal herb
2415. Coffee, caffeine, chlorogenic acid, and the purinergic system
2416. Coffee: A health fuel-blot popular drinking
2417. Coffee: Consumption and Health Implications
2418. Coffee: The revolutionary drink for pleasure and health
2419. Cognitive and behavioral assessment in dogs and pet food market applications
2420. Cognitive and cardiovascular aging: The effects of multivitamin supplementation
2421. Cognitive and mood improvements following acute supplementation with purple grape juice in healthy young adults
2422. Cognitive anxiolytics
2423. Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice
2424. Cognitive enhancement and neuroprotection by catechin‐rich oil palm leaf extract supplement
2425. Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs
2426. Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014
2427. Cognitive Enhancing, Anti-Acetylcholinesterase and Antioxidant Properties of Tagetes erecta against Diazepam Induced Amnesia in Rodents
2428. Cognitive function and tea consumption in community dwelling older Chinese in Singapore
2429. Cognitive impairment in patients with type 2 diabetes mellitus: Perspectives and challenges
2430. Cognitive impairments in type 2 diabetes, risk factors and preventive strategies
2431. Cognitive Improving Effects by Highbush Blueberry (Vaccinium crymbosum L.) Vinegar on Scopolamine-Induced Amnesia Mice Model
2432. Cognitive Nutrition
2433. Cognitive short-and long-term effects of coffee cherry extract in older adults with mild cognitive decline
2434. Combination Protocol of Surface Camouflage and Immunosuppressive Drugs for the Pancreatic Islet Transplantation
2435. Committee on herbal medicinal products (HMPC)
2436. Commonly used dietary supplements on coagulation function during surgery
2437. Comparative analysis of synthetic and nutraceutical antioxidants as possible neuroprotective agents
2438. Comparative approaches to understanding thyroid hormone regulation of neurogenesis
2439. Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors
2440. Comparative effect of Camellia sinensis teas on object recognition test deficit and metabolic changes induced by cafeteria diet
2441. Comparative evaluation of Prosopis cineraria (L.) druce and its ZnO nanoparticles on scopolamine induced amnesia
2442. Comparative Evaluation of the Antioxidant Properties of Prunella vulgaris L. and Thymus vulgaris L.
2443. Comparative qualitative and quantitative analysis of phytochemicals in five different herbal formulations of Bacopa monnieri
2444. Comparative study on anti-oxidant and anti-inflammatory activities of Caesalpinia crista and Centella asiatica leaf extracts
2445. Comparison between Hexane and Water Fractions from Equisetum hyemale L. for Antioxidant Activity
2446. Comparison of Consumer Acceptance, Physico-chemical Properties, and Bioactive Delivery of Blueberry Extract and Whole Blueberry Powder Confections
2447. Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice
2448. Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels
2449. Comparison of the neuroprotective and anti-inflammatory effects of the anthocyanin metabolites, protocatechuic acid and 4-hydroxybenzoic acid
2450. Comparison of two analytical methods for assessing antioxidant capacity of rapeseed and olive oils
2451. Comparison of α-synuclein fibril inhibition by four different amyloid inhibitors
2452. Complementary and alternative medicine for the treatment of multiple sclerosis
2453. Complementary and alternative medicines use against Neurodegenerative diseases
2454. Complementary and Integrative Therapies for Psychiatric Disorders, An Issue of Psychiatric Clinics, E-Book
2455. Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicity
2456. Computational insight into the effect of natural compounds on the destabilization of preformed amyloid-β (1–40) fibrils
2457. Computer aided drug design studies in the discovery of secondary metabolites targeted against age-related Neurodegenerative diseases
2458. Conditional Knockdown of p70 S6 Kinase in Liver Protects against Hepatic Steatosis and Systemic Insulin Resistance
2459. Conformation-Specific Chemical Probes for Amyloid
2460. Conformation-Specific Chemical probes for Amyloid-Beta
2461. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in Neurodegenerative diseases
2462. Considerations for evaluation of public health nutrition interventions in diverse communities
2463. Constituents with DNA Topoisomerase I and II Inhibitory Activity and Cytotoxicities from Euonymus alatus III
2464. Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice
2465. Consumption Of Drugs For Peptic Ulcer And Gastroesophageal Reflux Disease: An Analysis Focusing On Drug Claims 2006 To 2011
2466. Consumption of Nuts at Midlife and Healthy Aging in Women
2467. Contribution of Receptors, Transcription Factors, and Genes in the Induction of Neuroinflammation
2468. Contribution of Yeast and Plant Research for Improving Human Health
2469. Convenient determination of methylsulfonylmethane for a commercially available dietary supplement formulations using gas chromatography-flame ionization …
2470. Coordination complex formation and redox properties of kynurenic and xanthurenic acid can affect brain tissue homeodynamics
2471. Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer
2472. Coriander (Coriandrum sativum): A promising functional food toward the well-being
2473. Coriolus versicolor biomass increases dendritic arborization of newly-generated neurons in mouse hippocampal dentate gyrus
2474. Correlation between antibutyrylcholinesterasic and antioxidant activities of three aqueous extracts from Tunisian Rhus pentaphyllum
2475. Correlations Among Total Ash, Acid-Insoluble Ash, and Heavy Metals Contained in the Component Medicinal Herbs of “Ssanghwatang”, a Widely Used …
2476. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
2477. Coumarins and related compounds from the medicinal plants of Africa
2478. Coumarins as Promising Scaffold for the Treatment of Age-related Diseases–An Overview of the Last Five Years
2479. Coupling sea lavender (Limonium algarvense Erben) and green tea (Camellia sinensis (L.) Kuntze) to produce an innovative herbal beverage with enhanced …
2480. Crepis foetida L. subsp. rhoeadifolia (Bieb.) Celak. as a source of multifunctional agents: Cytotoxic and phytochemical evaluation
2481. Critical evaluation of ayurvedic plants for stimulating intrinsic antioxidant response
2482. Cross Talk Between Impaired Brain Glucose Metabolism and Tau hyperphosphorylation
2483. Cross-Talk for Health Care Providers Nutrition and Behavior as it Applies to Systemic and Ocular
2484. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related Neurodegenerative disease: Etiologies and therapeutic strategies
2485. Cu and Zn interactions with Aβ peptides: Consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers
2486. Cudratricusxanthone L Suppresses Lipopolysaccharide-induced Activation of BV2 and Primary Rat Microglial Cells by Inhibiting JNK, p38 MAPK, and NF-κB …
2487. Cultural and Natural Resources and Quality Control of Chinese Medicinal Materials
2488. Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha‐Synuclein Fibrillation and Cytotoxicity
2489. Curcuma longa L.: From Ethnomedicinal to Novel Biomedical Applications
2490. Curcumin activates defensive genes and protects neurons against oxidative stress
2491. Curcumin and health
2492. Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain
2493. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century
2494. Curcumin and Neurodegenerative diseases: a perspective
2495. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences
2496. Curcumin counteracts the aluminium-induced ageing-related alterations in oxidative stress, Na+, K+ ATPase and protein kinase C in adult and old rat brain regions
2497. Curcumin Impact on Multiple Sclerosis
2498. Curcumin-Loaded Nanocapsules Reverses the Depressant-Like Behavior and oxidative stress Induced by β-Amyloid in Mice
2499. Curcumin-supplemented diets improve antioxidant enzymes and alter acetylcholinesterase genes expression level in Drosophila melanogaster model
2500. Curcumin—from molecule to biological function
2501. Curcumin, an atoxic antioxidant and natural NFκB, cyclooxygenase‐2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic …
2502. Curcumin, Hormesis and the Nervous System
2503. Curcumin: Structure-activity relationship towards its role as a versatile multi-targeted therapeutics
2504. Curcuminoids promote neurite outgrowth in PC12 cells through MAPK/ERK-and PKC-dependent pathways
2505. Current and future treatment of amyloid diseases
2506. Current evidence of Chinese herbal constituents with effects on NMDA receptor blockade
2507. Current perspective in the discovery of anti-aging agents from natural products
2508. Current perspectives on anti-aging interventions
2509. Current State and Prospects of DNA Barcoding and DNA Fingerprinting in the Analysis of the Quality of Plant Raw Materials and Plant-Derived Drugs
2510. Current Status and Perspective of R&D Promotion in Food, Agriculture, Forestry and Fisheries
2511. Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery
2512. Current Supporting System for New Drug Development in the R&D Program of Ministry of Health and Welfare
2513. Current therapeutic molecules and targets in Neurodegenerative diseases based on in silico drug design
2514. Current trends and future perspectives on functional foods and nutraceuticals
2515. Current trends in glaucoma: what about neuroprotection?
2516. Cuttlebone has anti-inflammatory activity via the suppression of NF-κB activation
2517. Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases
2518. Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells
2519. Cytoprotective effect of methanolic extract of Nardostachys jatamansi against hydrogen peroxide induced oxidative damage in C6 glioma cells.
2520. Cytoprotective effects of hesperetin and hesperidin against amyloid β‐induced impairment of glucose transport through downregulation of neuronal autophagy
2521. Cytoprotective mechanism of baicalin against endothelial cell damage by peroxynitrite
2522. Cytotoxic and antioxidant activity in aqueous fraction of Opuntia elatior extract
2523. Cytotoxic Effects of Ginsenoside Rb1 and Ginsenoside Rh1 against HIV-1-Transduced Human Macrophages
2524. Cytotoxicity Models of Huntington’s Disease and Relevance of Hormetic Mechanisms: A Critical Assessment of Experimental Approaches and Strategies
2525. Daily consumption of antioxidants:-prevention of disease is better than cure
2526. Dalbergia ecastaphyllum leaf extracts: in vitro inhibitory potential against enzymes related to metabolic syndrome, inflammation and Neurodegenerative diseases
2527. Date palm (Phoenix dactylifera): novel findings and future directions for food and drug discovery
2528. Daumone Fed Late in Life Ameliorates Renal Aging in Mice
2529. Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration
2530. Dealing with skin and blood-brain barriers: The unconventional challenges of mesoporous silica nanoparticles
2531. Deciphering the enhanced inhibitory, disaggregating and cytoprotective potential of promethazine towards amyloid fibrillation
2532. Deciphering the molecular signaling cascade in rotenone-mediated neuronal death
2533. Decoding Longevity: Ending Aging as We Know It
2534. Decreasing effect of mast cell of dung beetle extracts on a high-fat diet in Sprague-Dawley rats
2535. Decursinol angelate isolated from Angelica Gigantis Radix potentiates pentobarbital-induced sleeping behaviors via GABAA-ergic systems.
2536. Degenerative Diseases of Ageing: Causes and Preventions
2537. Delivery of nanoformulated superoxide dismutase to the brain for the treatment of angiotensin II-mediated hypertension
2538. Demyelinating diseases
2539. Depressive symptoms and diet: their effects on prospective inflammation levels in the elderly
2540. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification
2541. Desflurane Induces Cardioprotection Against Myocardial Infarct in vivo Through Activation of Adenosine-Monophosphate-activated Protein Kinase
2542. Design of diarylheptanoid derivatives as dual inhibitors against class IIa histone deacetylase and β-amyloid aggregation
2543. Design of pharmacophoric group containing 1, 4-dihydropyridine derivatives and determination of spectrum of pharmacological activities
2544. Design, synthesis and in vitro biological evaluation of new transthyretin (TTR) amyloid fibril formation inhibitors
2545. Design, synthesis, and in vitro evaluation of a novel probucol derivative: protective activity in neuronal cells through GPx upregulation
2546. DESIGN, SYNTHESIS, ANTI-INFLAMMATORY ACTIVITY EVALUATION, AND STRUCTURE-ACTIVITY RELATIONSHIP (SAR) STUDY OF DIARYLPENTANOID …
2547. Designing Bioactive Nanoparticles: The Era of Nutraceuticals
2548. Designing drugs with multi-target activity: the next step in the treatment of Neurodegenerative disorders
2549. Determinants of Pharmaceutical Expenditure in National Health Insurance: Policy Implication of the Analysis
2550. Determination of aluminum and zinc in infusion tea cultivated in north of Iran
2551. Determination of anti-inflammatory activities of standardised preparations of plant-and mushroom-based foods
2552. Determination of Antioxidant and Antimicrobial Activity of Dichloromethane Extract of Garcinia cowa stem
2553. Determination of antioxidant capacities of vegetable oils by ferric-ion spectrophotometric methods
2554. Determination of antioxidant capacity of Chinese rice wine and Zhuyeqing Liquor using nanoparticle-based colorimetric methods
2555. Determination of Globotriaosyl Sphingosine (Lyso-Gb3) by LC-negative Electrospary Ionization Tandem Mass Spectrometry for Fabry Disease as a Biomarker
2556. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies
2557. Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
2558. Development and evaluation of polyherbal formulations for antidiabetic and antiphypertensive activities
2559. Development of a neuroprotective potential algorithm for medicinal plants
2560. Development of a New Adjuvant System for Vaccines against Infectious Diseases
2561. Development of a novel gold nanoparticle-based method to determine antioxidant capacity of Brassica oilseeds, white flakes and meal
2562. Development of Advance Extraction Methods for the Determination of Aluminum and Vanadium in Environmental, Biological and Pharmaceutical Samples
2563. Development of Biosensors to Monitor the Interaction of Small Molecules with Amyloidogenic Proteins using Optical and Electrochemical Methods
2564. Development of Chemical Modulators for Heat Shock Protein 70 (Hsp70): a Potential Therapeutic Target for Tauopathies.
2565. Development of Medication Adherence Management Program for Chronic Diseases using National Health Insurance Database
2566. Development of neuroprotective strategies utilizing selected spice actives
2567. Development of novel delivery systems for nose-to-brain drug delivery
2568. Development of Recombinant Protein Therapeutics for Immune and Metabolic Genetic Diseases
2569. Development of Shinbaro, a New Herbal Medicine in the Treatment of Osteoarthritis
2570. Development of Therapeutic Agent for Duchenne Muscular Dystrophy by Targeting NMD
2571. Developmental neurotoxicity of the organophosphorus pesticide chloryprifos: from animal behavior to molecular mechanisms
2572. DH504 inhibits endotoxin-induced inflammation in murine macrophages
2573. Diabetes mellitus: channeling care through cellular discovery
2574. Diagnostic and management challenges in chronic obstructive pulmonary disease and heart failure: the need for an interdisciplinary approach
2575. Diazepam-induced Cognitive Enhancement is Associated with the Alteration of GABAA Receptor Subunit in Transient Forebrain Ischemia Mice Model
2576. Dicarbonyl stress at the crossroads of healthy and unhealthy aging
2577. Diet and brain aging: effects on cell and mitochondrial function and structure
2578. Diet and cognition: interplay between cell metabolism and neuronal plasticity
2579. Diet and exercise interventions to promote metabolic homeostasis in TBI pathology
2580. Diet and herbal-derived medicines
2581. Diet and inflammation
2582. Diet and longevity: The effects of traditional eating habits on human lifespan extension
2583. Diet quality and cognition among older adults from the NuAge study
2584. Diet Science/Plant Medicine Research
2585. Diet supplementation with hydroxytyrosol ameliorates brain pathology and restores cognitive functions in a mouse model of amyloid-β deposition
2586. Diet, Exercise, and Chronic Disease: The Biological Basis of Prevention
2587. Dietary advanced glycation end products and their role in health and disease
2588. Dietary and Serum Level of Antioxidants in the Elderly with Mild Impaired and Normal Cognitive Function: A Case-Control Study
2589. Dietary antioxidant for disease prevention corroborated by the Nrf2 pathway
2590. Dietary antioxidants, peroxidation and cardiovascular risks
2591. Dietary Berry Supplementation in Aging
2592. Dietary Coumarins
2593. Dietary Curcumin And Caloric Restriction As Interventions For The Reversal Of Age Associated Functional Decline
2594. Dietary derived antioxidants: implications on health
2595. Dietary effects on cardiovascular disease risk biomarkers
2596. Dietary Factors in Geriatric Neurology
2597. Dietary guidelines for Indians
2598. Dietary impact on neuronal autophagy control and brain health
2599. Dietary Intake of AGEs and ALEs and Inflammation—Nutritional Aspects
2600. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging
2601. Dietary intervention and prevention of cognitive-related outcomes in healthy older adults without cognitive dysfunction
2602. Dietary Intervention of Utazi (Gongrenema Latifolium) Supplemented Diet Using Wistar Male Rat Animal Brain Model
2603. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China
2604. Dietary Patterns and Cognitive Decline: key features for prevention
2605. Dietary patterns and cognitive health in older adults: A systematic review
2606. Dietary patterns and risk of self-reported activity limitation in older adults from the Three-City Bordeaux Study
2607. DIETARY PATTERNS AND SUPPLEMENT INTAKE OF OLDER ADULTS IN
2608. Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges
2609. Dietary Phytochemicals in Neurodegenerative Disease
2610. Dietary phytochemicals in neuroimmunoaging: a new therapeutic possibility for humans?
2611. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice
2612. Dietary sources, bioavailability and biological activities of naringenin and its derivatives
2613. Dietary supplementation of Almond prevents oxidative stress by advocating antioxidants and attenuates impaired aversive memory in male rats
2614. Dietary supplements and military divers: A synopsis for undersea medical officers
2615. Dietary supplements and related products: a brief summary
2616. Dietary supplements for cognitive impairment
2617. Dietary supplements: current knowledge and future frontiers
2618. Dietary Supplements/Antioxidants: Impact on Redox Status in Brain Diseases
2619. Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in …
2620. Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats
2621. Dihydrobenzofuran Neolignans Isolated from Euonymus alatus Attenuated Excessive Inflammatory Responses in the Activated RAW264. 7 Macrophage Cells
2622. Dihydrochalcones: Methods of Acquisition and Pharmacological Properties—A First Systematic Review
2623. Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity
2624. Dihydropyrimidinones (DHPMs) Derivatives Suppress LPS-induced Nitric Oxide Productionin BV-2 Microglial Cells
2625. Dimethyl-carbamic acid 2, 3-Bis-Dimethylcarbamoyloxy-6-(4-Ethyl-Piperazine-1-Carbonyl)-phenyl ester: A novel multi-target therapeutic approach to neuroprotection
2626. Diminished brain resilience syndrome: a modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream …
2627. Diosmin is neuroprotective in a rat model of scopolamine-induced cognitive impairment
2628. Discovering Coffee’s Unique Health Benefits
2629. Discovery and Development of neuroprotective Agents from Natural Products
2630. Discovery and Mechanisms of Small Molecule Amyloid Formation Inhibitors
2631. Discovery of Hsp90 inhibitors form natural product and its analogues
2632. Discovery of Leonuri and therapeutical applications: From bench to bedside
2633. Discovery of Natural Product Analogs Against Ethanol-induced Cytotoxicity in Hippocampal Slice Cultures
2634. Discovery of novel genes for depressant in restraint-stress-induced depression in Wistar Kyoto Rat
2635. Discovery of Novel P2X7 Receptor Antagonists for Pain and Inflammatory Diseases
2636. Discovery of Novel Therapeutic Agents using Molecular Diversity and Chemical Biology
2637. Discovery of potential biomarkers in the prediction of diabetes acquisition
2638. Disease Biomarker Discovery and Validation Using Mass Spectrometry
2639. disease: A pharmacoinformatic approach, Informatics in Medicine Unlocked
2640. Distinct Role of Hippocampus and Prefrontal Cortex in Recognition Memory
2641. Diterpenes: advances in neurobiological drug research
2642. DNA damage protection: an excellent application of bioactive compounds
2643. Do Ganoderma lucidum and Salvia officinalis extracts exhibit synergistic antioxidant and antiNeurodegenerative effects?
2644. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid‐β oligomers
2645. Doenjang, A Korean Traditional Fermented Soybean Paste, Ameliorates Neuroinflammation and Neurodegeneration in Mice Fed a High-Fat Diet
2646. DOES MEDITERRANEAN DIET CONFER NEUROPROTECTION AGAINST NEUROINFLAMMATION AND RELATED DISEASES? AN OVERVIEW
2647. Does the addition of spices change the content of fluoride and antioxidants in black tea infusions?
2648. Dopamine neurotoxicity, oxidative stress and schizophrenia-in vitro and in vivo studies of peroxisomal reactions to increased dopamine
2649. Dopaminergic neurotoxicity by MPTP is enhanced in IL-32 transgenic mice
2650. Dosage effects of EGb761 on hydrogen peroxide-induced cell death in SH-SY5Y cells
2651. Dosage of Standard Herbal Decotion and Solid Extract
2652. DPPIV Inhibitor as an Antidiabetic Agents: from LC15-0133 to LC15-0444 (Zemiglo)
2653. Drosophila as a model system for studying lifespan and neuroprotective activities of plant-derived compounds
2654. Drosophila as a Model System for the Identification of Pharmacological Therapies in Neurodegenerative Diseases
2655. Drug Development for Neurodegenerative Diseases
2656. Drug discovery and design for complex diseases through QSAR computational methods
2657. Drug Discovery Approach on Tectona Grandis Linn Leaves Against Apicomplexan Plasmodium and Wound Links its Ethnopharmacological Validation and …
2658. Drug discovery from traditional Chinese medicine for neurogenesis: implications for stroke and Neurodegenerative diseases
2659. Drug treatment of cognitive impairment in the elderly
2660. Drug-delivery nanocarriers to cross the blood–brain barrier
2661. Drugs and dietary supplements with unproven effects in research and practice: Part 2
2662. Drugs to Treat Age‐Related Neurodegenerative Problems The Final Frontier of Medical Science?
2663. Dual Effects of AT1 Receptor Blocker on Catecholamine Release from the Rat Adrenal Medulla
2664. Dual Inhibitors of ROCK I and NOX to Attenuate Neuroinflammation in Neurological Disorders High Throughput Virtual and Biological screening
2665. Dual Therapeutic-imaging Nanoparticles for Triggered Tumor Delivery of Chemotherapeutic Adjuvant
2666. Duality of antidepressants and neuroprotectants
2667. Dysregulation of Heat Shock Proteins in Neurodegenerative Diseases: Restorative Roles of Small Molecules and Natural Compounds
2668. Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies
2669. Early neurophysiological diagnosis of true neurogenic «thoracic outlet syndrome»(TOS)
2670. Eat This and Live: Simple Food Choices That Can Help You Feel Better, Look Younger, and Live Longer!
2671. Echinacoside, an inestimable natural product in treatment of neurological and other disorders
2672. Eco-Agri-Food Ecology and Human Health
2673. Efectos saludables de la cúrcuma y de los curcuminoides
2674. Effect EtOH ext. of Chaenomeles sinensis fruit on the metabolism of APP from APPswe overexpressing Neuro2a cell line
2675. Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose
2676. Effect of Acacia catechu (Lf) Willd. on oxidative stress with possible implications in alleviating selected cognitive disorders
2677. Effect of alcoholic extracts of millet seed (Panicum miliaceum L.) on spatial memory in male mice
2678. Effect of Amaranthus on advanced glycation end-products induced cytotoxicity and proinflammatory cytokine gene expression in SH-SY5Y cells
2679. Effect of amyloid beta (25-35) peptide on mitochondrial respiratiory function in neuroral cells over expressing ape1
2680. Effect of Andrographis paniculata and Phyllanthus amarus leaf extracts on selected biochemical indices in Drosophila melanogaster model of neurotoxicity
2681. Effect of antioxidants supplementation on aging and longevity
2682. EFFECT OF AQUEOUS AND ETHANOL LEAF EXTRACTS OF ERIOSEMA PSORALEOIDES ON SOME oxidative stress PARAMETERS IN ALLOXAN …
2683. Effect of aqueous extract of ginger on acetylcholine in brain and it’sa possible role in learning and memory during ethanol withdrawal
2684. Effect of Capparis spinosa L. on cognitive impairment induced by D-galactosein mice via inhibition of oxidative stress
2685. Effect of chronic consumption of blackberry extract on high-fat induced obesity in rats and its correlation with metabolic and brain outcomes
2686. Effect of Chronic Treatment with Conventional and Organic Purple Grape Juices (Vitis labrusca) on Rats Fed with High-Fat Diet
2687. Effect of dietary interventions in mild cognitive impairment: a systematic review
2688. Effect of dietary phytochemicals on metabolic syndrome and neurological disorders
2689. Effect of Endocannabinoids on Soybean Lipoxygenase-1 Activity
2690. Effect of Epigallocatechin Gallate and Catechin on Overexpression of GSK-3β and IR Genes Induced by Streptozotocin in Rat Brain. Caspian J Neurol Sci. 2019 …
2691. Effect of Food on the Pharmacokinetics of Rosuvastatin Following Single Oral Administration in the Dog
2692. Effect of Gallic acid on memory and pain of male diabetic rats
2693. Effect of Ginkgo biloba Extract EGb 761 on Differential Gene Expression in the Brain
2694. Effect of Ginsenoside Rg3 on the Phosphorylation and Expression of Endothelial Nitric Oxide Synthase: Essential Roles of Estrogen Receptor-dependent PI3 …
2695. Effect of glycation inhibitors on aging and age-related diseases
2696. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment …
2697. Effect of lifestyle, aging, and phytochemicals on the onset of neurological disorders
2698. Effect of Lipid on Physicochemical Properties of Paclitaxel Loaded-solid Lipid Nanoparticle
2699. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide …
2700. Effect of Manasamitra Vatakam against aluminium induced learning and memory impairment of apoptosis in rat’s hippocampus and cortex
2701. Effect of Medicinal Herb Composites on Antioxidative and Cognition-Enhancing Activities in Rats
2702. Effect of Methyl 3, 5-Dicaffeoyl Quinate on ROS Level, Mitochondrial Membrane Potential and the Release of Cytochrome C in HT-29 Cells
2703. Effect of Microbiota on Neurodegenerative Diseases
2704. Effect of myricetin, pyrogallol, and phloroglucinol on yeast resistance to oxidative stress
2705. Effect of natural antioxidants on the aggregation and disaggregation of beta-amyloid
2706. Effect of natural exogenous antioxidants on aging and on Neurodegenerative diseases
2707. Effect of natural products on diabetes associated neurological disorders
2708. Effect of nutrition on Neurodegenerative diseases. A systematic review
2709. Effect of o-VA on mast cell-mediated allergic inflammation
2710. Effect of Paullinia cupana Mart. Commercial Extract During the Aging of Middle Age Wistar Rats: Differential Effects on the Hippocampus and Striatum
2711. Effect of PEGylation on the Cytotoxicity and Bioactivity of Pentapeptide
2712. Effect of Physicochemical Properties of Drug and Pressure Sensitive Adhesives on Transdermal Drug Delivery
2713. Effect of pineapple, orange and watermelon juices on phosphodiesterase, monoamine oxidase and angiotensin-I converting enzyme activities in rat heart and brain …
2714. Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model
2715. Effect of quercetin on learning and memory in STZ-induced diabetic rat.
2716. Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats
2717. Effect of Rosa rugosa (RR) flower on APPswe overexpressing Neuro2a cell line.
2718. Effect of Salvia officinalis Hydroalcoholic Extract on Iron Oxide Nanoparticle Induced Memory Impairment in the Presence and Absence of Beta-Adrenergic …
2719. Effect of Sub Lethal Concentration of Glyphosate Based Herbicide on Some Biochemical Parameters of Male Clarias Gariepinus
2720. Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron …
2721. Effect of the NU-AGE diet on cognitive functioning in older adults: a randomized controlled trial
2722. Effect of TIMBD on Neurotoxicity Associated with HIV-1 Gp120 and Tat
2723. Effect of Toasting on the Chemical Composition, Functional and Antioxidative Properties of Full Fat and Defatted Sesame (sesamum indicum L) Seed Flours
2724. Effect of Trigonella foenum-graecum Linn. seeds methanol extract on learning and memory
2725. Effect of vitamin D supplementation on CREB-TrkB-BDNF pathway in the hippocampus of diabetic rats
2726. Effectiveness of Opuntia ficus indica L. inermis Seed Oil in the Protection and the Healing of Experimentally Induced Gastric Mucosa Ulcer
2727. Effectiveness of Oriental Medicine Mainly Including Kudzu Root (Pueraria) for Controlling Blood Glucose in Patients with Diabetes
2728. Effects against Mercury Chloride-Induced Nephrotoxicity by Activated Cultivated-Wild Ginseng in Rats
2729. Effects and Mechanisms of Antioxidant-Rich Functional Beverages on Disease Prevention
2730. Effects of 1, 2, 3, 4, 6-Penta-O-Galloyl-β-D-Glucose on the Metabolism of Amyloid Precursor Protein
2731. Effects of 90 days of resveratrol supplementation on cognitive function in elders: a pilot study
2732. Effects of a 1-Piperonylpiperazine Analog on the Metabolism of Amyloid Precursor Protein
2733. Effects of a new nutraceutical combination on cognitive function in hypertensive patients
2734. Effects of a Propolis Extract on the Viability of and Levels of Cytoskeletal and Regulatory Proteins in Rat Brain Astrocytes: an In Vitro Study
2735. Effects of a Proprietary Standardized Orthosiphon stamineus Ethanolic Leaf Extract on Enhancing Memory in Sprague Dawley Rats Possibly via Blockade of …
2736. Effects of Anthocyanins 10 on Neuronal and Cognitive Brain Functions
2737. Effects of Anti-inflammatory Anthraquinones from Rhubarb on P-glycoprotein-mediated Drug Efflux in Caco-2 Cells.
2738. Effects of anti-inflammatory bioactives on diabetes-induced changes in cognition-related gene expression in the hippocampus
2739. Effects of Camellia Sinensis Extract on Passive Avoidance Learning and Hippocampal Neurogenesis in Rats
2740. Effects of Chronic Alcohol Consumption on Expression Levels of APP and Aβ-Producing Enzymes
2741. Effects of Chrysanthemum indicum Linne flowers on acetylcholinesterase activity and learning performance in mice
2742. Effects of coffee consumption on serum uric acid: systematic review and meta-analysis
2743. Effects of Constituents Identified in the Adults of Tenebrio molitor on Antioxidant and Anti-BACE-1 Activities
2744. Effects of Cysteine on the Pharmacokinetics of Etoposide in Rats with Protein–calorie Malnutrition
2745. Effects of Cysteine on the Pharmacokinetics of Tamoxifen in Rats with Protein-calorie Malnutrition: Enhanced Gastrointestinal Absorption by Cysteine
2746. Effects of Dark Chocolate Intake on Brain Electrical Oscillations in Healthy People
2747. Effects of DCM Leaf Extract of Gnidia glauca (Fresen) on Locomotor Activity, Anxiety, and Exploration-Like Behaviors in High-Fat Diet-Induced Obese Rats
2748. Effects of DHA and EGCG on the alpha-secretase mediated processing of APP
2749. Effects of dietary derived antioxidants on the central nervous system
2750. Effects of Dietary Supplements and Nutraceuticals of Plant Origin on Central and Peripheral Nervous System Pathology
2751. Effects of Distylium Recemosum on the Metabolism of Amyloid Precursor Protein
2752. Effects of Energy and Macronutrient Intake on Cognitive Function Through the Lifespan
2753. Effects of Enzogenol Extract on Regulating Blood Glucose and Lipid Metabolism in C57BL/KsJ-db/db Mice
2754. Effects of epigallocatechin-3-gallate on behavioral impairments induced by psychological stress in rats
2755. Effects of Eurycoma longifolia Jack on chronic cerebral hypoperfusion-induced oxidative damage and memory deficit in rats
2756. Effects of excipients on the permeability of BCS IV classcompounds
2757. Effects of Extra‐Virgin Olive Oil in Neurological Disorders
2758. Effects of grape skin extract on age-related mitochondrial dysfunction, memory and life span in C57BL/6J mice
2759. Effects of Gryllus bimaculatus (Gb) fractions on alcoholic hepatitis
2760. Effects of Gryllus bimaculatus (Gb) fractions on viral hepatitis
2761. Effects of Impurities on Stabilization of Amorphous Donepezil: Synthesis and Identification of Process-Induced Impurities of Donepezil.
2762. Effects of intrinsic and extrinsic factors on aggregation of physiologically important intrinsically disordered proteins
2763. Effects of Juglans sinensis Extract on the Metabolism of Amyloid Precursor Protein
2764. Effects of Korean Red Ginseng Extract on Immune Modulation and Anti-oxidation in Human Keratinocytes
2765. Effects of lotus-derived constituents on learning and memory activity of scopolamine-induced mice
2766. Effects of Matricaria chamomilla extract on motor coordination impairment induced by scopolamine in rats
2767. Effects of matricaria chamomilla extract on motor coordination impairment induced in rat and determination antioxidant properties of chamomile
2768. Effects of Mediterranean diet components on Neurodegenerative diseases
2769. Effects of methanolic extract of Bacopa
2770. Effects of Moringa oleifera on Glycaemia and Insulin Levels: A Review of Animal and Human Studies
2771. Effects of Moringa oleifera on the Acetylcholinesterase and Monoamine Oxidase Activities in the Streptozotocin-Induced Diabetic Rat Brains
2772. Effects of Multi-Ingredient Dietary Supplementation and Tai Chi on Cognitive and Physical Function in Middle-Aged and Older Individuals
2773. Effects of Nanomaterial Mixture on the Skin Corrosion and Irritation Tested by Alternative Method Using Reconstituted 3D Human Skin Model, KeraSkin™
2774. Effects of Natural Antioxidants on Motor and Cognitive Deficits in an Animal Model of Aging and Obesity and Dopaminergic-Like SH-SY5Y Cell Line
2775. Effects of natural products on sugar metabolism and digestive enzymes
2776. Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid
2777. Effects of Novel Benzofuran-2-carboxamide Derivatives on the Excitotoxic Neuronal Damage in Primary Cultured Rat Cortical Cells
2778. Effects of nutritional supplementation on the progression of motor neuron degeneration in a murine model of amyotrophic lateral sclerosis
2779. Effects of P-glycoprotein and CYP3A4 Inhibition by Amlodipine on the Pharmacokinetic Parameter of Warfarin
2780. Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive …
2781. Effects of phytochemicals on cellular signaling: reviewing their recent usage approaches
2782. Effects of Proton Radiation and Pomegranates on Hippocampus and Behavior
2783. Effects of Purple Coneflower (Echinacea purpurea) on CYP3A4 Metabolism and P-glycoprotein Mediated Transport in Vitro
2784. Effects of Red Ginseng on Radical Scavenging Activity and Collagen Synthesis
2785. Effects of Resveratrol on the Bioavailability and Pharmacokinetics of Losartan in Rats
2786. Effects of rhynchophylline derived from Uncariae Ramulus et uncus on pentobarbital-induced sleep
2787. Effects of Saffron (Crocus sativus L.) and its Active Constituent, Crocin, on Recognition and Spatial Memory after Chronic Cerebral Hypoperfusion in Rats
2788. Effects of Salvia officinalis in the liver: relevance of glutathione levels
2789. Effects of Side-Chain Length on Ring-Closing Metathesis to Form an All-Hydrocarbon Staple in α-Helical Peptides
2790. Effects of silibinin on hair follicle stem cells differentiation to neural-like cells
2791. Effects of Some Fractions Extracted from Korean Pine Needle on Catecholamine Release in the Rat Adrenal Gland
2792. Effects of SP-8203 Combined with Thrombolytic Therapy in a Rat Embolic Stroke Model
2793. Effects of the extract from the fruit hull of mangosteen (garainia mangostana l.) on learning memory and the central cholinergic system of male wistar rats
2794. Effects of the Mediterranean Diet on Brain Function: Underlying mechanisms
2795. Effects of the Methanolic Extract of Vitellaria paradoxa Stem Bark Against Scopolamine-Induced Cognitive Dysfunction and oxidative stress in the Rat Hippocampus
2796. Effects of Vehicles and Enhancers on the In Vitro Permeability of Meloxicam (MX) through Hairless Mouse Skin
2797. Effects of Vehicles and Enhancers on the In Vitro Permeation of Lornoxicam Across Excised Skin
2798. Effects of Western, Mediterranean, Vegetarian, and Okinawan Diet Patterns on Human Brain
2799. Efficacy and tolerability of phytomedicines in multiple sclerosis patients: a review
2800. Efficacy of herbal combination of sedge, saffron, and Astragalus honey on major neurocognitive disorder
2801. Efficacy of morin as a potential therapeutic phytocomponent: Insights into the mechanism of action
2802. Efficacy of natural compounds in Neurodegenerative disorders
2803. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP
2804. EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’of α-Synuclein
2805. Electrospinning of 3D poly (l-lactic acid) biodegradable scaffold containing tgf as potential for cartilage regeneration
2806. Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ
2807. Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
2808. Elucidating the inhibitory potential of designed peptides against amyloid fibrillation and amyloid associated cytotoxicity
2809. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
2810. Emblica officinalis (Amla): A review of potential therapeutic applications
2811. Embryonic Stem Cell as a Model System in Drug Discovery from Natural Products
2812. Emergence of nutraceuticals as the alternative medications for pharmaceuticals
2813. Emerging anti-aging strategies-scientific basis and efficacy
2814. Emerging Bioresources with nutraceutical and pharmaceutical prospects
2815. Emerging potential of natural products as an alternative strategy to pharmacological agents used against metabolic disorders
2816. Emerging roles of Sonic Hedgehog in adult neurological diseases: neurogenesis and beyond
2817. Emerging targets and latest proteomics based therapeutic approaches in Neurodegenerative diseases
2818. Encapsulation of cinnamon essential oil in whey protein enhances the protective effect against single or combined sub-chronic toxicity of fumonisin B 1 and/or …
2819. Encapsulation of Islets with Liposomal Clodronate in Matrigel in a Xenotransplantation Model
2820. Encephalopathy: a vicious cascade following forebrain ischemia and hypoxia
2821. Endocrine Disruptors: Mechanism of Action and Impacts on Health and Environment
2822. Endogenous Catalase Plays a Role in Adipose Tissue Macrophage Polarization
2823. Endogenous non-enzymatic antioxidants in the human body
2824. Endophytic microbes: a novel source for biologically/pharmacologically active secondary metabolites
2825. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?
2826. Enhanced antioxidant capacity and anti-ageing biomarkers after diet micronutrient supplementation
2827. Enhanced neuroprotective effects of combination therapy with bone marrow-derived mesenchymal stem cells and ginkgo biloba extract (EGb761) in a rat model of …
2828. Enhanced neuroprotective Effects of Panax ginseng G115® and Ginkgo biloba GK501® Combinations In Vitro Models of Excitotoxicity
2829. Enhancement of Functional Properties of Dairy Products by Date Fruits
2830. Enhancement of immune response and intestinal motility by Undariapinnatifidamedia cultured L. plantarum.
2831. Enhancement of the neuroprotective effect of fermented Spirulina maxima associated with antioxidant activities by ultrasonic extraction
2832. Enhancing learning and memory in the aged: Interactions between dietary supplementation and exercise
2833. ENTADA PHASEOLOIDES ATTENUATES SCOPOLAMINE INDUCED MEMORY IMPAIRMENT, NEURO-INFLAMMATION AND NEURO-DEGENERATION VIA …
2834. Entrepreneurial Opportunities in Nutraceuticals developed from fish and fish wastes
2835. Environmental effects of ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2017
2836. Environmental Neurotoxic Metabolites: 2, 5-Hexanedione and 1, 2-Diacetylbenzene
2837. Enzyme inhibitory and antioxidant activities of Viburnum tinus L. relevant to its neuroprotective potential
2838. Enzyme inhibitory properties of black tea and its components
2839. Epicatechin and catechin in cocoa inhibit amyloid β protein induced apoptosis
2840. Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double‐blind, placebo‐controlled, crossover …
2841. Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe …
2842. Epigallocatechin-3-gallate (EGCG): mechanisms and the combined applications
2843. Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down’s …
2844. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties
2845. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?
2846. Epigenetic modifications in neurological diseases: natural products as epigenetic modulators a treatment strategy
2847. Epigenetics and cognitive disorders—translational aspects
2848. Epigenetics of Brain Aging
2849. Epigenome-based Mechanisms of Disease Pathogenesis and the Therapy
2850. Equol, a dietary daidzein gut metabolite attenuates microglial activation and potentiates neuroprotection in vitro
2851. Ergothioneine–a diet‐derived antioxidant with therapeutic potential
2852. Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
2853. Essential oils and Neurodegenerative diseases: current data and future perspectives
2854. ESSENTIAL OILS AS MODIFIERS OF HUMAN BEHAVIOR
2855. ESSENTIAL OILS AS POTENTIAL ANTIOXIDANT AGENTS IN THE TREATMENT OF OXIDATIVE STRESS-RELATED Neurodegenerative DISEASES …
2856. Essential roles of natural products and gaseous mediators on neuronal cell death or survival
2857. Establishing a Leaf Proteome Reference Map for Ginkgo biloba Provides Insight into Potential Ethnobotanical Uses
2858. Establishment for Standardization of Herbal Medicines
2859. Establishment of a comprehensive list of candidate antiaging medicinal herb used in Korean medicine by text mining of the classical Korean medical literature,“ …
2860. Establishment of Analytical Methods and Monitoring for Marker Compounds of Herbal Medicines
2861. Establishment of the Database of Herbal Formulas in the 10 EFKM (Established Formularies of Korean Medicine)
2862. Estimation of UV-induced DNA Damages to Suppress Expression of Protein Using Reporter Gene Assay-Based Single Cell Cotransfection Imaging Cytometry
2863. Estrogen activates protein kinase C in neurons: role in neuroprotection
2864. Estrogen Receptor Beta inhibits HIF-1 Activity
2865. Estrogen Receptor Related Receptor Gamma Promotes Dopaminergic Neuronal Differentiation Estrogen Receptor Related Receptor Gamma Promotes …
2866. Estrogen Receptor β Regulates Brain Signaling Involved in Depression
2867. Estrogen—Mystery Drug for the Brain?: The neuroprotective Activities of the Female Sex Hormone
2868. Estrogenic and Antiestrogenic Effects of GBE on Uterus using Immature Rat Uterotrohpic Assay
2869. Ethanol extract of a Korean medicinal prescription (SSY) including Rehmanniae Radix Preparata promote hair growth in an alopecia animal model
2870. Ethanol Extract of Centipeda minima Exerts Antioxidant and neuroprotective Effects via Activation of the Nrf2 Signaling Pathway
2871. Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice
2872. Ethanol Induces oxidative stress via Up-Regulation of NADPH Oxidasederived ROS Generation in RAW264. 7 Macrophages
2873. Ethanolic extract of O. stamineus improves memory in scopolamine-induced amnesia model 2
2874. Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of …
2875. Ethnobotanical survey and biological screening of medicinal plants from Vanuatu
2876. Ethnobotanical, Antioxidant And Toxicity Study Of Selected Medicinal Plants Used In Nyamira North Sub-county, Nyamira County
2877. Ethnobotany, phytochemistry, toxicology and pharmacological properties of Terminalia sericea Burch. ex DC.(Combretaceae)–A review
2878. Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status
2879. Ethnopharmacological study of medicinal plants used in the treatment of CNS disorders in Sinai Peninsula, Egypt
2880. Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Alpinia oxyphylla Miquel: A review
2881. Ethyl acetate fraction from persimmon (Diospyros kaki) ameliorates cerebral neuronal loss and cognitive deficit via the JNK/Akt pathway in TMT-induced mice
2882. Eugenol Alleviates Hepatic Steatosis through AMPK-SREBP1 Pathway
2883. Evaluating the therapeutic efficiency and drug targeting ability of alkaloids present in Rauwolfia serpentina
2884. Evaluation for Protective Effects of β-Ionone against Gastric Lesions
2885. Evaluation of anti-amnesic effect of extracts of selected Ocimum species using in-vitro and in-vivo models
2886. Evaluation of anti-ischemic therapy in coronary artery disease: a review
2887. Evaluation of antiarthritic activity of Indigofera tinctoria L in Sprague-Dawley rats
2888. Evaluation of Antidiabetic, Antihyperlipidemic, and Antiglycation Effect of Moringa stenopetala (Baker f) Cufodontis leaves
2889. Evaluation of Antihyperlipidaemic and Antioxident Activity of Artocarpus Heterophyllus Stem Extract
2890. Evaluation of antioxidant activity of Safflower florets (Carthamus tinctorius L.) as food coloring agents
2891. Evaluation of antioxidant activity of Viscum articulatum (Burm. F)
2892. Evaluation of Antioxidant and Acetyl Cholinesterase inhibitory activity of Peltophorum pterocarpum in Scopolamine treated rats
2893. Evaluation of Antioxidant and Cholinesterase Inhibitory Activities of Hoya parasitica Variegata-An In-vitro Study
2894. Evaluation Of Antioxidant And Cytotoxicity Properties Of Amygdalin Extracted From Prunus Dulcis
2895. Evaluation of antioxidant and neuroprotective activities of Cassia fistula (L.) using the Caenorhabditis elegans model
2896. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion
2897. Evaluation of antioxidant nootropic and antidepressant properties of Litsea Floribunda BL gamble lauraceae
2898. Evaluation of Antioxidant, Anti-cholinesterase, and Anti-inflammatory Effects of Culinary Mushroom Pleurotus pulmonarius
2899. EVALUATION OF BARK EXTRACT OF SPATHODEA COMPANULATA P. BEAUV FOR ANTIOXIDANT AND neuroprotective ACTIVITY IN ALBINO RATS
2900. Evaluation of bioactive compounds as acetylcholinesterase inhibitors from medicinal plants
2901. Evaluation of Camellia Sinensis in the Alcohol Deprivation Effects in Rats Following Long-Term Voluntaty Alcohol Consumption
2902. Evaluation of Citrus aurantifolia peel and leaves extracts for their chemical composition, antioxidant and anti‐cholinesterase activities
2903. Evaluation Of Cytotoxic and Genotoxic Properties Of Sinapic Acid
2904. Evaluation of Drug Delivery Profiles in Geometric Three-layered Tablets with Various Mechanical Properties, in vitro-in vivo Drug Release, and Raman …
2905. Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on oxidative stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
2906. Evaluation of Impact of CCL2 on Vital Signaling Cascades in Microglial Cells using BV2 Cell Line as a Model
2907. Evaluation of In Vitro Anti-Oxidant Activity of Mentha arvensis Linn in Memory Enhancing Study
2908. Evaluation of in vitro free Radical Scavenging Activity of Tribulus terrestris
2909. EVALUATION OF IN VIVO ANTI-OXIDANT ACTIVITY OF MENTHA ARVENSIS LINN IN RAT BRAIN HOMOGENATES
2910. Evaluation of neuroprotective effects of natural extracts obtained from portuguese agro-food residues
2911. Evaluation of neuroprotective Properties of Ecchium Amoenum L. Ethanolic Extract
2912. Evaluation of neuroprotective Properties of Ellagic Acid and Caffeic Acid Phenethylester
2913. Evaluation of nootropic activity of Sida cordifolia in mice
2914. Evaluation of possible in vitro neurobiological effects of two varieties of Cupressus sempervirens (Mediterranean cypress) through their antioxidant and enzyme …
2915. Evaluation of Potential Central Protective Role of Ethanol Extract of Pedalium Murex Linn. In Acute and Chronic Unpredictable Stress (CUS) Induced Models in SD …
2916. Evaluation of protective effect of rutin on lead acetate-induced testicular toxicity in Wistar rats
2917. Evaluation of Safety and Efficacy of Carnosine, a neuroprotective Agent against Ischemic Sroke
2918. Evaluation of selected Libyan medicinal plant extracts for their antioxidant and anticholinesterase activities
2919. Evaluation of the antioxidant activity and antitumor activity of marine invertebrates extracts
2920. Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1, 3-Diketones
2921. Evaluation of the Effects of Storage Conditions on the Stability of Porcine Placenta Extract-loaded Liposome Formulations
2922. Evaluation of the neuroprotective and antioxidant effects of Dorema aucheri extract on cerebral ischaemia-reperfusion injury in rats
2923. Evaluation of the nutritional profile and antioxidant and anti-cholinesterase activities of Padina gymnospora (Phaeophyceae)
2924. Evaluation of the Remedy for Neuronal Diseases from Rhemannia glutinosa Liboschitz and Elucidation of their Underlying Mechanisms.
2925. Evaluation of the traditional and well-established use of Hyperici herba
2926. Evaluation on biological activity of triphenylpyridine derivatives
2927. Evaluation on biological activity of triphenylpyridine derivatives
2928. Every person’s guide to antioxidants
2929. Evidence for health benefits of berries
2930. Evidence of Anti-Obesity Effects of the Laminaria japonica Areshoung Ethanol Extract in High-Fat Diet Induced Obese Rat
2931. Evidence-Based Therapeutic Effects of Anthocyanins from Foods
2932. Exacerbation of MG132-induced Protein Accumulation in the Brain of LRRK2-G2019S Transgenic Mice
2933. Excitotoxicity: bridge to various triggers in Neurodegenerative disorders
2934. Exercise and the brain
2935. Expectation and Introduction of Reformed National Health Personnel Licensing Examination
2936. Experimental inhibition of fibrillogenesis and neurotoxicity by amyloid-beta (Aβ) and other disease-related peptides/proteins by plant extracts and herbal compounds
2937. Experimental Studies on the Hair Growth Activity of Herbal Extracts in C57BL/6 Mice
2938. Exploration of body weight regulation by polyunsaturated fatty acids in rat: potential association with hypothalamic neurogenesis
2939. Exploring anti-prion glyco-based and aromatic scaffolds: a chemical strategy for the quality of life
2940. Exploring cellular actions and interactions of SIRT1 that may counteract ageing
2941. Exploring in vitro neurobiological effects and high-pressure liquid chromatography-assisted quantitation of chlorogenic acid in 18 Turkish coffee brands
2942. Exploring Nanoformulations of Pomegranate as Promising Nutraceuticals
2943. Exploring the Role of “Brahmi”(Bacopa monnieri and Centella asiatica) in Brain Function and Therapy
2944. Exploring the role of genetic variability and lifestyle in oxidative stress response for healthy aging and longevity
2945. Exploring the structural diversity in inhibitors of α-synuclein amyloidogenic folding, aggregation, and neurotoxicity
2946. Expression of indoleamine 2, 3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons
2947. Extra virgin olive oil modulates brain docosahexaenoic acid level and oxidative damage caused by 2, 4-Dichlorophenoxyacetic acid in rats
2948. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases
2949. Extraction and chromatography-mass spectrometric analysis of the active principles from selected Chinese herbs and other medicinal plants
2950. Extracts from Quercus sp. acorns exhibit in vitro neuroprotective features through inhibition of cholinesterase and protection of the human dopaminergic cell line SH …
2951. Extracts of Liriopsis tuber protect AMPA induced brain damage and improve memory with the activation of insulin receptor and ERK I/II
2952. Extracts of Sideritis species as inhibitors of monoamine transporters: A pharmacological mechanism for efficacy in CNS disorders like depressive disorders and …
2953. Extracts of Twigs of Actinodaphne lancifolia Cause Nrf2-mediated Induction of Quinone Reductase
2954. FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced …
2955. Factors that influence adult neurogenesis as potential therapy
2956. FAG Inhibits Lipopolysaccharide Induced-iNOS Expression and Activity of NF-kB in Macrophage
2957. Familial Amyloid-Beta and Non-Amyloid-Beta Amyloidosis: Insights into Oligomerization, Toxicity, and Potential Therapeutic Strategies
2958. Fast access of some grape pigments to the brain
2959. Fasting for Life
2960. Fenugreek seed powder nullified aluminium chloride induced memory loss, biochemical changes, Aβ burden and apoptosis via regulating Akt/GSK3β …
2961. Fermentation enhances Ginkgo biloba protective role on gamma-irradiation induced neuroinflammatory gene expression and stress hormones in rat brain
2962. Fern to Pharma: Potential Neuroameliorative Properties of Pteridophytes
2963. Ferritin oxidation and proteasomal degradation: protection by antioxidants
2964. Ferulic acid ethyl ester as a potential therapy in Neurodegenerative disorders
2965. Ferulic Acid: A Promising Therapeutic Phytochemical and Recent Patents Advances
2966. First-in-Class Pan-Nox Inhibitor Targeting Diabetic Kidney Disease
2967. Fisetin acts on multiple pathways to reduce the impact of age and disease on CNS function
2968. Fisetin and its role in chronic diseases
2969. Fisetin reduces the impact of aging on behavior and physiology in the rapidly aging SAMP8 mouse
2970. Flammulina velutipes polysaccharides improve scopolamine-induced learning and memory impairment in mice by modulating gut microbiota composition
2971. Food and nutrients in disease management
2972. Food and nutrition controversies today: A reference guide
2973. Food Bioscience
2974. Food Choices
2975. Food colour additives of natural origin
2976. Food components with the potential to be used in the therapeutic approach of mental diseases
2977. Food for thought: The neuroscience of nutrition to fuel cognitive performance
2978. Food is Medicine
2979. Food processing and the Mediterranean diet
2980. Food Processing Technologies: Impact on Product Attributes
2981. Food Science and Human Wellness
2982. Foods and dietary supplements in the prevention and treatment of disease in older adults
2983. Forever Young: The Science of Nutrigenomics for Glowing, Wrinkle-free Skin and Radiant Health at Every Age
2984. Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation
2985. Formulated Chinese Medicine Shaoyao Gancao Tang reduces Tau aggregation and exerts neuroprotection through anti-oxidation and anti-inflammation
2986. Forsythiaside, a constituent of the fruits of forsythia suspense, ameliorates scopolamine-induced memory impairment in mice
2987. Fortification of Functional and Medicinal Beverages With Botanical Products and Their Analysis
2988. FoxO proteins in the nervous system
2989. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions
2990. free radical []: free radical is any stable chemical specimen that contains at least
2991. Free Radical Scavenging Activity and Docking Studies of Diarylheptanoids Isolated from Alnus hirsuta
2992. Free radical scavenging activity and protective ability of methanolic extract from Duchesnea indica against protein oxidation and DNA damage
2993. Free radical scavenging activity of antitumour polysaccharide fractions isolated from Ganoderma lucidum (Fr.) P. Karst
2994. Free radical scavenging activity of chloroform and ethyl acetate extracts of leaves of Piper betle Linn
2995. Free Radical Scavenging and Anti-inflammatory Activities of Ethyl Acetate Fraction of Pine Bark
2996. Free radical theory of ageing: applications
2997. Free Radical Theory of Aging
2998. Free radical theory of aging: an update: increasing the functional life span
2999. Free radical tissue damage: protective role of antioxidant nutrients.
3000. Free radicals and antioxidants in human health: current status and future prospects
3001. Free radicals and antioxidants–quo vadis?
3002. Free radicals and antioxidants: A review
3003. Free radicals and dietary antioxidants: a potential review
3004. Free radicals and other reactive species in disease
3005. Free radicals and oxidative damage in biology and medicine: An
3006. Free radicals and oxidative damage in biology and medicine: An introduction
3007. Free radicals and oxidative stress in Neurodegenerative diseases: relevance of dietary antioxidants
3008. Free radicals in brain pathophysiology
3009. Free radicals in brain pathophysiology
3010. Free Radicals in Oxidative Stress, Aging, and Neurodegenerative Disorders
3011. Free radicals, antioxidants and disease
3012. Free radicals, antioxidants in disease and health
3013. Free Radicals, Diabetes, and Its Complexities
3014. From folk medicine to functional food: a review on the bioactive components and pharmacological properties of citrus peels
3015. From small to big molecules: how do we prevent and delay the progression of age-related neurodegeneration?
3016. FRUITS, VEGETABLES, AND HERBS FOUND IN KYÄNI SUNRISE TM
3017. FULL-SPECTRUM ANTIOXIDANT THERAPY.
3018. Functional and Medicinal Beverages: Volume 11: The Science of Beverages
3019. Functional Food and Nutrition for the Management of Autism Spectrum Disorders and Schizophrenia
3020. Functional Food Consumption and Its Physiological Effects
3021. Functional foods
3022. Functional foods
3023. Functional foods and cognition
3024. Functional Foods and Men’s Health
3025. Functional Foods and Nutraceuticals
3026. Functional Foods and Nutraceuticals: An Overview of the Clinical Outcomes and Evidence-Based Archive
3027. Functional foods and physical activities in health promotion of aging people
3028. Functional Foods and Their Importance in Geriatric Nutrition
3029. Functional Foods as Source of Bioactive Principles: Some Marked Examples
3030. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging
3031. Functional Foods, Herbs, and Aging
3032. Functional foods, nutraceuticals, and degenerative disease prevention
3033. Functional foods: genetics, metabolome, and engineering phytonutrient levels
3034. Functional neurotoxicity of arsenic and manganese as environmental agents and the possible protective role of natural antioxidants
3035. Functional properties of green leafy vegetables and changes during processing
3036. Functional Role of Mixed Lineage Kinase 3 (MLK3) on Osteoclastogenesis
3037. Functional role of walnuts and acai fruits on brain health
3038. Functionality of anthocyanins as alternative medicine
3039. Fundamentals and health benefits of xanthohumol, a natural product derived from hops and beer
3040. Future Medicinal Chemistry
3041. Fyn Inhibition by Cycloalkane-Fused 1, 2-Dithiole-3-thiones Exerts Antioxidant Effect and Protects Mitochondria from Oxidative Injury
3042. Gamma-Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the NFêB-Bim Pathway in Ischemic stroke
3043. Garcinia kola diet provides slight protection to mice hippocampal neurons against neurotoxins
3044. Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice
3045. GC-MS analysis of the methanolic extracts of Smilax china and Salix alba and their antioxidant activity
3046. Gene Networks Governing Cholinergic Neuronal Identity in Vertebrate CNS
3047. Gene-coffee interactions and health
3048. Genetic Switches To Treat Obesity And Diabetes
3049. Genetically engineered resveratrol-enriched rice inhibits neuroinflammation in lipopolysaccharide-activated BV2 microglia via downregulating mitogen-activated …
3050. Genistein ameliorates scopolamine-induced amnesia in mice through the regulation of the cholinergic neurotransmission, antioxidant system and the ERK …
3051. Genomic and epigenomic insights into nutrition and brain disorders
3052. Genomic and proteomic mechanisms and models in toxicity and safety evaluation of nutraceuticals
3053. Genoprotective and neuroprotective effects of Daphne gnidium leaf methanol extract, tested on male mice
3054. Genus Spondias: A phytochemical and pharmacological review
3055. Geriatric nutrition
3056. Gerontology & Geriatric Research
3057. Get Smart: Samantha Heller’s Nutrition Prescription for Boosting Brain Power and Optimizing Total Body Health
3058. Ginkgo biloba
3059. Ginkgo biloba
3060. Ginkgo biloba
3061. Ginkgo biloba
3062. Ginkgo biloba extract (EGb 761) and CNS functions basic studies and clinical applications
3063. Ginkgo biloba extract (EGb 761) and CNS functions basic studies and clinical applications
3064. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma
3065. Ginseng: a promising neuroprotective strategy in stroke
3066. Ginsenosides from American ginseng: chemical and pharmacological diversity
3067. Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions
3068. Glabridin inhibits lipopolysaccharide‐induced activation of a microglial cell line, BV‐2, by blocking NF‐κB and AP‐1
3069. Gladiolus dalenii lyophilisate reverses scopolamine-induced amnesia and reduces oxidative stress in rat brain
3070. Glioprotective effects of lingonberry extract against altered cellular viability, acetylcholinesterase activity, and oxidative stress in lipopolysaccharide-treated astrocytes
3071. Global Botanical Drug Development for Respiratory Disease
3072. Global Botanical Drug Development Utilizing the Plant Stem Cell
3073. Global Metabolomic Analysis for Finding Biomarker Candidates from Acute Myocardial Infarction Disease
3074. Glucose‐mediated protein glycation: Contribution of methanolic extract of Ceratonia siliqua L. in protection and in vitro potential inhibition of acetylcholinesterase
3075. Glutamine synthetase: role in neurological disorders
3076. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species
3077. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species
3078. Glutathione, oxidative stress and neurodegeneration
3079. Glutathione, oxidative stress and neurodegeneration
3080. Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease
3081. Glycogen Synthase Kinase 3 alpha (GSK3a) Phosphorylates and Regulates the Osteogenic Activity of Osterix
3082. Glycosides: From biosynthesis to biological activity toward therapeutic application
3083. Glycyrrhizic Acid Ameliorates Mitochondrial Function and Biogenesis Against Aluminum Toxicity in PC12 Cells
3084. Glyphosate’s suppression of cytochrome P450 enzymes and amino acid biosynthesis by the gut microbiome: pathways to modern diseases
3085. Grape powder consumption affects the expression of neurodegeneration-related brain proteins in rats chronically fed a high-fructose–high-fat diet
3086. Grape seed and skin extract prevents high-fat diet-induced brain lipotoxicity in rat
3087. Grape Seeds Extract as Brain Food: A Review
3088. Grapes and the Brain
3089. Grapevine stilbenes and their biological effects
3090. Grapevine stilbenoids: Bioavailability and neuroprotection
3091. Green Coffee Bean Extract in Human Health
3092. Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington’s disease models
3093. Green Tea (Camellia sinensis) and its antioxidant property: A review
3094. Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans—A comprehensive review
3095. GREEN TEA AND POTENTIAL HUMAN HEALTH EFFECTS
3096. Green tea and vitamin C ameliorate some neuro-functional and biochemical signs of arsenic toxicity in rats
3097. Green tea catechins as neuroprotective agents: system-atic review of the literature in animal pre-clinical trials
3098. Green tea catechins change the aggregation behavior of proteins associated with Neurodegenerative disease
3099. Green Tea Effects on Age-Related Neurodegeneration: A Focus on Neuronal Plasticity
3100. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in …
3101. Green tea extract and (–)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities
3102. Green tea extract enhances parieto-frontal connectivity during working memory processing
3103. Green Tea Extract, Epigallocatechin Gallate, Protect Against Methamphetamine-Induced Striatal Neurotoxicity in Mice
3104. Green Tea Revealed: The Mind Blowing Truth Behind This Tea
3105. Green tea: A boon for periodontal and general health
3106. Growth inhibitory effects of SB365 in gefitinib-resistant HCC827 cells
3107. Guidance for New Extended-Release Solid Dosage Forms
3108. Guideline on Review of the Fixed-Dose Combination Products for Cardiovascular Disease
3109. Gut microbiota as a positive potential therapeutic factor in carcinogenesis: an overview of microbiota-targeted therapy
3110. Gut microbiota: a new angle for traditional herbal medicine research
3111. Hanbang’Cosmetics Based on The Korea’s Traditional Herbal Medicine: The History and Current Trends in R&D
3112. Handbook of nutraceuticals volume I: ingredients, formulations, and applications
3113. Handbook of research on food science and technology: Volume 3: Functional foods and nutraceuticals
3114. Harnessing the power of microbiome assessment tools as part of neuroprotective nutrition and lifestyle medicine interventions
3115. Harnessing the Self‐Assembling Properties of Proteins in Spider Silk and Lung Surfactant
3116. Hazelnut and neuroprotection: Improved memory and hindered anxiety in response to intra-hippocampal Aβ injection
3117. HDAC inhibitors from natural and synthetic libraries: towards the development of biochemical probes
3118. HDL and cognition in Neurodegenerative disorders
3119. Heal Your Heart: The Positive Emotions Prescription to Prevent and Reverse Heart Disease
3120. Health Benefits of Anthocyanins
3121. Health benefits of black tea
3122. Health Benefits of Functional Foods: Future Perspective
3123. Health benefits of green tea
3124. Health Benefits of Nut Consumption in Middle-Aged and Elderly Population
3125. Health benefits of the mediterranean diet: metabolic and molecular mechanisms
3126. Health benefits of wine and alcohol from neuroprotection to heart health
3127. Health Care for an Ageing Population E-Book: Meeting the Challenge
3128. HEALTH EFFECTS OF INDOLEAMINES IN THE PREVENTION OF COGNITIVE DECLINE ASSOCIATED WITH BRAIN AGING AND AGE-RELATED DISEASES
3129. HEALTH EFFECTS OF SPICES
3130. Health for Seniors
3131. Health Related Enzyme Inhibiting Natural Products from Medicinal Plants
3132. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition
3133. HEALTHY AGING
3134. Healthy Aging for the Brain
3135. Healthy components of coffee processing by-products
3136. Healthy foods: Fact versus fiction
3137. Healthy Heart: Strengthen Your Cardiovascular System Naturally
3138. Heme Oxygenase-1-Inducing Activity of 4-Methoxydalbergione and 4′-Hydroxy-4-methoxydalbergione from Dalbergia odorifera and Their Anti-inflammatory and …
3139. Heme oxygenase-1-mediated anti-inflammatory effects of tussilagonone on RAW 264.7 macrophages
3140. Heme stabilization of α-synuclein oligomers during amyloid fibril formation
3141. Hepatoprotective Impact of Cinnamon Aqueous Extract تأثیر المستخلص المائى للقرفة على حمایة الکبد
3142. Herb-drug Interaction by Inhibition and Induction of Cytochrome P450
3143. Herba Cistanches: anti-aging
3144. Herbal and nonherbal supplements in medical-psychiatric patient populations
3145. Herbal Beverages and Brain Function in Health and Disease
3146. Herbal Contraindications & Drug Interactions
3147. Herbal Drugs
3148. Herbal extract as potential modulator and drug for synaptic plasticity and Neurodegenerative disorders
3149. Herbal extracts and cognition in adulthood and ageing
3150. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function
3151. Herbal Medications: An Evidence-Based Review
3152. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature
3153. Herbal medicine for sports: a review
3154. Herbal medicine: biomolecular and clinical aspects
3155. Herbal medicines as neuroprotective agent: A mechanistic approach
3156. Herbal medicines in Neurodegenerative disorders: an evolutionary approach through novel drug delivery system
3157. Herbal nanoparticles: A patent review
3158. Herbal nootropic agents.
3159. Herbal preparations prevent beta-amyloid peptide induced hippocampal cell damage
3160. Herbal remedies for CNS disorders
3161. Herbal supplement extends life span under some environmental conditions and boosts stress resistance
3162. Herbal supplements and the brain: understanding their health benefits and hazards
3163. Herbal Therapeutics
3164. Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1‐dependent diseases and longevity
3165. Herbal Treatment of Major Depression: Scientific Basis and Practical Use: Scientific Basis and Practical Use
3166. Herbals in the control of ageing
3167. Herbs for Diabetes and Neurological Disease Management: Research and Advancements
3168. Herbs used for brain disorders
3169. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence
3170. Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction
3171. Heterogeneity of microglia phenotypes: developmental, functional and some therapeutic considerations
3172. Hibiscus sabdariffa L. extract prolongs lifespan and protects against amyloid-β toxicity in Caenorhabditis elegans: involvement of the FoxO and Nrf2 orthologues DAF …
3173. Hidroxycinnamic Acid, a Valid Scaffold for the Development of CNS Multitarget Drugs. Synthesis, Pharmacological and Toxicological Studies.
3174. High Omega-6/Omega-3 Fatty Acid Ratio Diets and Risk of Noncommunicable Diseases: Is the Tissue, the Main Issue?
3175. High Throughput Screening Technology and the Small Molecules Modulating Aging Related Signals
3176. High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals–clinical potential in inflammatory disorders
3177. Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model
3178. Histological and histochemical assessements on the effect of ethanol fruit extract of Phoenix dactylifera L.(Date Palm) on cerebral cortex of lead acetate treated …
3179. HISTORY, DEVELOPMENT AND CONSTITUENTS OF EGb 761
3180. HISTORY, DEVELOPMENT AND CONSTITUENTS OF EGb 761
3181. Holistic Beauty from the Inside Out: Your Complete Guide to Natural Health, Nutrition, and Skincare
3182. Honey as an antioxidant therapy to reduce cognitive ageing
3183. Hops and health
3184. HORMESIS AND GINKGO BILOBA (GB): Numerous Biological Effects of GB are Mediated via Hormesis
3185. Hormesis mediates dose-sensitive shifts in macrophage activation patterns
3186. How does physical activity and different models of exercise training affect oxidative parameters and memory?
3187. How the Precious Role of Wine in Mediterranean Diet Is Mediated by the Gastrointestinal Tract
3188. How to Grow & Eat Your Own Superfoods
3189. How xenohormetic compounds confer health benefits
3190. HPI axis effects on anxiety-like behavior in zebrafish
3191. HPLC-DAD finger printing, antioxidant, cholinesterase, and α-glucosidase inhibitory potentials of a novel plant Olax nana
3192. HPLC-DAD profiles and pharmacological insights of Onobrychis argyrea subsp isaurica extracts
3193. HPTLC fingerprinting and cholinesterase inhibitory and metal-chelating capacity of various Citrus cultivars and Olea europaea
3194. human health
3195. Human induced pluripotent stem cells: an in vitro model for oxidative stress in Rett syndrome and CDKL5 encephalopathy
3196. Human use of Leucoselect® Phytosome® with special reference to inflammatory-allergic pathologies in frail elderly patients
3197. Huperzia serrata: an unexploited potential medicinal pteridophyte from India.
3198. Hydrophobic tail length plays a pivotal role in amyloid beta (25–35) fibril–surfactant interactions
3199. Hydroxychavicol inhibits immune responses to mitigate cognitive dysfunction in rats
3200. Hydroxycinnamic acids (HCAS): Structure, biological properties and health effects
3201. Hydroxycinnamic acids and human health: recent advances
3202. Hydroxypyridinone derivatives: a fascinating class of chelators with therapeutic applications-an update
3203. Hype and hopes of stem cell research in Neurodegenerative diseases
3204. Hyperlipidaemia and cardiovascular disease
3205. Hyperphosporylation of Tau in Hippocampus in DAB-treated mice might be associated with cognitive skills.
3206. Hypoxia and Neuroinflammation: Connections with Toll-Like Receptor Signaling in Brain Microglia
3207. Hypoxia as an initiator of neuroinflammation: microglial connections
3208. Hypoxia inducible factor pathways as targets for functional foods
3209. I Complexation of iron (II), nickel (II), copper (II) and zinc (II) by hexadentate tripodal aminopyridyl chelators II The potential of curcumin in medicine: Synthesis and iron …
3210. Identification and characterization of potential anti proliferative and antioxidant secondary metabolites from Arisaema jacquemontii and Rosa brunonii
3211. Identification of an Analytical Marker/Bioactive Compounds in Natural Products Using TOF-LC/MS/MS and 4 Case Studies
3212. Identification of anticholinesterase compounds from Berberis integerrima, Rheum ribes and Levisticum officinale
3213. Identification of bioactive metabolites from endophytic actinomycetes isolated from medicinal plants
3214. Identification of NewTargets for Anti-inflammatory Therapy in the Gut
3215. Identification of non-alkaloid natural compounds of Angelica purpurascens (Avé-Lall.) Gilli.(Apiaceae) with cholinesterase and carbonic anhydrase inhibition …
3216. Identification of novel autophagic Radix Polygalae fraction by cell membrane chromatography and UHPLC-(Q)TOF-MS for degradation of Neurodegenerative …
3217. Identification of Novel Natural Product Compounds as Histone Deacetylase Inhibitors
3218. Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β25-35 Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
3219. Identifying the key residues instrumental in imparting stability to amyloid beta protofibrils–a comparative study using MD simulations of 17-42 residues
3220. Ilex paraguariensis extract provides increased resistance against oxidative stress and protection against Amyloid beta-induced toxicity compared to caffeine in …
3221. Immune effects and antiacetylcholinesterase activity of Polygonum hydropiper L.
3222. Immunohistochemical detection of dityrosine in lipofuscin pigments in the aged human brain
3223. Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation
3224. Immunoregulatory impact of food antioxidants
3225. Impact of diet on adult hippocampal neurogenesis
3226. Impact of diet-derived signaling molecules on human cognition: exploring the food–brain axis
3227. Impact of green tea (Camellia sinensis L.) consumption in diabetes mellitus-induced neurodegeneration
3228. Impact of non-enzymatic glycation in Neurodegenerative diseases: Role of natural products in prevention
3229. Impact of nutrition on ageing and disease
3230. Impact of obesity on the brain and dietary intervention with bamboo extract
3231. Impact of plant extracts upon human health: A review
3232. Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment
3233. Impact of supplementation of drumstick (Moringa oleifera) and amaranth (Amaranthus tricolor) leaves on the antioxidant status of the post menopausal women
3234. Impairment between oxidant and antioxidant systems: short-and long-term implications for athletes’ health
3235. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β‐peptide: Role of the lipid …
3236. Implementation Strategy of Specialized Pharmacy Services in a Healthcare Setting
3237. Implications of Advanced Glycation Endproducts in oxidative stress and Neurodegenerative Disorders
3238. Implications of plasma thiol redox in disease
3239. Improved blood oxidative status is not associated with better memory performance in postmenopausal women receiving Tualang honey supplementation
3240. Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract Formulation
3241. Improvement in long-term memory following chronic administration of Eryngium planum root extract in scopolamine model: behavioral and molecular study
3242. Improvement of a medicinally important herb Mandookaparni Centella Asiatica L urban through in vitro culture
3243. Improvement of memory and neurological deficit with Ocimum basilicum L. extract after ischemia reperfusion induced cerebral injury in mice
3244. Improving general intelligence with a nutrient-based pharmacological intervention
3245. Improving memory and cognition in individuals with Down syndrome
3246. Improving public health?: The role of antioxidant-rich fruit and vegetable beverages
3247. In Silico Prediction of the Cosmetic Whitening Effects of Naturally Occurring Lead Compounds
3248. In Silico studies in drug research against Neurodegenerative diseases
3249. In silico studies on potential binding sites of amyloid inhibitor compounds on amyloid beta peptide
3250. In silico studies reveal the mechanisms behind the antioxidant and anti-inflammatory activities of hydroxytyrosol
3251. in the Prevention and Management of Other Human Diseases
3252. In the rush for green gold: can green tea delay age-progressive brain neurodegeneration?
3253. In the search for new secondary metabolites with biopesticidal properties
3254. In vitro aggregation assays for the characterization of α-synuclein prion-like properties
3255. In vitro and in silico studies of the molecular interactions of epigallocatechin-3-o-gallate (egcg) with proteins that explain the health benefits of green tea
3256. In vitro and in vivo antioxidant, anti-hyperlipidemic properties and chemical characterization of Centella asiatica (L.) extract
3257. In vitro and in vivo evaluation of enzymatic and antioxidant activity, cytotoxicity and genotoxicity of curcumin-loaded solid dispersions
3258. In vitro anti-AChE, anti-BuChE, and antioxidant activity of 12 extracts of Eleutherococcus species
3259. In vitro anti-cholinesterase and antioxidant activity of extracts of Moringa oleifera plants from Rivers State, Niger Delta, Nigeria
3260. In vitro anti-neuroinflammatory and neuritogenic stimulatory effects of a medicinal mushroom lignosus rhinocerotis (Cooke) ryvarden
3261. In Vitro Anti-platelet Aggregation Activity of the extracts of Bulbine natalensis
3262. In vitro anticholinergic and antihistaminic activities of Acorus calamus Linn. leaves extracts
3263. In vitro antioxidant activities of proanthocyanidins extracted from the lotus seedpod and ameliorative effects on learning and memory impairment in scopolamine …
3264. In vitro antioxidant activities of the methanol extracts of four Helichrysum species from Turkey
3265. In vitro antioxidant activity of Anthriscus cerefolium L.(Hoffm.) extracts
3266. In vitro antioxidant activity of Anthriscus cerefolium L.(Hoffm.) extracts
3267. In vitro antioxidant activity of ethanolic extract of Mucuna pruriens (L.) DC. Seeds
3268. In vitro antioxidant activity of methanolic extract of Rhodiola imbricata Edgew
3269. In vitro antioxidant activity of methanolic leaves and flowers extracts of Lippia alba
3270. In vitro antioxidant activity of the aqueous of Angelicae gigas Nakai leaves
3271. In vitro antioxidant and anti-cholinesterase activities of Rhizophora mucronata
3272. In vitro antioxidant and cholinesterase inhibitory activities of methanolic fruit extract of 1 Phyllanthus acidus 2
3273. In vitro antioxidant and cholinesterase inhibitory activities of methanolic fruit extract of Phyllanthus acidus
3274. In Vitro Antioxidant Properties of Dichloromethanolic Leaf Extract of Gnidia glauca (Fresen) as a Promising Antiobesity Drug
3275. In vitro assessment of anticholinesterase and NADH oxidase inhibitory activities of an edible fern, Diplazium esculentum
3276. In vitro bioactivities of dietary anthocyanins and proanthocyanidins: implications for bioavailability, neuroprotection and safety
3277. In vitro effect of selected medicinal plants on β-amyloid induced toxicity in neuroblastoma cells
3278. In vitro effects of bioactive extracts of local Italian cultivars: from molecular mechanisms to potential nutraceutical applications for consumers’ well-being
3279. In vitro Evaluation of Anti-oxidative and Stabilizing Effect of Pectin on Retinyl Palmitate
3280. In vitro evaluation of antibacterial and antioxidant activities of the essential oil and methanol extract of endemic Zataria multiflora Boiss
3281. In vitro inhibition of acetylcholinesterase by crude plant extracts from Colombian flora
3282. In vitro inhibition of acetylcholinesterase, alphaglucosidase, and xanthine oxidase by bacteria extracts from coral reef in Hainan, South China Sea
3283. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies
3284. In vitro multiple pharmacological targets of Colutea cilicica Boiss. & Balansa against key enzymes linked to Neurodegenerative diseases, diabetes, and …
3285. In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation
3286. In vitro neuroprotective potentials of aqueous and methanol extracts from Heinsia crinita leaves
3287. In vitro neuroprotective properties of some commonly consumed green leafy vegetables in Southern Nigeria
3288. In vitro propagation, phytochemistry and pharmacology of the blood lily, Scadoxus puniceus.
3289. In Vitro Protection by Crataegus microphylla Extracts Against Oxidative Damage and Enzyme Inhibition Effects.
3290. In vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from southern Africa
3291. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of ayurvedic medicinal plants used for cognitive disorders
3292. In vitro screening of three Indian medicinal plants for their phytochemicals, anticholinesterase, antiglucosidase, antioxidant, and neuroprotective effects
3293. In vivo and in vitro data supporting the involvement of oxidative stress in aging-related and metabolic diseases
3294. In vivo Antioxidant and Modulating Enzymes of Wattakaka Volubilis and Kaempferol against Aluminium Sulphate Induced in Liver Toxicity
3295. In vivo determination of oxidative stress
3296. In vivo Investigation of antiamnesic effect of Asparagus racemosus root extract in scopolamine induced amnesic mice
3297. In vivo neuroprotective effects of cinnamon bioactive compounds in C. elegans and D. melanogaster
3298. In-vitro antioxidant activity of the ethyl acetate extract of gum guggul (Commiphora mukul)
3299. In-vitro Assessment of Cholinesterase Inhibitory and Thrombolytic Activity of Six Available Citrus Fruits in Bangladesh: Relevant for Treating Neurodegenerative …
3300. In-vitro studies on acetylcholinesterase and butyrylcholinesterase inhibitory potentials of aerial parts of Vernonia oligocephala (Asteraceae)
3301. Increasing protective activity of genistein by loading into transfersomes: A new potential adjuvant in the oxidative stress-related Neurodegenerative diseases?
3302. Index to Australian Journal of Medical Herbalism
3303. Index to Australian Journal of Medical Herbalism
3304. Indian herbs for the treatment of Neurodegenerative disease
3305. Indicators of Oxidative Stress, Antioxidants and Human Health
3306. Indigofera tinctoria Linn (Fabaceae) attenuates cognitive and behavioral deficits in scopolamine-induced amnesic mice
3307. Indoles as therapeutics of interest in medicinal chemistry: Bird’s eye view
3308. Induction of reactive oxygen species in neurons by haloperidol
3309. Industrial and medicinal application of Reishi and Lion’s Mane mushrooms
3310. Infant’s growth through the first year of life and maternal pre-pregnancy body mass index
3311. Inflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments
3312. Inflammasome signalling in brain function and Neurodegenerative disease
3313. Inflammation and oxidative stress in neurological disorders: effect of lifestyle, genes, and age
3314. Inflammation and the degenerative diseases of aging
3315. Inflammation in Neurodegenerative diseases
3316. Inflammation in Neurodegenerative diseases–an update
3317. Inflammation, advancing age and nutrition: research and clinical interventions
3318. Inflammatory oxidative aging: a new theory of aging
3319. Inflammatory Reaction in Neurological Diseases
3320. Inflammatory Responses by Suppressing NF-jB Signaling in BV-2 Microglial Cells
3321. Influence Factors of the Pharmacokinetics of Herbal Resourced Compounds in Clinical Practice
3322. Influence of a mediterranean diet supplemented in coenzyme Q10 on metabolomic profile and on the expression of antioxidante, pro-inflammatory and endoplasmis …
3323. Influence of dietary antioxidant and oxidant intake on leukocyte telomere length
3324. Influence of fisetin combined with hesperidin on chronic mild hyperhomocysteinemia induced cognitive dysfunction and oxidative stress in wistar rats
3325. Influence of paraoxonase-1 deficiency on metabolic alterations and inflammation
3326. Influence of roasting time on antibacterial and antioxidative effects of coffee extract
3327. Influence of selected natural products on neutral endopeptidase activity and β-amyloid production in SK-N-SH cells
3328. Influenza A (H1N1) Antiviral Agents from Panax ginseng
3329. Ingredient Spotlight: Resveratrol
3330. Ingredients for functional drinks in Neurodegenerative diseases: a review
3331. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases
3332. Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale)
3333. Inhibition of Acetylcholinesterase activity using various medicinal plants
3334. Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites
3335. Inhibition of amyloid formation
3336. Inhibition of Excitotoxic and Aβ (25-35)-induced Neuronal Damage by Fractions Prepared from Mangosteen Pericarp in Primary Cultured Rat Cortical Cells
3337. Inhibition of Excitotoxic Insults by Red Ginseng Extract in the Primary Cultured Rat Cortical Cells
3338. Inhibition of PP2A by hesperetin may contribute to Akt and ERK1/2 activation status in cortical neurons
3339. Inhibition of the Aβ (25-35)-Induced Neuronal Damage by Red Ginseng Extract in the Primary Cultured Rat Cortical Cells
3340. Inhibition of the formation of amyloid-like fibrils using herbal extracts
3341. Inhibition of Tumor Necrosis Factor-α-induced Expression of Cell Adhesion Molecules by Ginsenoside Rg3
3342. Inhibitors of microglial neurotoxicity: focus on natural products
3343. Inhibitory Activity on Amyloid-β Aggregation and Antioxidant Properties of Crocus sativus Stigmas Extract and Its Crocin Constituents
3344. Inhibitory Constituents from Euonymus alatus Leaves and Twigs on Nitric Oxide Production in RAW264. 7 Macrophage Cells
3345. Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia
3346. Inhibitory effect of hydroalcoholic extract of green tea on cognitive impairment and oxidative stress induced by streptozocin in rats
3347. Inhibitory Effects of Alpha-synuclein on the Catecholamine Biosynthesis
3348. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide‐activated BV2 microglia
3349. Inhibitory Effects of Dihydroartemisinin on PMAInduced Inflammatory Response in RAW264. 7 Macrophages
3350. Inhibitory Effects of KTJ406 on IgE-Mediated Allergic Response in Mast Cells
3351. Inhibitory Effects of Losartan and Fimasartan on Catecholamine Release in the Rat Adrenal Medulla
3352. Inhibitory Effects of Resveratrol on UVB-induced Skin Pigmentation in Animal Models
3353. Inhibitory Effects of Self-Fermented Pine Needle Fractions on Catecholamine Secretion from the Perfused Adrenal Medulla
3354. Inhibitory Mechanism for Amyloid β42 Aggregation by
3355. Inhibitory potential of acetylshikonin against CYP2J2 activity in human liver microsomes
3356. Inhibitory potential of some Romanian medicinal plants against enzymes linked to Neurodegenerative diseases and their antioxidant activity
3357. Injectable system for long-term alendroante delivery: preparation and evaluation of its antiosteoporotic activity in an ovariectomized rat model
3358. Innate Immune Receptors as Therapeutic Targets for Chronic Inflammatory Diseases
3359. Innate Immunity in Type 1 and Type 2 Diabetes
3360. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy
3361. Insights of antioxidants as molecules for drug discovery
3362. Insights of the Therapeutic Benefits of NT-020 in Cell Proliferation, Neurogenesis and Immune System
3363. Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology
3364. Insights on localized and systemic delivery of redox-based therapeutics
3365. Insights on the Emerging Role of Phytonutrients as Cognitive Enhancers; Potential Cellular and Molecular Mechanisms
3366. Insights on the neuromodulatory propensity of Selaginella (Sanjeevani) and its potential pharmacological applications
3367. Insulin pathway and its correlation with ageing and longevity
3368. Insurer’s Chronic Metabolic Disease Management Plan
3369. Integrating Cytosolic Phospholipase A2 with Oxidative/Nitrosative Signaling Pathways in Neurons: A Novel Therapeutic Strategy for AD
3370. Integrative Approaches to Cognitive Decline
3371. Inter-relationship of the intestinal microbiome, diet, and mental health
3372. Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy
3373. Interaction of plant extracts with central nervous system receptors
3374. Interaction of VeratrumNigrum with PanaxGinseng against Obesity: aSang-ban Relationship
3375. Interactions of herbs with cytochrome P450
3376. Interactive neuroprotective strategies employing phytochemicals and Omega 3 Fatty Acids
3377. Interleukin-22 as a Potential Therapeutic Agent for Alcoholic Liver Injury
3378. Interleukin-33 induces AP-1 activity and neoplastic cell transformation via upregulation of MAP3K8 activity
3379. Intermittent Fasting-Dietary Restriction as a Geroprotector
3380. Intermittent Fasting–Dietary Restriction as a Biological Hormetin for Health Benefits
3381. International conference on the healthy effect of virgin olive oil
3382. INTERNATIONAL JOURNAL OF ENGINEERING SCIENCES & RESEARCH TECHNOLOGY STUDY OF neuroprotective ACTIVITY OF METHANOLIC …
3383. Interventions to slow aging in humans: Are we ready?
3384. Intracellular Signaling of CCL2 and Its Effect on Neuronal Cell Viability in the Primary Cultured Rat Cortical Cells
3385. Intrastrain comparison of the chemical composition and antioxidant activity of an edible mushroom, Pleurotus giganteus, and its potent neuritogenic properties
3386. Intrinsically disordered domains, amyloids and protein liquid phases: evolving concepts and open questions
3387. Introduction to the proceedings of the fourth international scientific symposium on tea and human health
3388. Inverse Agonist of Nuclear Receptor ERRγ Mediates Anti-diabetic Effect through Inhibition of Hepatic Gluconeogenesis
3389. Investigating a novel antioxidant approach to the treatment of tardive dyskinesia
3390. INVESTIGATION INTO THE ROLE OF NARINGIN ON 3 NITROPROPIONIC ACID INDUCED NEURODEGENERATION CONVERGENCE OF BDNF TrkB AND …
3391. Investigation of anticholinesterase activity of a series of Salvia extracts and the constituents of Salvia staminea
3392. Investigation of novel quinoline heterocycles and some selected medicinal plants for various pharmacological activities
3393. Investigation of phytochemical and in-vitro biological potential of anisoptera scaphula
3394. Investigation of the antioxidant properties of five aromatic plants in model food systems
3395. INVESTIGATION OF THE EFFECT OF ARONIA MELANOCARPA FRUIT JUICE AND CHLOROGENIC ACID IN A RAT OVARIECTOMY INDUCED DEPRESSION …
3396. Investigation of the Effect of Quercitin on Type 2 Diabetes Associated Depressive Illness
3397. Investigation on chemical composition, anticholinesterase and antioxidant activities of extracts and essential oils of Turkish Pinus species and pycnogenol
3398. INVESTIGATION ON SOME PHYTOCHEMICAL CONSTITUENTS AND BIOACTIVITIES OF SEED EXTRACTS OF Mucuna Pruriens L.(KHWE-LEYA)
3399. Invitro Study of the Effects of Coffee and Thyme on Isolated Airway Smooth Muscle Tissue of Guinea Pigs
3400. Involvement of cAMP-ERK1/2 pathways on L-DOPA-induced Cytoxicity in Embryonic Rat Midbrain Primary Cells
3401. Involvement of heme oxygenase-1 in neuropsychiatric and Neurodegenerative diseases
3402. Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes
3403. Involvement of PKCα and ERK1/2 signaling pathways in EGCG’s protection against stress-induced neural injuries in Wistar rats
3404. Involvement of TRPM2 in a Defense Mechanism of Amyloid Precursor Protein against ROS-induced Cell Death
3405. Ion channels in neurological disorders
3406. Iron (FeII) chelation, ferric reducing antioxidant power, and immune modulating potential of Arisaema jacquemontii (Himalayan Cobra Lily)
3407. Iron overload: effects on cellular biochemistry
3408. Iron withholding: a defense against disease
3409. Is ‘Liver Endoplasmic Reticulum Stress’ Really a Disease-Progressing Stress?
3410. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence
3411. Is coffee a functional food?
3412. Is life-span under our control
3413. Is modulation of oxidative stress an answer? The state of the art of redox therapeutic actions in Neurodegenerative diseases
3414. Is the modulation of autophagy the future in the treatment of Neurodegenerative diseases?
3415. Is there any scientific basis of hawan to be used in epilepsy-prevention/cure?
3416. Ischemic optic neuropathy as a model of Neurodegenerative disorder: A review of pathogenic mechanism of axonal degeneration and the role of neuroprotection
3417. Isobavachalcone attenuates lipopolysaccharide-induced ICAM-1 expression in brain endothelial cells through blockade of toll-like receptor 4 signaling pathways
3418. Isolation and characterization of a phenylalanine ammonia-lyase gene (PAL) promoter from Ginkgo biloba and its regulation of gene expression in transgenic …
3419. Isolation and characterization of antibody fragments selective for toxic oligomeric tau
3420. Isolation and neuroprotective Effect of [4 (3, 4-Dihydroxybenzoyloxymethyl) Phenyl-Β-D Glucopyranoside] from Origanum micranthum on
3421. Isolation and Structure Elucidation of Bioactive Compounds (Dedicated to the memory of the late Professor Charles D. Hufford)
3422. Isolation of Acacetin from Calea urticifolia with Inhibitory Properties against Human Monoamine Oxidase-A and -B
3423. Isolation Of Rhinacanthus Nasutus Kurz Plant products And Their study On oxidative stress Systems In rats
3424. Isolation, characterization and insilico pharmacological screening of medicinally important bio-active phytoconstituents from the leaves of Ipomoea aquatica …
3425. Isoprostanes: markers and mediators of oxidative stress
3426. Isorhamnetin (IRN) Attenuates Cognitive Dysfunction Induced by the Intracerebroventricular Injection of Amyloid beta 25-35 (A [Beta] 25-35) in Sprague Dawley …
3427. Japanese, Mediterranean and Argentinean diets and their potential roles in Neurodegenerative diseases
3428. Jobelyn suppresses hippocampal neuronal apoptosis and necrosis in experimental alcohol-induced brain stress
3429. Journal of Aging Science
3430. Jump Start Autophagy: Activate Your Body’s Cellular Healing Process to Reduce Inflammation, Fight Chronic Illness and Live a Longer, Healthier Life
3431. Kaempferia parviflora rhizome extract and Myristica fragrans volatile oil increase the levels of monoamine neurotransmitters and impact the proteomic profiles …
3432. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates
3433. Ketofast: Rejuvenate Your Health with a Step-by-step Guide to Timing Your Ketogenic Meals
3434. Komatsuna seed extracts protection against amyloid β (1-42)-induced neuronal cell death
3435. Korean Red Ginseng Tonic Extends Lifespan in D. melanogaster
3436. l-Amino acid carbamate prodrugs of scutellarin: synthesis, physiochemical property, Caco-2 cell permeability, and in vitro anti-oxidative activity
3437. Lack of CCR5 Modifies Glial Phenotypes and Population of the Nigral Dopaminergic Neurons, but not MPTP-induced Dopaminergic Neurodegeneration
3438. Lactogenic activity of Gunnera perpensa L.(Gunneraceae) from South Africa
3439. Lawsonia Inermis markedly improves cognitive functions in animal models and modulate oxidative stress markers in the brain
3440. Lead compounds from medicinal plants for the treatment of Neurodegenerative diseases
3441. Leaf extracts from Dendropanax morbifera Léveille mitigate mercury-induced reduction of spatial memory, as well as cell proliferation, and neuroblast …
3442. Learning and memory effect of syringic acid on amyloid-β-induced neurotoxicity in ICR mice
3443. Learning and memory enhancing activity of Ficus carica (Fig): An experimental study in rats
3444. Lemonbalm: humble but potent herb
3445. Let Them Eat Flax: 70 all-new commentaries on the Science of everyday food & life
3446. Lichens of Parmelioid Clade as Promising Multitarget neuroprotective Agents
3447. Licochalcone A Suppresses Hepatic Lipid Accumulation via AMPK Activation in Human Hepatoma Cells
3448. Licochalcone-based Bromo-retrochalcome Derivatives, SN159 as Dual Peroxisome Proliferatoractivated Receptor (PPAR) Alpha/Gamma Agonist.
3449. Life and Achievements of Professor Koo Dong Han, the Father of Modern Pharmaceutical Sciences inKorea
3450. Lifespan and Healthspan Extension by Nutraceuticals: An Overview
3451. Lifestyle as a Risk Factor for Metabolic Syndrome and Neurological Disorders
3452. Lifestyle medicine for prevention of cognitive decline: Focus on green tea
3453. Lifestyle shapes the dialogue between environment, microglia, and adult neurogenesis
3454. Lifetime nutritional influences on cognition, behaviour and psychiatric illness
3455. Ligand design to target and modulate metal–protein interactions in Neurodegenerative diseases
3456. Linalool and Linalyl Acetate Isolated from Agastache rugosa (Fisch. & Mey.) Kuntze Inhibits the Production of Macrophage-Derived Inflammatory Mediators
3457. Linalool bioactive properties and potential applicability in drug delivery systems
3458. Lingonberries and their two separated fractions differently alter the gut microbiota, improve metabolic functions, reduce gut inflammatory properties, and improve brain …
3459. Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related Neurodegenerative diseases?
3460. Lipid oxidation in food systems
3461. Lipidomics analysis reveals the pharmacological effects of Platycodon grandiflorum extracts in high-fat diet induced obese mice
3462. Liquorice: from botany to phytochemistry
3463. LITERATURE REVIEW HEALTH BENEFITS RED WINE
3464. Live Better, Longer: The Science Behind the Amazing Health Benefits of OPCs
3465. Liver X Receptor alpha Enhances Transcriptional Activity of HIF-1a that Results in Lipid Accumulation in HepG2
3466. Living Long and Aging Well: Are Lifestyle Factors the Epigenetic Link in the Longevity Phenotype?
3467. Long acting Injectable Palmityl-acylated Exendin-4-loaded glycol Chitosan Hydrogels for Treating Type 2 Diabetes
3468. Long-term effects of aluminium on lipid peroxidation and antioxidant protection in experimental mice brain
3469. Long-term icariin treatment ameliorates cognitive deficits via CD4+ T cell-mediated immuno-inflammatory responses in APP/PS1 mice
3470. Long-term intake of vegetables and fruits and subjective cognitive function in US men
3471. Longevity and diet. Myth or pragmatism?
3472. Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial Cells
3473. Look Younger, Live Longer: 10 Steps to Reverse Aging and Live a Vibrant Life
3474. Low Carb High Quality Diet: Food for a Thinner, Healthier Life
3475. Low molecular proanthocyanidin dietary biofactor Oligonol: Its modulation of oxidative stress, bioefficacy, neuroprotection, food application and chemoprevention …
3476. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities
3477. Low-dose aronia melanocarpa concentrate attenuates paraquat-induced neurotoxicity
3478. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals
3479. Luteolin alleviates melanogenesis through regulation of oxidative insults
3480. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
3481. Luteolin from Purple Perilla mitigates ROS insult particularly in primary neurons
3482. Luteolin inhibits fibrillary β-Amyloid1–40-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-κB signaling …
3483. Luteolin inhibits microglial inflammation and improves neuron survival against inflammation
3484. Luteolin Protected against Beta-Amyloid-induced Neuronal Cell Death and Memory Impairment via Activation of Nrf2-HO-1 Signaling Pathway
3485. Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice
3486. Lycium chinensis Mill attenuates glutamate induced oxidative toxicity in PC12 cells by increasing antioxidant defense enzymes and down regulating ROS and Ca2+ …
3487. Lycopene and tomatoes in human nutrition and health
3488. Lycopene: A Natural Food Colorant Graduating to be a Potential Health Enhancer
3489. Lysophospholipid and Their Receptors in the Nervous System
3490. Maackiapterocarpan B from Sophora tonkinensis suppresses inflammatory mediators and mitogen-activated protein kinase pathways
3491. Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma
3492. MALDI Imaging Technology to Monitor the Drug Delivery
3493. Manganese superoxide dismutase and oxidative stress modulation
3494. Mapping NAD+ metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence
3495. Mapping of amyloidogenic peptides induced genotoxicity in relevance to neuronal cell death
3496. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation
3497. MARTINI-MORALES Sasi Elibeth. Antioxidant activity jobo’s pulp (Spondias mombin L.)
3498. Mass Spectrometric Characterization and Analysis of Anti-oxidative Properties of Medicinal Herbs
3499. Mass Spectrometry Based Metabolomics Approach on the Effects of Morin in Dimethylnitrosamine Treated Rats
3500. MASTER OF VETERINARY SCIENCE IN VETERINARY PHARMACOLOGY AND TOXICOLOGY
3501. Mate tea prevents oxidative stress in the blood and hippocampus of rats with acute or chronic ethanol administration
3502. Mathematical-Model-Based Assessment of Streptozotocin-Induced Diabetic Rats: Whole-Body Level Glucose-Insulin Dynamics and β-Cell Functions
3503. mberHappily (n) ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence
3504. MC5032 Inhibits Platelet-Derived Growth Factor-Induced Rat Aortic Smooth Muscle Cell Proliferation
3505. MCP‐1 (CCL2) protects human neurons and astrocytes from NMDA or HIV‐tat‐induced apoptosis
3506. Mechanism and implications of traditional Chinese medicine in amyotrophic lateral sclerosis therapy
3507. Mechanism of neurotrophic action of nobiletin in PC12D cells
3508. Mechanism of ROS scavenging and antioxidant signalling by redox metallic and fullerene nanomaterials: Potential implications in ROS associated degenerative …
3509. Mechanism Study of Therapeutic Anti-tumor Effect by Intratumoral Injection of Recombinant Attenuated Salmonella Vaccine Strain
3510. Mechanisms and Late-Life Intervention of Aging
3511. Mechanisms of action and therapeutic potential of neurohormetic phytochemicals
3512. Mechanisms of Action of Curcumin on Aging: Nutritional and Pharmacological Applications
3513. Mechanisms of neurodegeneration in Huntington’s disease
3514. Mechanisms of Obesity and Metabolic Syndrome and Targets for Functional Foods
3515. Mechanisms of protein misfolding: Novel therapeutic approaches to protein-misfolding diseases
3516. Mechanisms of target organ damage caused by hypertension: therapeutic potential
3517. Mechanistic and Structural Insights into the Chemical Modulation of Amyloid Aggregation
3518. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a …
3519. Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation
3520. Mechanistic targeting of advanced glycation end-products in age-related diseases
3521. Medical management, prevention and mitigation of environmental risks factors in Neurology
3522. Medical Medium Life-Changing Foods: Save Yourself and the Ones You Love with the Hidden Healing Powers of Fruits & Vegetables
3523. Medical toxicology of natural substances: foods, fungi, medicinal herbs, plants, and venomous animals
3524. Medicinal and beneficial health applications of Tinospora cordifolia (Guduchi): a miraculous herb countering various diseases/disorders and its Immunomodulatory …
3525. Medicinal and pharmacological role of traditional Asian Food condiment: Cinnamomum zeylanicum Blume
3526. Medicinal and Therapeutic Potential of Seed Spices
3527. Medicinal and therapeutic potentialities of tea (Camellia sinensis L.)–A review
3528. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
3529. Medicinal effect of nutraceutical fruits for the cognition and brain health
3530. Medicinal Mushrooms-A Clinical Guide
3531. Medicinal mushrooms: Valuable biological resources of high exploitation potential
3532. Medicinal phytochemical and pharmacological properties of kesum (Polygonum minus Linn.): A mini review
3533. Medicinal plants and their derivatives with amyloid beta inhibitory activity as potential targets for drug discovery
3534. Medicinal plants as antioxidant agents: understanding their mechanism of action and therapeutic efficacy
3535. Medicinal plants as natural polarizers of macrophages: Phytochemicals and Pharmacological effects
3536. Medicinal Plants as Novel Promising Therapeutics for Neuroprotection and Neuroregeneration
3537. Medicinal plants for the prevention and treatment of coronary heart disease
3538. Medicinal plants in Neurodegenerative diseases: perspective of traditional Persian medicine
3539. Medicinal plants in traumatic brain injury: neuroprotective mechanisms revisited
3540. Medicinal plants used for neurological and mental disorders in Navarra and their validation from official sources
3541. Medicinal plants with acetylcholinesterase inhibitory activity
3542. Medicinal plants with central nervous activity-An overview (Part 1)
3543. Medicinal plants with central nervous effects (part 2): plant based review
3544. Medicinal plants with cholinesterase inhibitory activity: a review
3545. Medicinal plants: a natural chaperones source for treating neurological disorders
3546. Medicinal Plants: Chemistry, Pharmacology, and Therapeutic Applications
3547. Medicinal Potential of Six Different Plant Species of Dehradun District, Uttarakhand
3548. Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds
3549. Medicinal properties in whole foods: whole food nutrition and Neurodegenerative disorders
3550. Medicinal uses of plants for nervous disorders
3551. Medicinal uses, phytochemistry and pharmacology of the genus Uncaria
3552. Medicinally Important Trees
3553. Mediterranean Diet (Prong-4)
3554. Mediterranean diet adherence is associated with reduced subjective cognitive decline in a healthy adult population
3555. Mediterranean Diet and Age-Related Cognitive Decline.
3556. Mediterranean diet and health outcomes in the SUN cohort
3557. Mediterranean diet and health: food effects on gut microbiota and disease control
3558. Mediterranean diet and inflammaging within the hormesis paradigm
3559. Mediterranean diet and prevention of chronic diseases
3560. Mediterranean diet and the elderly: a review
3561. Melandrii Herba extract attenuates H2O2-induced neurotoxicity in human neuroblastoma SH-SY5Y cells and Scopolamine-induced memory impairment in mice
3562. MELATONIN IN NEURODEGENERATIVE, PSYCHIATRIC AND SYSTEMIC INFLAMMATORY DISORDERS
3563. Melatonin reduces memory changes and neural oxidative damage in mice treated with D‐galactose
3564. Melissa officinalis L.: Overview of Pharmacological and Clinical Evidence of the Plant and Marketed Products in Spain
3565. Members of antioxidant machinery and their functions
3566. Membrane androgen receptor-induced oxidative stress: mechanism involved in neurodegeneration
3567. Memory bites and games-environmental and mental elements affect brain health for elderly
3568. Memory enhancement and reduction in lipid peroxidation by dietary antioxidants in brain
3569. Memory enhancing activity of Lawsonia inermis Linn. leaves against scopolamine induced memory impairment in Swiss albino mice
3570. Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement
3571. Memory modulatory effect of green tea aqueous extract in mice
3572. Memory Rescue: Supercharge Your Brain, Reverse Memory Loss, and Remember what Matters Most
3573. Memory-enhancing effect of Mori Fructus via induction of nerve growth factor
3574. Memory-vitalizing effect of twenty-five medicinal and edible plants and their isolated compounds
3575. Metabolic and Bioactivity Insights into Brassica oleracea var. acephala
3576. Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol
3577. Metabolic syndrome and neuroprotection
3578. Metabolomics Study of the Anti-depression Effect of Fluoxertine and Imipramine on Mouse Model with Chronic Mild Stress
3579. Metal coordination and peripheral substitution modulate the activity of cyclic tetrapyrroles on αS aggregation: a structural and cell-based study
3580. Metal dyshomeostasis and their pathological role in prion and prion-like diseases: the basis for a nutritional approach
3581. Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury
3582. Metals, oxidative stress and Neurodegenerative disorders
3583. Metformin reduces level of phosphorylated alpha-synuclein in normal mice brain via AMPK activation
3584. Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats
3585. Methodological Issues in Conducting Epidemiological Research on Nutraceuticals
3586. Methods for extractions of value-added nutraceuticals from lignocellulosic wastes and their health application
3587. Methylxanthines: Dietary sources, bioavailability, and health benefits
3588. Micro and nanoencapsulation: a new hope to combat the effects of chronic degenerative diseases
3589. Microalgae: a valuable source of natural carotenoids with potential health benefits
3590. Microalgal carotenoids: beneficial effects and potential in human health
3591. Microbial genetic screens for monitoring protein misfolding associated with neurodegeneration: tools for identifying disease-relevant genes and for screening synthetic …
3592. Microbial healthcare products
3593. Microbial Source of Astaxanthin: its use as a Functional Food and Therapeutic Agent
3594. Microfluidic Device-Based High-Content Screening of Drug-Induced Cardiotoxicity Using Quantitative Single Cell Imaging Cytometry
3595. Microglia and regulation of inflammationmediated neurodegeneration: Prevention and treatment by phytochemicals and metabolic nutrients
3596. Microglia in physiology and disease
3597. Micromorphological and cytological analysis of trichomes and biological effects of extracts of Salvia aegyptiaca L., S. fruticosa Mill. and S. lanigera Poir.(Lamiaceae) …
3598. Micronutrient-enriched rapeseed oils improve the brain oxidant/antioxidant system in rats fed a high-fat diet
3599. Micronutrients and brain health
3600. Micronutrients in Health and Disease
3601. Ministry of Health and Welfare R&D projects: Development of new drugs
3602. Minor constituents and phytochemicals of the kernel
3603. Mitigating the effects of high fat diet on the brain and behavior with berry supplementation
3604. Mitigation of lead-induced neurotoxicity by the naringin: erythrocytes as neurons substitute markers
3605. Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons
3606. Mitochondria as pharmacological targets in Down syndrome
3607. Mitochondria play a central role in estrogen-induced neuroprotection
3608. Mitochondria, oxygen free radicals, and apoptosis
3609. Mitochondrial Abnormalities in Down Syndrome: Pathogenesis, Effects and Therapeutic Approaches
3610. Mitochondrial biogenesis, protein misfolding and cellular stress response in aging and in Neurodegenerative disorders: proteomic approach
3611. Mitochondrial dysfunction and cell death in Neurodegenerative diseases through nitroxidative stress
3612. Mitochondrial dysfunction and molecular pathways of disease
3613. Mitochondrial effects of plant-made compounds
3614. Mitochondrial medicine for Neurodegenerative diseases
3615. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide
3616. Mitochondrial permeability transition pore: a potential drug target for neurodegeneration
3617. Mitochondrial Protection by Carnosine Contributes to the Attenuation of Brain Damage during Ischemic Stroke
3618. Mitochondrial SIRT3 and Neurodegenerative brain disorders
3619. Mitochondrial tolerance to drugs and toxic agents in ageing and disease
3620. Mixture of peanut skin extract and fish oil improves memory in mice via modulation of anti-oxidative stress and regulation of BDNF/ERK/CREB signaling pathways
3621. Mobility and cognition: End points for dietary interventions in aging
3622. Model of Chaperones in Aging
3623. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast?
3624. Modelos animales de degeneración cognitiva y uso de transplantes neurales de células madre como terapia
3625. Modification and PPAR Gamma-binding Activity of Marine derived Phthalide
3626. Modification of amyloid fiber formation of α-synuclein and amyloid-β by small molecules
3627. Modulating neuronal aging: insights from insulin signaling genes and Alaskan nutraceuticals
3628. Modulating the Amyloidogenesis of α-Synuclein
3629. Modulation and function of microglial phenotypes
3630. Modulation of Adenosine Receptors and Antioxidative Effect of Beer Extracts in in Vitro Models
3631. Modulation of Amyloid-β Aggregation via Small Molecules and Glycine Zipper Alterations
3632. Modulation of cognition: the role of Gnidia glauca on spatial learning and memory retention in high-fat diet-induced obese rats
3633. Modulation of inflammatory response to implanted biomaterials using natural compounds
3634. Modulation of neuroinflammation with the phytoestrogen, formononetin
3635. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2018
3636. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in A lzheimer’s disease transgenic mice
3637. Modulation of Restraint Stress Induced Biochemical Changes by Various Therapeutic Agents
3638. Modulation of T Helper Cell Lineage Commitment by T-bet Modification
3639. Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues
3640. Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01
3641. Modulators of amyloid β-protein (Aβ) self-assembly
3642. Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects
3643. Modulazione della risposta cellulare allo stress ossidativo nell’invecchiamento e nelle patologie neurodegenerative
3644. Molecular and Intracellular Signaling Mechanisms of Herbs, Spices, and Food Components in the Mediterranean Diet in Improving Cognitive Function
3645. Molecular Design and Discovery of Single and Dual Inhibitors of Amyloid Peptides
3646. Molecular docking and antiamnesic effects of nepitrin isolated from Rosmarinus officinalis on scopolamine-induced memory impairment in mice
3647. Molecular docking and ex vivo and in vitro anticholinesterase activity studies ofSalvia sp. and highlighted rosmarinic acid
3648. Molecular docking study of cassia tora, brassica campestris and calotropis procera as acetylcholinesterase inhibitor
3649. Molecular Imaging Technology in Drug Discovery and Development
3650. Molecular Inflammation Research Center for Aging Intervention (MRCA)
3651. Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects
3652. Molecular interventions in lifestyle-related diseases
3653. Molecular mechanism of Abeta recognition and neuroprotection by the glycoconjugate beta-sheet-breaker peptide Ac-LPFFD-Th
3654. Molecular mechanism of action of antioxidant biomolecules from higher plants
3655. Molecular mechanism underlying the therapeutic activities of propolis: a critical review
3656. Molecular mechanisms behind free radical scavengers function against oxidative stress
3657. Molecular mechanisms involved in the neuroprotective action of phytochemicals
3658. Molecular Mechanisms of Neuroprotection and Cognitive Enhancement by an Alternative drug Centella asiatica
3659. Molecular Mechanisms of Neuroprotection by an Alternative Drug Scutellaria lateriflora
3660. Momordica charantia ethanol extract attenuates H2O2-induced cell death by its antioxidant and anti-apoptotic properties in human neuroblastoma SK-N-MC cells
3661. Monitoring of Endogenous Antioxidants: An Electroanalytical Approach
3662. Monoamine oxidase inhibition by Rhodiola rosea L. roots
3663. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent Neurodegenerative disorders
3664. Montmorency Tart cherries (Prunus cerasus L.) modulate vascular function acutely, in the absence of improvement in cognitive performance
3665. More than just caffeine: Psychopharmacology of methylxanthine interactions with plant-derived phytochemicals
3666. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo
3667. Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
3668. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms
3669. Moringa oleifera extract attenuates the CoCl2 induced hypoxia of rat’s brain: expression pattern of HIF-1α, NF-kB, MAO and EPO
3670. Moringa Regimen Corrects Nicotine-induced Deficits in Behaviour, Altered Energy Metabolism and Neurotransmitter Processing in Rat Brain
3671. Moroydor Derun E., Piskin S.: Examination of the lemon effect on risk elements concentrations in herbal and fruit teas
3672. Motor and cognitive deficits due to permanent cerebral hypoperfusion/ischemia improve by pomegranate seed extract in rats
3673. MSTMP, a Stilbene Derivative, Protects SH-SY5Y Cells Against Oxidative Stress
3674. mTOR and neuroinflammation
3675. Multi-target compounds acting in the central nervous system designed from natural products
3676. Multi-target drug design approaches for multifactorial diseases: from Neurodegenerative to cardiovascular applications
3677. Multifaceted roles of curcumin: two sides of a coin!
3678. Multifunctional activities of green tea catechins in neuroprotection
3679. Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
3680. Multiple mechanisms of iron-induced amyloid beta-peptide accumulation in SHSY5Y cells: protective action of negletein
3681. Multiple pharmacological targets, cytotoxicity, and phytochemical profile of Aphloia theiformis (Vahl.) Benn.
3682. Multiplicity of effects and health benefits of resveratrol
3683. Multitargeted bioactive materials of plants in the Curcuma genus and related compounds: Recent advances
3684. Multivalent & multifunctional ligands to β-amyloid
3685. Multivariate Anti-inflammatory Approaches to Rescue Neurogenesis and Cognitive function in Aged Animals
3686. Mycosphere Essays 15. Ganoderma lucidum-are the beneficial medical properties substantiated?
3687. N-acetylcysteine Normalizes the Urea Cycle and DNA Repair in Cells from Patients with Batten Disease
3688. Nano-antioxidants: an emerging strategy for intervention against Neurodegenerative conditions
3689. Nano-medicine improving the bioavailability of small molecules for the prevention of Neurodegenerative diseases
3690. Nano-pillars of polymer gels with controlled mechanical properties
3691. Nanodelivery of phytobioactive compounds for treating aging-associated disorders
3692. Nanomedicines for Subcellular Targeting: The Mitochondrial Perspective
3693. Nanonutraceuticals in Central Nervous System Disorders
3694. Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
3695. Nanoparticles and controlled delivery for bioactive compounds: Outlining challenges for new “Smart-foods” for health
3696. Nanostructured Drug Delivery of Nutraceuticals for Counteracting Oxidative Stress
3697. Nanotechnological approaches using curcumin and Withania somnifera: neuroprotection and antimicrobial activities
3698. Nanotechnological Interventions for Neurodegenerative Disorders Using Phytoactives
3699. Nanotechnology in bioactive food ingredients: Its pharmaceutical and biomedical approaches
3700. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat
3701. Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress
3702. Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in male rats
3703. Naringin and rutin alleviates episodic memory deficits in two differentially challenged object recognition tasks
3704. NARINGIN REVEALS AMELIORATIVE PROPERTY OVER ELEVATED oxidative stress LEVELS IN ANIMAL MODELS
3705. Naringin reverses neurobehavioral and biochemical alterations in intracerebroventricular collagenase-induced intracerebral hemorrhage in rats
3706. National institutes of health discovers protective effects of coffee
3707. Natual Products, Business Model, Dynamics of Herbal Business Industry in India
3708. Natural and Artificial Beverages: Exploring the Pros and Cons
3709. Natural antidotes and management of metal toxicity
3710. Natural antioxidant anthocyanins—A hidden therapeutic candidate in metabolic disorders with major focus in neurodegeneration
3711. Natural antioxidants and Neurodegenerative diseases
3712. Natural antioxidants and their intrinsic worth for wellbeing
3713. Natural antioxidants: a review on therapeutic applications
3714. Natural Bioactive Compounds from Fruits and Vegetables as Health Promoters Part I
3715. Natural Bioactive Compounds from Fruits and Vegetables as Health Promoters Volume
3716. Natural biomolecules and protein aggregation: emerging strategies against amyloidogenesis
3717. Natural cognitive enhancers
3718. Natural compound 2 provides neuroprotection and anti-neuroinflammation via Nrf2/AREdependent HO-1 expression through activation of the PI3K/AKT …
3719. Natural compounds and neuroprotection: mechanisms of action and novel delivery systems
3720. Natural compounds as antioxidant and molting inhibitors can play a role as a model for search of new botanical pesticides
3721. Natural compounds as modulators of NADPH oxidases
3722. Natural compounds as therapeutic agents for amyloidogenic diseases
3723. Natural compounds isolated from wild Alaska bog blueberries intervene with molecular targets of neuroinflammation
3724. Natural compounds: evidence for a protective role in eye disease
3725. Natural extracts as possible protective agents of brain aging
3726. Natural Medicines Enhancing Neurite Growth in Central Nervous System Disorders: A Review
3727. Natural molecules for healthy lifestyles: oleocanthal from extra virgin olive oil
3728. Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive Oil
3729. Natural monoterpenes: Much more than only a scent
3730. Natural or plant products for the treatment of neurological disorders: current knowledge
3731. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system
3732. Natural product and natural product derived drugs in clinical trials
3733. Natural Product Studies of Marine Organisms from the
3734. Natural product-based amyloid inhibitors
3735. Natural Product-Based Strategy for Developing Anti-Osteoporotic Drugs
3736. Natural Products against Huntington’s Disease (HD): Implications of Neurotoxic Animal Models and Transgenics in Preclinical Studies
3737. Natural products against Neurodegenerative diseases: effects in the model organism Caenorhabditis elegans
3738. Natural products and related compounds of realized and potential use in treating Neurodegenerative disease
3739. Natural products and their active principles used in the treatment of Neurodegenerative diseases: a review
3740. Natural products and their derivatives as cholinesterase inhibitors in the treatment of Neurodegenerative disorders: an update
3741. Natural products as anti-HIV agents and role in HIV-associated neurocognitive disorders (HAND): a brief overview
3742. Natural products as building blocks and lead compounds for API production
3743. Natural products as modulator of autophagy with potential clinical prospects
3744. Natural Products Based Ayurvedic Formulations: Chemical Cons tituents and Treatment in Neurodegenerative Disorders# 130
3745. Natural Products Derived from the Mediterranean Diet with Antidiabetic Activity: from Insulin Mimetic Hypoglycemic to Nutriepigenetic Modulator Compounds
3746. Natural Products for the Prevention of Oxidative Stress-Related Diseases: Mechanisms and Strategies
3747. Natural products for the treatment of Neurodegenerative diseases
3748. Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge
3749. Natural Products in the Drug Discovery Programmes in
3750. Natural Products of the Rhizosphere and Its Microorganisms
3751. Natural red pigments from plants and their health benefits: A review
3752. Natural remedies for management of glaucoma.
3753. Natural Sex Boosters: Supplements That Enhance Stamina, Sensation, and Sexuality for Men and Women
3754. Natural steroids and androgen antagonists used as neuroprotection in common neurological disorders
3755. Natural withanolides in the treatment of chronic diseases
3756. Nature, nurture and neurology: gene–environment interactions in Neurodegenerative disease: FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th …
3757. Nature: a substantial source of auspicious substances with acetylcholinesterase inhibitory action
3758. Nauclea latifolia stem-bark extract protects the prefrontal cortex from valproic acid-induced oxidative stress in rats: Effect on B-cell lymphoma and neuron specific …
3759. Necroptosis modulated by autophagy contributes to hepatocellular damage during hepatic ischemia and reperfusion
3760. Neopicrorhiza scrophulariiflora (Pennell) Hong: A comprehensive review of its traditional uses, phytochemistry, pharmacology and safety
3761. Nerve growth factor mimetic effects of Momordica cochinchinensis in PC 12 cells
3762. NERVOUS SYSTEM PATHOLOGY
3763. Neural regeneration: role of traditional Chinese medicine in neurological diseases treatment
3764. Neurite outgrowth stimulatory activity of an edible mushroom Pleurotus Giganteus in differentiating neuroblastoma-2a cells/Phan Chia Wei
3765. Neuro vigilance of Syzygium Cumini plant phytochemicals
3766. Neuro-nutraceuticals: the path to brain health via nourishment is not so distant
3767. Neuro-protective Mechanisms of Lycium barbarum
3768. Neuroactive multifunctional tacrine congeners with cholinesterase, anti-amyloid aggregation and neuroprotective properties
3769. Neurobehavioral and neurochemical studies In Cerebral Ischemia and itsamelioration by herbal drugs
3770. Neurobehavioral aspects of antioxidants in aging
3771. Neurobehavioral aspects of antioxidants in aging
3772. neurochemIcal effects of Western dIet consumptIon on human BraIn
3773. Neurocognitive effects of multivitamin supplementation on the steady state visually evoked potential (SSVEP) measure of brain activity in elderly women
3774. Neurodegeneration and aging of the central nervous system: prevention and treatment by phytochemicals and metabolic nutrients
3775. Neurodegeneration During Aging: The Role of oxidative stress Through Epigenetic Modifications
3776. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets
3777. Neurodegeneration is dependant on microglial proximity and nitric oxide production
3778. Neurodegeneration: accelerated ageing or inadequate healthcare?
3779. Neurodegenerative Disease and Micronutrients: Prevention and Treatment
3780. Neurodegenerative diseases and neuroprotection: current views and prospects
3781. Neurodegenerative diseases and oxidative stress
3782. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review
3783. Neurodegenerative diseases–understanding their molecular bases and progress in the development of potential treatments
3784. Neurodegenerative diseases: from available treatments to prospective herbal therapy
3785. Neurodegenerative disorders and inflammation
3786. Neurogenesis, Neuroplasticity, and the Treatment of Brain Disorder
3787. Neurohormetic phytochemicals: An evolutionary–bioenergetic perspective
3788. Neuroinflammation and cognitive impairment in the aged: implications for nutritional intervention
3789. Neuroinflammation impact in epileptogenesis and new treatment strategy
3790. Neuroinflammation in CNS diseases: molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
3791. Neuroinflammation pathways: a general review
3792. Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review
3793. Neuroinflammation, neurodegeneration, and depression
3794. Neurological and Psychiatric management using COMT inhibitors: A review
3795. Neurological Disorders: Caus
3796. Neurological effects of honey: current and future prospects
3797. Neurologically potent molecules from Crataegus oxyacantha; isolation, anticholinesterase inhibition, and molecular docking
3798. Neuronal apoptosis in neurodegeneration
3799. Neuronal cell lipidomics and role of cholesterol in α-synuclein binding and aggregation
3800. Neuronal differentiation of human iPS cells induced by baicalin via regulation of bHLH gene expression
3801. Neuronutrition: An Emerging Concept
3802. Neuropathology and Iron: Central Nervous System Iron Homeostasis
3803. Neuropeptides: Function in Colorectal Tumoringenesis
3804. Neuropharmacological aspects of Crocus sativus L.: a review of preclinical studies and ongoing clinical research
3805. Neuropharmacological potential of the genus Citrus: A review
3806. Neuropharmacological profile of Indian medicinal plant.
3807. Neuropharmacology of Genus Hypericum: Hypericin and Hyperforin
3808. Neuroproetective effects of antidepressants via up-regulation of neurotrophic factors
3809. Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the Aβ-injected rat
3810. NEUROPROTECTION AND ITS PLACE IN GLAUCOMA TREATMENT
3811. Neuroprotection by bioactive components in medicinal and food plant extracts
3812. Neuroprotection by spice-derived nutraceuticals: you are what you eat!
3813. Neuroprotection Comparison of Different Nutraceutical Compounds Against Mechanistically Distinct Cell Death Inducing Agents.
3814. NEUROPROTECTION IN BRAIN HYPOXIA
3815. Neuroprotection in Cerebrovascular Disease
3816. Neuroprotection in glaucoma–is there a future role?
3817. Neuroprotection in glaucoma: old and new promising treatments
3818. Neuroprotection in glaucoma: old concepts, new ideas
3819. Neuroprotection of multifunctional phytochemicals as novel therapeutic strategy for Neurodegenerative disorders: Antiapoptotic and antiamyloidogenic activities by …
3820. Neuroprotection of N-benzylcinnamide on scopolamine-induced cholinergic dysfunction in human SH-SY5Y neuroblastoma cells
3821. Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
3822. neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons
3823. neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons
3824. neuroprotective activity of Crataeva nurvula Buch-Ham stem bark against Scopolamineinduced cognitive impairment via antioxidative activites in rats
3825. neuroprotective Activity of Evolvulus alsinoides & Centella asiatica Ethanolic Extracts in Scopolamine-Induced Amnesia in Swiss Albino Mice
3826. neuroprotective Activity of Evolvulus alsinoides & Centella asiatica Ethanolic Extracts in Scopolamine-Induced Amnesia in Swiss Albino Mice. Open Access …
3827. neuroprotective agents
3828. neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants
3829. neuroprotective and Anti-Inflammatory Properties from the Bioactive Constituents of Myracrodruon Urundeuva, a Brazilian Medicinal Species
3830. neuroprotective and antiamnesic effects of Mitragyna inermis willd (Rubiaceae) on scopolamine-induced memory impairment in mice
3831. neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
3832. neuroprotective AND COGNITIVE ENHANCING EFFECT OF METHANOLIC MORUS ALBA LEAF FRACTION IN U87MG CELL LINES AND …
3833. neuroprotective and cognitive-enhancing effects of microencapsulation of mulberry fruit extract in animal model of menopausal women with metabolic syndrome
3834. neuroprotective and Neurological Properties of Melissa officinalis
3835. neuroprotective and neurotrophic agents
3836. neuroprotective and Therapeutic Strategies for Manganese–Induced Neurotoxicity
3837. neuroprotective ANTIOXIDANT-BASED THERAPEUTIC PROPERTIES OF MALAYSIAN MEDICINAL PLANTS IN JAVANESE MEDAKA (Oryzias javanicus …
3838. neuroprotective behaviour of Phyllanthus emblica (L) on human neural cell lineage (PC12) against glutamate-induced cytotoxicity
3839. neuroprotective effect by Z-ligustilide extracted from Radix Angelica sinensis for the treatment of cerebral ischemia
3840. neuroprotective Effect of Aegle marmelos Leaf Extract in Scopolamine Induced Cognitive Impairment and oxidative stress in Mice
3841. neuroprotective effect of against aluminium-induced Gracilaria corticata neurotoxicity in the hippocampus and cerebral cortex of rat brain: Biochemical and …
3842. neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats
3843. neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 cells
3844. neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice
3845. neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity
3846. neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells
3847. neuroprotective effect of dietary black seed flour on key enzymes linked with neuronal signaling molecules in rats exposed to mixture of environmental metals
3848. neuroprotective Effect of Diosmin on Arsenic Trioxide Induced Neurotoxicity in Albino Wistar Rats.
3849. neuroprotective effect of epigallocatechin-3-gallate against β-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity
3850. neuroprotective effect of estradiol and phytoestrogens on MPP+‐induced cytotoxicity in neuronal PC12 cells
3851. neuroprotective Effect of Ethyl Acetate Fraction of Artemisia capillaris in Mice
3852. neuroprotective Effect of Ethyl Acetate Fraction of KMU-PO1301
3853. neuroprotective Effect of Hydroalcoholic Extract of Boerhaavia Diffusa Linn against MPTP Induced Neurodegenartion in Rats
3854. neuroprotective effect of purple rice extract and its constituent against amyloid beta-induced neuronal cell death in SK-N-SH cells
3855. neuroprotective effect of Quince leaf hydroalcoholic extract on intracerebroventricular streptozotocin-induced oxidative stress in cortical tissue of rat brain
3856. neuroprotective EFFECT OF SELECTED PLANTS AND THEIR FORMULATION AGAINST INDUCED NEURODEGENERATION
3857. neuroprotective effect of several phytochemicals and its potential application in the prevention of Neurodegenerative diseases
3858. neuroprotective Effect of vitex negundo Against Scopolamine Induced Cognitive Impairment and oxidative stress in Wistar albino Rats
3859. neuroprotective effects and mechanisms of tea bioactive components in Neurodegenerative diseases
3860. neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons
3861. neuroprotective Effects of Acetylcholinesterase Inhibitory Peptides from Anchovy (Coilia mystus) against Glutamate-Induced Toxicity in PC12 Cells
3862. neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review
3863. neuroprotective effects of anthocyanins on apoptosis induced by mitochondrial oxidative stress
3864. neuroprotective effects of chrysin: From chemistry to medicine
3865. neuroprotective Effects of Chunghyuldan in Neurodegenerative Disease Models
3866. neuroprotective effects of Ellagitannins: A brief review
3867. neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment
3868. neuroprotective effects of Foeniculum vulgare seeds extract on lead-induced neurotoxicity in mice brain
3869. neuroprotective effects of Ginkgo biloba extract
3870. neuroprotective effects of ginkgolide B against ischemic stroke: A review of current literature
3871. neuroprotective effects of green and black teas and their catechin gallate esters against β‐amyloid‐induced toxicity
3872. neuroprotective effects of herbal cocktail on cerebrovascular dysfunction in rats with induced hyperhomocysteinaemia
3873. neuroprotective Effects of Hydroalcoholic Extract of Ocimum sanctum Against H2O2 Induced Neuronal Cell Damage in SH-SY5Y Cells via Its Antioxidative Defence …
3874. neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells
3875. neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A
3876. neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin
3877. neuroprotective effects of peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands against oxidative stress
3878. neuroprotective effects of phytochemicals in neurological disorders
3879. neuroprotective effects of quercetin on memory and anxiogenic-like behavior in diabetic rats: Role of ectonucleotidases and acetylcholinesterase activities
3880. neuroprotective effects of quercetin: from chemistry to medicine
3881. neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C
3882. neuroprotective effects of silibinin: an in silico and in vitro study
3883. neuroprotective effects of some seaweeds against Zn–induced neuronal damage in HT-22 cells via modulation of redox imbalance, inhibition of apoptosis and …
3884. neuroprotective effects of Taraxacum officinale Wigg. extract on glutamate-induced oxidative stress in HT22 cells via HO-1/Nrf2 pathways
3885. neuroprotective effects of white tea against oxidative stress-induced toxicity in striatal cells
3886. neuroprotective efficacy of bacopa monnieri linn. Extract against paraquat induced oxidative stress and associated neurotoxicity in animal model
3887. neuroprotective Efficacy of Cadambine Against Cadmium in Primary Brain Neonatal Rat Cells
3888. neuroprotective Efficacy of Maytenus emarginata (Wild.) Ding Hou Against Paraquat Induced oxidative stress and Neurotoxicity in Drosophila Model System
3889. neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells
3890. neuroprotective Functions of Alpinia galanga in Forebrain Ischemia Induced Neuronal Damage and Oxidative Insults in Rat Hippocampus
3891. neuroprotective herbs and foods from different traditional medicines and diets
3892. neuroprotective herbs for stroke therapy in traditional eastern medicine
3893. neuroprotective mechanism of Loranthus parasiticus (L.) merr against oxidative stress-induced damage in NG108-15 cells/Daniel Wong Zin Hua
3894. neuroprotective Mechanisms of Dietary Phytochemicals: Implications for Successful Brain Aging
3895. neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
3896. neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities
3897. neuroprotective potential of Cucurbita maxima Duchesne ex Poir, Caeselpenia bunduc (L.) Roxb and Bombax ceiba Linn extracts
3898. neuroprotective potential of Myrciaria plinioides D. Legrand extract in an in vitro human neuroblastoma model
3899. neuroprotective potential of phytochemicals
3900. neuroprotective potential of secondary metabolites from melicope lunu-ankenda (rutaceae)
3901. neuroprotective Potential of Swietenia macrophylla Seed Extract in Lead-induced Neurodegeneration in Albino Rats
3902. neuroprotective potential of the fruit (acorn) from Quercus coccifera L.
3903. neuroprotective Propensity of Curcumin: Evidence in Animal Models, Mechanisms, and Its Potential Therapeutic Value
3904. neuroprotective properties of resveratrol in different Neurodegenerative disorders
3905. neuroprotective properties of some Indian medicinal plants
3906. neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil
3907. neuroprotective Properties of Wine: Implications for the Prevention of Cognitive Impairment
3908. neuroprotective properties of wine: Implications for the prevention of cognitive impairment
3909. neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats
3910. neuroprotective role of naringenin against methylmercury induced cognitive impairment and mitochondrial damage in a mouse model
3911. neuroprotective role of phytochemicals
3912. neuroprotective strategies for neurological disorders by natural products: an update
3913. neuroprotective therapeutics from botanicals and phytochemicals against Huntington’s disease and related Neurodegenerative disorders
3914. Neuroprotective, antidiabetic and antioxidant effect of Hedera nepalensis and lupeol against STZ + AlCl3 induced rats model
3915. Neuropsychological Effects of Pomegranate Supplementation Following Ischemic Stroke
3916. Neuroscience research highlights: towards new therapeutic avenues
3917. Neurosurgery Notes For The Graduate Students (Penerbit USM)
3918. Neurotheranostics as personalized medicines
3919. Neurotoxic effects of silver nanoparticles and the protective role of rutin
3920. Neurotoxicity and neuroprotective effects of African medicinal plants
3921. Neurotoxicity of β-amyloid protein: oligomerization, channel formation and calcium dyshomeostasis
3922. Neurotransmitter, Antioxidant and Anti-neuroinflammatory Mechanistic Potentials of Herbal Medicines in Ameliorating Autism Spectrum Disorder
3923. Neurotrophic function of phytochemicals for neuroprotection in aging and Neurodegenerative disorders: modulation of intracellular signaling and gene expression
3924. Neutriceuticals and Functions of Traditional Fermented Foods by Probiotic Microorganisms
3925. New beverages of lemon juice enriched with the exotic berries maqui, açaı, and blackthorn: Bioactive components and in vitro biological properties
3926. New concepts in nutraceuticals as alternative for pharmaceuticals
3927. New Developments in the Pathophysiology and Management of Diabetic Retinopathy
3928. New developments in understanding and treating neuroinflammation
3929. New Dietary Supplement Shows Dramatic Effects in Lowering Cholesterol, LDL, and Triglycerides
3930. New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach
3931. New insights into the ameliorative effects of ferulic acid in pathophysiological conditions
3932. New Marine and Terrestrial Plant Metabolites that Stabilize the Tumor Suppressor Pdcd4
3933. New medical applications of plant secondary metabolites
3934. New Medical Applications of Plant Secondary Metabolites (From APR Volume 39)
3935. New perspectives in iron chelation therapy for the treatment of Neurodegenerative diseases
3936. New potential pharmacological functions of Chinese herbal medicines via regulation of autophagy
3937. New therapeutic drugs from bioactive natural molecules: the role of gut microbiota metabolism in Neurodegenerative diseases
3938. New Therapies for HIV-1-Associated Neurocognitive Disorder (HAND): Animal Models and Gene Delivery of Antioxidant Enzymes by rSV40
3939. NF-κB signaling pathway and its therapeutic implications in human diseases
3940. Niches for the Development of Memory T Cells in Response to Acute Viral Infection
3941. Nitric oxide in health and disease of the nervous system
3942. Nitric oxide radical scavenging potential of some Elburz medicinal plants
3943. Nitric oxide-mediated manganese superoxide dismutase inactivation: An insigh into the mechanisms of chemotherapeutic-induced neuronal dysfunction
3944. NMDARs in neurological diseases: a potential therapeutic target
3945. Nobiletin Delays Aging and Enhances Stress Resistance of Caenorhabditis elegans
3946. Nobiletin Protects against systemic inflammation-stimulated memory impairment via MAPK and NF-κB signaling pathways
3947. Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice
3948. Nootropics
3949. Nootropics, Functional Foods, and Dietary Patterns for Prevention of Cognitive Decline
3950. Nourishing the brain from cradle to grave: The role of nutrients in neural development and neurodegeneration
3951. Novel Drug Delivery Systems for Phytoconstituents
3952. Novel effects of Rosa damascena extract on patients with neurocognitive disorder and depression: A clinical trial study
3953. Novel Immune Stimulating Natural Herb for the Treatment of Infectious Disease
3954. Novel leads from herbal drugs for Neurodegenerative diseases
3955. Novel modulators of amyloid‐β precursor protein processing
3956. Novel natural and synthetic ligands of the endocannabinoid system
3957. Novel nutraceutical compounds
3958. Novel PET Imaging Probes for the Detection and Monitoring of the Translocator Protein 18 kDaExpression in Pathological Disorders
3959. Novel plant-derived biomedical agents and their biosynthetic origin
3960. Novel Pro-Resolving Mediators in Inflammation & Infection
3961. Novel quercetin derivatives: from redox properties to promising treatment of oxidative stress related diseases
3962. Novel stilbenes as probes for amyloid plaques
3963. Novel therapeutic strategies for stroke: The role of autophagy
3964. Novel therapeutic strategies for the treatment of protein-misfolding diseases
3965. NOX activity is increased in mild cognitive impairment
3966. NRF2 and NF-қB interplay in cerebrovascular and Neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
3967. Nrf2 is necessary to recover AMPKalpha during the adaptation to hypergravity stress
3968. NRF2 negatively regulates phorbol-12-myristate-13-acetate (PMA)-induced differentiation of the promonocytic U937 cells
3969. Nrf2 Signaling: An Adaptive Response Pathway for Neurodegenerative Disorders
3970. Nrf2-mediated Liver Protection by an Antioxidant Lignan from Acetaminophen Toxicity, as Mediated by PKCδ-GSK3β Pathway
3971. Nrf2–ARE pathway: an emerging target against oxidative stress and neuroinflammation in Neurodegenerative diseases
3972. Nrf2/ARE pathway modulation by dietary energy regulation in neurological disorders
3973. Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs
3974. NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the …
3975. Nut consumption and age-related disease
3976. Nutraceutical and Pharmacological Appraisal of Āmla (Emblica officinalis Gaertn.): A Review
3977. Nutraceutical Antioxidants and Their Therapeutic Potential in Neurodegeneration
3978. Nutraceutical intervention in ageing brain
3979. Nutraceutical or pharmacological potential of Moringa oleifera Lam.
3980. Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms
3981. Nutraceutical: A Drug, Dietary Supplement and Food Ingredient
3982. Nutraceutical: A New Scope and Opportunity of Healthcare
3983. Nutraceuticals against neurodegeneration: a mechanistic insight
3984. Nutraceuticals and antioxidants in prevention of diseases
3985. Nutraceuticals and Cognitive Dysfunction
3986. Nutraceuticals and Functional Foods:: Chemistry And Health Promoting Properties Of Fruits And Beverages Involved In Prevention Of Chronic Diseases
3987. Nutraceuticals as therapeutic agents: A Review
3988. Nutraceuticals for Cognitive Dysfunction
3989. Nutraceuticals for geriatrics
3990. Nutraceuticals for older people: Facts, fictions and gaps in knowledge
3991. Nutraceuticals from Fish and Fish Wastes: Scopes and Innovations
3992. Nutraceuticals in Prophylaxis and Therapy of Neurodegenerative Diseases
3993. NUTRACEUTICALS–AN OPPORTUNITY OF HEALTHCARE: A
3994. Nutraceuticals: a boom to medical industry
3995. Nutraceuticals: A New Golden Era in Health and Disease
3996. Nutraceuticals: A Review
3997. Nutraceuticals: the link between nutrition and medicine
3998. Nutraceuticals: the link between nutrition and medicine
3999. Nutrients and brain health: an overview
4000. Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease
4001. Nutrients, bioactive compounds and bioactivity: The health benefits of sweet cherries (Prunus avium L.)
4002. Nutrients, Bioactive Compounds, and Health Benefits of Functional and Medicinal Beverages
4003. Nutrigenomics as a Strategy for Neuronal Health
4004. Nutrition and ageing
4005. Nutrition and Bone Health in Old Age
4006. Nutrition and cognition in older persons
4007. Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population
4008. Nutrition and mortality in the elderly over 10 years of follow-up: the Three-City study
4009. Nutrition and neurodegeneration: epidemiological evidence and challenges for future research
4010. Nutrition and Nutraceuticals in Neuroinflammatory and Brain Metabolic Stress: Implications for Neurodegenerative Disorders
4011. Nutrition and nutritional supplements to promote brain health
4012. Nutrition and Prevention of Diseases Topic 20
4013. Nutrition and the aging brain of dogs and cats
4014. Nutrition for brain health and cognitive performance
4015. Nutrition for Elderly
4016. Nutrition for Elderly 19
4017. Nutrition for the ageing brain: towards evidence for an optimal diet
4018. Nutrition in the prevention and treatment of cognitive decline
4019. Nutrition, adult hippocampal neurogenesis and mental health
4020. Nutrition, ageing and ill health
4021. Nutrition, diet and immunosenescence
4022. Nutrition, Diet, and Supplements for Peak Physical & Mental Performance
4023. Nutrition, macrobiotics, and the brain’s neuroinflammatory response
4024. Nutritional and medicinal aspects of d-amino acids
4025. Nutritional antioxidants and adaptive cell responses: an update
4026. Nutritional Antioxidants, Vitamins, Cognition, and Neurodegenerative Disease
4027. Nutritional approaches for healthy aging of the brain and the prevention of Neurodegenerative diseases
4028. Nutritional Cognitive Neuroscience Research at the Crossroads of Nutrition, Psychology, and Neuroscience
4029. Nutritional cognitive neuroscience: innovations for healthy brain aging
4030. Nutritional factors affecting adult neurogenesis and cognitive function
4031. Nutritional intervention as a preventive approach for cognitive-related outcomes in cognitively healthy older adults: a systematic review
4032. Nutritional intervention in brain aging
4033. Nutritional modulation of cognitive function and mental health
4034. Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological …
4035. Nutritional modulation of immune and central nervous system homeostasis: the role of diet in development of neuroinflammation and neurological disease
4036. Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
4037. Nutritional modulators of neuropsychiatric dysfunction
4038. Nutritional modulators of pain in the aging population
4039. Nutritional quality and health benefits of vegetables: a review
4040. Nutritional strategies for successful aging
4041. NUTRITIONAL STRATEGIES IN THE PREVENTION OF Neurodegenerative DISEASES IN THE UNTRAINED INDIVIDUAL
4042. Nutritional supplements and the brain
4043. o-Silicic Acid & Health
4044. Obesity and neurodegeneration
4045. Obesity and neurological disorders: Dietary perspective of a global menace
4046. Ocimum sanctum Linn.(Holy Basil) to Improve Cognition
4047. of Neurological Disorder, from Molecular Neurobiology to Clinical Therapy
4048. of Selected Dietary Fruits Consumed in Alice region of South Africa
4049. Oleuropein in olive and its pharmacological effects
4050. Oleuropein, a Bioactive Compound from Olea europaea L., as a Potential Preventive and Therapeutic Agent in Non-Communicable Diseases
4051. Olive Oil and huntington’s disease
4052. Olive Oil Antioxidants and Aging
4053. Olive oil as a functional food: nutritional and health benefits
4054. Olive Oil: Antioxidant Compounds and Their Potential Effects over Health
4055. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview
4056. On the neuroprotective effects of naringenin: Pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective
4057. One can slow down the aging through antioxidants
4058. Optical properties of indolizino [3, 2-c] quinolines as new class of fluorophores
4059. Optimization of ultrasonic-assisted extraction of natural antioxidants from rice bran using response surface methodology
4060. Optimized turmeric extracts have potent anti-amyloidogenic effects
4061. Optimizing Biopharmaceutical Properties of Proteasome Inhibitor Drugs: Current Strategies and Future Directions
4062. Oral Administration of Colon-targeted Cell-permeable NFκB inhibitory Peptide Alleviates Colonic Inflammation of Rats.
4063. Oral administration of Dolichoslablab L. extract controls irritable bowel syndrome-like behaviors and low grade inflammation in a zymosan-induced mouse …
4064. Orchids: A review of uses in traditional medicine, its phytochemistry and pharmacology
4065. Organic Phytonutrients, Vitamins, and Antioxidants
4066. Oroxylin A Enhances Memory Consolidation by Increasing Hippocampal BDNF Levels
4067. Orphan Drug and Rare Disease from the View of Pharmaceutical Industry
4068. Other health benefits of african medicinal spices and vegetables
4069. Overview of the Potential Effect of B Vitamins on Cognitive Health
4070. Overview of Therapeutic Efficacy of Mushrooms
4071. Oxidative damage and the pathogenesis of menopause related disturbances and diseases
4072. Oxidative damage and tyrosine nitration from peroxynitrite
4073. Oxidative DNA damage: mechanisms, mutation, and disease
4074. Oxidative processes and antioxidative defense mechanisms in the aging brain.
4075. Oxidative Role of HIV/AIDS. Antiretroviral Drugs and Medicinal Plants with Anti-HIV Activity
4076. oxidative stress and age-related neurodegeneration
4077. oxidative stress and aging: beyond correlation
4078. oxidative stress and antioxidant potential of one hundred medicinal plants
4079. oxidative stress and antioxidants in neurological diseases: is there still hope?
4080. oxidative stress and cerebral endothelial cells: regulation of the blood–brain-barrier and antioxidant based interventions
4081. oxidative stress and excitotoxicity: antioxidants from nutraceuticals
4082. oxidative stress and mule-driven X-linked intellectual disability
4083. oxidative stress and neurodegeneration: the involvement of iron
4084. oxidative stress and neurodegeneration: where are we now?
4085. oxidative stress and Neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options
4086. oxidative stress and Neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry
4087. oxidative stress and Neurodegenerative disorders
4088. oxidative stress and Neurodegenerative disorders
4089. oxidative stress and Neuronal Damages: Estrogenic Compounds, Anti-Apoptotic Factors, and Amyloidogenesis
4090. oxidative stress and Obesity: a Case-Control Study.
4091. oxidative stress and pyrogenic fever pathogenesis
4092. oxidative stress and the brain: an insight into cognitive aging
4093. oxidative stress and the viability of osteoblasts and cerebellar granule neurones
4094. oxidative stress in aging-matters of the heart and mind
4095. oxidative stress in biological systems and its relation with pathophysiological functions: the effect of physical activity on cellular redox homeostasis
4096. oxidative stress in brains of rats intoxicated with aluminum and the neuromodulating effect of different forms of sage
4097. oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection
4098. oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives
4099. oxidative stress in neurodegeneration: targeting mitochondria as a therapeutic aid
4100. oxidative stress in Neurodegenerative conditions and the protective potential of a natural antioxidant, dietary saffron
4101. oxidative stress in Neurodegenerative diseases
4102. oxidative stress in Neurodegenerative diseases: mechanisms and therapeutic perspectives
4103. oxidative stress in oral diseases: understanding its relation with other systemic diseases
4104. oxidative stress in Pathogenesis
4105. oxidative stress in the brain of cigarette smoke-induced noxiousness: neuroprotective role of Sesbania grandiflora
4106. oxidative stress induced-Neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
4107. oxidative stress mechanisms and their modulation
4108. oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention
4109. oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention
4110. oxidative stress Reduction (Prong-3)
4111. oxidative stress status and neuroprotection of tocotrienols in chronic cerebral hypoperfusion-induced neurodegeneration rat animal model
4112. oxidative stress treatment for clinical trials in Neurodegenerative diseases
4113. Oxidative stress, aging, and diseases
4114. Oxidative stress, antioxidants and Neurodegenerative diseases
4115. Oxidative Stress, GFAP and NFT Activities in Prefrontal Cortex of Rats Treated with Musanga cecropioides (Urticaceae) Stem-Bark Extract in Sodium Valproate …
4116. Oxidative stress, mitochondrial dysfunction, and aging
4117. Oxidative stress, plasma/salivary antioxidant status detection and health risk factors
4118. Oxidative stress, prooxidants, and antioxidants: the interplay
4119. Oxidative stress: a key modulator in Neurodegenerative diseases
4120. Oxidative Stress: Antioxidants in Degenerative Neurologic and Ophthalmologic Diseases
4121. Oxidative stress: harms and benefits for human health
4122. Oxidative stress: Lipid peroxidation products as predictors in disease progression.
4123. Oxidative Stress: Neuropathy, Excitability, and Neurodegeneration
4124. OXIDATIVE STRESS: The effect on mitochondria & energy production
4125. Oxidative stress: the paradox of aerobic life
4126. Oxidative toxicity in Neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies
4127. OXPHOS mutations and neurodegeneration
4128. Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition
4129. Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection via Activation of Immunoproteasome
4130. Oxytetracycline Exposure Induces Behavioral Changes in Zebrafish
4131. Pacemaker Calcium Activity in Myenteric Interstitial Cells of Cajal in Human Small Intestine
4132. Palladium-Catalyzed ortho-Acylation and Deprotection of Acetophenone N-Boc Hydrazones with Aldehydes
4133. Palladium-Catalyzed Oxidative Acylation of 2-Phenoxypyridineswith Alcohols
4134. Palm Fruit Bioactives modulate human astrocyte activity in vitro altering the cytokine secretome reducing levels of TNFα, RANTES and IP-10
4135. Palmityl-acylated Exendin-4-loaded Chitosan-PLGA Nanospheres for Treating Type 2 Diabetes with Protracted Hypoglycemic Efficacy
4136. Panax ginseng
4137. Partial Purification of Anti-Tumor and Antioxidant Components from Uvaria Narum (Dunal) Wall Seed
4138. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats
4139. Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain
4140. Patent application title: ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL …
4141. Pathogenesis of Neurodegenerative diseases and the effect of natural products on nitric oxide production implicating in these diseases
4142. Pathophysiology and Therapeutic Perspectives of oxidative stress and Neurodegenerative Diseases: A Narrative Review
4143. Pathophysiology of the Disease Causing Physical Disability
4144. Paths to recovery: Modulating Putative Depression Circuits using Deep Brain Stimulation
4145. Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition
4146. Pathways to Successful Aging
4147. Pattern analysis of nutrient biomarkers in neuroepidemiology
4148. Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
4149. Perfluorooctanoic acid aggravates mase cell-mediated allergic inflammation
4150. Performance functional foods
4151. Peripheral neuropathy caused by DCA-induced oxidative stress
4152. Peroxidation of linoleic acid and its relation to aging and age dependent diseases
4153. Perspective and Direction for Future Research on Phytochemicals in Neurological Disorders
4154. Perspective and Direction for Future Research: Modification of High Calorie Diet Needed for Optimal Health of Human Visceral and Brain Tissues
4155. Perspective uses of essential oils in functional foods and antimicrobial packaging material
4156. Perspective: neuroregenerative nutrition
4157. Perspectives for gallotannins neuroprotective potential-current experimental evidences
4158. Perspectives of P-glycoprotein modulating agents in oncology and Neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials
4159. Pertubation of brain neurotransmitters by aluminum in male rats and potential role of sage
4160. Peruvian Power Foods: 18 Superfoods, 101 Recipes, and Anti-aging Secrets from the Amazon to the Andes
4161. Peruvian Power Foods: 18 Superfoods, 101 Recipes, and Anti-aging Secrets from the Amazon to the Andes
4162. Phage-Mediated Inhibition of Bacterial Group Behaviors in Pseudomonas aeruginosa
4163. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review
4164. Pharmaceutical Biotechnology in Herbal Neuroprotection
4165. Pharmaceutical Market and Reimbursement Policies in the National Health Insurance
4166. Pharmaceutical Policy in National Health Insurance Context
4167. Pharmaceutical Pricing and Reimbursement under National Health Insurance Scheme-Lessons from OECD countries
4168. Pharmaceuticals Policy for Financial Stabilization of the National Health Insurance
4169. Pharmacognostic and pharmacological study of Fumaria vaillantii Loisel: a review.
4170. Pharmacognostic Phytochemical Psychopharmacological evaluation of Oldenlandia corymbosa and Grangea maderaspatana
4171. Pharmacognostical analysis and protective effect of standardized extract and rizonic acid from Erythrina velutina against 6-hydroxydopamine-induced …
4172. Pharmacognostical, Phytochemical and Pharmacological Evaluation of Rhynchoglossum Notonianum (Wall.) BL Burtt-An Underutilized Nature’s Treasure.
4173. Pharmacognostical, Phytochemical, Evaluvation of Sedative and Hypnotic Activity on Seed Aril of Myristica Malabarica Lam
4174. Pharmacokinetic Behaviors of Tiletamine and Zolazepam in Beagel Dogs
4175. Pharmacokinetics and metabolism of CNS-targeted natural products
4176. Pharmacokinetics and Metabolism of Cryptopleurine, a Natural Product Isolated from Cryptocarya pleurosperma
4177. Pharmacokinetics of (−)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution
4178. Pharmacologic approaches to the aging athlete
4179. Pharmacological activities and phytochemical constituents
4180. Pharmacological activities of chromene derivatives: an overview
4181. Pharmacological activity of Salvia lavandulifolia and chemical components of its essential oil. A review
4182. Pharmacological and Medicinal Properties of Turmeric
4183. Pharmacological and neuroprotective profile of an essential oil derived from leaves of Aloysia citrodora Palau
4184. Pharmacological and Toxicological Studies of Methanolic Extract of Mikania Cordata and Spilanthes Acmella
4185. Pharmacological applications of antioxidants: lights and shadows
4186. Pharmacological Approaches Targeting Brain Cell Survival in the Context of Neurodegeneration and Potential Treatment Strategies
4187. Pharmacological aspects and health impact of sports and energy drinks
4188. Pharmacological benefits of active components of natural products against traumatic brain injury-A review
4189. PHARMACOLOGICAL COGNITIVE ENHANCERS IN NEURO-PSYCHIATRY-A CRITICAL APPRAISAL
4190. Pharmacological effects of active compounds on Neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction
4191. Pharmacological effects of gallic acid in health and diseases: A mechanistic review
4192. Pharmacological effects of protocatechuic acid and its therapeutic potential in Neurodegenerative diseases: Review on the basis of in vitro and in vivo studies in …
4193. Pharmacological Evaluation of Cucumber for Cognition Enhancing Effect on Brain of Mice.
4194. Pharmacological exploration of Antiepileptic profile of selected Indian asparagus species
4195. Pharmacological properties and molecular mechanisms of thymol: prospects for its therapeutic potential and pharmaceutical development
4196. Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: a pentacyclic triterpenoid of therapeutic promise
4197. Pharmacological Uses of Ginkgo Biloba Extracts for Cardiovascular Disease and Coronary Heart Diseases
4198. Pharmacologically active compounds from latex-bearing plants
4199. Pharmacophore based 3D Quantitative structure–activity relationship model of Acetylcholinesterase inhibitor
4200. Pharmacotherapeutic Potential of Natural Products in Neurological Disorders
4201. Pharmacotherapies targeted to neurogenesis in order to rescue cognitive performance in Down syndrome
4202. Phenylindanes in brewed coffee inhibit amyloid-beta and tau aggregation
4203. Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro
4204. Phosphatidylinositol 3‐kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones
4205. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development
4206. Physicochemical Characterization, Microbiological Quality and Safety, and Pharmacological Potential of
4207. Physicochemical Characterization, Microbiological Quality and Safety, and Pharmacological Potential of Hancornia speciosa Gomes
4208. Physicochemical Characterization, Microbiological Quality and Safety, and Pharmacological Potential of Hancornia speciosa Gomes.
4209. Physicochemical Properties and Formation Mechanism of Albumin Nanoparticles
4210. Physiological components of kiwifruits with in vitro antioxidant and acetylcholinesterase inhibitory activities
4211. Physiological effects of hydrogen, aluminum, and manganese toxicities in acid soil
4212. Physiological targets for the treatment of diabetic encephalopathy
4213. Physiology & Behavior E ff ects of paeoni fl orin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular …
4214. Phyto-pharmacological effect of nine medicinal plants as a traditional treatment of depression
4215. Phytochemical Analyses of Bioactive Compounds in the Roots of Cassia Alata Linn and the Anti-Angiogenic Evaluation of Rhein as a Therapeutic Agent against …
4216. Phytochemical analysis and antioxidant profile of methanolic extract of seed, pulp and peel of Baccaurea ramiflora Lour.
4217. PHYTOCHEMICAL ANALYSIS AND BIOLOGICAL STUDIES OF SEEDS OF CASSIA ABSUS
4218. Phytochemical Analysis and In-Vitro Antioxidant Activity of Mimosa pudica Lin., Leaves
4219. Phytochemical analysis, antioxidant and antilipid peroxidation effects of a medicinal plant, Adhatoda vasica
4220. Phytochemical analysis, antioxidant, antistress, and nootropic activities of aqueous and methanolic seed extracts of ladies finger (Abelmoschus esculentus L.) in mice
4221. Phytochemical analysis, molecular docking and antiamnesic effects of methanolic extract of Silybum marianum (L.) Gaertn seeds in scopolamine induced memory …
4222. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts
4223. Phytochemical and Antioxidant Studies of Some Isolated Endophytic Fungi
4224. Phytochemical and biological activity study on Pseuduvaria Rugosa (annonaceae)/Hairin Taha
4225. Phytochemical and Biological Evaluation of Euphorbia serpens (Euphorbiaceae) & Cenchrus pennisetiformis (Poaceae)
4226. Phytochemical and Nutritional Status of Jatropha gossypifolia Leaves
4227. PHYTOCHEMICAL AND PHARMACOLOGICAL IMPORTANCE OF MALVA NEGLECTA: AN UPDATED REVIEW
4228. Phytochemical and pharmacological investigation of medicinal plants and synthesis of some simple molecules
4229. Phytochemical and Pharmacological Overview of Cistanche Species
4230. PHYTOCHEMICAL AND PHARMACOLOGICAL PROFILE OF BACOPA MONNIERI-AN ETHNOMEDICINAL PLANT
4231. Phytochemical and pharmacological role of liquiritigenin and isoliquiritigenin from Radix Glycyrrhizae in human health and disease models
4232. Phytochemical and Pharmacological Studies of Medicinal Plants and Synthesis of Some Simple Heterocyclic Compounds
4233. Phytochemical and Vitamin Contents of Mangifera indica (Mango) Fruits Subjected to Ripening by Artificial Methods
4234. PHYTOCHEMICAL CHARACTERIZATION AND neuroprotective ASSESSMENT OF STANDARDIZED EXTRACT OF PEDALIUM MUREX LINN. LEAVES …
4235. Phytochemical constituents and pharmacological properties of Garcinia xanthochymus-a review
4236. Phytochemical Constituents of Abutilon theophrasti
4237. Phytochemical content, health benefits, and toxicology of common edible flowers: a review (2000–2015)
4238. PHYTOCHEMICAL EVALUATION, IN VITRO ANTIOXIDANT AND ANTIBACTERIAL POTENTIAL OF INDIGOFERA ASPALATHOIDES
4239. Phytochemical ginkgolide B attenuates amyloid-β 1-42 induced oxidative damage and altered cellular responses in human neuroblastoma SH-SY5Y cells
4240. Phytochemical investigation and pharmacological screening of Cedrus deodara Loud and Pinus roxburghii Sarg for memory enhancing wound healing and antiulcer …
4241. Phytochemical optimisation of blueberry juice: a research report presented in partial fulfilment of the requirements for the degree of Master of Engineering in Food …
4242. Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential
4243. Phytochemical Screening and Biological Activities of Combretum adenogonium Leaves Extracts
4244. PHYTOCHEMICAL SCREENING AND BIOLOGICAL INVESTIGATION OF ROOTS OF VALERIANA OFFICINALIS
4245. Phytochemical screening and evaluation of hypoglycemic activity of Citrus sinensis peel extract
4246. Phytochemical screening, antioxidant and anticholinesterase effects of Alangium salvifolium (LF) Wang root extracts
4247. Phytochemical study and biological activities of diterpenes and derivatives from Plectranthus species
4248. Phytochemical study and evaluation of antioxidant, neuroprotective and acetylcholinesterase inhibitor activities of Galeopsis ladanum L. extracts
4249. Phytochemical Study and Evaluation of the Biological Activity of Anorectic Plants Used in the Seno Province (Burkina Faso)
4250. Phytochemical Study on Abutilon theophrasti
4251. Phytochemical Study on the Roots of Cynanchum wilfordii.
4252. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery
4253. Phytochemical, antimicrobial and antioxidant preliminary screening of a traditional Palestinian medicinal plant, Ononis pubescens L.
4254. Phytochemical, Biological and Safety Evaluation of Filago germanica (Asteraceae)
4255. Phytochemical, elemental and in-vitro anti-oxidant activity screening of crude methanol Tapinanthus globiferus leaf extract
4256. Phytochemical, nutraceutical and pharmacological attributes of a functional crop Moringa oleifera Lam: An overview
4257. Phytochemicals against TNFα-Mediated Neuroinflammatory Diseases
4258. Phytochemicals analysis of canna indica for identification of colorants and antioxidants
4259. Phytochemicals and antioxidants: An evaluation in understanding the human lifeline
4260. Phytochemicals and Bioactive Compounds in Tropical and Subtropical Fruits
4261. Phytochemicals and Brain Aging: A Multiplicity of Effects
4262. Phytochemicals and Human Health
4263. Phytochemicals and the Aging Brain
4264. Phytochemicals as therapeutic interventions in Neurodegenerative diseases
4265. Phytochemicals Effects on Neurodegenerative Diseases
4266. Phytochemicals for health, the role of pulses
4267. Phytochemicals for the Treatment of Multiple Sclerosis? A Review of Scientific Evidence
4268. Phytochemicals from mulberry extract (Morus sp.): antioxidant and neuroprotective potentials
4269. PHYTOCHEMICALS FROM TRADITIONAL MEDICINAL PLANTS
4270. Phytochemicals Having neuroprotective Properties from Dietary Sources and Medicinal Herbs.
4271. Phytochemicals prevent mitochondrial membrane permeabilization and protect SH-SY5Y cells against apoptosis induced by PK11195, a ligand for outer membrane …
4272. Phytochemicals that regulate Neurodegenerative disease by targeting neurotrophins: a comprehensive review
4273. Phytochemicals, Antioxidant and Anti‐Lipid Peroxidation Activities of Ethanolic Extract of a Medicinal Plant, Andrographis paniculata
4274. Phytochemicals, signal transduction, and neurological disorders
4275. Phytochemicals: aging and health
4276. Phytochemicals: Potential in management of climacteric neurobiology
4277. Phytochemistry and biological properties of glabridin
4278. Phytochemistry and neuroprotective effects of Eclipta alba (L.) Hassk
4279. Phytochemistry, bioactivity: suggestion of Ceratonia siliqua L. as Neurodegenerative disease therapy
4280. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L.
4281. Phytochemistry, pharmacology and medicinal properties of Hypericum perforatum L
4282. Phytocompounds modulating Aquaporins: Clinical benefits are anticipated
4283. Phytoconstituents and Anti Lipid Peroxidation Assessment Of Khadirarishta
4284. Phytoconstituents and evaluation of acetylcholinesterase inhibition by methanol extract of Liquidambar styraciflua (L.) aerial parts
4285. Phytoestrogen Analogues Targeting Neuroinflammation
4286. Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia
4287. Phytomedicine-Based Potent Antioxidant, Fisetin Protects CNS-Insult LPS-Induced Oxidative Stress-Mediated Neurodegeneration and Memory Impairment
4288. Phytomedicine: A Potential Alternative Medicine in Controlling Neurological Disorders
4289. PHYTOMEDICINES FOR CNS DISORDERS: SAFETY ISSUES FOR USE WITH ANTIEPILEPTIC DRUGS
4290. Phytomedicines, herbal drugs, and poisons
4291. Phytonutrients-the natural drugs of the future
4292. Phytopharmaceuticals for Brain Health
4293. Phytopharmacy: An evidence-based guide to herbal medicinal products
4294. Phytotherapy approaches in stress-related disorders
4295. PI3K/AKT Inhibitors Isolated for Natural Products by HIV-1-transfected CHME5, a Human Microglia Cell
4296. Piceatannol and other wine stilbenes: a pool of inhibitors against α-synuclein aggregation and cytotoxicity
4297. Pimpinella alpina Molk Administration is Capable of Increasing Antioxidant and Decreasing Prooxidant Level following UVB Irradiation
4298. Pinocembrin provides mitochondrial protection by the activation of the Erk1/2-Nrf2 signaling pathway in SH-SY5Y neuroblastoma cells exposed to paraquat
4299. Piperine-A Major Principle of Black Pepper: A review of its bioactivity and studies
4300. Pistacia Genus as a Potential Source of neuroprotective Natural Products
4301. Plant Adaptogens: Natural Medicaments for 21st Century?
4302. Plant and mushroom based foods that reduce inflammation
4303. Plant extracts as green reducing agents for the synthesis of antibacterial silver nanoparticles
4304. Plant food supplements with antioxidant properties for the treatment of chronic and Neurodegenerative diseases: benefits or risks?
4305. Plant foods and brain aging: a critical appraisal
4306. Plant foods and herbal sources of resveratrol
4307. Plant metabolites and nutritional quality of vegetables
4308. Plant minerals
4309. Plant nutrition and agronomic management to obtain crops with better nutritional and nutraceutical quality
4310. Plant secondary metabolites: Structure–activity relationships in human health prevention and treatment of common diseases
4311. Plant species and products of the traditional Chinese phytotherapy in the Ciudade Autónoma de Buenos Aires, Argentina
4312. Plant troponoids: chemistry, biological activity, and biosynthesis
4313. Plant-Derived Antiinflammatory Steroid Analogs for Neuroprotection: A Recent Update
4314. Plant-derived compounds in clinical trials
4315. PLANT-DERIVED DRUGS: ANEW PARADIGM OF BIOCHEMISTRY
4316. Plant-derived Health-Effects of turmeric and curcumenoids
4317. Plant-derived health-the effects of turmeric and curcuminoids
4318. Plants and phytochemicals for Huntington’s disease
4319. Plants and the human brain
4320. Plants and their chemical compounds affecting betha-amyloid and secretase activity as potential sources of neuroprotective herbal medicinal products. Part 1
4321. Plants and their chemical compounds affecting β-amyloid and secretase activity as potential sources of neuroprotective herbal medicinal products. Part 1
4322. Plants as natural antioxidants
4323. Plants traditionally used in age related brain disorders—a survey of ethnobotanical literature
4324. Plants with evidence-based therapeutic effects against Neurodegenerative diseases
4325. Plants with neurobiological activity as potential targets for drug discovery
4326. Plants-derived neuroprotective agents: cutting the cycle of cell death through multiple mechanisms
4327. Platelet-activating factor (PAF)-antagonists of natural origin
4328. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine
4329. Pocket Antioxidants
4330. Polycyclic compounds as carriers for neuroactive non-steroidal anti-inflammatory drugs
4331. Polydiguanide Silver Complexes: Synthesis and Bactericidal Activity Against Burn Wound Pathogens
4332. Polymeric Nanoparticles for Drug Delivery to the Brain
4333. Polypharmacy and food–drug interactions among older persons: a review
4334. Pomegranate as a possible treatment in reducing risk of developing wound healing, obesity, Neurodegenerative disorders, and diabetes mellitus
4335. Pomegranate peel attenuates aluminum-induced hepatorenal toxicity
4336. Pomegranate seed oil modulates functions and survival of BV-2 microglial cells in vitro
4337. Pomegranate seed oil nanoemulsions for the prevention and treatment of Neurodegenerative diseases: the case of genetic CJD
4338. Pomegranate seed oil nanoemulsions for the prevention and treatment of Neurodegenerative diseases: the case of genetic CJD
4339. Pomegranate seed oil: effect on 3-nitropropionic acid-induced neurotoxicity in PC12 cells and elucidation of unsaturated fatty acids composition
4340. POMEGRANATE: AHEALTH PROMOTING FOOD
4341. Poor cognitive ageing: vulnerabilities, mechanisms and the impact of
4342. Poor cognitive ageing: Vulnerabilities, mechanisms and the impact of nutritional interventions
4343. Population Pharmacokinetic Analysis of Cilostazol in Healthy Korean Subjects
4344. Population pharmacokinetic modeling of midazolam in healthy volunteers: evaluation for drug drug-interaction
4345. Possible implications of Chrysanthellum sp. in psychiatric disorders treatment
4346. Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice
4347. Possible Targets of Herbals for Type 3 Diabetes: A Review
4348. Postconcussion syndrome: a review of pathophysiology and potential nonpharmacological approaches to treatment
4349. POSTER ABSTRACTS CARDIOVASCULAR PHARMACOLOGY
4350. Potential Antidiabetic Effect of Herb Formula in Streptozotocin-Induced Diabetic Rats
4351. Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases
4352. Potential applications of antioxidants–A review
4353. Potential Biological Effects of Methanolic Extracts from Natural Herbs
4354. Potential biomarkers and novel pharmacological targets in protein aggregation-related Neurodegenerative diseases
4355. Potential Covalent Modification of Amyloid-BetaProtein and its Effect on Aggregation
4356. Potential effects of blueberries on markers of Neurodegenerative disease
4357. Potential for diet to prevent and remediate cognitive deficits in neurological disorders
4358. Potential for Ginkgo biloba as a functional food
4359. Potential health benefits of major seed spices
4360. Potential involvement of oxidative stress in induction of Neurodegenerative diseases: Actions, mechanisms and neurotherapeutic potential of natural antioxidants
4361. Potential mechanisms mediating the protective effects of a peptide from walnut (Juglans mandshurica Maxim.) against hydrogen peroxide induced neurotoxicity in …
4362. Potential neuroprotective effects of Blueberry and Lingonberry fruits and Leaves
4363. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
4364. Potential of Asian Natural Products for Health in Aging
4365. Potential of Ayurvedic Drugs in Differentiating Neuronal Stem Cells from Human Breast Milk: A Review
4366. Potential of neuroprotective antioxidant-based therapeutics from Peltophorum africanum Sond.(Fabaceae)
4367. Potential of phytochemicals as immune-regulatory compounds in atopic diseases: a review
4368. Potential of Portuguese vine shoot wastes as natural resources of bioactive compounds
4369. Potential plant-derived catecholaminergic activity enhancers for neuropharmacological approaches: A review
4370. Potential protective effects of extra virgin olive oil on the hepatotoxicity induced by co-exposure of adult rats to acrylamide and aluminum
4371. Potential role of honey in learning and memory
4372. Potential role of lycopene as antioxidant and implications for human health and disease
4373. Potential Therapeutic Anti-tumor Effect of a Salmonella-Based Vaccine
4374. Potential Therapeutic Impacts of Curcumin Against Age-Related Impaired Cognition and Memory
4375. Potential Therapeutic Impacts of Curcumin for Improving Memory Impairment
4376. Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment
4377. Potential use of nanomedicine for the anti-inflammatory treatment of Neurodegenerative diseases
4378. Potential use of Turkish medicinal plants in the treatment of various diseases
4379. Potentiation of NMDA Receptors by Withania somnifera on Hippocampal CA1 Pyramidal Neurons
4380. Power Juices, Super Drinks: Quick, Delicious Recipes to Prevent & Reverse Disease
4381. Power Juices, Super Drinks: Quick, Delicious Recipes to Prevent & Reverse Disease
4382. PPARγ and Cognitive Performance
4383. Practical Strategies for Preserving Good Cognitive Function into Old Age
4384. Practice in NECA, research for evidence-based healthcare
4385. Pre-training Catechin gavage prevents memory impairment induced by intracerebroventricular streptozotocin in rats
4386. Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases
4387. Premature or pathological aging: longevity
4388. Preparation and Characterization of Long-acting Intrapulmonary Delivery System using Chitosan Nanogels for Treating Type 2 Diabetes
4389. Preparation and Structural Characterization of Pre-fibrillar Assemblies of Amyloidogenic Proteins
4390. Preparation of Chalcones, their Dihydro-Thio Derivatives and Study of their Effect on Central Nervous System
4391. Prescription Drug Expenditures of Hyerlipidemia in Korea National Health Insurance
4392. Preserving And Restoring Brain Function
4393. Prevention and treatment of Neurodegenerative diseases by spice-derived phytochemicals
4394. Prevention of Brain Hypoperfusion-Induced Neurodegeneration in Rat’s Hippocampus by Black Cumin Fixed Oil Treatment
4395. Prevention of cadmium‑induced neurotoxicity in rats by essential nutrients present in nuts
4396. Prevention of chronic diseases by tea: possible mechanisms and human relevance
4397. Prevention of cognitive decline
4398. Prevention of Cognitive Decline
4399. Prevention of Neurodegenerative Disorders by Nutraceuticals
4400. Preventive agents for Neurodegenerative diseases from resin of Dracaena cochinchinensis attenuate LPS-induced microglia over-activation
4401. Preventive Effect of Resveratrol against Brain Mitochondria DNA Damage, Lipid Peroxidation, Inflammation and Seizures Induced by Kainic Acid in Mice
4402. Preventive effects of blueberry extract on behavioral and biochemical dysfunctions in rats submitted to a model of manic behavior induced by ketamine
4403. Prion-like mechanisms and potential therapeutic targets in Neurodegenerative disorders
4404. Priority Considerations for Medicinal Cannabis-Related Research
4405. Priority Therapeutic Groups to Expand Development of Prescribing Indicators in Korea
4406. Pro-oxidative effect of peroxynitrite regarding biological systems: a special focus on high-molar-mass hyaluronan degradation
4407. Probable benefits of green tea with genetic implications
4408. Proceedings of conference on Mechanism-Based Development of Natural Products for Human Health
4409. Production of three phenylethanoids, tyrosol, hydroxytyrosol, and salidroside, using plant genes expressing in Escherichia coli
4410. Products of plant origin–benefits and the potential risk for the consumer
4411. Progress in researches on the pharmaceutical mechanism and clinical application ofGinkgo Biloba extract on various kinds of diseases
4412. Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration
4413. Promising neuroprotective effects of oligostilbenes
4414. Promising neuroprotective plants from north-east India
4415. Promising Roles of Dietary Antioxidants in the Prevention of Certain Age-Related Diseases
4416. Promoting Predictive Diagnosis, Targeted Preventive Measures and Personalised Medicine in Handling of Neurodegeneration: Time for New Guidelines
4417. Prooxidant action of aluminum ion–stimulation of iron-mediated lipid peroxidation by aluminum
4418. PROPHYLACTIC PROPENSITY OF CITRUS PHYTOCHEMICALS: ACTION AND MECHANISMS
4419. Prosopis cineraria: A potential nootropic agent
4420. Prospecção por enzimas da microbiota ruminal capazes de aumentar a capacidade antioxidante
4421. Prospective neurobiological effects of the aerial and root extracts and some pure compounds of randomly selected Scorzonera species
4422. Proteasome activation: an innovative promising approach for delaying aging and retarding age-related diseases
4423. Protection against brain tissues oxidative damage as a possible mechanism for the beneficial effects of Rosa damascena hydroalcoholic extract on scopolamine …
4424. Protection of cultured cortical neurons by luteolin against oxidative damage through inhibition of apoptosis and induction of heme oxygenase-1
4425. Protective action of Grewia asiatica (phalsa) berries against scopolamine-induced deficit in learning and memory using behavior paradigms in rats
4426. Protective activity of plant extracts against genotoxicity of nitric oxide
4427. Protective effect of Calendula Officinalis L. extract against non-enzymatic peroxidation of rat kidney microsomes and mitochondria.
4428. Protective Effect of Cimicifuga heracleifolia Ethanol Extract and its Constituents on Gastritis and Gastric Lesions
4429. Protective Effect of COR against Ototoxicity by Cisplatin in Mice
4430. Protective effect of curcumin in behavioral impairment induced by pentylenetetrazol in rats
4431. Protective effect of Cyperi rhizoma against 6-hydroxydopamine-induced neuronal damage
4432. Protective effect of ECQ on indomethacin-induced gastric damage in rats
4433. Protective effect of ethanolic extract and raw juice of Solanum betaceum on aluminum induced oxidative stress and associated memory deficits in rats
4434. Protective effect of ethanolic extract of Psidium guajava L. leaves in tacrine-induced orofacial dyskinesia by assessing its neurobehavioral and biochemical …
4435. Protective Effect of Fermented Soybean against UVB-Induced Skin Inflammation in Hairless Mice
4436. Protective effect of grape seed and skin extract on cerebral ischemia in rat: implication of transition metals
4437. Protective effect of jakyak-gamcho-tang extract and its constituents against t-BHP-induced oxidative damage in HT22 cells
4438. Protective effect of kumquat fruits and carrot seeds extracts against brain aging in rats
4439. Protective effect of Sestrin2 in APAP-induced hepatotoxicity
4440. Protective effect of the aerial parts of Silybum marianum against amyloid β protein (25-35)-induced neuronal death in cultured neurons
4441. Protective effect of two essential oils isolated from Rosa damascena Mill. and Lavandula angustifolia Mill, and two classic antioxidants against L-dopa oxidative toxicity …
4442. Protective effect of Zizyphus spinachristi on MPP+-induced oxidative stress
4443. Protective effects of Abelmoschus moschatus seed extract on neurotransmitter system of developing brain of Wistar rats with gestational and post-natal exposure of …
4444. Protective Effects of Activated Cultivated-Wild Ginseng Against Hepatotoxicity Induced by Carbon Tetrachloride in Rats
4445. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats
4446. Protective effects of antioxidants in Huntington’s disease: an extensive review
4447. Protective effects of chronic green tea consumption on age-related neurodegeneration
4448. Protective effects of Chrysin against memory impairment, cerebral hyperemia and oxidative stress after cerebral hypoperfusion and reperfusion in rats
4449. Protective effects of cyperus rotundus extract on amyloid β-peptide (1-40)-induced memory impairment in male rats: a behavioral study
4450. Protective effects of green tea and its main constituents against natural and chemical toxins: A comprehensive review
4451. Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: A review
4452. Protective effects of memantine and epicatechin on catechol-induced toxicity on Müller cells in vitro
4453. Protective effects of myricetin on chronic stress-induced cognitive deficits
4454. Protective Effects of Phytochemicals, Quercetin and Ferulic acid, on Transthyretin fibril-induced amyloidosis in Neuronal cells
4455. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration
4456. Protective effects of quercetin glycosides, rutin, and isoquercetrin against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in rat pheochromocytoma (PC-12) cells
4457. Protective Effects of Red Onion (Allium cepa) Ethanolic Extract on Learning and Memory Impairments in Animal Models of Diabetes
4458. Protective effects of resveratrol in age-related Neurodegenerative diseases and gene regulatory action
4459. Protective effects of Stachys sieboldii MIQ extract in SK‐N‐SH cells and its memory ameliorative effect in mice
4460. Protective Effects of the Pectin Hydrolysates on UVB-irradiated Human Epithelial Cell Damage through Increase Collagen Synthesis
4461. Protective Efficacy of the Caterpillar Mushroom, Ophiocordyceps sinensis (Ascomycetes), from India in Neuronal Hippocampal Cells against Hypoxia
4462. Protective function of autophagy during VLCFA-induced cytotoxicity in a Neurodegenerative cell model
4463. Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats
4464. Protective role of epigallocatechin-3-gallate in health and disease: a perspective
4465. Protective role of functional food in cognitive deficit in young and senile rats
4466. Protective role of Spondias mombin leaf and Cola acuminata seed extracts against scopolamineinduced cognitive dysfunction
4467. Protective Roles of Hop Proanthocyanidins on Alcohol-Induced SH-SY5Y Cell Damage
4468. Protein Kinase A Regulates the Osteogenic Activity of Osterix
4469. Protein kinases CK1 and CK2 as new targets for Neurodegenerative diseases
4470. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation
4471. Protein Misfolding, Aggregation, Amyloid Formation in Neurodegenerative Diseases: Latest Therapeutic Approaches for Treating Neurodegenerative Diseases
4472. Protein tyrosine nitration: Chemistry and role in diseases
4473. Proteomic analysis of a neurodegeneration cell model, treated with plant extracts with potential neuroprotective activity
4474. Proteomics analysis of rat brain protein modulations by grape seed extract
4475. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes
4476. Psychiatric Disorders
4477. Psychoactive Properties of Microalgae
4478. Psychoimmunomodulatory Effects of Onosma bracteatum Wall.(Gaozaban) on Stress Model in Sprague Dawley Rats.
4479. Psychotropic medication-induced weight gain or loss looked through the lens of age and psychiatric diagnoses: A narrative review
4480. Public Health and Social & Administrative Pharmacy: Focused on National Health Insurance (1)
4481. Public Health and Social & Administrative Pharmacy: Focused on Safe Use of Drugs (2)
4482. Public Health Approaches to Promoting Physical Activity and a Healthy Diet to Reduce Risk of Cognitive Decline Among Older Adults
4483. Putative neuroprotective compounds in in vitro models of dopaminergic neurodegeneration
4484. Putative Roles of Plant-Derived Tannins in Neurodegenerative and Neuropsychiatry Disorders: An Updated Review
4485. PYCNOGENOL
4486. Qualitative versus quantitative caloric intake: are they equivalent paths to successful aging?
4487. Quality Control of Herbal Medicine Material
4488. Quality Control of Plant-Based Foods in Terms of Nutritional Values: Influence of Pesticides Residue and Endogenous Compounds
4489. Quantitative Estimation of UV-induced DNA Damages to Suppress Protein Expression Using Reporter Gene Assaybased Single Cell Co-transfection Imaging …
4490. Quantitative Multi-Target-Multi-Drug Analysis Using Single Cellular Cotransfection Imaging Cytometry Combined with Reporter Gene Assay
4491. Quercetin and omega 3 ameliorate oxidative stress induced by aluminium chloride in the brain
4492. Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders
4493. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells
4494. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish
4495. Quercetin and the mitochondria: a mechanistic view
4496. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus
4497. Quercetin Exerts Differential neuroprotective Effects Against H2O2 and Aβ Aggregates in Hippocampal Neurons: the Role of Mitochondria
4498. Quercetin in brain diseases: Potential and limits
4499. Quercetin in food: Possible mechanisms of its effect on memory
4500. Quercetin mitigates Adriamycin-induced anxiety-and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats
4501. Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats
4502. Quercetin protects against the Aβ25–35-induced amnesic injury: Involvement of inactivation of RAGE-mediated pathway and conservation of the NVU
4503. Quercetin Regulates the Integrated Stress Response to Improve Memory
4504. Quercetin, not caffeine, is a major neuroprotective component in coffee
4505. Quinic acid transport to brain through blood-brain barrier by organic anion transporter (OAT)
4506. Radical Medicine: Cutting-Edge Natural Therapies That Treat the Root Causes of Disease
4507. Radical scavenging potential, antiinflammatory and antiarthritic activity of isolated isomer Methyl-γ-Orsellinate and roccellatol from Roccella montagnei Bel
4508. Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
4509. Raging the war against inflammation with natural products
4510. Raman spectroscopy: an emerging tool in Neurodegenerative disease research and diagnosis
4511. Rapid in vivo Screening Method for the Anti-melanogenic Activity
4512. Rasayana herbs of ayurveda to treat age related cognitive decline: An update
4513. Rational Basis for Nutraceuticals in the Treatment of Glaucoma
4514. Rationally designed multi-targeted agents against Neurodegenerative diseases
4515. Reactive oxygen and nitrogen species: weapons of neuronal destruction
4516. Reactive Oxygen and Nitrogen Species: Weapons of Neuronal Destruction
4517. Reactive oxygen species and antioxidants: implications for clinical nutrition.
4518. Reactive oxygen species and the central nervous system
4519. Reactive Oxygen Species Insufficiency (ROSI) as the Basis for Disease Allowance and Coexistence
4520. Reactive oxygen/nitrogen species and their functional correlations in Neurodegenerative diseases
4521. Reasonably activating Nrf2: A long-term, effective and controllable strategy for Neurodegenerative diseases
4522. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)
4523. Recent advances in chemistry, therapeutic properties and sources of polydatin
4524. Recent advances in chemistry, therapeutic properties and sources of polydatin
4525. Recent advances in pharmacological research on Ecklonia species: a review
4526. Recent approaches towards selected lamiaceae plants for their prospective use in neuroprotection
4527. Recent conjugation strategies of small organic fluorophores and ligands for bioimaging application
4528. Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
4529. Recent Natural Products R&D Activities in the Japanese Pharmaceutical Industry and Academia: Discovery Support at Eli Lilly & Co.
4530. Recent progress in research on the pharmacological potential of mushrooms and prospects for their clinical application
4531. Recent progress regarding kaempferol for the treatment of various diseases
4532. Recent research on the health benefits of blueberries and their anthocyanins
4533. Recent status of nanomaterial fabrication and their potential applications in neurological disease management
4534. Recent trends in treating neuronal proteinopathies
4535. Recent updates in neuroprotective and neuroregenerative potential of Centella asiatica
4536. Recent updates in the treatment of Neurodegenerative disorders using natural compounds
4537. Reconvene and reconnect the antioxidant hypothesis in human health and disease
4538. Red Ginseng Extracts Exerted Strong Estrogenic Effects in MCF-7 Cells
4539. Red palm oil: nutritional, physiological and therapeutic roles in improving human wellbeing and quality of life
4540. Red wine consumption: dietary option in the healthy lifestyle modification?
4541. Redefining oxidative stress
4542. Redox homeostasis and cellular stress response in aging and neurodegeneration
4543. Redox proteomics, thiol homeostasis and neurophysiologicla correlations in aging and neurodegeneration
4544. Redox regulation of cellular stress response in aging and Neurodegenerative disorders: role of vitagenes
4545. Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ
4546. Redoxomics and oxidative stress: from the basic research to the clinical practice
4547. Reduced Autophagy Aggravates Hepatocellular Damage in Alcoholic Fatty Liver
4548. Reduction of Cerebral Ischemic Injury by trans-Caryophyllenevia Activation of Neuronal Cannabinoid II Receptor
4549. Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents
4550. Reformulating Pro-Oxidant Microglia in Neurodegeneration
4551. REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I: THE DISPOSITION OF [3H]NOREPINEPHRINE, [3H]DOPAMINE AND [3H]DOPA IN VARIOUS …
4552. Regnase-1-Mediated Posttranscriptional Regulation of Inflammation
4553. Regulation of Artemisinin and Its Derivatives on the Assembly Behavior and Cytotoxicity of Amyloid Polypeptides hIAPP and Aβ
4554. Regulation Of Diabetes And Metabolic Pathways On Supplementation Of Aloe Vera In Albino Rats
4555. Regulation of inducible nitric oxide synthase gene in glial cells
4556. Regulation of inflammation-mediated chronic diseases by botanicals
4557. Regulation of neural stem cell fate by natural products
4558. Regulation of neuroinflammation by herbal medicine and its implications for Neurodegenerative diseases
4559. Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract
4560. Relationship between diet, the gut microbiota, and brain function
4561. Relationships among diet, physical activity and other lifestyle factors and debilitating diseases in the elderly
4562. Relationships among diet, physical activity and other lifestyle factors and debilitating diseases in the elderly
4563. Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism
4564. REMS: A New Approach to Managing Risk and Drug Development
4565. Repeated administration of almonds increases brain acetylcholine levels and enhances memory function in healthy rats while attenuates memory deficits in animal …
4566. Repressions of the toxic α, β-hydroxyaldehyde homologues, HHE, HOE, HNE and HDE formations by synthetic and natural antioxidants in commercial corn oil at frying …
4567. Reprint of: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs
4568. Research & Reviews: Journal of Medicinal & Organic Chemistry
4569. Research on drug candidate anticholinesterase molecules from Achillea biebersteinii Afan. using by molecular docking and in vitro methods
4570. Research on experimental models of Neurodegenerative disorders and radiation-induced brain injury
4571. Research on the Effects of Vitamins and Minerals on Cognitive Function in Older Adults
4572. Research on the Modes of Antigen Recognition by Variable Lymphocyte receptors (VLRs)
4573. Resolvin D1 Protects Livers from Ischemia/Reperfusion Injury by Enhancing M2 Macrophage Polarization and Efferocytosis
4574. Resolvin D1, a Lipid Mediator Derived from Docosahexaenoic Acid, Promotes Resolution of Inflammation by Stimulating Efferocytosis and Protecting …
4575. Resveratrol
4576. Resveratrol activates autophagy via AKT/mTOR signaling pathway to improve cognitive dysfunction in rats with chronic cerebral hypoperfusion
4577. Resveratrol administration Increases transthyretin Protein Levels, ameliorating aD Features: the Importance of transthyretin tetrameric Stability
4578. Resveratrol and Aging
4579. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence
4580. Resveratrol and pterostilbene: A comparative overview of their chemistry, biosynthesis, plant sources and pharmacological properties
4581. Resveratrol as a therapeutic agent for Neurodegenerative diseases
4582. Resveratrol attenuates oxidative stress and improves behaviour in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) challenged mice
4583. Resveratrol bioavailability and toxicity in humans
4584. Resveratrol brain delivery for neurological disorders prevention and treatment
4585. Resveratrol counteracts lipopolysaccharide-mediated microglial inflammation by modulating a SOCS-1 dependent signaling pathway
4586. Resveratrol from underutilized fruits and effect of fermentation for functional properties
4587. Resveratrol increases vascular oxidative stress resistance
4588. Resveratrol induces the expression of interleukin-10 and brain-derived neurotrophic factor in BV2 microglia under hypoxia
4589. Resveratrol mitigates lipopolysaccharide‐and Aβ‐mediated microglial inflammation by inhibiting the TLR4/NF‐κB/STAT signaling cascade
4590. Resveratrol promotes the expression of interleukin-10 and brain-derived neurotrophic factor in microglia under hypoxia.
4591. Resveratrol Supplementation has Anti-skin Aging Effects in Obesity Induced by High Fat Diet in C57BL/6J Mice
4592. Resveratrol supplementation, where are we now and
4593. Resveratrol supplementation: where are we now and where should we go?
4594. Resveratrol: a focus on several Neurodegenerative diseases
4595. Resveratrol: a natural compound with pharmacological potential in Neurodegenerative diseases
4596. Resveratrol: Biological Activities and Potential Use in Health and Disease
4597. Resveratrol: biological activities and therapeutic potential
4598. Resveratrol: From enhanced biosynthesis and bioavailability to multitargeting chronic diseases
4599. Resveratrol: new avenues for a natural compound in neuroprotection
4600. Retarding brain ageing and cognitive decline
4601. Retracted: Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion
4602. Revalidation of the neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in …
4603. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary …
4604. Review of the Effect of Natural Compounds and Extracts on Neurodegeneration in Animal Models of Diabetes Mellitus
4605. Review on discovery and development of novel phytochemicals which can be used in functional foods
4606. Review on experimental research of herbal medicines with anti-amnesic activity
4607. REVIEW ON POTENTIAL PLANT BASED DRUGS FOR MEMORY ENHANCER
4608. Reviewing the role of resveratrol as a natural modulator of microglial activities
4609. Rh-catalyzed Oxidative Carbonylation of Benzamides with Aldehydes: Direct Functionalization of sp2 CH Bond
4610. Rhinacanthus nasutus protects cultured neuronal cells against hypoxia induced cell death
4611. Rhodiola (Rhodiola rosea L.)
4612. Rhodiola rosea from the Selection of Traditional Applications to the Novel Phytotherapy for the Prevention and Treatment of Serious Diseases.
4613. Rhodium (III)-Catalyzed Oxidative C–C Bond Formation and C–N Bond Cleavage
4614. RNA as a new target for toxic and protective agents
4615. Role and health benefits of different functional food components
4616. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage
4617. Role of Antioxidants in Human Health
4618. Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment
4619. Role of complementary and alternative medicine in geriatric care: A mini review
4620. Role of Crataegus oxyacantha (Hawthorn) on scopolamine induced memory deficit and monoamine mediated behaviour in rats
4621. Role of dietary and endogenous antioxidants in diabetes
4622. Role of Dietary Antioxidants in Neurodegenerative Diseases. Where are We Standing?
4623. Role of dietary antioxidants in the prevention of in vivo oxidative DNA damage
4624. Role of dietary fat and supplementation in modulating Neurodegenerative pathology in two animal model systems
4625. Role of environmental and inflammatory toxicity in neuronal cell death
4626. Role of free radicals in aging and disease
4627. Role of free radicals in the Neurodegenerative diseases
4628. ROLE OF FRUITS IN BRAIN HEALTH
4629. Role of Glycation in Amyloid: Effect on the Aggregation Process and Cytotoxicity
4630. Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective
4631. Role of Gut Microbiota in Combating Oxidative Stress
4632. Role of medicinal plants for health perspective: special references to antioxidant potential
4633. Role of medicinal plants in Neurodegenerative diseases
4634. Role of microglia in ethanol-induced Neurodegenerative disease: Pathological and behavioral dysfunction at different developmental stages
4635. Role of Natural Antioxidants from Functional Foods in Neurodegenerative and Metabolic Disorders
4636. Role of Natural Antioxidants from Selected Plants Belonging to the Scrophulariaceae and Buddlejaceae Families in the Prevention and Treatment of …
4637. ROLE OF NATURAL SUBSTANCES AND VITAMIN SUPPLEMENTATION IN TINNITUS PREVENTION AND TREATMENT
4638. Role of nicotine in oxidative stress
4639. Role of NRF2 in Photodynamic Therapy
4640. Role of Nutraceuticals in Modulation of Gut-Brain Axis in Elderly Persons
4641. Role of Nutraceuticals in Neurodegenerative Diseases
4642. Role of nutraceuticals in various diseases: A comprehensive review
4643. Role of Nutraceuticals in Various Diseases: A Comprehensive Review
4644. Role of nutraceuticals on health promotion and disease prevention: A review
4645. Role of oxidative stress and antioxidants in Neurodegenerative diseases
4646. Role of oxidative stress in various diseases: relevance of dietary antioxidants
4647. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing
4648. Role of phytotherapy in diabetic neuropathy and neurodegeneration: from pathogenesis to treatment
4649. Role of plant derived alkaloids and their mechanism in Neurodegenerative disorders
4650. Role of plant-based diets in the prevention and regression of metabolic syndrome and Neurodegenerative diseases
4651. Role of Prolyl Isomerase Pin1 on the Activity of AMPK and Tumorigenicity of Hepatocarcinoma Cells
4652. Role of quercetin benefits in neurodegeneration
4653. Role of reactive oxygen species as signaling molecules in the regulation of physiological processes of the nervous system
4654. Role of Reactive Oxygen Species in signalling and oxidative stress
4655. Role of ROS and nutritional antioxidants in human diseases
4656. Role of St. John’s Wort (Hypericum perforatum L.) in the Management of Diabetes and Neurological Disorders
4657. Role of the Genus Cinnamomum in the Management of Neurodegenerative Diseases: Outcomes and Shortcomings
4658. Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases
4659. Role of vital trace elements in nanocurcumin-centered formulation: a novel approach to resuscitate the immune system
4660. Role of Walnuts in Maintaining Brain Health with
4661. Role of walnuts in maintaining brain health with age
4662. Role of Wine Components in Inflammation and Chronic Diseases
4663. ROLES OF ANTI-NEUROINFLAMMATION AND ANTI-OXIDATIVE PROPERTIES OF A STANDARDISED Andrographis paniculata BURM. NEES AQUEOUS …
4664. Roles of facilitative glucose transporter GLUT1 in [18F] FDG positron emission tomography (PET) imaging of human diseases
4665. ROSELLE (HIBISCUS SABDARIFFA) AND THEIR POTENTIAL BENEFITS FOR THE BRAIN: AREVIEW
4666. Rosenroot (Rhodiola): potential applications in aging-related diseases
4667. Rosmarinic acid isolated fromPerillaeHerbaenhances pentobarbital-induced sleep via GABAAergic systems
4668. Rosmarinic acid prevents against memory deficits in ischemic mice
4669. Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells
4670. Rutin as a potent antioxidant: implications for Neurodegenerative disorders
4671. Rutin as neuroprotective agent: from bench to bedside
4672. Rutin from Dendropanax morbifera Leveille Protects Human Dopaminergic Cells Against Rotenone Induced Cell Injury Through Inhibiting JNK and p38 MAPK …
4673. Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress
4674. Rutin: therapeutic potential and recent advances in drug delivery
4675. S. choloroleuca, S. mirzayanii and S. santolinifolia protect PC12 cells from H2O2-induced apoptosis by blocking the intrinsic pathway
4676. S22 Induces Immunostimulatory Effects in Peritoneal Macrophage
4677. Safety, efficacy and preclinical evaluation of plant products
4678. Safflower (Carthamus tinctorius L.) seed attenuates memory impairment induced by scopolamine in mice via regulation of cholinergic dysfunction and oxidative stress
4679. Saffron: a natural product with potential pharmaceutical applications
4680. Salidroside protects PC12 cells from MPP+-induced apoptosis via activation of the PI3K/Akt pathway
4681. Salidroside, a bioactive compound of rhodiola rosea, ameliorates memory and emotional behavior in adult mice
4682. Salt marsh plants as source of bioactive compounds
4683. Salvia (sage): a review of its potential cognitive-enhancing and protective effects
4684. Salvia officinalis induces antidepressant-like effect, anxiolytic activity and learning improvement in hippocampal lesioned and intact adult rats
4685. Salvia spp.: An Updated on Antioxidant Activity and Pharmacological Uses
4686. Salvianolic acid B promotes microglial M2-polarization and rescues neurogenesis in stress-exposed mice
4687. SAR228810: an antiprotofibrillar beta-amyloid antibody designed to reduce risk of amyloid-related imaging abnormalities (ARIA)
4688. Saxifragifolin A Induces Differential Apoptotic Effects in Human Breast Saxifragifolin A Induces Differential Apoptotic Effects in Human Breast
4689. Schizandra chinensis alkaloids inhibit lipopolysaccharide-induced inflammatory responses in BV2 microglial cells
4690. Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia
4691. Science-based anti-ageing nutritional recommendations
4692. Scientific and regulatory aspects of nutraceutical products in the United States
4693. Screening for amyloid-β aggregation inhibitor and neuronal toxicity of eight Tunisian medicinal plants
4694. Screening for Small Molecule Probe of in vitro-in vivo Lipid Research and its Use for in vivo Lipid Imaging
4695. Screening for Undeclared Erectile Dysfunction Drugs and Analogues in Dietary Supplements by Liquid Chromatography Hybrid Ion Trap-time of Flight (LC-IT …
4696. Screening neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation …
4697. Screening of plants used in the European traditional medicine to treat memory disorders for acetylcholinesterase inhibitory activity and anti amyloidogenic activity
4698. Screening of Radical Scavenging Activity of Jupgolmok
4699. Screening of selected medicinal plants for their hepatoprotective activity.
4700. Screening of some plant species for their total antioxidant and antimicrobial activities
4701. Screening of Suppressive Effect on Th2-associated Cytokines Expression in Folk Medicinal Used Plants
4702. Screening of the Biologoical Activity from Water Extracts of the Medicinal Plants and the Protective Effect of R. palmatum on MTPT-induced Neurotoxicity
4703. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity
4704. Scutellaria baicalensis: bioactive components, bioactivities and therapeutic potential
4705. Secondary metabolite profiling, cytotoxicity, anti-inflammatory potential and in vitro inhibitory activities of Nardostachys jatamansi on key enzymes linked to …
4706. Secondary Metabolites from Rosemary (Rosmarinus officinalis L.): Structure, Biochemistry and Therapeutic Implications Against Neurodegenerative Diseases
4707. Secret talk between adipose tissue and central nervous system via secreted factors—an emerging frontier in the Neurodegenerative research
4708. Secrets of Longevity: Hundreds of Ways to Live to be 100
4709. SECRETS to LOSE TOXIC BELLY FAT! Heal Your Sick Metabolism Using State-Of-The-Art Medical Testing and Treatment With Detoxification, Diet, Lifestyle …
4710. Secrets to Lowering Cholesterol with Nutrition and Natural Supplements, Safely
4711. Securidaca longipedunculata Fresen (Polygalaceae): A review of its ethnomedicinal uses, phytochemistry, pharmacological properties and toxicology
4712. Seed extract of Abelmoschus moschatus Medik reverses NaF-induced behavioral changes through neurodegeneration and oxidative stress in brain of rat
4713. Selected commercial plants: A review of extraction and isolation of bioactive compounds and their pharmacological market value
4714. Selectively Enhancing the Clearance of Pathological Tau Through the Use of Phytochemical Compounds
4715. SELEZIONE BIBLIOGRAFICA SU POLYGONUM CUSPIDATUM E RESVERATROLO
4716. Self-Assembling Micelle-like Nanoparticles with Detachable Envelope for Enhanced Intracellular Delivery of Nucleic Acid Therapeutics
4717. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
4718. Sesame cake hydrolysates improved spatial learning and memory of mice
4719. Seven new sesquineolignans isolated from the seeds of hawthorn and their neuroprotective activities
4720. Shoot cultures of Hoppea fastigiata (Griseb.) CB Clarke as potential source of neuroprotective xanthones
4721. Short overview on metabolomic approach and redox changes in psychiatric disorders
4722. Short-and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down …
4723. Short-term green tea supplementation prevents recognition memory deficits and ameliorates hippocampal oxidative stress induced by different stroke models …
4724. Side effects of selected nautral compounds.
4725. Significance of antioxidants in the treatment and prevention of Neurodegenerative diseases
4726. Silent Inflammation: The Single Phenomenon Behind Many of The Most Feared Diseases of Middle & Old Age
4727. Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice
4728. Silymarin attenuates aspartame-induced variation in mouse behaviour, cerebrocortical morphology and oxidative stress markers
4729. Silymarin has antioxidant potential and changes the activity of Na+/K+-ATPase and monoamine oxidase in vitro
4730. Silymarin protects dopaminergic neurons against lipopolysaccharide‐induced neurotoxicity by inhibiting microglia activation
4731. Similarities and interactions between the ageing process and high chronic intake of added sugars
4732. Simultaneous Occurrence of Bioactive Compounds (Melatonin, Protocatechuic Acid and Hydroxytyrosol) Increases Their neuroprotective Effects Against Alpha …
4733. Sinapic acid and its derivatives: natural sources and bioactivity
4734. Síndrome de disfunción cognitiva: actualización del conocimiento como herramienta para el bienestar animal en perros seniles
4735. Single-micronutrient and broad-spectrum micronutrient approaches for treating mood disorders in youth and adults
4736. SIRT2 Interferes with Autophagy Turnover in Neuronal Cells
4737. Sirtuins: possible clinical implications in cardio and cerebrovascular diseases
4738. Slimming Meals That Heal: An Empath’s Guide to Evading Relationships That Drain You and Restoring Your Health and Power
4739. Small molecular inhibitors of Amyloid β and α Synuclein amyloidogenic aggregation, toxicity and in silico design of amyloid-binding ligands
4740. Small Molecule Inhibitors of NF- B and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
4741. Small-molecule protein–protein interaction inhibitors as therapeutic agents for Neurodegenerative diseases: recent progress and future directions
4742. Smart dietary interventions and prevention of cognitive decline with aging
4743. Smart drugs and orthomolecular substances for aging minds
4744. Smoking Effects on CYP24A1 in Lung Adenocarcinoma: Epigenetic Changes by Smoking
4745. SNDRI Antidepressant Drug Development
4746. SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration
4747. Soldier health habits and the metabolically optimized brain
4748. Solvent Effects on the Cleavage of Emodin’s Non H-bonded OH Link: A Theoretical Study
4749. Some chemical characteristics and antioxidant capacity of novel Merlot wine clones developed in Montenegro
4750. Some functional properties of khambir, an ethnic fermented cereal-based food of Western Himalayas
4751. SOME MEDICINAL PLANTS USED FOR NERVOUS DISORDERS: A REVIEW
4752. Some Positive Effects of Pine Oil on Brain Tissue in Streptozotocin-Induced Diabetic Rats.
4753. Soursop fruit extract mitigates scopolamine-induced amnesia and oxidative stress via activating cholinergic and Nrf2/HO-1 pathways
4754. Soybean aglycones antioxidant activity. A theoretical investigation
4755. Spatial Memory and Antioxidant Protective Effects of Raisin (Currant) in Aged Rats
4756. Special Issue on “Analytical Methods for Oxidized Biomolecules and Antioxidants” The use of isoprostanoids as biomarkers of oxidative damage, and their role in …
4757. Sphingosylphosphorylcholine (SPC) Induced Invasion through Matrix Metalloproteinase-3 Upregulation in Breast Cells.
4758. Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in Breast Cells
4759. Spices and Herbs as Therapeutic Foods
4760. Spinal Muscular Atrophy, Motor Neuron Disease or Muscle Disease?
4761. Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats
4762. Staying Healthy from 1 to 100
4763. Stem Cells for Neurodegenerative Diseases
4764. Stratagems of Nanotechnology Augmenting the Bioavailability and Therapeutic Efficacy of Traditional Medicine to Formulate Smart Herbal Drugs Combating
4765. Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases
4766. Strategies for the discovery of anti-aging compounds
4767. Strategies of antioxidant defense
4768. Strategy against Nagoya Protocol in the filed of Food and Drug
4769. Strategy Establishment for Oral Dosage form Development of Ginsenosides in Red Ginseng
4770. Stresses, Aging, and Age-Related Disorders
4771. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
4772. Stroke and neuroplasticity
4773. Stroke: roles of B vitamins, homocysteine and antioxidants
4774. Structural and Molecular Basis of Interaction of Curcumin with Proteins
4775. Structural evidence of quercetin multi-target bioactivity: A reverse virtual screening strategy
4776. Structural perspective on the direct inhibition mechanism of EGCG on mammalian histidine decarboxylase and DOPA decarboxylase
4777. Structural Remodeling Of Alpha-Synuclein By Small Molecules: A Novel Path To neuroprotective Therapeutics
4778. Structural Studies of Cystatin B Amyloid Fibre and Oligomer
4779. Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure
4780. Structural, morphological, and functional diversity of amyloid oligomers
4781. Structure-activity Relationship Study of Moracins O and P Analogues as Potential HIF-1α Inhibitor
4782. Structure-activity relationships for interactions of hydroxylated polychlorinated biphenyls with human hydroxysteroid sulfotransferase hSULT2A1
4783. Structure-bioactivity relationships of methylxanthines: Trying to make sense of all the promises and the drawbacks
4784. Structure–activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: Correlation between experimental & theoretical data and synergistic effect
4785. Structure–activity relationships of quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells
4786. Structure–property relationships of trimetazidine derivatives and model compounds as potential antioxidants
4787. Stuck at the bench: Potential natural neuroprotective compounds for concussion
4788. Studies of intracellular cascades mediating neuronal damage in two animal models of neurodegeneration
4789. Studies of Molecular Mechanisms of Cranberry Mediated Healthspan Promotion in Caenorhabditis Elegans
4790. Studies of natural products on treating neurological disorders in China
4791. Studies of the Constituents from the Whole Plants of Geum japonicum
4792. Studies on Aggregation Behavior of some Proteins and its Inhibition by Small Molecules
4793. Studies on Antidepressant Drug and oxidative stress induced Structural and Functional Modification of Buffalo Brain Purified Cystatin
4794. Studies on free radicals, antioxidants, and co-factors
4795. Studies on medicinal herbs for cognitive enhancement based on the text mining of Dongeuibogam and preliminary evaluation of its effects
4796. STUDIES ON MICROPROPAGATION, ANTIOXIDANT ACTIVITY AND ANALYSIS OF SECONDARY METALBOLITES IN WITHANIA SOMNIFERA LEAVES
4797. Studies on phytochemical analysis, antioxidant and lipid peroxidation inhibitory effects of a medicinal plant, Coleus forskohlii
4798. Studies on phytochemicals, antioxidant, free radical scavenging and lipid peroxidation inhibitory effects of Trachyspermum ammi seeds
4799. Studies on Potential neuroprotective Activity of Selected Medicinal Herbs.
4800. Studies on structural and functional properties of purified caprine brain cysteine proteinase inhibitor: Interaction with nanoparticles, amyloid fibrillation and …
4801. STUDIES ON THE EFFECTS OF MYRICETIN DERIVATIVES FROM SYZYGIUM MALACCENSE IN HYPERGLYCEMIA AND RELATED COMPLICATIONS
4802. Study of Pharmacological Activities of Methanolic Extract of Aglaonema hookerianum Leaf
4803. Study of Pharmacological Activities of Methanolic Extract of Phyla Nodiflora
4804. Study of Prodelphinidins: synthesis, detection, identification and reactivity with anthocyanins
4805. Study of protective effect of ethanolic root extract of Clitoria ternatea against stress induced amnesia
4806. Study on acetylcholinesterase inhibitor derived from Datura metel L.
4807. Study on digestion activity test of enzymatic drugs in Korean Pharmacopoeia
4808. Study on Neuroendocrine Disrupting Potential of Cadmium in Rats and Evaluation of Role of Green Tea
4809. STUDY ON PHARMACOLOGY AND TOXICOLOGY OF CARISSA CARANDAS (AUCT.) AND HERBAL PRODUCTS USED IN CARDIOVASCULAR DISEASES
4810. Studying Huntington’s disease in yeast: from mechanisms to pharmacological approaches
4811. Success stories of natural product-based hybrid molecules for multi-factorial diseases
4812. Sugar in mind: untangling a sweet and sour relationship beyond type 2 diabetes
4813. Sulforaphane as a potential nutritional intervention to reduce neuroinflammation associated with aging and sickness behavior
4814. Sulforaphane as a potential protective phytochemical against Neurodegenerative diseases
4815. Sulphonamides incorporating 1, 3, 5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile
4816. Superfoods: Nature’s Top Ten
4817. Supplementing cognitive aging: a selective review of the effects of ginkgo biloba and a number of everyday nutritional substances
4818. Suppressed LPS-induced Inflammatory Response by (-)-Nyasol in BV-2 Microglial Cells
4819. Suppression of 6-Hydroxydopamine-Induced oxidative stress by Hyperoside Via Activation of Nrf2/HO-1 Signaling in Dopaminergic Neurons
4820. Suppression of Adipose Inflammation and Macrophage Chemotaxis by Butein Protects against Glucose Intolerance in Mice Fed High Fat Diet
4821. Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10)
4822. Suppressive effects of the peel of Citrus kawachiensis (Kawachi Bankan) on astroglial activation, tau phosphorylation, and inhibition of neurogenesis in the …
4823. Surfactant-mediated amyloidogenesis behavior of stem bromelain; a biophysical insight
4824. SURVEY, DOCUMENTATION AND SCEINTIFIC STUDIES OF PLANT REMEDIES USED FOR THE TREATMENT OF THE INFECTIOUS SKIN DISEASES IN …
4825. Sustainability of Health Insurance Financing and the Growth of Pharmaceutical Industry
4826. Sutherlandia frutescens Ethanol Extracts Inhibit oxidative stress and Inflammatory
4827. Sutherlandia frutescens ethanol extracts inhibit oxidative stress and inflammatory responses in neurons and microglial cells
4828. Sweet cherries from Fundão as health promotors: chemical characterization and biological potential
4829. Symposium on nutrition and cognition: towards research and application for different life stages
4830. Synaptic Proteins and Brain Dysfunctions
4831. Synaptic signalling and its interface with neuropathologies: snapshots from the past, present and future
4832. Synaptosomal and mitochondrial oxidative damage followed by behavioral impairments in streptozotocin induced diabetes mellitus: restoration by Malvastrum …
4833. Synergistic Effect of Quercetin and α-Lipoic Acid on Aluminium Chloride Induced Neurotoxicity in Rats
4834. Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives
4835. Syntheses and Chemopreventive Activities of Diyne Natural Products
4836. Synthesis and aniviral activity of seleno-acyclovir and seleno-ganciclovir
4837. Synthesis and Antifungal Activity of 1H-Benzofuro [6, 7-d] imidazol-4-ols
4838. Synthesis and Antifungal Activity of Benzo [f] pyrido [1, 2-a] indole-6, 11-Diones
4839. Synthesis and Antifungal Activity of Methyl 4, 11-dioxo-4, 11-dihydropyrido [1, 2-a] thieno [2, 3-f] indole-2-carboxylates
4840. Synthesis and antioxidant properties of (3, 4‐dihydroxyphenyl)(2, 3, 4‐trihydroxyphenyl) methanone and its derivatives
4841. Synthesis and antiviral activity of 2′, 5′, 5′-trifluoro-3′-hydroxy-apiosyl nucleoside phosphonic acid analogues
4842. Synthesis and Bactericidal Activity of Ploydiguanide Silver Complexes as New-Generation Antibacterial Agents in Wound Care Applications
4843. Synthesis and Biological Evaluation of Novel Pyrimidine Derivatives as Potent GPR119 Agonists for the Treatment of Type 2 Diabetes
4844. Synthesis and Biological Properties of Benzoannulated Tryptanthrin
4845. Synthesis and Properties of Dextran-Metronidazole Succinate as a Colon-Specific Prodrug of Metronidazole
4846. Synthesis of Peptidomimetic Compounds for Inhibition of PLD1 Activity
4847. Synthesis of peptidomimetics containing bifunctional diketoopiperazine scaffolds and their evaluation as modulators of amyloid-B peptide oligomerization
4848. Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax/Bcl-2 ratio and caspase-dependent apoptosis …
4849. Synthetic and Natural Inhibitors of Phospholipases A2: Their Importance for Understanding and Treatment of Neurological Disorders
4850. SYNTHETIC TOCOPHEROL ANALOGUES: ROLE AND THERAPEUTICS IMPLICATIONS IN AGING DISEASES
4851. Systematic overview of Bacopa monnieri (L.) Wettst. dominant poly-herbal formulas in children and adolescents
4852. Systematic Strategy for Standardization of Herbal Medicine in Korea
4853. Systems pharmacology uncovers serotonergic pathway mediated psychotherapeutic effects of Lonicerae Japonicae Flos
4854. Tackling the aging process with bio-molecules: a possible role for caloric restriction, food-derived nutrients, vitamins, amino acids, peptides, and minerals
4855. Tacrine-Silibinin Codrug Shows Neuro- and Hepatoprotective Effects in Vitro and Pro-Cognitive and Hepatoprotective Effects in Vivo
4856. Tandem Rhodium-Catalyzed Oxidative Allylation and Annulation of Acetanilides with Allyl Acetate via CH Activation
4857. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells
4858. Tannoid principles of Emblica officinalis attenuated aluminum chloride induced apoptosis by suppressing oxidative stress and tau pathology via Akt/GSK-3βsignaling …
4859. Tanshinones and mental diseases: from chemistry to medicine
4860. Tanshinones, critical pharmacological components in Salvia miltiorrhiza
4861. Target-and mechanism-based therapeutics for Neurodegenerative diseases: strength in numbers
4862. Targeted Metabolomics Approach for Cardiovascular Diseases
4863. Targeting amyloidogenic immunoglobulin light chain aggregates with small molecules
4864. Targeting BDNF modulation by plant glycosides as a novel therapeutic strategy in the treatment of depression
4865. Targeting BDNF signaling by natural products: novel synaptic repair therapeutics for neurodegeneration and behavior disorders
4866. Targeting dysregulation of brain iron homeostasis in ageing
4867. Targeting free radicals in oxidative stress-related human diseases
4868. Targeting glucose metabolism for healthy aging
4869. Targeting mitochondrial dysfunction as in aging and glaucoma
4870. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against Neurodegenerative diseases
4871. Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?
4872. Targeting multiple Neurodegenerative diseases etiologies with multimodal-acting green tea catechins
4873. Targeting natural antioxidant compounds to the brain: a metabolomic assessment
4874. Targeting nitrosative stress for neurovascular protection: new implications in brain diseases
4875. Targeting of disordered proteins by small molecules in Neurodegenerative diseases
4876. Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases
4877. Targeting protein quality control mechanisms by natural products to promote healthy ageing
4878. Targeting the NLRP3 Inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders
4879. Targeting the prodromal stage of spinocerebellar ataxia type 17 mice: G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels
4880. Targeting ubiquitin proteasome pathway with traditional Chinese medicine for treatment of spinocerebellar ataxia type 3
4881. Targeting Wnt Signaling through Small molecules in Governing Stem Cell Fate and Diseases
4882. Tau protein and tau aggregation inhibitors
4883. TCM, brain function and drug space
4884. Tea and coffee consumption in relation to DNA methylation in four European cohorts
4885. Tea catechins induce the conversion of preformed lysozyme amyloid fibrils to amorphous aggregates
4886. Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice
4887. Tea consumption and disease correlations
4888. Tea in health and disease prevention
4889. TEACHING PHARMACOLOGY IN THE MEDICAL FACULTY OF MEDICAL UNIVERSITY IN SOFIA
4890. Technical Development of UV Protection Cosmetics
4891. Technology Development for Production of High-value Proteins in Cultured Plant Cells
4892. Terminalia arjuna bark extract attenuates picrotoxin-induced behavioral changes by activation of serotonergic, dopaminergic, GABAergic and antioxidant systems
4893. Terminalia chebula extract prevents scopolamine-induced amnesia via cholinergic modulation and anti-oxidative effects in mice
4894. Terpenoids Against Human Diseases
4895. Tests for antioxidant activity and their relevance to herbal medicinal products
4896. The ‘Natural Health Service’: natural does not mean safe
4897. The 7 Principles of Stress: Extend Life, Stay Fit, and Ward Off Fat–What You Didn’t Know about How Stress Can Reboot Your Mind, Energy, and Sex Life
4898. The action of plants and their constituents on the central nervous system
4899. The advances in neurobiology
4900. The advisability of dietary changes in the prevention and treatment of Neurodegenerative disease
4901. The Alkaline Reset Cleanse: The 7-Day Reboot for Unlimited Energy, Rapid Weight Loss, and the Prevention of Degenerative Disease
4902. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes–including …
4903. The Ameliorating Effect of Beta Vulgaris Extract on Memory and Learning Impairment Induced by Lesions of the Nucleus Basalis of Meynert in Rat.
4904. The Ameliorating Effect of Oroxylin A Derivatives Against Drug-Induced Cognitive Dysfunction and Prepulse Inhibition Deficit in Mice
4905. The ameliorating effect ofVitislabruscanaextract on scopolamine-induced memory impairments in mice
4906. The Ameliorating Effects of Kami-OnDam-tang (KODT) on the MK-801-Induced Schizophrenic Phenotypes in Mice
4907. The amelioration of the impact of physical fatigue on cognitive performance by phytochemicals: a thesis presented in partial fulfillment of the requirements for the …
4908. The anti-AChE and anti-proliferative Activities of Glaucium acutidentatum and Glaucium corniculatum Alkaloid Extracts
4909. The Anti-amyloidogenic effect of natural product extracts on amyloid-like fibril formation of trypsin in aqueous organic solvents
4910. The anti-platelet aggregation activity of Rapanea melanophloeos-A Zulu medicinal plant
4911. The Antioxidant Effect of Methylene Blue, a Repurposed Drug, Results from the Induction of SIRT1
4912. The antioxidant myth: a medical fairy tale
4913. The antioxidant properties of bufadienolides, analogous to the orbicusides of Cotyledon orbiculata L. var orbiculata (Haw.) DC
4914. The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice
4915. The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in Neurodegenerative diseases
4916. The association between macronutrient intake and cognition in individuals aged under 65 in China: a cross-sectional study
4917. The Association Between Macronutrient Intake and Cognitive Function in Community-Dwelling Elders
4918. THE AYURVEDIC TREATMENT OF Neurodegenerative DISEASES
4919. The bad, the good, and the ugly about oxidative stress
4920. The Basics of Biogerontology
4921. The Behavioral and Endocrine Changes Induced by Long Term Exposure to OTC in Zebrafish
4922. The Benefits of Catechin on the Cerebral Circulation and Memory
4923. The Best Things You Can Eat: For Everything from Aches to Zzzz, the Definitive Guide to the Nutrition-packed Foods that Energize, Heal, and Help You Look …
4924. The Biology of Aging and Related Nuclear Medicine Studies
4925. The biology of aging: implications for diseases of aging and health care in the twenty-first century
4926. The blood-brain barrier: roles of multidrug resistance transporter P-glycoprotein
4927. The brain as a target of inflammation: common pathways link inflammatory and Neurodegenerative diseases
4928. The brain gate: The little-known doorway that lets nutrients in and keeps toxic agents out
4929. The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs
4930. The Canadian encyclopedia of natural medicine
4931. The cellular protective effects of rosmarinic acid: from bench to bedside
4932. The chalcone derivative Chana 1 protects against amyloid β peptide-induced oxidative stress and cognitive impairment
4933. The Changes of Taurine Transporter (TauT) in Motor Neurons of Amyotrophic Lateral Sclerosis
4934. The Charnoly Body: A Novel Biomarker of Mitochondrial Bioenergetics
4935. The Chemical Composition of Essential Oil and the Antioxidant Activity of Egyptian Wild Peppermint
4936. The Clinician’s Handbook of Natural Medicine E-Book
4937. The complete encyclopedia of natural healing
4938. The Complete Idiot’s Guide to Natural Remedies
4939. The Complete Idiot’s Guide to the Coconut Oil Diet: Boost Your Health and Wellness with This Healing Food
4940. The Confrontation between Ethnopharmacology and Pharmacological Tests of Medicinal Plants Associated with Mental and Neurological Disorders
4941. THE CONSTITUENTS ACTION OF ON PLANTS THE CENTRAL AND THEIR NERVOUS SYSTEM
4942. The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
4943. The Cytoprotective Effect of Eupatilin to the 5-Lipoxygenase on Hydrogen Peroxide-induced Injury of Feline Esophageal Epithelial Cells
4944. The cytoprotective effect of Rumex Aquaticus HerbaeExtract against oxidative stress through HO-1 signaling pathway in AGS cells
4945. The Cytotoxic, Antibacterial and Free Radical Scavenging Activities of Crude Extracts of Matricaria chamomilla, Salvadora persica and Artemisia annua
4946. The Development of Diabetic Retinopathy Therapeutic EG-Mirotin
4947. The Development of HPLC-DAD Method for Simultaneous Determination of Eight Major Components in the Traditional Herbal Prescription, Sipjundaebo-tang
4948. The Development of Orphan Drugs Development for Rare Diseases. A Perspective.
4949. The diet-induced proinflammatory state:: A cause of chronic pain and other degenerative diseases?
4950. The Difference of Efficacy for Oral Hypoglysemic Pharmacotherapy Based on Sasang Constitutional Medicine among Type Ⅱ Diabetes Mellitus Patients in …
4951. The discovery and development of new potential antioxidant agents for the treatment of Neurodegenerative diseases
4952. The discovery of potential anticholinesterase compounds from Achillea millefolium L.
4953. The Doctors 5-Minute Health Fixes: The Prescription for a Lifetime of Great Health
4954. The Doctors Book of Food Remedies: The Latest Findings on the Power of Food to Treat and Prevent Health Problems–from Aging and Diabetes to Ulcers …
4955. The Effect of (−)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism
4956. The effect of açai (Euterpe spp.) Fruit pulp on brain health and performance
4957. The Effect of Alcoholic Extract of Morus Alba Leaves on Learning and Spatial Memory in Male Rats
4958. The Effect of Alcoholic Extract of Morus Alba Leaves on Learning and Spatial Memory in Male Rats
4959. The Effect of Cabbage and Broccoli on Antioxidation and Anti-inflammation
4960. The effect of cysteine-reactive catechol antioxidants on alcohol dehydrogenase as a model for oxidative stress in Neurodegenerative disease
4961. The effect of grape seed extract (GSE) on spatial memory in aged male rats
4962. The effect of green tea extract on oxidative stress and spatial learning in streptozotocin-diabetic rats
4963. The effect of herbal materials on the P-glycoprotein activity and function
4964. The Effect of Hif-1α Inhibitors on Taurine Transport in vitro BBB Model at High Glucose Condition
4965. The effect of hydro-alcoholic Ferulago angulata extract on locomotor activity and anxiety caused by hypoperfusion ischemia in adult male rats
4966. The effect of in vitro enzyme digestion on antioxidant and anticholinesterase potential of tomato (Lycopersicum esculentum) fruit and two commercially processed …
4967. The effect of Indian cooking style on the nutritional and anti-nutritional properties of spinach
4968. The Effect of Oroxylin A on Neurogenesis in the Hippocampus of Adult Mice
4969. The effect of Oxalis corniculata extract against the behavioral changes induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in mice
4970. The effect of paeonol to organic cation/carnitine transport in conditionally immortalized rat brain capillary endothelial cell lines
4971. The effect of pomegranate on anthropometric, biochemical, cognitive and satiety indicators of risk factors for non-communicable diseases
4972. The effect of Pyrroloquinoline quinone and Resveratrol on the Survival and Regeneration of Cerebellar Granular Neurons
4973. The effect of recent consumption of caffeine-containing foodstuffs on neuropsychological tests in the elderly
4974. The effect of resveratrol on Neurodegenerative disorders: Possible protective actions against autophagy, apoptosis, inflammation and oxidative stress
4975. The effect of Salvia officinalis hydroalcoholic extract on scopolamine-induced memory impairment in adult male mice
4976. The effect of selected medicinal plants on rotenone-induced toxicity in SH-SY5Y neuroblastoma cells
4977. THE EFFECT OF WILD YAM (Dioscorea villosa) TINCTURE ON MEMORY AND LEARNING IN MICE
4978. The effects of baicalein and baicalin on mitochondrial function and dynamics: A review
4979. The effects of baicalin and baicalein on cerebral ischemia: a review
4980. The effects of Chinese medicines on cAMP/PKA signaling in central nervous system dysfunction
4981. The effects of chronic multivitamin supplementation on neurocognition in the elderly
4982. The Effects of Diet, Exercise, and Sleep on Brain Metabolism and Function
4983. The effects of ethanol and aspalathus linearis on immortalized mouse brain endothelial cells (bEnd5)
4984. The effects of gallic acid on pain and memory following transient global ischemia/reperfusion in Wistar rats
4985. The effects of Ginkgo biloba extract on cognitive functions in aged female rats: the role of oxidative stress and brain-derived neurotrophic factor
4986. The effects of green tea on oxidative stress and working memory
4987. The Effects of Macronutrient and Micronutrient Diet Manipulation on Human Insulin Sensitivity
4988. The Effects of Sildenafil and Its Derivatives on Aromatase Activity in Human H295R Adrenocortical Carcinoma Cells
4989. The Effects of Sugar Addition and Degree of Roast on the Bioactive Compounds and Antioxidant Activity of Turkish-Style Coffee Brews
4990. The effects of the Mediterranean Diet on Chronic Diseases: Cardiovascular Diseases, Oxidative Stress, Dyslipidemia, Diabetes Mellitus, Blood Pressure …
4991. The effects of walnut supplementation on hippocampal NMDA receptor subunits NR2A and NR2B of rats
4992. The Effects of Yuzu (yuja) Extracts on Blood Circulation
4993. The efficiency of Saliva officinalis to reduce the biochemical and immunological effects induced by manganese chloride in rats
4994. The Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration
4995. The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG
4996. The Evaluation of P-Glycoprotein Activity by Tumor Necrosis Factor-α and Interferon-γ Using Brain Efflux Index Method
4997. The Everything Healthy Tea Book: Discover the Healing Benefits of Tea
4998. The Expression and Function of ABC Transporters at the Blood-Brain Barrier
4999. The First Global Screening of Protein Substrates Bearing Protein-bound 3, 4-Dihydroxyphenylalanine in E. coli and Human Mitochondria
5000. The Fly in the Ointment: 70 Fascinating Commentaries on the Science of Everyday Life
5001. The food and medicinal values of indigenous leafy vegetables
5002. The fortification of tea with sweeteners and milk and its effect on in vitro antioxidant potential of tea product and glutathione levels in an animal model
5003. The free radical theory of aging
5004. The Functional Nutrition Cookbook: Addressing Biochemical Imbalances Through Diet
5005. The fungal endobiome of medicinal plants: a prospective source of bioactive metabolites
5006. The genetic aspects of berries: from field to health
5007. The genus Anemarrhena Bunge: a review on ethnopharmacology, phytochemistry and pharmacology
5008. The GI Mediterranean diet: the glycemic index-based life-saving diet of the Greeks
5009. The good and bad of therapeutic strategies that directly target α‐synuclein
5010. The Great Physician’s Rx for Health and Wellness: Seven Keys to Unlock Your Health Potential
5011. The handbook of neuroprotection
5012. The happiness diet: A nutritional prescription for a sharp brain, balanced mood, and lean, energized body
5013. The healing effects of spices in chronic diseases
5014. The Healing Power of Tea: Simple Teas & Tisanes to Remedy and Rejuvenate Your Health
5015. The Healing Power of Vitamins, Minerals, and Herbs
5016. The Health-Boosting Properties of Super Foods
5017. The heme oxygenase/biliverdin reductase system as effector of the neuroprotective outcomes of herb-based nutritional supplements
5018. The Herbal Brain: Nootropics from a Garden, Not a Lab
5019. The holistic nursing approach to chronic disease
5020. The Home Reference to Holistic Health and Healing: Easy-to-Use Natural Remedies, Herbs, Flower Essences, Essential Oils, Supplements, and Therapeutic …
5021. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health
5022. The immunomodulatory effects of plant extracts and plant secondary metabolites on chronic neuroinflammation and cognitive aging: a mechanistic and …
5023. The Impact of 2006 Rationalization Plan on Health Insurance Expenditures for Pharmaceuticals in Korea
5024. The impact of Champagne wine consumption on vascular and cognitive functions
5025. The impact of chronic blackberry intake on the neuroinflammatory status of rats fed a standard or high-fat diet
5026. The impact of coffee on health
5027. The Impact of Functional Food and Nutraceuticals in Health
5028. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII)
5029. The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
5030. The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
5031. The Impact of Pomegranate on Memory Dysfunction after Cardiac Surgery
5032. The industrial potential of herbs and spices? a mini review
5033. The influence of fruit ripening on the phytochemical content and biological activity of Capsicum chinense Jacq. cv Habanero
5034. The influence of nutritional factors on the prognosis of multiple sclerosis
5035. The inhibitory activities of constituents of the three main categorites in ginkgo biloba towards amyloidi-ß peptide aggregation
5036. The Inhibitory Effect of Some Plant Extracts on Acetylcholinesterase Activity in Mice
5037. The Inhibitory Effect on the Esophagitis and Gastritis Models Using Synthetic Chemicals and Natural Product
5038. The Inhibitory Effects of Several Drugs on Carnitine Transport through Placental Barrier during Pregnancy
5039. The Interest of Adding Micronutrients to Docosahexaenoic Acid Supplementation to Prevent Age-Related Cognitive Decline
5040. The Investigation on Cholinesterases and BACE1 Inhibitory Activities in Various Tea Infusions
5041. The invisible illness of depression:“Never Say Never Mind, Mind the Mind,” and Mind the “Science Gap”
5042. The iron chelator desferrioxamine (Desferal) retards 6‐hydroxydopamine‐induced degeneration of nigrostriatal dopamine neurons
5043. The Juice Lady’s Anti-Inflammation Diet: 28 Days to Restore Your Body and Feel Great
5044. The Juice Lady’s Guide to Juicing for Health: Unleashing the Healing Power of Whole Fruits and Vegetables
5045. The Life Pill: Why Not Take Life for Life?
5046. The Longevity Code: Secrets to Living Well for Longer from the Front Lines of Science
5047. The Longevity Code: Slow Down the Aging Process and Live Well for Longer—Secrets from the Leading Edge of Science
5048. The mechanism of neuroprotective action of natural compounds
5049. The mechanisms for nitration and nitrotyrosine formation in vitro and in vivo: Impact of diet
5050. The mediterranean diet: an evidence-based approach
5051. The Mediterranean Diet: from an environment-driven food culture to an emerging medical prescription
5052. The Mediterranean diet: health and science
5053. The Mediterranean diet: metabolic and molecular mechanisms
5054. The Mediterranean Prescription: meal plans and recipes to help you stay slim and healthy for the rest of your life
5055. The Memory Ameliorating Effects of KHUR-34 and Its Compound KHUR-34-1 on Scopolamine-induced Cognitive Impairments in Mice
5056. The Memory Diet: More Than 150 Healthy Recipes for the Proper Care and Feeding of Your Brain
5057. The Memory Enhancing Effects of the Extract from the Fruit Hull of Mangosteen (Garcinia mangostana L.) in Healthy Adult Male Rats
5058. The Memory-ameliorating Effects of Artemisia princeps in Cholinergic Dysfunction
5059. The metabolic, cerebral haemodynamic, and cognitive effects of trans-resveratrol in healthy, young and older humans
5060. The mitochondrial carnitine palmitoyltransferase system—from concept to molecular analysis
5061. The Molecular Basis for Protective Effect of Mediterranean Diet in Neurodegenerative Disorders
5062. THE MOLECULAR BASIS OF AMYLOID AGGREGATE CYTOTOXICITY New S-acyl-glutathione derivatives prevent amyloid oxidative attack
5063. The multifunctional effects of nobiletin and its metabolites in vivo and in vitro
5064. The Natural Physician’s Healing Therapies: Proven Remedies Medical Doctors Don’t Know
5065. The nearest thing to a perfect food: part 2
5066. The neglected significance of “antioxidative stress”
5067. The neuro-protective effect of the methanolic extract of Perilla frutescens var. japonica and rosmarinic acid against H2O2-induced oxidative stress in C6 glial …
5068. The Neuro-Protective effects of Quercetin
5069. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory
5070. The neuroprotective action of naringenin on oseltamivir (Tamiflu) treated male rats
5071. The neuroprotective and therapeutic effects of anthocyanins and their metabolites in vitro and in a mouse model of amyotrophic lateral sclerosis
5072. The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation
5073. The neuroprotective effects of apocynin
5074. The neuroprotective effects of thymoquinone: A review
5075. The new application of UHPLC-DAD-TOF/MS in identification of inhibitors on β-amyloid fibrillation from Scutellaria baicalensis
5076. The Next Generation of Therapeutic Antibodies
5077. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of Neurodegenerative diseases
5078. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in Neurodegenerative disorders
5079. The Nutraceuticals: A Voluminous Torrent in Pharmaceuticals-coupling Health & Drugs
5080. The oxidant/antioxidant equilibrium in horses
5081. The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein
5082. The past and present of paraoxonase enzyme: its role in the cardiovascular system and some diseases
5083. The Pharmacist as a Health Counselor
5084. The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective
5085. The pharmacological Importance of Antirrhinum majus-A review
5086. The Phytochemical Analysis and Evaluation of the Antioxidant and Antidiabetic Potentials of Ethanolic Leaf Extract of Nephrolepis Biserrata
5087. The Pillars of Health
5088. The pivotal neuroinflammatory, therapeutic and neuroprotective role of alpha-mangostin
5089. The pivotal role of copper in neurodegeneration: a new strategy for the therapy of Neurodegenerative disorders
5090. The Plant that Survived Atomic Explosion, Can it Survive Human Threat?
5091. The Plant-based Solution: America’s Healthy Heart Doc’s Plan to Power Your Health
5092. The Possible Role of Intestinal Microflora in Pharmacological Activities of Natural Products
5093. The potential neuroprotective effects of two South African plant extracts in hydrogen peroxide-induced neuronal toxicity
5094. The Potential of Caffeine for the Inhibition of Cognitive Decline in the Aged
5095. The potential of epigenetic therapies in Neurodegenerative diseases
5096. The Potential of Small Molecules in Preventing Tau Oligomer Formation and Toxicity
5097. The Potential Role of Methanolic Extract of Pomegranate Peel on Aluminum Chloride-Induced Hepatorenal Toxicity in Female Albino Rats
5098. The Potential Role of Nutraceutical in Health and Disease
5099. The potential use of plant natural products and plant extracts with antioxidant properties for the prevention/treatment of Neurodegenerative diseases: in vitro, in vivo …
5100. The Prevalence of Potentially Inappropriate Medication Use among Elderly in Korea
5101. The Protective effect of Natural Product on Age-related Macular Degeneration in APRE-19 cells
5102. The protective effect of olive cake treatment on oxidant/antioxidant biomarkers, on serum, red blood cells and liver, in streptozotocin-induced diabetic rats fed …
5103. The protective effects of green tea catechins in the management of Neurodegenerative diseases: A review
5104. THE PROTECTIVE EFFECTS OF HONEY PROPOLIS ON oxidative stress IN KAINIC ACID MEDIATED EXCITOTOXICITY IN RAT BRAIN
5105. The protective role of coffea arabica L. and crocus sativus L. against the neurotoxicity induced by chronic administration of aluminium chloride
5106. The Psychopharmacological Effects of Blackcurrant Phytochemicals in Humans
5107. The quest to extend life and overcome aging and death: past, present, and future attempts
5108. The Reduction Effect of Polyopes affinis on Airway Inflammation in a Murine 1 Model of Allergic Asthma
5109. The Rejuvenation Solution: Age in Reverse–7 Proven Medical Breakthroughs That Prevent Disease and Make You Feel Years Younger
5110. The relationship between dietary advanced glycation end products and diabetes related complications
5111. The Relationship Between Markers of oxidative stress and Depressive Symptoms in Coronary Artery Disease Patients
5112. The relationship between the consumption of fruits and vegetables and health status
5113. The relevance of theobromine for the beneficial effects of cocoa consumption
5114. The relieving effects of brainpower advanced, a dietary supplement, in older adults with subjective memory complaints: a randomized, double-blind, placebo …
5115. The rhodiola revolution: Transform your health with the herbal breakthrough of the 21st century
5116. The role of antioxidants in human health
5117. The role of antioxidants in the chemistry of oxidative stress: A review
5118. The role of aromatic plant compounds in the prevention and treatment of neurological disorders
5119. The role of DYRK1A in Neurodegenerative diseases
5120. The role of food antioxidants, benefits of functional foods, and influence of feeding habits on the health of the older person: an overview
5121. The Role of Herbal and Nutraceutical Supplementation in the Amelioration of Schizophrenia and Schizoaffective Symptomology
5122. The role of inflammation in neurological disorders
5123. The Role Of Long-Chain Polyunsaturated Fatty Acids And Resveratrol In Brain Nutrition: From Brain Development To Aging
5124. The role of mitochondrial DNA mutations and free radicals in disease and ageing
5125. The Role of Mufarrehat (Exhilarants) in the Management of Depression: An Evidence Based Approach
5126. The role of NADPH oxidases and oxidative stress in Neurodegenerative disorders
5127. The Role of Natural Products on the Discovery of New Drug Candidates for Neurogenerative Disorders
5128. The Role of NF-kB in Regulatory T cells and Autoimmune Diseases
5129. The role of Nigella sativa and its active constituents in learning and memory
5130. The role of nutrition in cognitive function and brain ageing in the elderly
5131. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
5132. The role of oxidative stress in Huntington’s disease: are antioxidants good therapeutic candidates?
5133. The role of PI3K/Akt and ERK in Neurodegenerative disorders
5134. The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein
5135. The role of the C. elegans Aryl hydrocarbon receptor in environmentally-driven aging
5136. The Role of Tumor Necrosis Factor (TNF) in Microglial Activation and Progressive Degeneration of Dopaminergic Neurons
5137. The role of α-synuclein in Neurodegenerative diseases: from molecular pathways in disease to therapeutic approaches
5138. The Root of Ostericum koreanum Maxim. Ameliorates Learning and Memory Impairments Induced by Scopolamine in Mice
5139. The secret life of mitochondria
5140. The seed extract of Cassia obtusifolia offers neuroprotection to mouse hippocampal cultures
5141. The Serotonergic System and Neuroplasticity are Implicated in the Effect of Phytochemicals on Mood and Cognitive Disorders
5142. The Shocking Truth About Palm Oil: How It Affects Your Health and the Environment
5143. THE SPICES IN THE EVERYDAY OF THE ELDERLY
5144. The Stability of Silver Nanoparticles in Exposure Media and their Effects on the Early Development of Zebrafish Embryos
5145. The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington’s disease
5146. The Therapeutic Activities of Selected Scrophulariaceae and Buddlejaceae Species and Their Secondary Metabolites Against Neurodegenerative Diseases
5147. The therapeutic effects of medicinal plants on depression and anxiety disorders
5148. The therapeutic potential of apigenin
5149. The thioredoxin system as a therapeutic target in human health and disease
5150. The Thioredoxin System as a Therapeutic Target in Human Health and Disease
5151. The Top 101 Superfoods That Fight Aging
5152. The transition metals copper and iron in Neurodegenerative diseases
5153. The transition metals copper and iron in Neurodegenerative diseases
5154. The underlying role of oxidative stress in neurodegeneration: a mechanistic review
5155. The united chemicals of cannabis: Beneficial effects of cannabis phytochemicals on the brain and cognition
5156. The use of fibroblasts from patients with inherited mitochondrial disorders for pathomechanistic studies and evaluation of therapies
5157. The uses of plant natural products by humans and risks associated with their use
5158. The value of plants used in traditional medicine for drug discovery.
5159. The Walnuts and Healthy Aging Study (WAHA): protocol for a nutritional intervention trial with walnuts on brain aging
5160. The wanderings of a free radical
5161. The water extract of tutsan (Hypericum androsaemum L.) red berries exerts antidepressive-like effects and in vivo antioxidant activity in a mouse model of post …
5162. Theoretical investigation of stereochemistry and solvent influence on antioxidant activity of ferulic acid
5163. Theories and mechanisms of aging
5164. Therapeutic and Diagnostic Nanomaterials
5165. Therapeutic and Diagnostic Potential of Tryptophanyl-tRNASynthetase in Infectious Disease
5166. Therapeutic applications of compounds in the Magnolia family
5167. Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
5168. Therapeutic approaches targeting pathological tau aggregates
5169. Therapeutic Area-oriented Drug Discovery
5170. Therapeutic effects of Aloe spp. in traditional and modern medicine: A review
5171. Therapeutic effects of anthocyanins and environmental enrichment in R6/1 Huntington’s disease mice
5172. Therapeutic Effects of Gallic Acid: Current Scenario
5173. Therapeutic Effects of Natural Antioxidant on Neurodegenerative Disease
5174. Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
5175. Therapeutic Efficacy of Tumeric on 6-OHDA-Induced-neurodegeneration in albino rats
5176. Therapeutic Interventions to Block Oxidative Stress-Associated Pathologies
5177. Therapeutic perspectives of epigenetically active nutrients
5178. Therapeutic potential and health benefits of Sargassum species
5179. Therapeutic potential of culinary-medicinal mushrooms for the management of Neurodegenerative diseases: diversity, metabolite, and mechanism
5180. Therapeutic potential of curcumin for multiple sclerosis
5181. Therapeutic potential of free radical scavengers in neurological disorders
5182. Therapeutic potential of mistletoe in CNS-related neurological disorders and the chemical composition of Viscum species
5183. Therapeutic potential of naringin in neurological disorders
5184. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and Neurodegenerative disorders: a patent review
5185. Therapeutic Potential of Phytoestrogens
5186. Therapeutic Potential of Plant Alkaloids as Antidepressant
5187. Therapeutic propensity of selected spice actives against experimentally induced Neuropathy
5188. Therapeutic properties of medicinal plants: a review of medicinal plants with central nervous effects (part 1)
5189. Therapeutic role of L-DOPA produced as a secondary metabolite from different legumes and plant sources
5190. Therapeutic strategy at the crossroad of neuroinflammation and oxidative stress in age-related Neurodegenerative diseases
5191. Therapeutic targeting of NLRP3 inflammasomes by natural products and pharmaceuticals: a novel mechanistic approach for inflammatory diseases
5192. Therapeutic Targeting of the Wnt Signaling Network
5193. Thin-layer Chromatography with Biodetection in the Search for New Potential Drugs to Treat eurodegenerative Diseases-State of the Art and Future Perspectives
5194. Three structural features of functional food components and herbal medicine with amyloid β42 anti-aggregation properties
5195. Thymelaea lythroides extract attenuates microglial activation and depressive-like behavior in LPS-induced inflammation in adult male rats
5196. Thymol polymeric nanoparticle synthesis and its effects on the toxicity of high glucose on OEC cells: involvement of growth factors and integrin‐linked kinase
5197. Time for new guidelines in handling of Neurodegenerative disorders: optimistic versus pessimistic prognosis by application of PPPM
5198. Tinospora crispa (L.) Hook. f. & Thomson: a review of its ethnobotanical, phytochemical, and pharmacological aspects
5199. TLC bioautography: high throughput technique for screening of bioactive natural products
5200. TMEM16A, a calcium activated chloride channel, modulates spontaneous activity in the developing mammalian cochlea
5201. TNF-α inhibitors with anti-oxidative stress activity from natural products
5202. To be or not to be (inflamed)–is that the question in anti-inflammatory drug therapy of Neurodegenerative disorders?
5203. To eat or not to eat–Anti‐ageing effects of energy restriction
5204. To investigate neuroprotective mechanism in female brain
5205. To Study the Diabetes Mediated CNS Complications in Mouse Model of Diabetes Mellitus II
5206. Tom J. Mabry’s Natural Products Chemistry Program: 1960–2007
5207. Total antioxidant capacity
5208. Total antioxidant capacity of the diet and major neurologic outcomes in older adults
5209. Total Synthesis of Natural Products Existence in Fruits and Vegetables
5210. Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
5211. Toward the molecular mechanism (s) by which EGCG treatment remodels mature amyloid fibrils
5212. TOX-2 Evaluation of hepatoprotective activity of vitex negundo linn. leaf extract against paracetamol induced liver damage in rats
5213. Toxicity of imine–iminium dyes and pigments: electron transfer, radicals, oxidative stress and other physiological effects
5214. TOXICITY PROFILE OF THE NATIVE HERBS IN KERALA WITH THE neuroprotective POTENTIAL
5215. Toxin-induced experimental models of learning and memory impairment
5216. Trace Minerals in Human Health: Iron, Zinc, Copper, Manganese and Fluorine
5217. Traditional Chinese Medicine
5218. Traditional Chinese medicines: evaluation of botanical extracts and dietary supplements
5219. Traditional foods, functional foods and nutraceuticals
5220. Traditional Korean East Asian medicines and herbal formulations for cognitive impairment
5221. Traditional usage, phytochemistry and pharmacology of the South African medicinal plant Boophone disticha (Lf) Herb.(Amaryllidaceae)
5222. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review
5223. Traditional uses, phytochemistry and pharmacology of Ficus religiosa: A review
5224. Transcriptional regulation of brain-derived neurotrophic factor (BDNF) by methyl CpG binding protein 2 (MeCP2): a novel mechanism for re-myelination and/or myelin …
5225. Transdermal Delivery of Tizanidine Hydrochloride: Effects of Various Vehicles and Enhancers
5226. Translating cognitive neuroscience to fitness to drive using a neuroergonomic approach
5227. Transport of gallocatechin gallate and catechin gallate in high-temperature-processed green tea extract from gastrointestinal tract to brain by an in vitro bio-mimic …
5228. Transthyretin deposition in familial amyloidotic polyneuropathy
5229. Traumatic Brain Injury: Natural Therapeutics and New Perspectives for Clinical Practice
5230. Treat Concussion, TBI, and PTSD with Vitamins and Antioxidants
5231. Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17
5232. Trends in ethnopharmacology
5233. Tumor-Targeting Drug Delivery of Chemotherapeutic Agents
5234. Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons
5235. Tyrosinase inhibition, anti-acetylcholinesterase, and antimicrobial activities of the phytochemicals from Gynotroches axillaris Blume
5236. Tyrosol controls mast cell-mediated allergic inflammation through the inhibition of phosphoinositide 3-kinase
5237. U; a cure is found, the number of individuals afflicted by
5238. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer
5239. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding Neurodegenerative diseases
5240. Understanding Mechanism of Action of Herbal Drugs in Age Related Degenerative Brain Disorders
5241. Understanding the ‘traditional’Mediterranean cuisine: relationship to cognitive health and advances in measurement of adherence
5242. Understanding the antioxidant controversy: scrutinizing the” fountain of youth”
5243. Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition
5244. UNDERSTANDING THE INTERACTION OF APOLIPOPROTEIN E WITH AMYLOID-BETA IN THE PRESENCE OF EPIGALLOCATECHIN GALLATE AND ITS …
5245. Understanding the mecahanisms of acetyl-l-carnitine through neuroprotection after methamphetamine administration
5246. Underutilized indigenous vegetable (UIV) in Nigeria: a rich source of nutrient and antioxidants-a review
5247. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in Neurodegenerative diseases
5248. Unique intracellular localization and potent anti-inflammatory activity of rhodamine-labelled dieckol in RAW 264.7 macrophages
5249. Updating Chemical Profiling of Red Ginseng via the Elucidation of two Geometric Isomers of Ginsenosides Rg9 and Rg10
5250. UPLC–TOF-MS analysis of Galium spurium towards its neuroprotective and anticonvulsant activities
5251. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion
5252. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?
5253. Use of Herbal Products/Alternative Medicines in Neurodegenerative
5254. Use of liquid chromatography with electrochemical detection for the determination of antioxidants in less common fruits
5255. Use of Phytochemicals against Neuroinflammation
5256. Use of STAT1 inhibitors in the treatment of brain I/R injury and Neurodegenerative diseases
5257. User’s Guide to Antioxidant Supplements
5258. Using the Herbal Materal the Origin Identified
5259. Utilization of grape seeds in ruminant nutrition: Effects of this by-product on health conditions, milk production and quality, and ruminal metabolism in Sarda …
5260. UVA-mediated Pin1 Induction is Involved in Cell Proliferation and Malignant Transformation of Epidermal Cells
5261. Vaccinium bracteatum Thunb. Exerts anti-inflammatory activity by inhibiting NF-κB activation in BV-2 microglial cells
5262. Valeriana jatamansi: An herbaceous plant with multiple medicinal uses
5263. Validation of Cell-based Permeability Assay in MDCK and Caco-2 System Using LC-MS/MS in Early Stage of Drug Discovery
5264. Validation of Diabetic Zebrafish Model
5265. Validation of ethnopharmacology of ayurvedic sarasvata ghrita and comparative evaluation of its neuroprotective effect with modern alcoholic and lipid based extracts …
5266. Valuing the endangered species Antirrhinum lopesianum: neuroprotective activities and strategies for in vitro plant propagation
5267. Vanillin A Food Additive Ameliorates Harmaline Induced Tremor in Rats
5268. Varietal Differences in the Antioxidative Properties of Soybean [Glycine Max (L.) Merr.] Seeds
5269. Vascular niche for adult hippocampal neurogenesis
5270. Vascular niche for adult hippocampal neurogenesis
5271. VEGF mimic peptides: Potential applications in central nervous system therapeutics
5272. Versatility of 7-substituted coumarin molecules as antimycobacterial agents, neuronal enzyme inhibitors and neuroprotective agents
5273. Vincamine alleviates amyloid-β 25–35 peptides-induced cytotoxicity in PC12 cells
5274. Vitamin A has anti-oligomerization effects on amyloid-β in vitro
5275. Vitamin A potently destabilizes preformed α-synuclein fibrils in vitro: implications for Lewy body diseases
5276. Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain
5277. Vitamin D: oxidative stress, immunity, and aging
5278. Vitamin E Status in the Elderly
5279. Vitamin E-occurrence, biosynthesis by plants and functions in human nutrition
5280. Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases
5281. Vitamin status and psychiatric disorders
5282. Vitamins in the prevention or delay of cognitive disability of aging
5283. Vitamins, Nutraceuticals, Food Additives, Enzymes, Anesthetic Aids, and Cosmetics
5284. Volatile profiling of aromatic traditional medicinal plant, Polygonum minus in different tissues and its biological activities
5285. Voltammetric determination of aluminum (III) as Al-Alizarin S complex in tea leaves and infusions
5286. Walnut diet reduces accumulation of polyubiquitinated proteins and inflammation in the brain of aged rats
5287. Walnut supplementation reverses the scopolamine-induced memory impairment by restoration of cholinergic function via mitigating oxidative stress in rats: a potential …
5288. Water Extractable Phytochemicals from Some Nigerian Spices Inhibit Fe2+-Induced Lipid Peroxidation in Rat’s Brain
5289. Water-soluble ferulic acid derivatives improve amyloid-β-induced neuronal cell death and dysmnesia through inhibition of amyloid-β aggregation
5290. Welcom Message from the President
5291. Wellness ingredients and functional foods
5292. Western diet and behavior: the columbus concept
5293. What Makes Us Sick And What Keeps Us Healthy
5294. What your doctor may not tell you about Heart Disease
5295. When NRF2 talks, who’s listening?
5296. Where environment meets cognition: a focus on two developmental intellectual disability disorders
5297. White mulberry (Morus alba): A brief phytochemical and pharmacological evaluations account
5298. Whole Foods Diet Cookbook: 200 Recipes for Optimal Health
5299. Why are the majority of active compounds in the CNS domain natural products? A critical analysis
5300. Why Fish and Fruit are better than fish and chips in the aging process
5301. WHY WINE IS DIFFERENT TO OTHER ALCOHOLIC BEVERAGES
5302. Will it ever become possible to prevent dopaminergic neuronal degeneration
5303. Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
5304. Wine
5305. Wine analysis and production
5306. Wine and health: state of proofs and research needs
5307. Wine health properties
5308. Wine Index of Salubrity and Health (WISH): an evidence-based instrument to evaluate the impact of good wine on well-being
5309. Wine, alcohol and atherosclerosis: clinical evidences and mechanisms
5310. Winery-Derived By-Products: Valorization and Potential
5311. Wonders of the Earth as Solutions for Vibrant Health: Ten Discourses
5312. WS-5 Extract of Curcuma longa, Chaenomeles sinensis, and Zingiber officinale Contains Anti-AChE Compounds and Improves-Amyloid-Induced Memory Impairment …
5313. Xanthine oxidase inhibition and antioxidant activity of an artichoke leaf extract (Cynara scolymus L.) and its compounds
5314. Xanthine oxidase: isolation, assays of activity, and inhibition
5315. Xanthohumol from Hop Plant Stimulate Osteoblast Differentiation by Runx2 Activation
5316. Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery
5317. Your brain on food: How chemicals control your thoughts and feelings
5318. Zebrafish as an emerging model for bioassay-guided natural product drug discovery for neurological disorders
5319. Zinc in infection and inflammation
5320. Zinc ionophore activity of quercetin and epigallocatechin-gallate: From Hepa 1-6 cells to a liposome model
5321. Zinc ionophore activity of quercetin and epigallocatechin-gallate: From Hepa1-6 cells to a liposome model
5322. ZnO Nanoflower petals mediated amyloid degradation-An in vitro electrokinetic potential approach
5323. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis
5324. : Study of the Potential Hepatoprotective Effect of Inulin Nanoparticles against Chlorpromazine Induced-Hepatic Damage in Rats
5325. “Ectopic” Gustative and Olfactory Receptors in the Brain–New Targets for Neurodegeneration Therapy?
5326. “Reflections”: The 9th Annual Conference of the Natural Health Products Research Society of Canada, May 22-25, 2012, Kelowna, BC, Canada
5327. (‐) Epicatechin stimulates ERK‐dependent cyclic AMP response element activity and up‐regulates GluR2 in cortical neurons
5328. (−)‐Epigallocatechin gallate inhibits lipopolysaccharide‐induced microglial activation and protects against inflammation‐mediated dopaminergic neuronal injury
5329. (Bio) Chemical strategies to modulate amyloid-β self-assembly
5330. 1-Palmitoyl-2-(9′-oxononanoyl)-sn-glycero-3-phosphocholine, an Oxidized Phospholipid, Accelerates Finnish Type Familial Gelsolin Amyloidosis in Vitro
5331. 1. Phytochemicals and their role in curing fatal diseases: A Review
5332. 1. University of East Anglia, Norwich Medical School, Faculty of Medicine and Health Sciences Norwich, NR4 7TJ, United Kingdom 2. Molecular Nutrition Group …
5333. 10 Biochemical Activity and Therapeutic Role of Antioxidants in Plants and Humans
5334. 10 Chinese Medicine Used
5335. 10 Nano Resveratrol: A Promising Future Nanonutraceutical
5336. 11 Overview of the Health Properties of Blueberries
5337. 12 Commercialization of Rhodiola rosea
5338. 12 Prevention of Cognitive Decline
5339. 12 The Role of Diet in Slowing or Accelerating Aging
5340. 12 Theanine, Mood, and Behavior
5341. 13 Anti‐Aging Strategies
5342. 14 Dietary Factors and the Emerging Role of Epigenetics in Neurodegenerative Diseases
5343. 14 Modulation of Multiple Pathways Involved in the Maintenance of Neuronal Function by Fisetin
5344. 14. WHY SAGE MAY BE A WISE REMEDY: EFFECTS OF SALVIA ON THE NERVOUS SYSTEM
5345. 14. WHY SAGE MAY BE A WISE REMEDY: EFFECTS OF SALVIA ON THE NERVOUS SYSTEM
5346. 15 Effect of Phytochemicals on Stress Management and Mental Health
5347. 15 Neurophysiology and physical activity
5348. 16 Free radicals as toxic agents: nutritional aspects
5349. 17 The Essentiality of Iron Chelation in Neuroprotection: A Potential Role of Green Tea Catechins
5350. 18 Furan in Coffee
5351. 19 CHAPTER Dietary Foods
5352. 1Chapter 3 Fruits, Nuts, and Brain Aging: Nutritional Interventions Targeting Age-Related Neuronal and Behavioral Decits
5353. 1st Joint European Conference on Therapeutic Targets and Medicinal Chemistry (TTMC 2015)
5354. 2 Nutrition and Cognition in the Context of Ageing
5355. 2-Furoylglycine as a candidate biomarker of coffee consumption
5356. 20 Nutrigenomics: Nurturing of Genotype and Role in Human Health
5357. 21 Food Intake Regulation and Aging
5358. 23 Phytochemicals in Foods and Beverages: Effects on the Central Nervous System
5359. 27 Pharmacokinetics and Metabolism of Resveratrol
5360. 27th Annual GP2A Medicinal Chemistry Conference
5361. 29 Antiamyloidogenic Effect of
5362. 3 Environmental Pollution and Climate Change Impacts on Human Health with Particular Reference to Brain
5363. 30 Neuropharmacological
5364. 39 Nutraceuticals from Microalgae
5365. 3O Neuropharmacological Properties of Marine Plants
5366. 3β,23,28-Trihydroxy-12-oleanene 3β-Caffeate from Desmodium sambuense-Induced Neurogenesis in PC12 Cells Mediated by ER Stress and BDNF–TrkB Signaling …
5367. 4 Metal Toxicity and oxidative stress in the Brain
5368. 4 Nutraceuticals and Their Role in Human Health
5369. 5-Hydroxy-1-tetralone analogues as dual A1/A2A receptor antagonists for the potential treatment of neurological conditions
5370. 5‐S‐Cysteinyl‐conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase‐3 activity in neurons
5371. 52 Small Changes for the Family: Build Confidence* Deepen Connections* Get Healthy* Increase Intelligence
5372. 5H-Indeno [1, 2-b] pyridine derivative inhibits catalytic activity of topoisomerase II by intercalating in DNA
5373. 6 Brain injury as Therapeutic implications
5374. 7 Diet and Nutrition
5375. 7 Neurodegenerative
5376. 8 Research on the Effects of Vitamins and Minerals